Gene	O
annotations	O
were	O
generated	O
for	O
predicted	O
genes	O
from	O
bacterial	O
MAGs	O
,	O
and	O
were	O
used	O
as	O
input	O
to	O
MetaPathPredict	B-BT
,	O
which	O
generated	O
predictions	O
for	O
the	O
presence	O
or	O
absence	O
of	O
KEGG	O
modules	O
based	O
on	O
the	O
gene	O
annotations	O
of	O
all	O
bacterial	O
MAGs	O
.	O

For	O
example	O
,	O
eTBLAST	B-BT
extracts	O
a	O
weighted	O
keyword	O
set	O
from	O
the	O
input	O
article	O
abstract	O
to	O
gather	O
the	O
top	O
400	O
most	O
similar	O
articles	O
in	O
MEDLINE	O
[	O
11	O
].	O

PhageTB	B-BT
is	O
an	O
easy	O
-	O
to	O
-	O
use	O
method	O
of	O
assigning	O
hosts	O
to	O
bacteriophages	O
,	O
studying	O
their	O
interactions	O
,	O
and	O
narrowing	O
down	O
the	O
search	O
space	O
for	O
candidate	O
phages	O
that	O
can	O
successfully	O
lyse	O
the	O
query	O
bacteria	O
and	O
thus	O
be	O
utilized	O
in	O
phage	O
therapy	O
for	O
treating	O
bacterial	O
infections	O
caused	O
by	O
it	O
.	O

Theoretical	O
FRET	O
fluorophore	O
distances	O
were	O
calculated	O
from	O
the	O
MD	O
trajectories	O
using	O
FRETpredict52	O
and	O
subsequently	O
fitted	O
with	O
a	O
normal	O
distribution	O
using	O
scipy53	O
.	O

These	O
individual	O
techniques	O
can	O
be	O
combined	O
to	O
mitigate	O
or	O
even	O
eliminate	O
these	O
challenges	O
(	O
e	O
.	O
g	O
.,	O
the	O
KVFinder	B-BT
project	O
and	O
ghecom	O
).	O

In	O
order	O
to	O
serve	O
the	O
scientific	O
community	O
,	O
we	O
have	O
also	O
developed	O
a	O
webserver	O
named	O
PhageTB	B-BT
and	O
provided	O
a	O
standalone	O
software	O
package	O
(	O
https	O
://	O
webs	O
.	O
iiitd	O
.	O
edu	O
.	O
in	O
/	O
raghava	O
/	O
phagetb	B-BT
/)	O
for	O
the	O
same	O
.	O

The	O
accuracy	O
of	O
the	O
annotation	O
transfer	O
procedure	O
by	O
AuCoMe	B-BT
was	O
further	O
assessed	O
using	O
two	O
pathways	O
in	O
which	O
there	O
were	O
clear	O
biological	O
expectations	O
in	O
the	O
algal	O
data	O
set	O
.	O

vcfdist	O
v2	O
.	O
5	O
.	O
0	O
was	O
run	O
with	O
“	O
gap	O
n	O
”	O
clustering	O
for	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$	O
n	O
=(	O
10	O
,	O
100	O
,	O
500	O
)$$\	O
end	O
{	O
document	O
}	O
n	O
=(	O
10	O
,	O
100	O
,	O
500	O
)	O
in	O
addition	O
to	O
the	O
default	O
biWFA	B-BT
clustering	O
using	O
the	O
command	O
line	O
options	O
—-	O
cluster	O
gap	O
10	O
.	O

Schematic	O
of	O
the	O
GPMsDB	B-BT
-	I-BT
tk	I-BT
.	O

Centrifuger	B-BT
adopts	O
a	O
novel	O
compact	O
data	O
structure	O
,	O
run	O
-	O
block	O
compressed	O
sequence	O
,	O
to	O
achieve	O
sublinear	O
storage	O
space	O
for	O
BWT	O
sequence	O
without	O
sacrificing	O
much	O
time	O
efficiency	O
.	O

The	O
cooltools	B-BT
used	O
for	O
the	O
computation	O
of	O
insulation	O
score	O
is	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
open2c	O
/	O
cooltools	B-BT
.	O

Similar	O
to	O
our	O
other	O
software	O
MerCat2	B-BT
for	O
massively	O
parallel	O
processing	O
(	O
MPP	O
),	O
it	O
utilizes	O
a	O
byte	O
chunking	O
algorithm	O
1	O
(‘	O
Chunker	O
’)	O
to	O
split	O
files	O
for	O
MPP	O
for	O
further	O
utilization	O
in	O
RAY	O
,	O
a	O
massive	O
open	O
-	O
source	O
parallel	O
computing	O
framework	O
to	O
scale	O
Python	O
applications	O
and	O
workflows	O
(	O
Figueroa	O
III	O
et	O
al	O
.	O

Vincent	O
(	O
18	O
)	O
-	O
Osama	O
Zaidat	O
(	O
PI	O
),	O
Eugene	O
Lin	O
(	O
Sub	O
-	O
I	O
),	O
Tina	O
M	O
Steinhauser	O
(	O
CRC	O
),	O
Dee	O
Tilley	O
(	O
CRC	O
),	O
Julie	O
Goins	O
-	O
Whitmore	O
(	O
past	O
CRC	O
),	O
Brandi	O
Breseman	O
(	O
past	O
CRC	O
),	O
Melissa	O
A	O
Thomas	O
(	O
past	O
CRC	O
);	O
University	O
of	O
Pittsburgh	O
(	O
17	O
)	O
-	O
Ashutosh	O
Jadhav	O
(	O
PI	O
and	O
past	O
Sub	O
-	O
I	O
),	O
Bradley	O
Gross	O
(	O
Sub	O
-	O
I	O
),	O
Lisa	O
Baxendell	O
(	O
CRC	O
),	O
Patricia	O
Feineigle	O
(	O
CRC	O
),	O
Vicki	O
Gilchrist	O
(	O
CRC	O
),	O
Brian	O
Jankowitz	O
(	O
past	O
Sub	O
-	O
I	O
and	O
past	O
PI	O
),	O
Andrew	O
Ducruet	O
(	O
past	O
Sub	O
-	O
I	O
),	O
David	O
Panczkowski	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Hazem	O
Shoirah	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Alhamza	O
Al	O
-	O
Bayati	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Amin	O
Aghaebrahim	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Tudor	O
Jovin	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Greg	O
Weiner	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Cynthia	O
Kenmuir	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Prasanna	O
Tadi	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Gregory	O
Walker	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Kelsea	O
Haibach	O
(	O
past	O
CRC	O
),	O
Carlynn	O
Graves	O
(	O
past	O
CRC	O
),	O
Yvonne	O
Cannon	O
(	O
past	O
CRC	O
);	O
WellStar	O
Research	O
Institute	O
(	O
16	O
)	O
-	O
Ahmad	O
Khaldi	O
(	O
PI	O
),	O
Rishi	O
Gupta	O
(	O
Sub	O
-	O
I	O
),	O
Marianne	O
Bain	O
(	O
CRC	O
),	O
Laura	O
Murphy	O
(	O
CRC	O
),	O
Andrew	O
K	O
Johnson	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Barbara	O
A	O
Foster	O
(	O
past	O
CRC	O
),	O
Tasha	O
Futch	O
(	O
past	O
CRC	O
),	O
Portia	O
Thomas	O
(	O
past	O
CRC	O
);	O
RIA	O
/	O
Swedish	O
(	O
14	O
)	O
-	O
Don	O
Frei	O
(	O
current	O
PI	O
and	O
past	O
Sub	O
-	O
I	O
),	O
Richard	O
Bellon	O
(	O
Sub	O
-	O
I	O
),	O
Benjamin	O
Atchie	O
(	O
Sub	O
-	O
I	O
),	O
Ian	O
Kaminsky	O
(	O
Sub	O
-	O
I	O
),	O
Lisa	O
Kodis	O
(	O
CRC	O
),	O
Mark	O
Talley	O
(	O
CRC	O
),	O
Tiffany	O
Talley	O
(	O
CRC	O
),	O
Alex	O
Edinger	O
(	O
CRC	O
),	O
David	O
Loy	O
(	O
past	O
PI	O
and	O
Sub	O
-	O
I	O
),	O
Dan	O
Huddle	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Michelle	O
Lexin	O
(	O
past	O
CRC	O
),	O
Brad	O
Fasbinder	O
(	O
CRC	O
),	O
Alicia	O
Drew	O
(	O
past	O
CRC	O
),	O
Joanna	O
Snead	O
(	O
past	O
CRC	O
),	O
Ashley	O
Bitner	O
(	O
past	O
CRC	O
),	O
Sarah	O
Weiss	O
(	O
past	O
CRC	O
),	O
Nouara	O
Sadaoui	O
(	O
past	O
CRC	O
);	O
Tufts	O
Medical	O
Center	O
(	O
12	O
)	O
-	O
Adel	O
Malek	O
(	O
PI	O
),	O
Emma	O
Jost	O
-	O
Price	O
(	O
CRC	O
),	O
Keri	O
Sullivan	O
(	O
CRC	O
),	O
Haley	O
Huggins	O
(	O
past	O
CRC	O
),	O
Lindsey	O
Soll	O
(	O
past	O
CRC	O
),	O
Sarah	O
Gans	O
(	O
past	O
CRC	O
),	O
Michelle	O
Bettle	O
(	O
past	O
CRC	O
);	O
Cleveland	O
Clinic	O
Foundation	O
(	O
10	O
)	O
-	O
Gabor	O
Toth	O
(	O
PI	O
),	O
Mark	O
Bain	O
(	O
Sub	O
-	O
I	O
),	O
Peter	O
Rasmussen	O
(	O
Sub	O
-	O
I	O
),	O
M	O
Shazam	O
Hussain	O
(	O
Sub	O
-	O
I	O
),	O
Nina	O
Moore	O
(	O
Sub	O
-	O
I	O
),	O
Thomas	O
Masaryk	O
(	O
Sub	O
-	O
I	O
),	O
Mohamed	O
Elgabaly	O
(	O
Sub	O
-	O
I	O
),	O
Erin	O
Bynum	O
(	O
CRC	O
),	O
Russell	O
Cerejo	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Julian	O
Hardman	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Seby	O
John	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Andrew	O
Bauer	O
(	O
past	O
Sub	O
-	O
I	O
),	O
Erin	O
Mayock	O
(	O
past	O
CRC	O
),	O
Vikram	O
Puvenna	O
(	O
past	O
CRC	O
),	O
Jenny	O
Peih	O
-	O
Chir	O
Tsai	O
(	O
past	O
Sub	O
-	O
I	O
);	O
SUNY	O
Buffalo	O
(	O
9	O
)	O
-	O
Adnan	O
Siddiqui	O
(	O
PI	O
),	O
Elad	O
Levy	O
(	O
Sub	O
-	O
I	O
),	O
Kenneth	O
Snyder	O
(	O
Sub	O
-	O
I	O
),	O
Jason	O
Davies	O
(	O
Sub	O
-	O
I	O
),	O
Mary	O
Hartney	O
(	O
CRC	O
),	O
Jonna	O
Sakowski	O
(	O
CRC	O
),	O
Courtney	O
Drozdowski	O
(	O
past	O
CRC	O
),	O
Heather	O
Ross	O
(	O
past	O
CRC	O
),	O
Linda	O
Bookhagen	O
(	O
past	O
CRC	O
);	O
Beth	O
Israel	O
Deaconess	O
(	O
7	O
)	O
-	O
Ajith	O
Thomas	O
(	O
PI	O
),	O
Christopher	O
Ogilvy	O
(	O
Sub	O
-	O
I	O
),	O
Patricia	O
Baum	O
(	O
CRC	O
);	O
Virginia	O
Commonwealth	O
(	O
7	O
)	O
-	O
John	O
Reavey	O
-	O
Cantwell	O
(	O
PI	O
),	O
Dennis	O
Rivet	O
(	O
Co	O
-	O
PI	O
),	O
Charlotte	O
Gilman	O
(	O
CRC	O
);	O
Cedars	O
Sinai	O
Medical	O
Center	O
(	O
6	O
)	O
-	O
Michael	O
Alexander	O
(	O
PI	O
),	O
Franklin	O
Moser	O
(	O
Sub	O
-	O
I	O
),	O
Marcel	O
Maya	O
(	O
Sub	O
-	O
I	O
),	O
Michael	O
Schiraldi	O
(	O
Sub	O
-	O
I	O
),	O
Vicki	O
Manoukian	O
,	O
MA	O
(	O
CRC	O
),	O
Paula	O
Eboli	O
(	O
past	O
Sub	O
-	O
I	O
);	O
Johns	O
Hopkins	O
University	O
(	O
6	O
)	O
-	O
Justin	O
Caplan	O
(	O
current	O
PI	O
),	O
Bowen	O
Jiang	O
(	O
Sub	O
-	O
I	O
),	O
Matthew	O
Bender	O
(	O
Sub	O
-	O
I	O
),	O
Ellen	O
Sheehan	O
(	O
CRC	O
),	O
Jessica	O
Wollett	O
(	O
CRC	O
),	O
Geoffrey	O
Colby	O
(	O
past	O
PI	O
),	O
Lauren	O
Dise	O
(	O
past	O
CRC	O
),	O
Anna	O
Bugaeva	O
(	O
past	O
CRC	O
),	O
Barbara	O
Michniewicz	O
(	O
past	O
CRC	O
),	O
Thomas	O
Hemmingson	O
(	O
past	O
CRC	O
);	O
Christiana	O
Care	O
Health	O
Services	O
(	O
5	O
)	O
-	O
Sudhakar	O
Satti	O
(	O
PI	O
),	O
Thinesh	O
Sivapatham	O
(	O
Sub	O
-	O
I	O
),	O
Robie	O
Zent	O
(	O
CRC	O
),	O
Ann	O
Marie	O
Le	O
Noir	O
(	O
CRC	O
);	O
Hospital	O
of	O
the	O
University	O
of	O
PA	O
(	O
5	O
)	O
-	O
David	O
Kung	O
(	O
current	O
PI	O
and	O
past	O
Sub	O
-	O
I	O
),	O
Bryan	O
Pukenas	O
(	O
Sub	O
-	O
I	O
),	O
Robert	O
Hurst	O
(	O
Sub	O
-	O
I	O
),	O
Timothy	O
Prior	O
(	O
CRC	O
),	O
Whitney	O
Sarchiapone	O
(	O
CRC	O
),	O
Yelena	O
Gorelik	O
(	O
past	O
CRC	O
),	O
Francis	O
Quattrone	O
(	O
past	O
CRC	O
),	O
Michelle	O
J	O
.	O

Workflow	O
of	O
the	O
PM	B-BT
-	I-BT
CNN	I-BT
.	O

In	O
recognising	O
that	O
MSFragger	B-BT
-	O
Glyco	O
is	O
a	O
strong	O
search	O
engine	O
in	O
glycoproteomics	O
(	O
Polasky	O
et	O
al	O
.	O

TrimAL	B-BT
is	O
a	O
tool	O
for	O
automated	O
alignment	O
trimming	O
.	O

2017	O
),	O
converted	O
into	O
a	O
community	O
metabolic	O
model	O
using	O
PyCoMo	B-BT
(	O
Predl	O
et	O
al	O
.	O

Genomic	O
comparisons	O
between	O
vB_PaeM	O
-	O
G11	O
and	O
the	O
most	O
closely	O
related	O
phage	O
were	O
performed	O
using	O
DiGAlign	B-BT
(	O
https	O
://	O
www	O
.	O
genome	O
.	O
jp	O
/	O
digalign	B-BT
/,	O
accessed	O
on	O
2	O
December	O
2022	O
).	O

Second	O
,	O
trans	B-BT
-	I-BT
PCO	I-BT
and	O
ARCHIE	O
are	O
designed	O
to	O
capture	O
different	O
trans	O
-	O
regulatory	O
effects	O
.	O

Across	O
global	O
regions	O
,	O
lower	O
-	O
SES	O
populations	O
,	O
immigrants	O
,	O
and	O
racial	O
/	O
ethnic	O
minorities	O
are	O
generally	O
more	O
exposed	O
to	O
heat	O
stress	O
and	O
have	O
lower	O
adaptive	O
capacity	O
,	O
and	O
lower	O
-	O
SES	O
and	O
minority	O
neighborhoods	O
are	O
generally	O
hotter	O
and	O
less	O
green	O
.	O

This	O
amount	O
is	O
more	O
than	O
double	O
the	O
estimated	O
cost	O
of	O
medicines	O
for	O
treatment	O
of	O
outpatient	O
pneumonia	O
in	O
Fiji	O
[	O
29	O
];	O
in	O
that	O
study	O
,	O
the	O
average	O
cost	O
of	O
medicines	O
ranged	O
from	O
$	O
1	O
.	O
3	O
for	O
Nausori	O
PHC	O
to	O
$	O
2	O
.	O
6	O
for	O
CWMH	O
(	O
in	O
2020	O
values	O
).	O

Irrespective	O
of	O
the	O
surface	O
treatment	O
methods	O
,	O
IPS	O
e	O
.	O
max	O
CAD	O
ceramic	O
showed	O
a	O
relatively	O
smoother	O
surface	O
than	O
did	O
Suprinity	O
and	O
Celtra	O
Duo	O
.	O

The	O
MetaPathPredict	B-BT
Python	O
module	O
is	O
available	O
from	O
the	O
following	O
GitHub	O
repository	O
:	O
https	O
://	O
github	O
.	O
com	O
/	O
d	O
-	O
mcgrath	O
/	O
MetaPathPredict	B-BT
and	O
XetHub	O
repository	O
:	O
https	O
://	O
xethub	O
.	O
com	O
/	O
dgellermcgrath	O
/	O
MetaPathPredict	B-BT
.	O

Ivar	O
Rønnestad	O
:	O
Conceptualization	O
,	O
Methodology	O
,	O
Investigation	O
,	O
Writing	O
–	O
review	O
&	O
editing	O
.	O

Despite	O
L1HS	O
and	O
L1PA2	O
being	O
recognized	O
as	O
overexpressed	O
in	O
CRC	O
(	O
17	O
),	O
scTE	B-BT
failed	O
to	O
detect	O
them	O
as	O
differentially	O
expressed	O
and	O
SoloTE	O
identified	O
them	O
as	O
expressed	O
indiscriminately	O
in	O
both	O
cancerous	O
and	O
normal	O
cells	O
(	O
Figure	O
2E	O
,	O
Supplementary	O
Figure	O
S2G	O
).	O

In	O
the	O
Abstract	O
,	O
the	O
github	O
link	O
was	O
connecting	O
to	O
an	O
incorrect	O
url	O
and	O
has	O
been	O
updated	O
to	O
https	O
://	O
github	O
.	O
com	O
/	O
dmitrymyl	O
/	O
BaRDIC	B-BT
.	O

scDREAMER	B-BT
-	O
Sup	O
was	O
further	O
able	O
to	O
capture	O
rare	O
cell	O
identities	O
very	O
well	O
as	O
indicated	O
by	O
its	O
top	O
performance	O
in	O
terms	O
of	O
isolated	O
f1	O
score	O
(	O
Supplementary	O
Figs	O
.	O

LTR_FINDER	O
v1	O
.	O
0520	O
and	O
RepeatScout	O
v1	O
.	O
0521	O
were	O
primarily	O
used	O
to	O
build	O
a	O
de	O
novo	O
repeat	O
sequences	O
library	O
of	O
Sijihua	O
genome	O
,	O
which	O
was	O
classified	O
by	O
using	O
PASTEClassifier	B-BT
v1	O
.	O
022	O
and	O
merged	O
with	O
Repbase	O
v19	O
.	O
0623	O
database	O
as	O
the	O
final	O
repeat	O
sequences	O
database	O
.	O

Data	O
,	O
Analysis	O
,	O
and	O
OmicNavigator	B-BT
build	O
scripts	O
for	O
this	O
study	O
can	O
be	O
found	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
abbvie	O
-	O
external	O
/	O
OmicNavigatorExample	B-BT
.	O

a	O
:	O
Excluded	O
from	O
the	O
model	O
by	O
the	O
stepwise	O
method	O
;	O
D1	O
:	O
Discriminant	O
equation	O
based	O
on	O
isokinetic	O
torque	O
data	O
;	O
D2	O
:	O
Discriminant	O
function	O
based	O
on	O
kinematic	O
data	O
on	O
kick	O
performance	O
;	O
D3	O
:	O
Discriminant	O
equation	O
based	O
on	O
isokinetic	O
torques	O
and	O
kinematic	O
data	O
on	O
kick	O
performance	O
;	O
TqHE240	O
:	O
Peak	O
torque	O
of	O
hip	O
extension	O
at	O
240	O
°/	O
s	O
;	O
TqHF240	O
:	O
Peak	O
torque	O
of	O
hip	O
flexion	O
at	O
240	O
°/	O
s	O
;	O
AVKnExt	O
:	O
Peak	O
angular	O
velocity	O
of	O
knee	O
extension	O
;	O
LKV	O
:	O
Linear	O
Knee	O
Velocity	O
.	O

Measures	O
should	O
be	O
taken	O
in	O
design	O
to	O
strengthen	O
these	O
two	O
places	O
to	O
ensure	O
the	O
performance	O
of	O
the	O
assembled	O
arch	O
structure	O
.	O

After	O
vaccine	O
construction	O
,	O
the	O
physiochemical	O
properties	O
of	O
the	O
vaccine	O
construct	O
were	O
analyzed	O
through	O
the	O
ExPASy	B-BT
ProtParam	O
tool	O
.	O

However	O
,	O
it	O
depends	O
on	O
the	O
housing	O
conditions	O
whether	O
overgrown	O
hooves	O
,	O
as	O
in	O
pasture	O
-	O
based	O
housing	O
conditions	O
,	O
or	O
short	O
dorsal	O
claw	O
walls	O
,	O
as	O
in	O
loose	O
housing	O
systems	O
,	O
are	O
more	O
common	O
[	O
35	O
].	O

In	O
LipidSig	O
2	O
.	O
0	O
,	O
the	O
assignment	O
of	O
lipid	O
characteristics	O
to	O
each	O
lipid	O
species	O
has	O
been	O
substantially	O
enhanced	O
,	O
encompassing	O
29	O
characteristics	O
derived	O
from	O
a	O
combination	O
of	O
resources	O
,	O
including	O
the	O
packages	O
LipidOne	O
,	O
LION	O
,	O
and	O
Goslin	B-BT
,	O
and	O
three	O
individual	O
studies	O
(	O
13	O
–	O
15	O
).	O

Antibodies	O
induced	O
by	O
Sputnik	O
V	O
can	O
recognize	O
,	O
persist	O
,	O
and	O
neutralize	O
SARS	O
-	O
CoV	O
-	O
2	O
variants	O
,	O
with	O
Omicron	O
being	O
the	O
one	O
that	O
best	O
evades	O
this	O
response	O
.	O

Recently	O
,	O
we	O
used	O
SynDesign	B-BT
to	O
develop	O
a	O
saturation	O
resistance	O
profiling	O
library	O
of	O
the	O
EGFR	O
gene	O
against	O
various	O
the	O
chemotherapy	O
drugs	O
,	O
afatinib	O
and	O
osimertinib	O
.	O

In	O
addition	O
to	O
the	O
tools	O
outlined	O
above	O
for	O
studying	O
bnAb	O
reactivity	O
,	O
strain	O
sensitivity	O
,	O
and	O
bnAb	O
cross	O
-	O
sensitivity	O
,	O
several	O
graphical	O
interfaces	O
are	O
available	O
including	O
heatmaps	O
generated	O
for	O
clustering	O
selected	O
sets	O
of	O
HIV	O
-	O
1	O
strains	O
and	O
antibodies	O
,	O
pairwise	O
and	O
multiple	O
sequence	O
alignment	O
tools	O
with	O
output	O
displayed	O
in	O
a	O
standard	O
HIResist	B-BT
format	O
,	O
and	O
visualization	O
of	O
resistance	O
/	O
sensitivity	O
signatures	O
of	O
HIV	O
-	O
1	O
Envs	O
.	O

Based	O
on	O
our	O
performance	O
tests	O
of	O
MetaPathPredict	B-BT
,	O
the	O
recall	O
of	O
its	O
models	O
was	O
robust	O
(	O
mean	O
>	O
0	O
.	O
9	O
)	O
even	O
when	O
protein	O
sets	O
were	O
down	O
-	O
sampled	O
to	O
10	O
%.	O

The	O
establishment	O
of	O
individual	O
LOVD	O
-	O
based	O
variant	O
databases	O
in	O
GGN	O
member	O
countries	O
and	O
their	O
integration	O
with	O
the	O
ITHANET	B-BT
Portal	O
as	O
a	O
central	O
resource	O
for	O
hemoglobinopathies	O
as	O
part	O
of	O
this	O
effort	O
may	O
be	O
instrumental	O
in	O
initiating	O
essential	O
data	O
-	O
guided	O
disease	O
management	O
in	O
LMICs	O
and	O
in	O
capturing	O
the	O
diversity	O
of	O
hemoglobinopathies	O
as	O
an	O
international	O
resource	O
.	O

AlphaFind	B-BT
provided	O
biologically	O
relevant	O
results	O
even	O
for	O
small	O
,	O
large	O
and	O
lower	O
quality	O
structures	O
.	O

Troubleshooting	O
2	O
....#	O
Load	O
sam	O
/	O
bedtoolsmodule	O
load	O
bedtools	O
/	O
2	O
.	O
29	O
.	O
0module	O
load	O
samtools	B-BT
/	O
1	O
.	O
16	O
.	O
1	O
#	O
Convert	O
BAM	O
files	O
BEDPE	O
files	O
using	O
bedtoolsfor	O
f	O
in	O
$(	O
find	O
$	O
fbam_dir	O
-	O
maxdepth	O
1	O
-	O
iname	O
"""∗."	O
bam	O
""""	O
-	O
type	O
f	O
)	O
do	O
id	O
=$(	O
basename	O
-	O
a	O
-	O
s	O
f1	O
.	O
bam	O
$	O
f	O
|	O
cut	O
-	O
d	O
""""	O
_	O
""""	O
-	O
f	O
1	O
)	O
#	O
Files	O
must	O
be	O
sorted	O
bam	O
before	O
converting	O
to	O
BEDPE	O
samtools	B-BT
sort	O
-	O
n	O
$	O
f	O
|	O
\	O
#	O
Convert	O
to	O
BEDPE	O
file	O
bedtools	O
bamtobed	O
-	O
i	O
-	O
-	O
bedpe	O
|\	O
#	O
Calculate	O
insert	O
size	O
and	O
add	O
‘	O
chr	O
’	O
to	O
chromosome	O
fields	O
awk	O
'	O
OFS	O
=	O
"""\"	O
t	O
""""	O
{	O
print	O
""""	O
chr	O
"""$"	O
1	O
,	O
$	O
2	O
,	O
$	O
3	O
,	O
""""	O
chr	O
"""$"	O
4	O
,	O
$	O
5	O
,	O
$	O
6	O
,	O
$	O
7	O
,	O
$	O
8	O
,	O
$	O
9	O
,	O
$	O
10	O
,	O
$	O
6	O
-$	O
2	O
}'	O
-	O
>	O
$	O
beddir	O
/${	O
id	O
}.	O
bedpedone3	O
.	O
Run	O
‘	O
03	O
-	O
filter_frags_gc	O
.	O
sh	O
’	O
to	O
filter	O
out	O
cfDNA	O
fragments	O
from	O
problematic	O
regions	O
of	O
the	O
reference	O
genome	O
.	O
Note	O
:	O
Problematic	O
regions	O
of	O
the	O
genome	O
consist	O
of	O
regions	O
such	O
as	O
repetitive	O
elements	O
(	O
e	O
.	O
g	O
.,	O
satellite	O
,	O
telomeric	O
,	O
and	O
centromeric	O
repeats	O
)	O
that	O
result	O
in	O
high	O
rates	O
multi	O
-	O
mapping	O
reads	O
that	O
can	O
produce	O
artifacts	O
and	O
spurious	O
signals	O
in	O
downstream	O
sequence	O
analysis	O
.	O
a	O
.	O
Define	O
input	O
and	O
output	O
file	O
directories	O
.	O
PROJECT_DIR	O
=/	O
user	O
/	O
projectcd	O
"""$"	O
PROJECT_DIR	O
"""#"	O
Define	O
directories	O
for	O
input	O
and	O
output	O
filesbed_dir	O
"=""${"	O
PROJECT_DIR	O
}/	O
02	O
-	O
bamtobed	O
""""	O
#	O
BEDPE	O
filesout_dir	O
"=""${"	O
PROJECT_DIR	O
}/	O
03	O
-	O
filter_frags_gc	O
""""	O
#	O
filtered	O
fragmentshg19	O
"=""${"	O
PROJECT_DIR	O
}/	O
files	O
/	O
hg19	O
.	O
fa	O
""""	O
#	O
h19	O
reference	O
genomefilter	O
"=""${"	O
PROJECT_DIR	O
}/	O
files	O
/	O
hg19	O
-	O
blacklist	O
.	O
v2	O
.	O
bed	O
""""	O
#	O
blacklisted	O
regiongap	O
"=""${"	O
PROJECT_DIR	O
}/	O
files	O
/	O
gaps	O
.	O
hg19	O
.	O
bed	O
""""	O
#	O
genomic	O
gapsmkdir	O
-	O
p	O
"""$"	O
out_dir	O
""""	O
#	O
Create	O
directories	O
if	O
needed	O
...	O
b	O
.	O
Convert	O
BEDPE	O
file	O
into	O
BED	O
format	O
.	O
Note	O
:	O
The	O
‘	O
bedtools	O
nuc	O
’	O
does	O
not	O
support	O
BEDPE	O
file	O
format	O
.	O

The	O
alignment	O
was	O
visualised	O
using	O
ESPript	O
3	O
.	O
0	O
,	O
and	O
the	O
E	O
.	O
coli	O
LexA	O
structural	O
features	O
with	O
the	O
docked	O
compound	O
1	O
was	O
visualised	O
with	O
ENDscript	B-BT
2	I-BT
.	I-BT
0	I-BT
(	O
Robert	O
and	O
Gouet	O
,	O
2014	O
).	O

The	O
ExPASy	B-BT
ProtParam	O
tool	O
server	O
predicted	O
234	O
amino	O
acids	O
,	O
25	O
.	O
86257	O
kDa	O
molecular	O
weight	O
,	O
8	O
.	O
54	O
theoretical	O
pI	O
,	O
36	O
.	O
86	O
instability	O
index	O
,	O
and	O
−	O
0	O
.	O
424	O
grand	O
average	O
of	O
hydropathicity	O
.	O

OralExplorer	B-BT
collects	O
oral	O
inflammatory	O
disease	O
data	O
from	O
the	O
GEO	O
database	O
and	O
performs	O
subsequent	O
analysis	O
and	O
web	O
tool	O
construction	O
.	O

B	O
Calculations	O
done	O
in	O
PyChelator	B-BT
using	O
the	O
four	O
sets	O
of	O
stability	O
constants	O
,	O
sourced	O
from	O
the	O
National	O
Institute	O
of	O
Standards	O
and	O
Technology	O
‘	O
NIST	O
’	O
[	O
11	O
],	O
‘	O
SPECS	O
’	O
by	O
Fabiato	O
[	O
2	O
],	O
‘	O
Chelator	O
’	O
by	O
Schoenmakers	O
et	O
al	O
.	O

The	O
developed	O
vaccine	O
construct	O
secondary	O
structure	O
was	O
determined	O
by	O
PSIPRED	B-BT
(	O
http	O
://	O
bioinf	O
.	O
cs	O
.	O
ucl	O
.	O
ac	O
.	O
uk	O
/	O
psipred	B-BT
/)	O
online	O
tool	O
.	O

For	O
convenience	O
,	O
the	O
presentation	O
of	O
the	O
database	O
is	O
hosted	O
alongside	O
the	O
Privateer	B-BT
Web	O
App	O
[	O
26	O
];	O
the	O
database	O
part	O
can	O
be	O
accessed	O
at	O
https	O
://	O
privateer	B-BT
.	O
york	O
.	O
ac	O
.	O
uk	O
/	O
database	O
or	O
by	O
navigating	O
to	O
the	O
database	O
icon	O
on	O
the	O
top	O
right	O
of	O
the	O
screen	O
.	O

Furthermore	O
,	O
to	O
provide	O
users	O
with	O
a	O
visual	O
representation	O
of	O
the	O
selected	O
PDB	O
structure	O
,	O
a	O
MolStar	B-BT
viewer	O
is	O
embedded	O
directly	O
into	O
the	O
page	O
[	O
19	O
]	O
(	O
Fig	O
.	O

Table	O
3Subgroup	O
analysis	O
of	O
per	O
case	O
medical	O
expenditure	O
(	O
US	O
$)	O
of	O
six	O
cancersLung	O
cancerBreast	O
cancerColorectal	O
cancerEsophageal	O
cancerLiver	O
cancerGastric	O
cancerMean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Mean	O
(	O
95	O
%	O
CI	O
)	O
P	O
-	O
Value	O
*	O
Overall	O
10	O
,	O
286	O
(	O
9	O
,	O
187	O
,	O
11	O
,	O
386	O
)	O
10	O
,	O
772	O
(	O
10	O
,	O
161	O
,	O
11	O
,	O
382	O
)	O
10	O
,	O
886	O
(	O
10	O
,	O
232	O
,	O
11	O
,	O
541	O
)	O
10	O
,	O
236	O
(	O
9	O
,	O
566	O
,	O
10	O
,	O
905	O
)	O
9	O
,	O
663	O
(	O
9	O
,	O
005	O
,	O
10	O
,	O
322	O
)	O
10	O
,	O
766	O
(	O
9	O
,	O
782	O
,	O
11	O
,	O
749	O
)	O
Region	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001North10	O
,	O
530	O
(	O
5	O
,	O
201	O
,	O
15	O
,	O
859	O
)	O
9	O
,	O
453	O
(	O
8	O
,	O
609	O
,	O
10	O
,	O
297	O
)	O
12	O
,	O
553	O
(	O
10	O
,	O
709	O
,	O
14	O
,	O
397	O
)	O
7	O
,	O
570	O
(	O
6	O
,	O
353	O
,	O
8	O
,	O
786	O
)	O
8	O
,	O
476	O
(	O
6	O
,	O
915	O
,	O
10	O
,	O
038	O
)	O
14	O
,	O
221	O
(	O
12	O
,	O
771	O
,	O
15	O
,	O
672	O
)	O
East11	O
,	O
852	O
(	O
10	O
,	O
722	O
,	O
12	O
,	O
983	O
)	O
12	O
,	O
462	O
(	O
11	O
,	O
053	O
,	O
13	O
,	O
872	O
)	O
11	O
,	O
407	O
(	O
10	O
,	O
319	O
,	O
12	O
,	O
495	O
)	O
11	O
,	O
040	O
(	O
9	O
,	O
663	O
,	O
12	O
,	O
417	O
)	O
9	O
,	O
935	O
(	O
8	O
,	O
433	O
,	O
11	O
,	O
437	O
)	O
11	O
,	O
342	O
(	O
8	O
,	O
271	O
,	O
14	O
,	O
413	O
)	O
Middle11	O
,	O
410	O
(	O
9	O
,	O
600	O
,	O
13	O
,	O
221	O
)	O
10	O
,	O
827	O
(	O
9	O
,	O
259	O
,	O
12	O
,	O
395	O
)	O
9	O
,	O
121	O
(	O
8	O
,	O
312	O
,	O
9	O
,	O
930	O
)	O
10	O
,	O
555	O
(	O
9	O
,	O
378	O
,	O
11	O
,	O
733	O
)	O
9	O
,	O
815	O
(	O
8	O
,	O
635	O
,	O
10	O
,	O
994	O
)	O
10	O
,	O
498	O
(	O
9	O
,	O
289	O
,	O
11	O
,	O
706	O
)	O
South11	O
,	O
015	O
(	O
9	O
,	O
621	O
,	O
12	O
,	O
410	O
)	O
14	O
,	O
851	O
(	O
12	O
,	O
811	O
,	O
16	O
,	O
891	O
)	O
16	O
,	O
262	O
(	O
13	O
,	O
393	O
,	O
19	O
,	O
131	O
)	O
13	O
,	O
633	O
(	O
11	O
,	O
469	O
,	O
15	O
,	O
797	O
)	O
12	O
,	O
115	O
(	O
10	O
,	O
150	O
,	O
14	O
,	O
080	O
)	O
7	O
,	O
020	O
(	O
6	O
,	O
223	O
,	O
7	O
,	O
817	O
)	O
West6	O
,	O
891	O
(	O
6	O
,	O
150	O
,	O
7	O
,	O
632	O
)	O
7	O
,	O
038	O
(	O
6	O
,	O
244	O
,	O
7	O
,	O
832	O
)	O
7	O
,	O
138	O
(	O
6	O
,	O
055	O
,	O
8	O
,	O
222	O
)	O
7	O
,	O
670	O
(	O
6	O
,	O
515	O
,	O
8	O
,	O
824	O
)	O
7	O
,	O
638	O
(	O
6	O
,	O
636	O
,	O
8	O
,	O
639	O
)	O
8	O
,	O
083	O
(	O
6	O
,	O
827	O
,	O
9	O
,	O
338	O
)	O
Hospital	O
type	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001General	O
hospital9	O
,	O
098	O
(	O
7	O
,	O
130	O
,	O
11	O
,	O
066	O
)	O
7	O
,	O
579	O
(	O
6	O
,	O
969	O
,	O
8	O
,	O
190	O
)	O
9	O
,	O
939	O
(	O
9	O
,	O
122	O
,	O
10	O
,	O
755	O
)	O
9	O
,	O
029	O
(	O
7	O
,	O
965	O
,	O
10	O
,	O
093	O
)	O
8	O
,	O
101	O
(	O
7	O
,	O
344	O
,	O
8	O
,	O
859	O
)	O
9	O
,	O
848	O
(	O
8	O
,	O
705	O
,	O
10	O
,	O
991	O
)	O
Specialized	O
hospital11	O
,	O
613	O
(	O
10	O
,	O
849	O
,	O
12	O
,	O
377	O
)	O
13	O
,	O
348	O
(	O
12	O
,	O
379	O
,	O
14	O
,	O
316	O
)	O
12	O
,	O
181	O
(	O
11	O
,	O
111	O
,	O
13	O
,	O
250	O
)	O
11	O
,	O
247	O
(	O
10	O
,	O
402	O
,	O
12	O
,	O
092	O
)	O
11	O
,	O
014	O
(	O
9	O
,	O
982	O
,	O
12	O
,	O
047	O
)	O
11	O
,	O
452	O
(	O
9	O
,	O
960	O
,	O
12	O
,	O
943	O
)	O
Diagnostic	O
method	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
0010	O
.	O
0830	O
.	O
4	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001Free	O
screening	O
by	O
government7	O
,	O
610	O
(	O
5	O
,	O
815	O
,	O
9	O
,	O
405	O
)	O
16	O
,	O
058	O
(	O
11	O
,	O
686	O
,	O
20	O
,	O
431	O
)	O
10	O
,	O
528	O
(	O
7	O
,	O
825	O
,	O
13	O
,	O
230	O
)	O
7	O
,	O
300	O
(	O
5	O
,	O
797	O
,	O
8	O
,	O
804	O
)	O
17	O
,	O
881	O
(	O
9	O
,	O
337	O
,	O
26	O
,	O
426	O
)	O
16	O
,	O
861	O
(	O
1	O
,	O
357	O
,	O
35	O
,	O
080	O
)	O
Physical	O
examination12	O
,	O
655	O
(	O
8	O
,	O
344	O
,	O
16	O
,	O
966	O
)	O
12	O
,	O
337	O
(	O
10	O
,	O
690	O
,	O
13	O
,	O
983	O
)	O
14	O
,	O
077	O
(	O
10	O
,	O
495	O
,	O
17	O
,	O
658	O
)	O
11	O
,	O
930	O
(	O
9	O
,	O
522	O
,	O
14	O
,	O
338	O
)	O
10	O
,	O
253	O
(	O
9	O
,	O
096	O
,	O
11	O
,	O
411	O
)	O
13	O
,	O
982	O
(	O
11	O
,	O
975	O
,	O
15	O
,	O
989	O
)	O
Incidentally	O
detected10	O
,	O
487	O
(	O
8	O
,	O
880	O
,	O
12	O
,	O
094	O
)	O
8	O
,	O
454	O
(	O
5	O
,	O
421	O
,	O
11	O
,	O
488	O
)	O
10	O
,	O
241	O
(	O
8	O
,	O
081	O
,	O
12	O
,	O
400	O
)	O
10	O
,	O
760	O
(	O
6	O
,	O
817	O
,	O
14	O
,	O
704	O
)	O
11	O
,	O
352	O
(	O
8	O
,	O
563	O
,	O
14	O
,	O
142	O
)	O
10	O
,	O
422	O
(	O
7	O
,	O
683	O
,	O
13	O
,	O
160	O
)	O
With	O
symptoms9	O
,	O
566	O
(	O
8	O
,	O
805	O
,	O
10	O
,	O
327	O
)	O
10	O
,	O
336	O
(	O
9	O
,	O
665	O
,	O
11	O
,	O
008	O
)	O
10	O
,	O
528	O
(	O
9	O
,	O
882	O
,	O
11	O
,	O
173	O
)	O
10	O
,	O
075	O
(	O
9	O
,	O
357	O
,	O
10	O
,	O
793	O
)	O
9	O
,	O
083	O
(	O
8	O
,	O
290	O
,	O
9	O
,	O
877	O
)	O
10	O
,	O
264	O
(	O
9	O
,	O
165	O
,	O
11	O
,	O
362	O
)	O
Comorbidity	O
0	O
.	O
20	O
.	O
40	O
.	O
50	O
.	O
2	O
<	O
0	O
.	O
0010	O
.	O
2Yes10	O
,	O
332	O
(	O
9	O
,	O
419	O
,	O
11	O
,	O
245	O
)	O
10	O
,	O
286	O
(	O
9	O
,	O
272	O
,	O
11	O
,	O
300	O
)	O
10	O
,	O
771	O
(	O
9	O
,	O
337	O
,	O
12	O
,	O
206	O
)	O
11	O
,	O
194	O
(	O
9	O
,	O
798	O
,	O
12	O
,	O
591	O
)	O
10	O
,	O
581	O
(	O
9	O
,	O
600	O
,	O
11	O
,	O
562	O
)	O
10	O
,	O
199	O
(	O
9	O
,	O
103	O
,	O
11	O
,	O
295	O
)	O
No10	O
,	O
263	O
(	O
8	O
,	O
666	O
,	O
11	O
,	O
859	O
)	O
10	O
,	O
949	O
(	O
10	O
,	O
202	O
,	O
11	O
,	O
696	O
)	O
10	O
,	O
944	O
(	O
10	O
,	O
273	O
,	O
11	O
,	O
615	O
)	O
9	O
,	O
838	O
(	O
9	O
,	O
088	O
,	O
10	O
,	O
588	O
)	O
8	O
,	O
787	O
(	O
7	O
,	O
906	O
,	O
9	O
,	O
669	O
)	O
11	O
,	O
078	O
(	O
9	O
,	O
677	O
,	O
12	O
,	O
479	O
)	O
Complication	O
<	O
0	O
.	O
0010	O
.	O
0910	O
.	O
4	O
<	O
0	O
.	O
0010	O
.	O
0510	O
.	O
9Yes15	O
,	O
832	O
(	O
10	O
,	O
152	O
,	O
21	O
,	O
512	O
)	O
10	O
,	O
743	O
(	O
8	O
,	O
464	O
,	O
13	O
,	O
021	O
)	O
11	O
,	O
200	O
(	O
9	O
,	O
289	O
,	O
13	O
,	O
112	O
)	O
13	O
,	O
816	O
(	O
11	O
,	O
412	O
,	O
16	O
,	O
221	O
)	O
13	O
,	O
935	O
(	O
9	O
,	O
924	O
,	O
17	O
,	O
946	O
)	O
13	O
,	O
214	O
(	O
5	O
,	O
107	O
,	O
21	O
,	O
321	O
)	O
No9	O
,	O
888	O
(	O
8	O
,	O
783	O
,	O
10	O
,	O
993	O
)	O
10	O
,	O
773	O
(	O
10	O
,	O
143	O
,	O
11	O
,	O
403	O
)	O
10	O
,	O
854	O
(	O
10	O
,	O
159	O
,	O
11	O
,	O
549	O
)	O
9	O
,	O
641	O
(	O
8	O
,	O
973	O
,	O
10	O
,	O
309	O
)	O
9	O
,	O
185	O
(	O
8	O
,	O
608	O
,	O
9	O
,	O
762	O
)	O
10	O
,	O
516	O
(	O
9	O
,	O
809	O
,	O
11	O
,	O
222	O
)	O
Treatment	O
phases	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
001Initial10	O
,	O
102	O
(	O
8	O
,	O
641	O
,	O
11	O
,	O
563	O
)	O
10	O
,	O
142	O
(	O
9	O
,	O
438	O
,	O
10	O
,	O
845	O
)	O
10	O
,	O
750	O
(	O
10	O
,	O
007	O
,	O
11	O
,	O
492	O
)	O
11	O
,	O
275	O
(	O
10	O
,	O
408	O
,	O
12	O
,	O
142	O
)	O
9	O
,	O
640	O
(	O
8	O
,	O
888	O
,	O
10	O
,	O
392	O
)	O
11	O
,	O
848	O
(	O
10	O
,	O
538	O
,	O
13	O
,	O
158	O
)	O
Follow	O
-	O
up4	O
,	O
726	O
(	O
3	O
,	O
697	O
,	O
5	O
,	O
755	O
)	O
6	O
,	O
057	O
(	O
4	O
,	O
851	O
,	O
7	O
,	O
264	O
)	O
8	O
,	O
276	O
(	O
6	O
,	O
044	O
,	O
10	O
,	O
507	O
)	O
4	O
,	O
170	O
(	O
3	O
,	O
370	O
,	O
4	O
,	O
970	O
)	O
6	O
,	O
487	O
(	O
5	O
,	O
293	O
,	O
7	O
,	O
681	O
)	O
5	O
,	O
587	O
(	O
3	O
,	O
673	O
,	O
7	O
,	O
501	O
)	O
Relapse	O
/	O
metastasis13	O
,	O
461	O
(	O
11	O
,	O
458	O
,	O
15	O
,	O
465	O
)	O
16	O
,	O
452	O
(	O
14	O
,	O
756	O
,	O
18	O
,	O
148	O
)	O
13	O
,	O
368	O
(	O
11	O
,	O
671	O
,	O
15	O
,	O
066	O
)	O
11	O
,	O
975	O
(	O
10	O
,	O
284	O
,	O
13	O
,	O
666	O
)	O
11	O
,	O
328	O
(	O
9	O
,	O
480	O
,	O
13	O
,	O
176	O
)	O
10	O
,	O
382	O
(	O
8	O
,	O
872	O
,	O
11	O
,	O
892	O
)	O
Clinical	O
stages	O
0	O
.	O
045	O
<	O
0	O
.	O
001	O
<	O
0	O
.	O
0010	O
.	O
0770	O
.	O
40	O
.	O
3I10	O
,	O
141	O
(	O
6	O
,	O
686	O
,	O
13	O
,	O
597	O
)	O
7	O
,	O
859	O
(	O
7	O
,	O
053	O
,	O
8	O
,	O
666	O
)	O
9	O
,	O
658	O
(	O
7	O
,	O
856	O
,	O
11	O
,	O
459	O
)	O
9	O
,	O
681	O
(	O
7	O
,	O
904	O
,	O
11	O
,	O
458	O
)	O
9	O
,	O
120	O
(	O
7	O
,	O
822	O
,	O
10	O
,	O
418	O
)	O
9	O
,	O
945	O
(	O
8	O
,	O
449	O
,	O
11	O
,	O
442	O
)	O
II8	O
,	O
718	O
(	O
7	O
,	O
735	O
,	O
9	O
,	O
701	O
)	O
9	O
,	O
415	O
(	O
8	O
,	O
510	O
,	O
10	O
,	O
319	O
)	O
8	O
,	O
951	O
(	O
8	O
,	O
245	O
,	O
9	O
,	O
657	O
)	O
9	O
,	O
304	O
(	O
8	O
,	O
223	O
,	O
10	O
,	O
386	O
)	O
8	O
,	O
745	O
(	O
7	O
,	O
797	O
,	O
9	O
,	O
694	O
)	O
9	O
,	O
726	O
(	O
8	O
,	O
305	O
,	O
11	O
,	O
146	O
)	O
III10	O
,	O
453	O
(	O
9	O
,	O
465	O
,	O
11	O
,	O
441	O
)	O
12	O
,	O
599	O
(	O
10	O
,	O
959	O
,	O
14	O
,	O
238	O
)	O
10	O
,	O
086	O
(	O
9	O
,	O
309	O
,	O
10	O
,	O
862	O
)	O
11	O
,	O
053	O
(	O
9	O
,	O
785	O
,	O
12	O
,	O
321	O
)	O
10	O
,	O
883	O
(	O
9	O
,	O
250	O
,	O
12	O
,	O
515	O
)	O
9	O
,	O
833	O
(	O
8	O
,	O
940	O
,	O
10	O
,	O
727	O
)	O
IV11	O
,	O
137	O
(	O
9	O
,	O
678	O
,	O
12	O
,	O
597	O
)	O
15	O
,	O
378	O
(	O
13	O
,	O
665	O
,	O
17	O
,	O
090	O
)	O
15	O
,	O
021	O
(	O
13	O
,	O
159	O
,	O
16	O
,	O
882	O
)	O
10	O
,	O
471	O
(	O
9	O
,	O
142	O
,	O
11	O
,	O
801	O
)	O
9	O
,	O
602	O
(	O
8	O
,	O
503	O
,	O
10	O
,	O
700	O
)	O
13	O
,	O
040	O
(	O
10	O
,	O
146	O
,	O
15	O
,	O
933	O
)	O

Although	O
PERSEUS	B-BT
was	O
initially	O
targeted	O
towards	O
woody	O
crop	O
species	O
,	O
it	O
will	O
be	O
expanded	O
to	O
include	O
other	O
plant	O
or	O
animal	O
species	O
.	O

Graphical	O
summary	O
of	O
the	O
computational	O
(	O
top	O
)	O
and	O
the	O
visual	O
component	O
(	O
bottom	O
)	O
of	O
ChimericFragments	B-BT
.	O

DandD	B-BT
uses	O
a	O
measure	O
from	O
data	O
compression	O
to	O
measure	O
amount	O
of	O
distinct	O
sequence	O

DiGAlign	B-BT
has	O
unique	O
features	O
to	O
address	O
these	O
issues	O
,	O
such	O
as	O
(	O
i	O
)	O
an	O
automatic	O
sequence	O
position	O
adjustment	O
function	O
including	O
circular	O
permutations	O
and	O
inversions	O
,	O
(	O
ii	O
)	O
a	O
“	O
guide	O
tree	O
”	O
to	O
facilitate	O
the	O
selection	O
of	O
closely	O
related	O
sequences	O
,	O
and	O
(	O
iii	O
)	O
dot	O
plots	O
accompanied	O
by	O
synteny	O
maps	O
.	O

In	O
this	O
section	O
,	O
we	O
employed	O
PermuteDDS	B-BT
to	O
predict	O
novel	O
synergistic	O
drug	O
combinations	O
that	O
had	O
not	O
been	O
previously	O
tested	O
.	O

DeePhys	B-BT
allows	O
for	O
phenotypic	O
screenings	O
at	O
the	O
cellular	O
and	O
network	O
levels	O

This	O
will	O
allow	O
users	O
to	O
easily	O
automate	O
their	O
analyses	O
and	O
integrate	O
123VCF	B-BT
into	O
their	O
existing	O
workflows	O
.	O

The	O
Rummagene	B-BT
data	O
is	O
served	O
on	O
the	O
website	O
https	O
://	O
rummagene	B-BT
.	O
com	O
with	O
three	O
search	O
engines	O
.	O

Guguchkin	O
Egor	O
,	O
Kasianov	O
Artem	O
,	O
Belenikin	O
Maksim	O
,	O
Zobkova	O
Gaukhar	O
,	O
Kosova	O
Ekaterina	O
,	O
Makeev	O
Vsevolod	O
and	O
Karpulevich	O
Evgeny	O

In	O
contrast	O
,	O
for	O
the	O
Figure	O
1A	O
scenario	O
,	O
BayesKAT	B-BT
calculated	O
the	O
posterior	O
probability	O
of	O
a	O
true	O
association	O
given	O
the	O
data	O
P	O
(\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}	O
$	O
H_	O
{	O
1	O
}|	O
data	O
$\	O
end	O
{	O
document	O
})=	O
0	O
.	O
19	O
,	O
i	O
.	O
e	O
.	O

In	O
MS	O
-	O
Finder	O
,	O
a	O
total	O
of	O
93	O
compounds	O
were	O
successfully	O
identified	O
as	O
correct	O
candidates	O
,	O
among	O
which	O
10	O
compounds	O
were	O
erroneously	O
filtered	O
out	O
by	O
the	O
RT	B-BT
-	I-BT
Transformer	I-BT
.	O

Figure	O
5A	O
shows	O
the	O
results	O
of	O
a	O
ppd	O
between	O
graphite	O
and	O
KNeXT	B-BT
.	O

OpenChrom	B-BT
can	O
read	O
the	O
sample	O
data	O
folder	O
generated	O
by	O
ChemStation	O
without	O
any	O
modification	O
.	O

SynDesign	B-BT
determines	O
the	O
top	O
pegRNAs	O
for	O
each	O
position	O
according	O
to	O
our	O
DeepPrime	O
/	O
DeepPrime	O
-	O
FT	O
prediction	O
models	O
and	O
automatically	O
incorporates	O
a	O
synonymous	O
mutation	O
marker	O
that	O
further	O
enhances	O
pegRNA	O
efficiency	O
and	O
sequenced	O
product	O
identification	O
.	O

scalepopgen	B-BT
is	O
mainly	O
developed	O
using	O
the	O
Nextflow	O
workflow	O
management	O
system	O
(	O
Di	O
Tommaso	O
et	O
al	O
.	O

The	O
genotypes	O
of	O
targeted	O
regions	O
were	O
called	O
by	O
bcftools	B-BT
call	O
.	O

All	O
genomes	O
were	O
annotated	O
in	O
the	O
Integrated	B-BT
Microbial	I-BT
Genomes	I-BT
(	I-BT
IMG	I-BT
)	I-BT
database	O
(≥	O
IMG	O
Annotation	O
Pipeline	O
v	O
.	O
5	O
.	O
0	O
.	O
19	O
)	O
(	O
19	O
).	O

The	O
ORFs	O
were	O
annotated	O
using	O
MetaPathways	B-BT
v2	O
.	O
5	O
with	O
default	O
settings	O
(	O
24	O
,	O
25	O
).	O

The	O
predicted	O
bacterial	O
host	O
genus	O
,	O
determined	O
from	O
iPHoP	B-BT
[	O
50	O
],	O
of	O
complete	O
bacteriophage	O
genomes	O
from	O
the	O
Inoviridae	O
and	O
Microviridae	O
families	O
and	O
Caudoviricetes	O
order	O
identified	O
in	O
this	O
study	O
from	O
fecal	O
and	O
oral	O
samples	O
of	O
diverse	O
lemur	O
genera	O
(	O
Varecia	O
,	O
Eulemur	O
,	O
Lemur	O
,	O
Propithecus	O
).	O

Marker	O
genes	O
for	O
different	O
clusters	O
were	O
identified	O
from	O
prior	O
studies	O
(	O
Alchahin	O
et	O
al	O
.,	O
2022	O
)	O
with	O
the	O
assistance	O
of	O
the	O
automatic	O
annotation	O
tool	O
“	O
MetaTiME	B-BT
”	O
(	O
Zhang	O
et	O
al	O
.,	O
2023	O
).	O

One	O
limitation	O
of	O
the	O
CAMI	O
ePGDB	O
as	O
a	O
benchmark	O
is	O
that	O
it	O
is	O
automatically	O
generated	O
using	O
MetaPathways	B-BT
but	O
the	O
predictions	O
have	O
not	O
been	O
curated	O
so	O
it	O
can	O
be	O
said	O
that	O
the	O
results	O
demonstrate	O
more	O
how	O
similar	O
the	O
other	O
prediction	O
methods	O
are	O
with	O
MetaPathways	B-BT
and	O
PathoLogic	O
than	O
their	O
actual	O
prediction	O
performance	O
.	O

In	O
such	O
cases	O
,	O
DandD	B-BT
initializes	O
the	O
search	O
for	O
the	O
union	O
k	O
∗	O
by	O
taking	O
the	O
maximum	O
of	O
the	O
previously	O
-	O
computed	O
k	O
∗	O
s	O
of	O
the	O
inputs	O
.	O
Figure	O
1Different	O
pangenomes	O
find	O
their	O
maxima	O
at	O
different	O
values	O
of	O
kVertical	O
axis	O
shows	O
dk	O
(	O
S	O
)	O
k	O
standardized	O
to	O
between	O
0	O
and	O
1	O
per	O
pangenome	O
.	O

Influence	O
of	O
different	O
retention	O
periods	O
on	O
the	O
efficiency	O
of	O
cowpea	O
mild	O
mottle	O
virus	O
transmission	O
by	O
single	O
individuals	O
of	O
Bemisia	O
tabaci	O
MEAM1	O
and	O
MED	O
species	O
.	O

An	O
older	O
version	O
of	O
this	O
draft	O
genome	O
is	O
available	O
in	O
the	O
US	O
DOE	O
Joint	O
Genome	O
Institute	O
’	O
s	O
Integrated	B-BT
Microbial	I-BT
Genomes	I-BT
(	I-BT
IMG	I-BT
)	I-BT
system	O
(	O
ID	O
:	O
2835707023	O
).	O

Under	O
highly	O
reducing	O
conditions	O
created	O
by	O
large	O
H2	O
envelopes	O
,	O
the	O
reaction	O
of	O
H2	O
with	O
the	O
silicate	O
magma	O
ocean	O
produces	O
metallic	O
iron	O
,	O
that	O
is	O
either	O
sequestered	O
in	O
the	O
core	O
or	O
remains	O
in	O
the	O
mantle	O
(	O
two	O
endmember	O
assumptions	O
).	O

These	O
features	O
are	O
now	O
part	O
of	O
the	O
latest	O
version	O
of	O
parKVFinder	B-BT
(	O
v1	O
.	O
2	O
.	O
0	O
)	O
and	O
enable	O
users	O
to	O
obtain	O
more	O
robust	O
and	O
detailed	O
results	O
.	O

The	O
milking	O
parlor	O
was	O
equipped	O
with	O
Metatron	O
electronic	O
milk	O
metres	O
,	O
P21	O
bail	O
controllers	O
,	O
and	O
electronic	O
identification	O
tags	O
(	O
Metatron	O
DairyPlan	O
,	O
GEA	O
GmbH	O
).	O

Making	O
the	O
macros	O
available	O
from	O
a	O
Fiji	B-BT
menu	O
.	O

Unlike	O
sRNAfrag	B-BT
,	O
Flaimapper	O
generates	O
annotations	O
for	O
users	O
,	O
which	O
is	O
admittedly	O
convenient	O
.	O

Using	O
META	O
-	O
pipe	O
for	O
gene	O
prediction	O
and	O
functional	O
assignment	O
allowed	O
us	O
to	O
generate	O
a	O
consistent	O
catalog	O
across	O
the	O
datasets	O
in	O
MarCat	B-BT
(	O
See	O
https	O
://	O
f1000research	O
.	O
com	O
/	O
articles	O
/	O
6	O
–	O
70	O
/	O
v1	O
for	O
a	O
more	O
detailed	O
description	O
of	O
functional	O
assignment	O
).	O

Hi	O
-	O
C	O
map	O
representing	O
the	O
scaffolds	O
of	O
Redsnapper	O
genome	O
assembly	O
.	O

PathoLogic	O
was	O
not	O
included	O
in	O
the	O
comparison	O
since	O
MetaPathways	B-BT
uses	O
it	O
to	O
create	O
the	O
ePGDB	O
.	O

PSIPRED	B-BT
is	O
a	O
common	O
server	O
to	O
predict	O
protein	O
secondary	O
structure	O
,	O
using	O
two	O
feedforward	O
neural	O
networks	O
for	O
the	O
analysis	O
of	O
PSIBLAST	O
-	O
produced	O
protein	O
output	O
with	O
high	O
accuracy	O
.	O

The	O
PMechDB	B-BT
search	O
interface	O
is	O
accessible	O
at	O
https	O
://	O
deeprxn	O
.	O
ics	O
.	O
uci	O
.	O
edu	O
/	O
pmechdb	B-BT
/	O
rsearch	O
.	O

The	O
first	O
use	O
case	O
of	O
Cat	B-BT
-	I-BT
E	I-BT
is	O
the	O
LUAD	O
dataset	O
,	O
which	O
was	O
chosen	O
from	O
among	O
the	O
33	O
different	O
types	O
of	O
cancer	O
tissues	O
available	O
in	O
Cat	B-BT
-	I-BT
E	I-BT
.	O

The	O
Supreme	O
Court	O
’	O
s	O
ruling	O
further	O
perpetuates	O
and	O
extends	O
the	O
marginalisation	O
of	O
LGBTQ	O
+	O
couples	O
from	O
social	O
structures	O
crucial	O
to	O
their	O
health	O
and	O
well	O
-	O
being	O
.	O

APE	O
was	O
isolated	O
,	O
and	O
its	O
phytochemical	O
and	O
anticancer	O
activities	O
were	O
evaluated	O
.	O

HTSLIB	B-BT
(	O
Bonfield	O
et	O
al	O
.	O

For	O
example	O
,	O
DefenseFinder	O
,	O
MacSyFinder	B-BT
,	O
and	O
GapMind	O
took	O
around	O
one	O
and	O
a	O
half	O
minutes	O
or	O
less	O
to	O
run	O
for	O
each	O
test	O
genome	O
.	O

The	O
HAIviz	B-BT
user	O
interface	O
(	O
UI	O
)	O
consists	O
of	O
five	O
integrated	O
pages	O
:	O
Home	O
,	O
Input	O
,	O
Map	O
editor	O
,	O
Dashboard	O
,	O
and	O
Documentation	O
.	O

What	O
’	O
s	O
more	O
,	O
T33	O
is	O
composed	O
of	O
five	O
traditional	O
Chinese	O
herbs	O
,	O
namely	O
,	O
Kansui	O
Radix	O
,	O
Glycyrrhizae	O
Radix	O
et	O
Rhizoma	O
Praeparata	O
cum	O
Melle	O
,	O
Paeoniae	O
Radix	O
Alba	O
,	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Zingibere	O
et	O
Alumine	O
,	O
and	O
Rhei	O
Radix	O
et	O
Rhizoma	O
.	O

An	O
experimental	O
medical	O
device	O
,	O
the	O
Voyager	O
leverages	O
the	O
power	O
of	O
localized	O
,	O
ultra	O
-	O
low	O
(	O
0	O
-	O
22kHz	O
)	O
radio	O
frequency	O
energy	O
(	O
ulRFE	O
)	O
to	O
inhibit	O
cancers	O
including	O
GBM	O
(	O
Barkhoudarian	O
et	O
al	O
.	O

Qualitative	O
interviews	O
were	O
conducted	O
to	O
assess	O
engagement	O
and	O
pain	O
points	O
with	O
the	O
InPACT	O
at	O
Home	O
website	O
.	O

In	O
this	O
DEA	O
benchmark	O
,	O
prolfqua	B-BT
performed	O
slightly	O
but	O
not	O
significantly	O
better	O
than	O
proDA	O
(	O
section	O
Material	O
S5	O
“	O
DEA	O
benchmark	O
:	O
IonStar	O
/	O
FragPipeV14	O
/	O
combined_protein	O
.	O
tsv	O
”	O
in	O
the	O
SI	O
).	O

SyntenyViewer	B-BT
allows	O
deep	O
investigation	O
of	O
evolutionary	O
fates	O
of	O
ancestral	O
genes	O
/	O
genomes	O
,	O
through	O
precise	O
identification	O
of	O
the	O
changes	O
involved	O
(	O
gains	O
and	O
losses	O
of	O
genes	O
and	O
associated	O
gene	O
ontologies	O
)	O
and	O
their	O
assignment	O
to	O
specific	O
species	O
or	O
botanical	O
families	O
(	O
Figure	O
3a	O
).	O

binotii	O
Au	O
-	O
Mic3	O
were	O
also	O
subjected	O
to	O
comparative	O
genome	O
analysis	O
using	O
DiGAlign	B-BT
[	O
22	O
].	O

The	O
third	O
use	O
case	O
shows	O
how	O
AlphaFind	B-BT
can	O
help	O
answer	O
actual	O
research	O
questions	O
.	O

This	O
work	O
was	O
supported	O
by	O
10	O
.	O
13039	O
/	O
100000002NIH	O
grants	O
for	O
the	O
MoTrPAC	O
:	O
U24DK112331	O
(	O
Chemical	O
Analysis	O
Site	O
),	O
U24OD026629	O
(	O
Bioinformatics	O
Center	O
),	O
U24AR071113	O
(	O
Consortium	O
Coordinating	O
Center	O
),	O
U01AG055133	O
,	O
U01AG055137	O
,	O
and	O
U01AG055135	O
(	O
Animal	O
Study	O
Sites	O
).	O

Two	O
SwivelLock	O
(	O
Arthrex	O
,	O
Inc	O
)	O
suture	O
anchors	O
at	O
the	O
inferior	O
pole	O
of	O
the	O
patella	O
with	O
a	O
Krackow	O
stitch	O
brought	O
down	O
the	O
patella	O
in	O
a	O
locking	O
stitch	O
configuration	O
.	O

In	O
the	O
new	O
cost	O
matrix	O
calculation	O
method	O
,	O
we	O
use	O
weighted	O
FCs	O
as	O
the	O
feature	O
to	O
calculate	O
the	O
distance	O
between	O
CT	O
and	O
spots	O
and	O
then	O
optimize	O
the	O
baseline	O
mapping	O
matrix	O
(	O
e	O
.	O
g	O
.,	O
TACCO	B-BT
output	O
).	O

For	O
instance	O
,	O
ExtraTrees	O
achieved	O
highly	O
accurate	O
on	O
the	O
TKI	O
dataset	O
when	O
training	O
on	O
the	O
subset	O
of	O
MdrDB_CoreSet	B-BT
with	O
low	O
absolute	O
errors	O
(	O
RMSE	O
=	O
0	O
.	O
656	O
kcal	O
mol	O
−	O
1	O
),	O
strong	O
correlation	O
(	O
Pearson	O
=	O
0	O
.	O
607	O
),	O
and	O
good	O
classification	O
performance	O
(	O
AUPRC	O
=	O
0	O
.	O
538	O
).	O

For	O
this	O
purpose	O
,	O
they	O
had	O
set	O
up	O
a	O
test	O
bed	O
consisting	O
of	O
25	O
identical	O
Pycom	O
IoT	O
devices	O
used	O
as	O
transmitters	O
and	O
one	O
single	O
USRP	O
B210	O
SDR	O
as	O
a	O
receiver	O
.	O

Effect	O
of	O
retention	O
period	O
(	O
RP	O
)	O
on	O
the	O
transmission	O
of	O
cowpea	O
mild	O
mottle	O
virus	O
by	O
Bemisia	O
tabaci	O
Middle	O
East	O
–	O
Asia	O
Minor	O
1	O
and	O
Bemisia	O
tabaci	O
Mediterranean	O
.	O

To	O
overcome	O
the	O
problems	O
,	O
LORA	O
builds	O
on	O
the	O
Goslin	B-BT
standardization	O
approach	O
and	O
known	O
lipid	O
structural	O
characteristics	O
provided	O
by	O
novel	O
analytical	O
techniques	O
.	O

In	O
the	O
broader	O
scope	O
,	O
we	O
envision	O
that	O
tools	O
like	O
shinyDeepDR	B-BT
will	O
advance	O
cancer	O
research	O
by	O
making	O
sophisticated	O
computational	O
models	O
more	O
FAIR	O
(	O
findable	O
,	O
accessible	O
,	O
interoperable	O
,	O
and	O
reusable	O
).	O

This	O
study	O
examines	O
the	O
formidable	O
and	O
complex	O
challenge	O
of	O
insider	O
threats	O
to	O
organizational	O
security	O
,	O
addressing	O
risks	O
such	O
as	O
ransomware	O
incidents	O
,	O
data	O
breaches	O
,	O
and	O
extortion	O
attempts	O
.	O

PyCoMdb	B-BT
contains	O
annotated	O
information	O
of	O
457	O
622	O
proteins	O
with	O
corresponding	O
coevolution	O
matrices	O
.	O

[	O
15	O
]	O
developed	O
the	O
protein	O
kinase	O
ontology	O
(	O
ProKinO	B-BT
)	O
framework	O
for	O
human	O
kinases	O
,	O
which	O
now	O
also	O
provides	O
family	O
annotations	O
for	O
1321	O
species	O
,	O
by	O
mapping	O
sequences	O
to	O
KinBase	O
(	O
version	O
2012	O
)	O
and	O
integrating	O
data	O
from	O
COSMIC	O
,	O
UniProt	O
and	O
Reactome	O
[	O
15	O
].	O

The	O
comparison	O
with	O
other	O
methods	O
in	O
Figure	O
S7	O
reveals	O
that	O
RAScore	B-BT
and	O
CLScore	O
tend	O
to	O
overestimate	O
the	O
synthetic	O
accessibility	O
of	O
HS	O
molecules	O
,	O
while	O
SYBA	O
underestimates	O
the	O
accessibility	O
of	O
ES	O
molecules	O
.	O

FlexStat	B-BT
provides	O
users	O
with	O
convenient	O
options	O
to	O
download	O
protein	O
matrices	O
at	O
various	O
stages	O
of	O
processing	O
and	O
analysis	O
.	O

After	O
registering	O
RBD	O
region	O
in	O
the	O
GenBank	O
,	O
physicochemical	O
parameters	O
,	O
secondary	O
structure	O
,	O
homology	O
modeling	O
,	O
3D	O
structure	O
of	O
RBD	O
region	O
and	O
antigenicity	O
were	O
determined	O
using	O
ProtParam	O
ExPASy	B-BT
,	O
PSIPRED	O
,	O
MolProbity	O
,	O
IEDB	O
and	O
Vaxijen	O
online	O
tools	O
,	O
respectively	O
.	O

As	O
depicted	O
in	O
Table	O
8	O
,	O
we	O
evaluate	O
various	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
insider	O
threat	O
detection	O
methods	O
using	O
the	O
CERT	O
r4	O
.	O
2	O
datasets	O
.	O

DataColor	B-BT
empowers	O
visualization	O
of	O
gene	O
expressions	O
.	O

b	O
The	O
top	O
L	O
precisions	O
of	O
DeepTMP	O
,	O
CDPred	B-BT
,	O
DeepHomo2	O
.	O
0	O
,	O
GLINTER	O
,	O
DeepHomo	O
,	O
and	O
DNCON2_Inter	O
in	O
different	O
ranges	O
of	O
ln	O
(	O
Meff	O
).	O

To	O
view	O
syntenic	O
blocks	O
and	O
homologous	O
gene	O
pairs	O
between	O
different	O
kiwifruit	O
genome	O
assemblies	O
,	O
we	O
developed	O
‘	O
SyntenyViewer	B-BT
’,	O
an	O
extension	O
module	O
of	O
Tripal	O
,	O
in	O
KGD	O
.	O

Depending	O
on	O
the	O
environmental	O
conditions	O
at	O
each	O
location	O
,	O
traps	O
were	O
placed	O
either	O
indoors	O
or	O
outdoors	O
in	O
areas	O
known	O
to	O
harbor	O
sand	O
flies	O
,	O
such	O
as	O
animal	O
sheds	O
,	O
areas	O
near	O
shrubs	O
and	O
trees	O
,	O
and	O
rock	O
fissures	O
or	O
cave	O
entrances	O
in	O
forests	O
or	O
national	O
parks	O
.	O

GEMLI	B-BT
resulted	O
in	O
high	O
percentages	O
of	O
cells	O
correctly	O
assigned	O
to	O
their	O
crypt	O
or	O
organoid	O
of	O
origin	O
with	O
default	O
lineage	O
size	O
parameters	O
and	O
parameters	O
in	O
the	O
ground	O
truth	O
lineage	O
size	O
range	O
,	O
allowing	O
the	O
recovery	O
of	O
mid	O
-	O
sized	O
lineages	O
(	O
Fig	O
.	O

The	O
MTPpilot	B-BT
website	O
does	O
not	O
collect	O
any	O
personally	O
identifiable	O
information	O
and	O
anonymizes	O
any	O
collected	O
data	O
.	O

coli	O
,	O
ChimericFragments	B-BT
successfully	O
predicted	O
the	O
reported	O
interaction	O
in	O
40	O
cases	O
(∼	O
73	O
%)	O
and	O
similar	O
numbers	O
were	O
obtained	O
in	O
V	O
.	O

Therefore	O
,	O
to	O
derive	O
the	O
Pfam	O
domains	O
distribution	O
among	O
the	O
entries	O
of	O
Hmrbase	B-BT
,	O
a	O
domain	O
search	O
facility	O
has	O
been	O
embedded	O
.	O

The	O
most	O
commonly	O
used	O
algorithms	O
to	O
calculate	O
cavities	O
are	O
geometric	O
(	O
see	O
description	O
of	O
geometric	O
algorithms	O
below	O
),	O
as	O
they	O
only	O
require	O
the	O
Cartesian	O
coordinates	O
of	O
the	O
molecule	O
and	O
are	O
therefore	O
easy	O
to	O
implement	O
.	O
19	O
−	O
21	O
Based	O
on	O
geometric	O
methods	O
,	O
several	O
software	O
tools	O
have	O
been	O
developed	O
for	O
detecting	O
,	O
analyzing	O
,	O
and	O
visualizing	O
cavities	O
,	O
as	O
analyzed	O
in	O
comprehensive	O
reviews	O
.	O
19	O
−	O
21	O
These	O
tools	O
are	O
primarily	O
used	O
to	O
identify	O
protein	O
-	O
binding	O
pockets	O
but	O
have	O
also	O
been	O
used	O
to	O
calculate	O
the	O
cavities	O
of	O
supramolecular	O
cages	O
.	O
21	O
The	O
following	O
selected	O
list	O
shows	O
examples	O
of	O
cavity	O
calculation	O
software	O
for	O
different	O
types	O
of	O
hollow	O
structures	O
,	O
such	O
as	O
proteins	O
,	O
cages	O
,	O
representative	O
fragments	O
of	O
metal	O
–	O
organic	O
frameworks	O
,	O
etc	O
.:	O
VOIDOO	O
,	O
22	O
McVol	O
,	O
23	O
Volarea	O
,	O
24	O
CAVER	O
,	O
25	O
KVFinder	B-BT
(	O
including	O
pyKVFinder	B-BT
,	O
parKVFinder	B-BT
,	O
and	O
KVFinder	B-BT
-	I-BT
web	I-BT
),	O
26	O
−	O
29	O
Fpocket	O
(	O
including	O
its	O
molecular	O
dynamics	O
(	O
MDs	O
)	O
implementation	O
MDpocket	O
and	O
FpocketWeb	O
),	O
30	O
−	O
32	O
PoreBlazer	O
,	O
33	O
Zeo	O
++,	O
34	O
CavVis	O
,	O
35	O
POVME	O
,	O
36	O
ghecom	O
,	O
37	O
PyWindow	O
,	O
38	O
MoloVol	O
,	O
39	O
CAST	O
,	O
40	O
ProteinVolume	O
,	O
41	O
3	O
V	O
,	O
42	O
and	O
Voronoia	O
.	O
43	O
Additionally	O
,	O
other	O
software	O
that	O
is	O
no	O
longer	O
available	O
includes	O
GRASP44	O
and	O
HOLLOW	O
.	O
45	O
It	O
is	O
worth	O
noting	O
that	O
VOIDOO	O
,	O
which	O
is	O
probably	O
the	O
most	O
popular	O
tool	O
used	O
by	O
the	O
supramolecular	O
community	O
,	O
46	O
−	O
48	O
has	O
not	O
been	O
updated	O
since	O
1999	O
,	O
making	O
it	O
challenging	O
to	O
use	O
on	O
modern	O
computers	O
.	O

A	O
total	O
of	O
16	O
,	O
055	O
(	O
38	O
.	O
1	O
%)	O
of	O
the	O
41	O
,	O
855	O
adult	O
TTS	O
admissions	O
had	O
composite	O
cardiovascular	O
outcomes	O
(	O
TACCO	O
).	O

The	O
data	O
underlying	O
this	O
article	O
are	O
available	O
in	O
this	O
article	O
and	O
its	O
supplementary	O
material	O
,	O
and	O
at	O
https	O
://	O
pypi	O
.	O
org	O
/	O
project	O
/	O
pycomo	B-BT
/.	O

The	O
unsupervised	O
version	O
of	O
scDREAMER	B-BT
employs	O
an	O
adversarial	O
variational	O
autoencoder	O
and	O
a	O
batch	O
classifier	O
(	O
a	O
multi	O
-	O
layer	O
neural	O
network	O
)	O
which	O
are	O
trained	O
adversarially	O
for	O
learning	O
batch	O
-	O
invariant	O
lower	O
-	O
dimensional	O
cellular	O
embeddings	O
.	O

The	O
interactive	O
cluster	O
for	O
Cluster_30	O
can	O
be	O
accessed	O
at	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
/	O
cluster	O
/	O
graph	O
/	O
367	O

We	O
then	O
transduced	O
these	O
cells	O
with	O
lentiviruses	O
with	O
PCP	O
-	O
sfGFP	O
—	O
the	O
original	O
protein	O
of	O
the	O
CRISPR	O
-	O
Sirius	O
system	O
[	O
22	O
]—	O
and	O
selected	O
cells	O
expressing	O
PCP	O
-	O
sfGFP	O
by	O
FACS	O
.	O

Since	O
a	O
full	O
cell	O
cycle	O
in	O
MaBoSS	B-BT
is	O
achieved	O
in	O
24	O
units	O
of	O
time	O
,	O
we	O
proceeded	O
to	O
set	O
the	O
scaling	O
value	O
to	O
60	O
,	O
similar	O
to	O
what	O
was	O
done	O
with	O
the	O
previous	O
TNF	O
model	O
.	O

LB	O
and	O
KMK	O
developed	O
the	O
Torch	B-BT
-	I-BT
eCpG	I-BT
tool	O
.	O

We	O
present	O
shaPRS	B-BT
,	O
a	O
method	O
that	O
leverages	O
widespread	O
pleiotropy	O
between	O
traits	O
or	O
shared	O
genetic	O
effects	O
across	O
ancestries	O
,	O
to	O
improve	O
the	O
accuracy	O
of	O
polygenic	O
scores	O
.	O

The	O
gp120	O
V1	O
/	O
V2	O
loop	O
,	O
gp120	O
V3	O
-	O
glycan	O
,	O
and	O
gp120	O
/	O
gp41	O
interface	O
sites	O
were	O
identified	O
by	O
HIResist	B-BT
(	O
https	O
://	O
hiresist	B-BT
.	O
umn	O
.	O
edu	O
/)	O
using	O
data	O
sourced	O
from	O
CATNAP	O
(	O
Los	O
Alamos	O
National	O
Laboratory	O
).	O

Dataset	O
IV	O
[	O
65	O
]	O
is	O
collected	O
using	O
25	O
LoRa	O
transmitters	O
from	O
different	O
models	O
including	O
five	O
SX1272MB2xAS	O
Mbed	O
shield	O
,	O
five	O
SX1261	O
MB2xAS	O
mbed	O
shield	O
,	O
five	O
Pycom	O
FiPy	O
,	O
five	O
Pycom	O
LoPy	O
,	O
and	O
five	O
Dragino	O
SX1276	O
shields	O
.	O

Data	O
were	O
obtained	O
from	O
the	O
Privateer	B-BT
database	O
(	O
Dialpuri	O
,	O
Bagdonas	O
,	O
Schofield	O
,	O
Pham	O
,	O
Holland	O
&	O
Agirre	O
,	O
2024	O
▸;	O
Dialpuri	O
,	O
Bagdonas	O
,	O
Schofield	O
,	O
Pham	O
,	O
Holland	O
,	O
Bond	O
et	O
al	O
.,	O
2024	O
▸).	O

Perseus	O
crashes	O
frequently	O
,	O
causing	O
loss	O
of	O
work	O
as	O
it	O
does	O
not	O
save	O
temporary	O
files	O
.	O

Within	O
these	O
layers	O
,	O
L	O
sets	O
of	O
MSCAN	O
blocks	O
are	O
stacked	O
.	O

In	O
another	O
study	O
[	O
46	O
],	O
A	O
novel	O
Fuzzy	O
Unique	O
Image	O
Transformation	O
(	O
FUIT	O
)	O
technique	O
defends	O
COVID	O
-	O
19	O
deep	O
models	O
against	O
six	O
adversarial	O
attacks	O
(	O
FGSM	O
,	O
BIM	O
,	O
PGD	B-BT
without	O
random	O
start	O
,	O
PGD	B-BT
-	O
r	O
with	O
random	O
start	O
,	O
Deep	O
Fool	O
,	O
C	O
&	O
W	O
)	O
by	O
downsampling	O
image	O
pixels	O
to	O
an	O
interval	O
before	O
training	O
.	O

The	O
glycopeptides	O
identified	O
by	O
GlycReSoft	O
(	O
supplemental	O
File	O
S9	O
)	O
were	O
analyzed	O
using	O
RAMZIS	B-BT
,	O
an	O
R	O
toolkit	O
for	O
assessing	O
glycoproteomic	O
data	O
using	O
contextual	O
similarity	O
(	O
38	O
).	O

Conservation	O
of	O
the	O
HbYX	O
motif	O
in	O
jawed	O
vertebrates	O
A	O
total	O
of	O
379	O
GPM6A	O
sequences	O
from	O
jawed	O
vertebrates	O
were	O
retrieved	O
,	O
and	O
an	O
MSA	O
was	O
constructed	O
using	O
Jalview	B-BT
,	O
highlighting	O
the	O
conserved	O
features	O
of	O
this	O
protein	O
.	O

Figure	O
1	O
shows	O
the	O
graphical	O
user	O
interface	O
of	O
RmsiGUI	B-BT
with	O
the	O
TrIQ	O
option	O
selector	O
.	O

First	O
,	O
we	O
obtain	O
a	O
pre	O
-	O
trained	O
model	O
by	O
training	O
RT	B-BT
-	I-BT
Transformer	I-BT
on	O
the	O
large	O
small	O
molecule	O
retention	O
time	O
dataset	O
containing	O
80	O
038	O
molecules	O
,	O
and	O
then	O
transfer	O
the	O
resulting	O
model	O
to	O
different	O
chromatographic	O
methods	O
based	O
on	O
transfer	O
learning	O
.	O

In	O
MetaTron	B-BT
,	O
two	O
Fleiss	O
’	O
kappa	O
agreement	O
values	O
are	O
computed	O
for	O
each	O
annotation	O
type	O
:	O
one	O
concerns	O
the	O
entire	O
collection	O
of	O
documents	O
,	O
and	O
one	O
concerns	O
each	O
single	O
document	O
.	O

2a	O
Illustration	O
of	O
a	O
typical	O
pyHiM	B-BT
analysis	O
on	O
mouse	O
tissues	O
:	O
examples	O
of	O
raw	O
data	O
are	O
shown	O
in	O
the	O
top	O
row	O
and	O
the	O
most	O
relevant	O
pyHiM	B-BT
outputs	O
are	O
shown	O
in	O
the	O
bottom	O
row	O
.	O

Furthermore	O
,	O
all	O
SNP	O
sites	O
which	O
were	O
found	O
by	O
the	O
PHARE	B-BT
pipeline	O
in	O
pfdhps	O
and	O
pfdhfr	O
are	O
known	O
sites	O
of	O
drug	O
resistance	O
.	O

However	O
,	O
to	O
allow	O
comparisons	O
between	O
outcomes	O
of	O
different	O
magma	O
ocean	O
duration	O
,	O
we	O
do	O
continue	O
atmospheric	O
evolution	O
after	O
magma	O
ocean	O
solidification	O
permitting	O
atmospheric	O
escape	O
to	O
continue	O
alongside	O
stellar	O
evolution	O
,	O
and	O
continuous	O
re	O
-	O
equilibration	O
of	O
surface	O
volatiles	O
at	O
a	O
plausible	O
quench	O
temperature	O
(	O
1000	O
K	O
);	O
surface	O
climate	O
evolves	O
self	O
-	O
consistently	O
with	O
atmospheric	O
composition	O
and	O
stellar	O
evolution	O
.	O

With	O
a	O
provided	O
database	O
consisting	O
of	O
the	O
genome	O
of	O
the	O
host	O
organism	O
,	O
RepairNatrix	B-BT
uses	O
the	O
basic	O
local	O
alignment	O
tool	O
(	O
BLAST	O
)	O
to	O
separate	O
the	O
input	O
data	O
into	O
two	O
files	O
:	O
one	O
containing	O
reads	O
that	O
are	O
likely	O
part	O
of	O
the	O
host	O
genome	O
and	O
do	O
not	O
contain	O
stored	O
data	O
,	O
and	O
a	O
second	O
one	O
containing	O
the	O
reads	O
that	O
either	O
did	O
not	O
match	O
any	O
target	O
of	O
the	O
database	O
or	O
only	O
match	O
with	O
low	O
confidence	O
(	O
i	O
.	O
e	O
.	O

The	O
Open	O
LabBot	O
and	O
its	O
control	O
software	O
RmsiGUI	B-BT
were	O
released	O
as	O
a	O
community	O
development	O
kit	O
[	O
19	O
].	O

The	O
UMAP	O
(	O
28	O
)	O
generated	O
from	O
the	O
Cell	O
Ranger	O
output	O
shows	O
that	O
the	O
129	O
cells	O
that	O
appear	O
in	O
the	O
Cell	O
Ranger	O
results	O
but	O
not	O
in	O
scPipe	B-BT
tend	O
to	O
cluster	O
together	O
away	O
from	O
the	O
large	O
clusters	O
or	O
in	O
the	O
margins	O
of	O
them	O
(	O
Figure	O
2E	O
).	O

Taxonomy	O
information	O
and	O
microbial	O
genomes	O
were	O
downloaded	O
using	O
the	O
“	O
centrifuger	B-BT
-	O
download	O
”	O
script	O
in	O
June	O
2023	O
.	O

The	O
Rummagene	B-BT
web	O
server	O
application	O
is	O
available	O
from	O
:	O
https	O
://	O
rummagene	B-BT
.	O
com	O
/.	O

[	O
10	O
]	O
demonstrated	O
the	O
superior	O
efficacy	O
of	O
Supreme	O
over	O
ProSeal	O
,	O
using	O
a	O
16	O
-	O
Fr	O
GT	O
,	O
regarding	O
success	O
rate	O
and	O
insertion	O
time	O
.	O

The	O
MarRef	O
,	O
MarDB	O
and	O
MarCat	B-BT
contextual	O
databases	O
are	O
built	O
by	O
compiling	O
data	O
from	O
a	O
number	O
of	O
publicly	O
available	O
sequence	O
,	O
taxonomy	O
and	O
literature	O
databases	O
in	O
a	O
semi	O
-	O
automatic	O
fashion	O
.	O

Postoperative	O
complications	O
following	O
iris	O
-	O
claw	O
IOL	O
implantation	O
were	O
present	O
in	O
29	O
patients	O
(	O
19	O
.	O
6	O
%)	O
and	O
included	O
ocular	O
hypertension	O
(	O
IOP	O
>	O
30	O
mmHg	O
)	O
(	O
n	O
=	O
9	O
)	O
or	O
hypotony	O
(	O
IOP	O
<	O
6	O
mmHg	O
)	O
(	O
n	O
=	O
2	O
),	O
retinal	O
detachment	O
(	O
n	O
=	O
8	O
),	O
corneal	O
decompensation	O
(	O
n	O
=	O
5	O
),	O
iris	O
-	O
claw	O
lens	O
subluxation	O
(	O
n	O
=	O
3	O
),	O
lens	O
fragment	O
in	O
the	O
anterior	O
chamber	O
(	O
n	O
=	O
1	O
)	O
and	O
acute	O
endophthalmitis	O
(	O
n	O
=	O
1	O
).	O

Figure	O
6	O
includes	O
some	O
of	O
the	O
currently	O
available	O
models	O
and	O
their	O
corresponding	O
tours	O
,	O
as	O
more	O
fully	O
described	O
in	O
the	O
documentation	O
(	O
https	O
://	O
molstar	B-BT
.	O
org	O
/	O
me	O
-	O
docs	O
/).	O

NanoDeep	B-BT
can	O
be	O
applied	O
to	O
microbial	O
species	O
that	O
do	O
not	O
exist	O
in	O
training	O
sets	O
,	O
albeit	O
with	O
a	O
performance	O
decrease	O
of	O
~	O
5	O
%–	O
15	O
%.	O

We	O
also	O
compared	O
PEbA	O
to	O
vcMSA	O
,	O
or	O
Vector	B-BT
-	I-BT
clustering	I-BT
Multiple	I-BT
Sequence	I-BT
Alignment	I-BT
,	O
a	O
novel	O
multiple	O
sequence	O
alignment	O
algorithm	O
that	O
aligns	O
proteins	O
based	O
on	O
the	O
clustering	O
and	O
ordering	O
of	O
protein	O
language	O
model	O
embeddings	O
[	O
12	O
].	O

MacSyFinder	B-BT
with	O
the	O
TXSScan	O
models	O
is	O
used	O
to	O
identify	O
genes	O
and	O
gene	O
clusters	O
encoding	O
for	O
diverse	O
secretion	O
systems	O
(	O
24	O
,	O
56	O
).	O

The	O
Hmrbase	B-BT
entries	O
provide	O
links	O
to	O
many	O
external	O
databases	O
such	O
as	O
Swiss	O
-	O
Prot	O
,	O
NCBI	O
Gene	O
,	O
PDB	O
,	O
Pfam	O
etc	O
.	O

Traditional	O
proteomic	O
approaches	O
typically	O
provide	O
static	O
snapshots	O
of	O
protein	O
expression	O
(	O
e	O
.	O
g	O
.,	O
ProteoSign	O
[	O
11	O
],	O
prolfqua	B-BT
[	O
12	O
],	O
ProStaR	O
[	O
13	O
],	O
MixProTool	O
[	O
14	O
]),	O
which	O
are	O
insufficient	O
to	O
capture	O
the	O
dynamic	O
changes	O
and	O
complex	O
interactions	O
that	O
occur	O
over	O
time	O
in	O
response	O
to	O
DNA	O
damage	O
[	O
15	O
,	O
16	O
].	O

The	O
comprehensive	O
list	O
of	O
reactions	O
used	O
in	O
ChemoDOTS	B-BT
,	O
along	O
with	O
their	O
SMARTS	O
representations	O
,	O
is	O
available	O
in	O
Supplementary	O
Tables	O
S3	O
–	O
S5	O
.	O

We	O
trained	O
ML	O
models	O
on	O
the	O
datadiscovery	O
using	O
a	O
Five	O
-	O
fold	O
cross	O
-	O
validation	O
,	O
the	O
generalization	O
test	O
is	O
performed	O
on	O
datainfer	O
by	O
using	O
the	O
datatest	O
as	O
the	O
test	O
data	O
.	O

To	O
this	O
end	O
,	O
we	O
compared	O
the	O
N	O
-	O
glycosylated	O
MHC	O
-	O
II	O
-	O
bound	O
immunopeptides	O
that	O
were	O
reported	O
from	O
tumour	O
tissues	O
of	O
14	O
meningioma	O
patients	O
in	O
the	O
MSFragger	B-BT
-	O
HLA	O
-	O
Glyco	O
database	O
(	O
Bedran	O
,	O
Nat	O
Commun	O
,	O
2023	O
)	O
to	O
those	O
we	O
identified	O
with	O
the	O
commercial	O
Byonic	O
software	O
.	O

We	O
compared	O
these	O
with	O
the	O
high	O
frequency	O
contacts	O
identified	O
by	O
cooltools	B-BT
and	O
reported	O
by	O
Oksuz	O
et	O
al	O
.	O
20	O
for	O
the	O
combined	O
H1	O
and	O
HFFc6	O
data	O
(	O
Fig	O
.	O

Functional	O
Enrichment	O
Analysis	O
(	O
FEA	O
)	O
was	O
performed	O
using	O
Subtiwiki	B-BT
functional	O
categories	O
.	O

novaeangliaeComplete	O
BUSCOs	O
(	O
C	O
):	O
95	O
.	O
4	O
%	O
[	O
Single	O
-	O
copy	O
:	O
92	O
.	O
7	O
%,	O
Duplicated	O
:	O
2	O
.	O
7	O
%]	O
Fragmented	O
BUSCOs	O
(	O
F	O
):	O
1	O
.	O
4	O
%	O
Missing	O
BUSCOs	O
(	O
M	O
):	O
3	O
.	O
2	O
%	O
Total	O
number	O
of	O
BUSCOs	O
searched	O
(	O
n	O
):	O
9	O
,	O
226	O

In	O
the	O
future	O
,	O
we	O
will	O
continue	O
to	O
update	O
DDK	B-BT
-	I-BT
Linker	I-BT
to	O
alleviate	O
the	O
bottleneck	O
in	O
the	O
interpretation	O
of	O
omics	O
data	O
.	O

Figure	O
2	O
,	O
panel	O
c	O
,	O
""""	O
DCPred	O
""""	O
in	O
the	O
legend	O
should	O
be	O
""""	O
CDPred	B-BT
""""	O

Access	O
to	O
the	O
data	O
in	O
kmerDB	B-BT
is	O
facilitated	O
via	O
the	O
Browse	O
menu	O
located	O
at	O
the	O
kmerDB	B-BT
navigation	O
bar	O
.	O

Even	O
when	O
substantially	O
increasing	O
the	O
number	O
of	O
trees	O
in	O
RF	O
,	O
the	O
selection	O
of	O
points	O
and	O
assignment	O
of	O
importance	O
are	O
nearly	O
identical	O
to	O
those	O
selected	O
with	O
the	O
lower	O
number	O
of	O
trees	O
,	O
and	O
still	O
do	O
not	O
capture	O
the	O
points	O
selected	O
by	O
LAVASET	B-BT
.	O

The	O
steps	O
to	O
contributing	O
to	O
the	O
project	O
are	O
described	O
on	O
the	O
GitHub	O
page	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
Popgen48	O
/	O
scalepopgen	B-BT
).	O

A	O
slim	O
cholangioscope	O
(	O
9	O
-	O
Fr	O
eyeMAX	O
;	O
Micro	O
-	O
Tech	O
,	O
Nanjing	O
,	O
China	O
)	O
was	O
inserted	O
into	O
the	O
afferent	O
loop	O
via	O
the	O
EUS	O
-	O
HGS	O
and	O
hepaticojejunostomy	O
anastomoses	O
.	O

Alignments	O
were	O
created	O
using	O
the	O
L	O
-	O
INS	O
-	O
i	O
algorithm	O
in	O
MAFFT	O
(	O
Katoh	O
and	O
Standley	O
2013	O
)	O
and	O
assessed	O
in	O
AliView	O
(	O
Larsson	O
2014	O
),	O
and	O
phylogenetically	O
informative	O
sites	O
were	O
selected	O
with	O
trimAl	B-BT
(	O
Capella	O
-	O
Gutiérrez	O
et	O
al	O
.	O

Some	O
phage	O
genomes	O
were	O
predicted	O
,	O
with	O
high	O
confidence	O
(>	O
90	O
%	O
iPHoP	B-BT
confidence	O
score	O
),	O
to	O
infect	O
bacteria	O
across	O
multiple	O
genera	O
.	O

Table	O
1	O
demonstrates	O
that	O
cloudrnaSPAdes	B-BT
is	O
capable	O
of	O
assembling	O
isoforms	O
,	O
more	O
than	O
98	O
%	O
of	O
which	O
are	O
accurately	O
assigned	O
using	O
IsoQuant	O
.	O

Table	O
2Correlations	O
of	O
the	O
mean	O
NC	O
curves	O
among	O
synergies	O
across	O
groups	O
with	O
Pearson	O
correlation	O
coefficient	O
test	O
.	O
Normal	O
p	O
-	O
valueLow	O
Arch	O
p	O
-	O
valueNC	O
1	O
Low	O
Arch0	O
.	O
935	O
0	O
.	O
01	O
High	O
Arch0	O
.	O
771	O
0	O
.	O
0290	O
.	O
776	O
0	O
.	O
032NC	O
2	O
Low	O
Arch0	O
.	O
804	O
0	O
.	O
02	O
High	O
Arch0	O
.	O
860	O
0	O
.	O
0110	O
.	O
820	O
0	O
.	O
01NC	O
3	O
Low	O
Arch0	O
.	O
940	O
0	O
.	O
01	O
High	O
Arch0	O
.	O
675	O
0	O
.	O
0380	O
.	O
663	O
0	O
.	O
036NC	O
4	O
Low	O
Arch0	O
.	O
634	O
0	O
.	O
027	O
High	O
Arch0	O
.	O
645	O
0	O
.	O
0310	O
.	O
871	O
0	O
.	O
03NC	O
5	O
Low	O
Arch0	O
.	O
866	O
0	O
.	O
02	O
High	O
Arch0	O
.	O
938	O
0	O
.	O
010	O
.	O
854	O
0	O
.	O
01Significant	O
correlations	O
are	O
indicated	O
by	O
bold	O
values	O
(	O
p	O
˂	O
0	O
.	O
001	O
).	O

Applied	O
on	O
the	O
SNP	O
groups	O
aggregated	O
from	O
co	O
-	O
expression	O
gene	O
modules	O
,	O
BayesKAT	B-BT
is	O
able	O
to	O
pinpoint	O
specific	O
modules	O
as	O
significantly	O
associated	O
with	O
the	O
whole	O
brain	O
volume	O
trait	O
(	O
Figure	O
6B	O
Left	O
).	O

MarkerScan	B-BT
aims	O
to	O
change	O
this	O
approach	O
by	O
additionally	O
generating	O
high	O
quality	O
genomes	O
for	O
all	O
additional	O
species	O
present	O
in	O
the	O
sample	O
.	O

We	O
present	O
shinyseg	B-BT
,	O
a	O
comprehensive	O
web	O
application	O
for	O
clinical	O
cosegregation	O
analysis	O
.	O

Concept	O
and	O
design	O
:	O
Manxue	O
Zhang	O
,	O
Jianqun	O
Fang	O
Acquisition	O
,	O
analysis	O
,	O
or	O
interpretation	O
of	O
data	O
:	O
Manxue	O
Zhang	O
,	O
Chujun	O
Wu	O
,	O
Shihao	O
Lu	O
,	O
Yunyun	O
Du	O
,	O
Shaoxia	O
Wang	O
,	O
Rui	O
Ma	O
Drafting	O
of	O
the	O
manuscript	O
:	O
Manxue	O
Zhang	O
.	O

“	O
Problems	O
paying	O
medical	O
bills	O
”	O
is	O
based	O
on	O
a	O
positive	O
response	O
to	O
the	O
question	O
,	O
“	O
In	O
the	O
past	O
12	O
months	O
,	O
did	O
you	O
/	O
anyone	O
in	O
the	O
family	O
have	O
problems	O
paying	O
or	O
were	O
unable	O
to	O
pay	O
any	O
medical	O
bills	O
?	O

Performance	O
comparison	O
of	O
various	O
prediction	O
heads	O
on	O
the	O
DisGeNET	B-BT
-	O
EVAL	O
dataset	O

Patient	O
metadata	O
were	O
retrieved	O
from	O
electronic	O
records	O
and	O
movements	O
visualized	O
with	O
HAIviz	B-BT
v	O
.	O
0	O
.	O
3	O
(	O
https	O
://	O
haiviz	B-BT
.	O
beatsonlab	O
.	O
com	O
/).	O

Visualization	O
efficiency	O
for	O
two	O
types	O
of	O
CRISPR	O
-	O
Sirius	O
system	O
with	O
different	O
target	O
loci	O
.	O

Proteomics	O
,	O
transcriptomics	O
,	O
mutations	O
and	O
copy	O
number	O
alteration	O
(	O
CNA	O
)	O
data	O
can	O
be	O
used	O
to	O
modify	O
different	O
variables	O
of	O
the	O
MaBoSS	B-BT
framework	O
,	O
such	O
as	O
node	O
activity	O
status	O
,	O
transition	O
rates	O
and	O
initial	O
conditions	O
.	O

Figure	O
1c	O
shows	O
that	O
JCAT	B-BT
uses	O
the	O
most	O
prevalent	O
codon	O
in	O
highly	O
expressed	O
genes	O
,	O
resulting	O
in	O
a	O
CAI	O
of	O
1	O
.	O

Following	O
this	O
methodology	O
,	O
SyntenyViewer	B-BT
delivers	O
published	O
comparative	O
genomics	O
data	O
(	O
listed	O
in	O
Table	O
1	O
)	O
obtained	O
for	O
the	O
two	O
major	O
angiosperm	O
families	O
with	O
the	O
grasses	O
within	O
the	O
monocots	O
[	O
ancestral	O
grass	O
karyotype	O
(	O
AGK	O
)	O
with	O
12	O
protochromosomes	O
and	O
16	O
560	O
PGs	O
(	O
21	O
,	O
22	O
)]	O
and	O
the	O
eudicots	O
[	O
ancestral	O
eudicot	O
karyotype	O
(	O
AEK	O
)	O
with	O
21	O
chromosomes	O
and	O
10	O
286	O
PGs	O
(	O
23	O
)].	O

All	O
the	O
retained	O
SNP	O
sites	O
were	O
divided	O
into	O
three	O
groups	O
according	O
to	O
the	O
magnitude	O
of	O
AStruct	B-BT
score	O
,	O
which	O
are	O
‘	O
Low	O
’	O
(	O
0	O
),	O
‘	O
Medium	O
’	O
(	O
0	O
,	O
1	O
],	O
and	O
‘	O
High	O
’	O
(	O
1	O
,	O
+	O
∞).	O

For	O
instance	O
,	O
the	O
number	O
of	O
peptides	O
with	O
1	O
variable	O
modification	O
reported	O
by	O
Dear	O
‐	O
PSM	O
,	O
MSFragger	B-BT
,	O
and	O
Sage	O
were	O
7544	O
,	O
7015	O
,	O
and	O
6492	O
,	O
respectively	O
(	O
Figure	O
5C	O
).	O

Default	O
values	O
for	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}	O
}{}	O
k	O
\	O
end	O
{	O
document	O
}	O
k	O
and	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}	O
}{}	O
q	O
\	O
end	O
{	O
document	O
}	O
q	O
in	O
RmsiGUI	B-BT
are	O
100	O
and	O
98	O
%,	O
respectively	O
.	O

tRigon	B-BT
session	O
report	O
in	O
html	O
-	O
format	O
for	O
a	O
k	O
-	O
means	O
clustering	O
analysis	O
including	O
all	O
inputs	O
,	O
setting	O
options	O
and	O
outputs	O
.	O
Additional	O
file	O
2	O
.	O

Through	O
extensive	O
studies	O
with	O
simulated	O
and	O
empirical	O
datasets	O
,	O
we	O
have	O
shown	O
that	O
scTensor	B-BT
can	O
detect	O
some	O
hypergraphs	O
that	O
cannot	O
be	O
detected	O
using	O
conventional	O
CCI	O
detection	O
methods	O
,	O
especially	O
when	O
they	O
include	O
many	O
-	O
to	O
-	O
many	O
relationships	O
.	O

AlphaFind	B-BT
was	O
developed	O
to	O
provide	O
an	O
intuitive	O
and	O
useful	O
interface	O
for	O
discovering	O
structurally	O
similar	O
proteins	O
within	O
AlphaFold	O
DB	O
.	O

PhysiBoSS	O
utilizes	O
MaBoSS	B-BT
[	O
17	O
,	O
18	O
],	O
a	O
tool	O
that	O
models	O
signaling	O
pathways	O
as	O
Boolean	O
networks	O
,	O
thus	O
simplifying	O
the	O
description	O
of	O
intracellular	O
models	O
.	O

Nucleotide	O
coverage	O
of	O
reference	O
genomes	O
upon	O
use	O
of	O
single	O
-	O
target	O
tiled	O
amplicon	O
PCR	O
(	O
TA	O
-	O
PCR	O
)	O
custom	O
primer	O
sets	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
(	O
A	O
)	O
and	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
)	O
(	O
B	O
)	O
present	O
in	O
positive	O
control	O
samples	O
.	O

Jalview	B-BT
a	O
free	O
cross	O
-	O
platform	O
program	O
for	O
multiple	O
sequence	O
alignment	O
editing	O
,	O
visualization	O
,	O
and	O
analysis	O
.	O

All	O
this	O
supports	O
the	O
assessment	O
that	O
MACS2	O
does	O
not	O
take	O
into	O
account	O
RD	O
-	O
scaling	O
and	O
overestimates	O
the	O
significance	O
of	O
cis	O
peaks	O
close	O
to	O
the	O
Malat1	O
gene	O
boundaries	O
,	O
which	O
is	O
corrected	O
by	O
the	O
BaRDIC	B-BT
algorithm	O
(	O
Figure	O
4D	O
).	O

Values	O
close	O
to	O
zero	O
suggest	O
no	O
strong	O
systematic	O
relationship	O
under	O
the	O
PhyloAcc	B-BT
-	I-BT
C	I-BT
model	O
.	O

The	O
strains	O
(	O
PGRG2	O
and	O
PGRG5	O
)	O
were	O
initially	O
mapped	O
to	O
the	O
reference	O
genomes	O
using	O
Burrows	O
-	O
Wheeler	O
aligner	O
“	O
mem	O
”	O
algorithm	O
(	O
BWA	O
-	O
mem	O
)	O
v	O
.	O
0	O
.	O
7	O
.	O
17	O
(	O
5	O
)	O
and	O
converted	O
and	O
sorted	O
into	O
BAM	O
file	O
using	O
SAMtools	B-BT
v	O
.	O
0	O
.	O
1	O
.	O
18	O
(	O
6	O
).	O

Bulleted	O
list	O
of	O
achievements	O
(	O
success	O
stories	O
)	O
derived	O
from	O
using	O
OmicNavigator	B-BT
at	O
AbbVie	O
.	O

vcfdist	O
segments	O
contigs	O
into	O
independent	O
superclusters	O
using	O
heuristics	O
or	O
a	O
bidirectional	O
wavefront	O
algorithm	O
(	O
biWFA	B-BT
)	O
[	O
36	O
],	O
as	O
shown	O
in	O
Additional	O
File	O
1	O
:	O
Table	O
S2	O
.	O

Critical	O
review	O
of	O
the	O
manuscript	O
for	O
important	O
intellectual	O
content	O
:	O
Madalena	O
Carvalho	O
,	O
Francisca	O
Galhardo	O
Saraiva	O
,	O
Inês	O
Coutinho	O
,	O
Vanda	O
Bento	O
,	O
Marta	O
Cabral	O

FRETpredict	B-BT
consists	O
of	O
two	O
main	O
routines	O
:	O
rotamer	O
library	O
generation	O
(	O
a	O
,	O
b	O
)	O
and	O
FRET	O
efficiency	O
calculation	O
(	O
c	O
,	O
d	O
).	O

In	O
addition	O
to	O
the	O
typical	O
viruses	O
and	O
tlaRNAs	O
known	O
to	O
cause	O
CMD	O
and	O
to	O
occur	O
in	O
the	O
U	O
.	O
S	O
.—	O
the	O
polerovirus	O
carrot	O
red	O
leaf	O
virus	O
(	O
CtRLV	O
),	O
the	O
umbraviruses	O
carrot	O
mottle	O
virus	O
(	O
CMoV	O
)	O
and	O
carrot	O
mottle	O
mimic	O
virus	O
(	O
CMoMV	O
),	O
and	O
CtRLVaRNAs	O
(	O
CtRLVaRNAs	O
)—	O
we	O
identified	O
the	O
emergent	O
poleroviruses	O
Torilis	O
crimson	O
leaf	O
virus	O
(	O
TorCLV	O
)	O
and	O
Foeniculum	O
vulgare	O
polerovirus	O
(	O
FvPV	O
),	O
two	O
potentially	O
divergent	O
,	O
strains	O
of	O
CMoV	O
,	O
which	O
we	O
refer	O
to	O
by	O
the	O
names	O
given	O
them	O
in	O
published	O
reports	O
—	O
Pastinaca	O
umbravirus	O
1	O
(	O
PasUV1	O
)	O
and	O
wild	O
carrot	O
mottle	O
virus	O
(	O
WCMoV	O
),	O
and	O
the	O
tlaRNA	O
,	O
arracacha	O
latent	O
virus	O
E	O
associated	O
RNA	O
(	O
ALVEaRNA	O
),	O
none	O
of	O
which	O
have	O
been	O
previously	O
identified	O
in	O
the	O
U	O
.	O
S	O
.	O

Furthermore	O
,	O
post	O
-	O
transplant	O
,	O
per	O
our	O
institutional	O
protocol	O
,	O
we	O
initiated	O
maintenance	O
therapy	O
without	O
the	O
requirement	O
of	O
two	O
additional	O
cycles	O
of	O
consolidation	O
,	O
as	O
was	O
done	O
in	O
both	O
the	O
GRIFFIN	O
and	O
PERSEUS	O
trials	O
.	O

FRETpredict	B-BT
systematically	O
takes	O
into	O
account	O
the	O
protein	O
conformational	O
ensemble	O
and	O
accurately	O
models	O
the	O
conformational	O
ensemble	O
of	O
the	O
fluorophore	O
labels45	O
.	O

coli	O
were	O
compared	O
using	O
Jalview	B-BT
.	O

DiGAlign	B-BT
is	O
provided	O
through	O
GenomeNet	O
(	O
https	O
://	O
www	O
.	O
genome	O
.	O
jp	O
/).	O

Raw	O
images	O
and	O
segmented	O
single	O
-	O
cell	O
crops	O
associated	O
with	O
PIFiA	B-BT
are	O
available	O
for	O
download	O
at	O
https	O
://	O
thecellvision	O
.	O
org	O
/	O
pifia_files	B-BT
.	O

In	O
addition	O
to	O
the	O
GI	O
KBs	O
,	O
we	O
built	O
two	O
automated	O
services	O
to	O
extend	O
the	O
existing	O
MatchMiner	B-BT
infrastructure	O
in	O
support	O
of	O
GI	O
TARGET	O
to	O
facilitate	O
case	O
review	O
and	O
report	O
generation	O
(	O
Supplemental	O
Figure	O
1	O
,	O
Data	O
Supplement	O
).	O

•	O
Comprehensive	O
protocol	O
for	O
analyzing	O
differential	O
protein	O
complex	O
compositions	O
•	O
Guide	O
to	O
process	O
from	O
cell	O
extract	O
preparation	O
to	O
publication	O
-	O
quality	O
figures	O
•	O
Includes	O
statistical	O
peptide	O
analysis	O
through	O
Perseus	O
,	O
a	O
user	O
-	O
friendly	O
software	O

We	O
used	O
an	O
R	O
toolkit	O
called	O
RAMZIS	B-BT
(	O
23	O
)	O
that	O
calculates	O
a	O
modified	O
Tanimoto	O
coefficient	O
to	O
estimate	O
the	O
similarity	O
of	O
glycosylation	O
between	O
two	O
experimental	O
groups	O
,	O
A	O
and	O
B	O
(	O
e	O
.	O
g	O
.,	O
WT	O
versus	O
mutant	O
,	O
DDA	O
versus	O
DIA	O
,	O
etc	O
.).	O

We	O
considered	O
separately	O
the	O
best	O
prediction	O
by	O
iPHoP	B-BT
versus	O
the	O
set	O
of	O
hosts	O
predicted	O
by	O
iPHoP	B-BT
when	O
evaluating	O
its	O
performance	O
on	O
the	O
complete	O
host	O
range	O
studies	O
.	O

The	O
current	O
methodology	O
is	O
also	O
implemented	O
as	O
an	O
R	O
package	O
entitled	O
Single	O
Cell	O
Ranking	O
Analysis	O
Toolkit	O
(	O
scRANK	B-BT
)	O
and	O
is	O
available	O
for	O
download	O
and	O
installation	O
via	O
GitHub	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
aoulas	O
/	O
scRANK	B-BT
).	O

Sixty	O
recreational	O
male	O
runners	O
with	O
a	O
heel	O
-	O
toe	O
running	O
pattern	O
participated	O
in	O
this	O
study	O
and	O
were	O
divided	O
into	O
three	O
groups	O
of	O
LA	O
,	O
HA	O
and	O
normal	O
arch	O
.	O

We	O
developed	O
scPrisma	B-BT
,	O
a	O
spectral	O
analysis	O
framework	O
that	O
uses	O
topological	O
priors	O
over	O
underlying	O
signals	O
in	O
single	O
-	O
cell	O
data	O
,	O
to	O
allow	O
for	O
their	O
inference	O
,	O
enhancement	O
and	O
filtering	O
.	O

The	O
C	O
API	O
of	O
HTSlib	B-BT
(	O
Bonfield	O
et	O
al	O
.	O

More	O
expensive	O
amberjack	O
or	O
snapper	O
were	O
less	O
well	O
represented	O
.	O

In	O
[	O
25	O
,	O
26	O
],	O
the	O
authors	O
introduced	O
a	O
DSC	O
method	O
to	O
replace	O
the	O
traditional	O
backstepping	O
control	O
method	O
,	O
and	O
proposed	O
an	O
adaptive	O
DSC	O
strategy	O
to	O
solve	O
the	O
control	O
problem	O
of	O
nonlinear	O
systems	O
with	O
sensor	O
faults	O
.	O

The	O
high	O
correlation	O
suggests	O
that	O
the	O
probability	O
of	O
inter	O
-	O
chain	O
contacts	O
predicted	O
by	O
CDPred	B-BT
can	O
be	O
used	O
to	O
estimate	O
the	O
confidence	O
of	O
the	O
inter	O
-	O
chain	O
prediction	O
.	O
Fig	O
.	O

In	O
response	O
to	O
the	O
Supreme	O
Court	O
’	O
s	O
directive	O
to	O
prevent	O
discrimination	O
against	O
LGBTQ	O
+	O
individuals	O
,	O
policymakers	O
are	O
also	O
urged	O
to	O
enact	O
laws	O
explicitly	O
prohibiting	O
it	O
across	O
various	O
domains	O
of	O
society	O
,	O
with	O
health	O
and	O
social	O
care	O
crucial	O
among	O
them	O
.	O

The	O
source	O
code	O
and	O
documentation	O
are	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
ysekig	O
/	O
GPMsDB	O
-	O
tk	O
[	O
59	O
]	O
and	O
https	O
://	O
github	O
.	O
com	O
/	O
ysekig	O
/	O
GPMsDB	B-BT
-	I-BT
dbtk	I-BT
[	O
60	O
].	O

The	O
efficiency	O
of	O
the	O
InPACT	O
at	O
Home	O
website	O
was	O
also	O
deemed	O
low	O
,	O
and	O
errors	O
were	O
deemed	O
high	O
.	O

MetaPathPredict	B-BT
cannot	O
yet	O
be	O
applied	O
to	O
archaeal	O
MAGs	O
.	O

REAGENT	O
or	O
RESOURCESOURCEIDENTIFIERAntibodiesAnti	O
-	O
γH2AX	O
Ser139Cell	O
signaling	O
TechnologyCat	O
#	O
9718	O
,	O
RRID	O
:	O
AB_2118009Anti	O
-	O
H2AXCell	O
signaling	O
TechnologyCat	O
#	O
2595	O
,	O
RRID	O
:	O
AB_10694556Anti	O
-	O
p21Cell	O
signaling	O
TechnologyCat	O
#	O
2947	O
,	O
RRID	O
:	O
AB_823586Anti	O
-	O
CDC2Cell	O
signaling	O
TechnologyCat	O
#	O
9116	O
,	O
RRID	O
:	O
AB_2074795Anti	O
-	O
CDC25cCell	O
signaling	O
TechnologyCat	O
#	O
4688	O
,	O
RRID	O
:	O
AB_560956Anti	O
-	O
cyclin	O
B1Cell	O
signaling	O
TechnologyCat	O
#	O
12231	O
,	O
RRID	O
:	O
AB_2783553Anti	O
-	O
c	O
-	O
MycCell	O
signaling	O
TechnologyCat	O
#	O
9402	O
,	O
RRID	O
:	O
AB_2151827Anti	O
-	O
BidCell	O
signaling	O
TechnologyCat	O
#	O
2002	O
,	O
RRID	O
:	O
AB_10692485Anti	O
-	O
ATMCell	O
signaling	O
TechnologyCat	O
#	O
2873	O
,	O
RRID	O
:	O
AB_2062659Anti	O
-	O
p	O
-	O
ATM	O
Ser1981Cell	O
signaling	O
TechnologyCat	O
#	O
5883	O
,	O
RRID	O
:	O
AB_10835213Anti	O
-	O
ATRCell	O
signaling	O
TechnologyCat	O
#	O
2790	O
,	O
RRID	O
:	O
AB_2227860Anti	O
-	O
p	O
-	O
ATRCell	O
signaling	O
TechnologyCat	O
#	O
2853	O
,	O
RRID	O
:	O
AB_2290281Anti	O
-	O
Chk1Cell	O
signaling	O
TechnologyCat	O
#	O
2360	O
,	O
RRID	O
:	O
AB_2080320Anti	O
-	O
p	O
-	O
Chk1	O
Ser348Cell	O
signaling	O
TechnologyCat	O
#	O
2348	O
,	O
RRID	O
:	O
AB_331212Anti	O
-	O
Chk2Cell	O
signaling	O
TechnologyCat	O
#	O
6334	O
,	O
RRID	O
:	O
AB_11178526Anti	O
-	O
p	O
-	O
Chk2	O
Thr68Cell	O
signaling	O
TechnologyCat	O
#	O
2661	O
,	O
RRID	O
:	O
AB_331479Anti	O
-	O
caspase	O
9Cell	O
signaling	O
TechnologyCat	O
#	O
9508	O
,	O
RRID	O
:	O
AB_2068620Anti	O
-	O
caspase	O
8Cell	O
signaling	O
TechnologyCat	O
#	O
9746	O
,	O
RRID	O
:	O
AB_2275120Anti	O
-	O
p	O
-	O
Rb	O
(	O
Ser807	O
/	O
811	O
)	O
Cell	O
signaling	O
TechnologyCat	O
#	O
8516	O
,	O
RRID	O
:	O
AB_11178658Anti	O
-	O
p53Cell	O
signaling	O
TechnologyCat	O
#	O
2524	O
,	O
RRID	O
:	O
AB_331743Anti	O
-	O
cyclin	O
ASanta	O
Cruz	O
BiotechnologyCat	O
#	O
sc	O
-	O
751	O
,	O
RRID	O
:	O
AB_631329Anti	O
-	O
cyclin	O
ESanta	O
Cruz	O
BiotechnologyCat	O
#	O
sc	O
-	O
247	O
,	O
RRID	O
:	O
AB_627357Anti	O
-	O
cyclin	O
D1Santa	O
Cruz	O
BiotechnologyCat	O
#	O
sc	O
-	O
753	O
,	O
RRID	O
:	O
AB_2070433Anti	O
-	O
CDK2Cell	O
signaling	O
TechnologyCat	O
#	O
2546	O
,	O
RRID	O
:	O
AB_2276129Anti	O
-	O
RbSanta	O
Cruz	O
BiotechnologyCat	O
#	O
sc	O
-	O
50	O
,	O
RRID	O
:	O
AB_632339Anti	O
-	O
p	O
-	O
Rb	O
(	O
Ser249	O
)	O
Santa	O
Cruz	O
BiotechnologyCat	O
#	O
sc	O
-	O
16671	O
,	O
RRID	O
:	O
AB_655229Anti	O
-	O
β	O
-	O
actinSigma	O
-	O
AldrichCat	O
#	O
A5441	O
,	O
RRID	O
:	O
AB_476744Anti	O
-	O
Mouse	O
IgG	O
,	O
HRP	O
-	O
linkedCell	O
signaling	O
TechnologyCat	O
#	O
7076	O
,	O
RRID	O
:	O
AB_330924Anti	O
-	O
Rabbit	O
IgG	O
,	O
HRP	O
-	O
linkedCell	O
signaling	O
TechnologyCat	O
#	O
7074	O
,	O
RRID	O
:	O
AB_2099233Chemicals	O
,	O
peptides	O
,	O
and	O
recombinant	O
proteinsDMSOSigma	O
-	O
AldrichCat	O
#	O
8418DoxorubicinSigma	O
-	O
AldrichCat	O
#	O
D1515Protease	O
/	O
phosphatase	O
inhibitors	O
cocktailSigma	O
-	O
AldrichCat	O
#	O
MSSAFEEnhanced	O
Chemiluminescence	O
reagentBioradCat	O
#	O
1705061SYBR	O
goldInvitrogenCat	O
#	O
S11494Critical	O
commercial	O
assaysRNA	O
extraction	O
kitNorgen	O
BiotekCat	O
#	O
17200Comet	O
assay	O
kitTrevigenCat	O
#	O
4250	O
-	O
050	O
-	O
KSuperScript	O
VILO	O
cDNA	O
Synthesis	O
kitInvitrogenCat	O
#	O
11754050Ion	O
Library	O
TaqMan	O
™	O
Quantitation	O
KitApplied	O
BiosystemsCat	O
#	O
4468802GoTaq	O
qPCR	O
master	O
mixPromegaCat	O
#	O
A6001FITC	O
Annexin	O
V	O
Apoptosis	O
Detection	O
KitBecton	O
DickensonCat	O
#	O
556547Experimental	O
models	O
:	O
Cell	O
linesMCF7University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AMDA	O
-	O
MB	O
-	O
231University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AA549University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AHCT116University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AHepG2University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AU87University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AU373University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AHeLaUniversity	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AF180University	O
Medical	O
Center	O
Hamburg	O
-	O
EppendorfN	O
/	O
AHME1ATCCCat	O
#	O
CRL	O
-	O
4010HCT116	O
CDK4	O
KOUniversity	O
of	O
SharjahN	O
/	O
ASoftware	O
and	O
algorithmsGraphPad	O
Prism6GraphPadhttps	O
://	O
www	O
.	O
graphpad	O
.	O
com	O
/	O
scientificsoftware	O
/	O
prism	O
/	O
ImageJImageJhttps	O
://	O
imagej	O
.	O
nih	O
.	O
gov	O
/	O
ij	O
/	O
Image	O
LabBioradhttps	O
://	O
www	O
.	O
bio	O
-	O
rad	O
.	O
com	O
/	O
en	O
-	O
ae	O
/	O
product	O
/	O
image	O
-	O
lab	O
-	O
software	O
?	O
ID	O
=	O
KRE6P5E8ZRotor	O
-	O
gene	O
QQiagenhttps	O
://	O
www	O
.	O
qiagen	O
.	O
com	O
/	O
kr	O
/	O
resources	O
/	O
resourcedetail	O
?	O
id	O
=	O
8435805b	O
-	O
2c5d	O
-	O
4fa9	O
-	O
948c	O
-	O
a43de75a7ee1	O
&	O
lang	O
=	O
enFlow	O
JoTree	O
Starhttps	O
://	O
www	O
.	O
flowjo	O
.	O
com	O
/	O
Ion	O
Torrent	O
Software	O
SuiteThermo	O
Fisher	O
Scientifichttps	O
://	O
www	O
.	O
thermofisher	O
.	O
com	O
/	O
ae	O
/	O
en	O
/	O
home	O
/	O
life	O
-	O
science	O
/	O
sequencing	O
/	O
next	O
-	O
generation	O
-	O
sequencing	O
/	O
ion	O
-	O
torrent	O
-	O
next	O
-	O
generation	O
-	O
sequencing	O
-	O
workflow	O
/	O
ion	O
-	O
torrent	O
-	O
next	O
-	O
generation	O
-	O
sequencing	O
-	O
data	O
-	O
analysis	O
-	O
workflow	O
/	O
ion	O
-	O
torrent	O
-	O
suite	O
-	O
software	O
.	O
htmlMSD	O
Enhanced	O
ChemstationShimadzuhttps	O
://	O
www	O
.	O
shimadzu	O
.	O
com	O
/	O
an	O
/	O
products	O
/	O
gas	O
-	O
chromatograph	O
-	O
mass	O
-	O
spectrometry	O
/	O
gc	O
-	O
ms	O
-	O
software	O
/	O
index	O
.	O
html	O

VCF	O
-	O
Miner	O
[	O
9	O
],	O
BrowseVCF	O
[	O
10	O
],	O
and	O
123VCF	B-BT
[	O
11	O
]	O
are	O
tools	O
that	O
allow	O
users	O
to	O
filter	O
VCF	O
files	O
dynamically	O
according	O
to	O
the	O
annotations	O
present	O
in	O
them	O
and	O
by	O
genomic	O
regions	O
.	O

S2D	O
),	O
LAVASET	B-BT
has	O
F1	O
-	O
scores	O
at	O
96	O
%	O
and	O
89	O
%	O
in	O
the	O
two	O
doublets	O
.	O

Human	B-BT
Splicing	I-BT
Finder	I-BT
Version	O
2	O
.	O
4	O
.	O
1	O
suggested	O
that	O
the	O
c	O
.	O
5633A	O
>	O
T	O
of	O
DYSF	O
mutation	O
caused	O
alteration	O
of	O
auxiliary	O
sequences	O
and	O
significant	O
alteration	O
of	O
the	O
ESE	O
/	O
ESS	O
motif	O
ratio	O
.	O

Examples	O
include	O
the	O
market	O
names	O
of	O
snapper	O
,	O
tuna	O
,	O
and	O
cod	O
,	O
which	O
could	O
acceptably	O
be	O
used	O
in	O
Canada	O
for	O
the	O
sale	O
of	O
96	O
,	O
14	O
,	O
and	O
two	O
species	O
,	O
respectively	O
.	O

REAGENT	O
or	O
RESOURCESOURCEIDENTIFIERBiological	O
samplesGastrocnemius	O
muscle	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Heart	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Kidney	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Liver	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Lung	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Hippocampus	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Subcutaneous	O
white	O
adipose	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Subcutaneous	O
brown	O
adipose	O
rat	O
tissueMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358Chemicals	O
,	O
peptides	O
,	O
and	O
recombinant	O
proteins100	O
%	O
ethanolThermo	O
Fisher	O
ScientificBP2818500HPLC	O
grade	O
100	O
%	O
acetonitrileThermo	O
Fisher	O
ScientificA998	O
-	O
11x	O
PBSThermo	O
Fisher	O
Scientific1001002320X	O
TE	O
buffer	O
(	O
200	O
mM	O
Tris	O
-	O
HCL	O
,	O
20	O
mM	O
EDTA	O
,	O
pH	O
7	O
.	O
5	O
)	O
Thermo	O
Fisher	O
ScientificR11490Low	O
-	O
EDTA	O
TE	O
buffer	O
(	O
10	O
mM	O
Tris	O
,	O
20	O
mM	O
EDTA	O
,	O
pH	O
8	O
.	O
0	O
)	O
Thermo	O
Fisher	O
ScientificJ75793	O
-	O
AEUltraPure	O
DNase	O
/	O
RNase	O
-	O
free	O
distilled	O
waterInvitrogen10977015Unmethylated	O
Lambda	O
DNAPromegaD1521PhiX	O
control	O
v3Illumina	O
Inc	O
.	O
FC	O
-	O
110	O
-	O
3001Critical	O
commercial	O
assaysGenFind	O
V3	O
kit	O
–	O
384	O
prepsBeckman	O
CoulterC34881Qubit	O
dsDNA	O
quantitation	O
,	O
high	O
sensitivity	O
assay	O
(	O
Qubit	O
dsDNA	O
HS	O
assay	O
kit	O
,	O
500	O
assays	O
)	O
Thermo	O
Fisher	O
ScientificQ32854Qubit	O
dsDNA	O
quantitation	O
,	O
broad	O
range	O
assay	O
(	O
Qubit	O
dsDNA	O
BR	O
assay	O
kit	O
,	O
500	O
assays	O
)	O
Thermo	O
Fisher	O
ScientificQ32853Ovation	O
RRBS	O
Methyl	O
-	O
Seq	O
system	O
with	O
TrueMethyl	O
oxBS	O
,	O
96	O
reactionsTecan9522	O
-	O
A01MiSeq	O
reagent	O
kit	O
v2	O
(	O
300	O
-	O
cycles	O
)	O
Illumina	O
Inc	O
.	O
MS	O
-	O
102	O
-	O
2002AMPure	O
XP	O
beadsBeckman	O
CoulterA63881NovaSeq	O
6000	O
S4	O
reagent	O
kit	O
v1	O
.	O
5	O
(	O
200	O
cycles	O
)	O
Illumina	O
Inc	O
.	O
20028313High	O
sensitivity	O
NGS	O
fragment	O
analysis	O
kit	O
(	O
1	O
bp	O
–	O
6	O
,	O
000	O
bp	O
),	O
500	O
samplesAgilent	O
TechnologiesDNF	O
-	O
474	O
-	O
0500Deposited	O
dataMoTrPAC	B-BT
raw	O
and	O
processed	O
dataMoTrPAC	B-BT
Study	O
Group	O
20224GEO	O
:	O
GSE242358MoTrPAC	B-BT
processed	O
data	O
and	O
analysis	O
resultsMoTrPAC	B-BT
Study	O
Group	O
20224Zenodo	O
:	O
10099329	O
;	O
GitHub	O
:	O
MoTrPAC	B-BT
/	O
MotrpacRatTraining6moDataStudy	B-BT
analysis	O
resultsNair	O
et	O
al	O
.,	O
20241https	O
://	O
doi	O
.	O
org	O
/	O
10	O
.	O
5281	O
/	O
zenodo	O
.	O
7199920	O
;	O
https	O
://	O
zenodo	O
.	O
org	O
/	O
deposit	O
/	O
7199920Experimental	O
models	O
:	O
Organisms	O
/	O
strainsFischer	O
344	O
(	O
F344	O
),	O
inbred	O
rat	O
strain	O
,	O
8	O
months	O
of	O
age	O
,	O
males	O
and	O
femalesNational	O
Institute	O
of	O
Aging	O
(	O
NIA	O
)	O
RRID	O
:	O
RGD_734478Software	O
and	O
algorithmsbcl2fastq2	O
Conversion	O
Software	O
v2	O
.	O
20Illuminahttps	O
://	O
support	O
.	O
illumina	O
.	O
com	O
/	O
downloads	O
/	O
bcl2fastq	O
-	O
conversion	O
-	O
software	O
-	O
v2	O
-	O
20	O
.	O
htmlRRBS	O
data	O
processing	O
pipelineMoTrPAC	B-BT
Study	O
Group	O
20224Zenodo	O
:	O
7853676	O
;	O
GitHub	O
:	O
MoTrPAC	B-BT
/	O
motrpac	B-BT
-	O
rrbs	O
-	O
pipelineR	O
package	O
RnBeads	O
v2	O
.	O
0	O
.	O
Müller	O
et	O
al	O
.	O

We	O
introduce	O
an	O
algorithm	O
“	O
cubeVB	B-BT
”	O
specifically	O
for	O
cubes	O
and	O
show	O
through	O
well	O
calibrated	O
simulation	O
study	O
that	O
it	O
is	O
possible	O
to	O
recover	O
parameters	O
of	O
interest	O
like	O
tree	O
height	O
and	O
length	O
.	O

We	O
performed	O
gene	O
expression	O
analysis	O
of	O
the	O
identified	O
StSET	O
genes	O
across	O
fifteen	O
tissues	O
using	O
the	O
expression	O
data	O
available	O
in	O
the	O
StCoExpNet	B-BT
database	O
[	O
37	O
].	O

Vector	B-BT
-	I-BT
clustering	I-BT
Multiple	I-BT
Sequence	I-BT
Alignment	I-BT

Most	O
steps	O
in	O
tiny	O
-	O
count	O
and	O
tinyRNA	B-BT
run	O
concurrently	O
across	O
libraries	O
to	O
minimize	O
runtime	O
.	O

(	O
genta	O
=	O
gentamicin	O
;	O
vanco	O
=	O
vancomycin	O
)	O
GroupBone	O
cementPremixed	O
gentaPremixed	O
vancoAddition	O
of	O
gentaAddition	O
of	O
vancoTotal	O
gentaTotal	O
vancoA	O
Copal	O
spacem	B-BT
--	O
0	O
.	O
5	O
g2	O
g0	O
.	O
5	O
g2	O
g	O
(	O
low	O
)	O
BCopal	O
spacem	B-BT
--	O
0	O
.	O
5	O
g4	O
g0	O
.	O
5	O
g4	O
g	O
(	O
high	O
)	O
CPalacos	O
R	O
+	O
G0	O
.	O
5	O
g	O
--	O
2	O
g0	O
.	O
5	O
g2	O
g	O
(	O
low	O
)	O
D	O
Palacos	O
R	O
+	O
G0	O
.	O
5	O
g	O
--	O
4	O
g0	O
.	O
5	O
g4	O
g	O
(	O
high	O
)	O
ECopal	O
G	O
+	O
V0	O
.	O
5	O
g2	O
g	O
--	O
0	O
.	O
5	O
g2	O
g	O
(	O
low	O
)	O
FCopal	O
G	O
+	O
V0	O
.	O
5	O
g2	O
g	O
-	O
2	O
g0	O
.	O
5	O
g4	O
g	O
(	O
high	O
)	O

(	O
C	O
)	O
Bar	O
graphs	O
comparing	O
the	O
current	O
PIFiA	B-BT
architecture	O
with	O
a	O
common	O
baseline	O
,	O
DenseNet	O
-	O
121	O
,	O
across	O
four	O
different	O
standards	O
(	O
Gene	O
Ontology	O
Cellular	O
Component	O
,	O
Gene	O
Ontology	O
Bioprocess	O
Slim	O
,	O
KEGG	O
Pathways	O
,	O
EBI	O
Protein	O
complexes	O
)	O
in	O
terms	O
of	O
average	O
precision	O
,	O
F	O
-	O
score	O
and	O
adjusted	O
mutual	O
information	O
(	O
assessed	O
on	O
aFPs	O
of	O
4049	O
proteins	O
).	O

Cavities	O
shown	O
as	O
blue	O
surfaces	O
were	O
calculated	O
with	O
pyKVFinder	B-BT
(	O
https	O
://	O
github	O
.	O
com	O
/	O
LBC	O
-	O
LNBio	O
/	O
pyKVFinder	B-BT
),	O
and	O
their	O
sizes	O
are	O
represented	O
by	O
the	O
number	O
of	O
hydrogen	O
atoms	O
that	O
can	O
be	O
accommodated	O
in	O
the	O
cavity	O
.	O

Unfortunately	O
,	O
the	O
seasonal	O
variation	O
of	O
sand	O
fly	O
species	O
could	O
not	O
be	O
explored	O
in	O
this	O
study	O
,	O
as	O
most	O
sand	O
flies	O
were	O
collected	O
during	O
the	O
rainy	O
seasons	O
.	O

The	O
interactive	O
clusters	O
for	O
Cluster_90	O
and	O
Cluster_78	O
can	O
be	O
accessed	O
at	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
/	O
cluster	O
/	O
graph	O
/	O
434	O
and	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
/	O
cluster	O
/	O
graph	O
/	O
439	O
,	O
respectively	O

All	O
positive	O
samples	O
are	O
obtained	O
from	O
the	O
DisGeNET	B-BT
dataset	O
and	O
do	O
not	O
overlap	O
with	O
DisGeNET	B-BT
-	O
PT	O
,	O
DisGeNET	B-BT
-	O
EVAL	O
and	O
TDC	O
.	O

Since	O
there	O
are	O
many	O
molecular	O
fingerprints	O
available	O
in	O
cheminformatics	O
and	O
new	O
ones	O
can	O
be	O
created	O
for	O
a	O
collection	O
of	O
chemical	O
structures	O
,	O
IDSL_MINT	B-BT
supports	O
any	O
type	O
of	O
user	O
-	O
provided	O
fingerprint	O
as	O
long	O
as	O
it	O
is	O
in	O
the	O
binary	O
vector	O
format	O
.	O

Note	O
:	O
(	O
A	O
)	O
The	O
morphology	O
of	O
the	O
Pinellia	O
ternata	O
(	O
Thunb	O
.)	O
Breit	O
;	O
(	O
B	O
)	O
the	O
whole	O
plant	O
or	O
overground	O
part	O
of	O
Pinellia	O
ternata	O
(	O
Thunb	O
.)	O
Breit	O
;	O
(	O
C	O
)	O
Pinellia	O
ternata	O
decoction	O
pieces	O
;	O
(	O
D	O
)	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
(	O
Fa	O
-	O
Banxia	O
,	O
法半夏	O
);	O
(	O
E	O
)	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Zingibere	O
et	O
Alumine	O
(	O
Jiang	O
-	O
Banxia	O
,	O
姜半夏	O
);	O
(	O
F	O
)	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Alumine	O
(	O
Qing	O
-	O
Banxia清半夏	O
).	O

It	O
then	O
overlays	O
mutation	O
data	O
,	O
categorizes	O
mutations	O
based	O
on	O
structural	O
context	O
,	O
and	O
visualizes	O
them	O
using	O
advanced	O
tools	O
like	O
MolStar	B-BT
.	O

a	O
Translational	O
and	O
rotational	O
equivariance	O
is	O
not	O
preserved	O
for	O
I2I	O
generated	O
images	O
,	O
b	O
the	O
fake	O
BF	O
images	O
(	O
even	O
rows	O
,	O
middle	O
)	O
do	O
not	O
preserve	O
the	O
structure	O
and	O
appearance	O
of	O
the	O
corresponding	O
real	O
BF	O
images	O
,	O
but	O
appear	O
similar	O
,	O
independent	O
of	O
the	O
content	O
of	O
the	O
SHG	O
images	O
they	O
are	O
generated	O
from	O
.	O

We	O
implemented	O
a	O
systematic	O
review	O
to	O
answer	O
the	O
question	O
:	O
In	O
the	O
general	O
population	O
,	O
what	O
is	O
the	O
effect	O
of	O
social	O
disadvantage	O
on	O
exposure	O
to	O
subjective	O
and	O
objective	O
heat	O
stress	O
and	O
adaptive	O
capacity	O
to	O
prevent	O
/	O
reduce	O
exposure	O
to	O
heat	O
stress	O
?	O

The	O
median	O
lengths	O
of	O
intronic	O
terminal	O
exons	O
identified	O
by	O
InPACT	B-BT
in	O
two	O
HEK293	O
RNA	O
-	O
seq	O
replicates	O
were	O
found	O
to	O
be	O
shorter	O
compared	O
to	O
annotated	O
ones	O
(	O
Fig	O
.	O

Wild	O
-	O
type	O
profilaggrin	O
sequence	O
and	O
its	O
mutated	O
variants	O
were	O
analysed	O
in	O
silico	O
using	O
the	O
DEGRONOPEDIA	B-BT
and	O
Clustal	O
Omega	O
tool	O
.	O

glabra	O
(	O
Licorice	O
)	O
were	O
investigated	O
on	O
the	O
docking	O
behaviour	O
of	O
hSOD	O
,	O
hPDE	O
9	O
and	O
hDPP	O
4	O
by	O
using	O
the	O
PatchDock	B-BT
method	O
.	O

For	O
instance	O
,	O
BoostDiff	B-BT
can	O
be	O
applied	O
to	O
proteomics	O
or	O
metabolomics	O
studies	O
that	O
aim	O
to	O
detect	O
changes	O
in	O
dependencies	O
of	O
proteins	O
or	O
metabolites	O
.	O

EmbedPVP	B-BT
is	O
not	O
the	O
first	O
approach	O
that	O
uses	O
ontology	O
semantics	O
in	O
detecting	O
genotype	O
–	O
phenotype	O
relations	O
;	O
in	O
particular	O
semantic	O
similarity	O
measures	O
have	O
been	O
used	O
for	O
a	O
long	O
time	O
to	O
predict	O
gene	O
–	O
disease	O
associations	O
(	O
Köhler	O
et	O
al	O
.	O

Here	O
we	O
have	O
introduced	O
MdrDB	B-BT
,	O
the	O
largest	O
drug	O
resistance	O
database	O
to	O
provide	O
all	O
information	O
highly	O
relevant	O
to	O
protein	O
mutation	O
-	O
induced	O
drug	O
binding	O
affinity	O
changes	O
.	O

Even	O
without	O
hyperparameter	O
optimization	O
,	O
Zoish	B-BT
maintains	O
its	O
core	O
functionality	O
,	O
allowing	O
for	O
a	O
balance	O
between	O
efficiency	O
and	O
interpretability	O
.	O

The	O
Hifiasm	O
raw	O
genome	O
assembly	O
included	O
2	O
,	O
960	O
Mb	O
in	O
580	O
contigs	O
(	O
L50	O
=	O
37	O
and	O
N50	O
=	O
22	O
.	O
14	O
Mb	O
),	O
with	O
a	O
high	O
BUSCO	B-BT
completeness	O
(	O
97	O
.	O
2	O
%	O
complete	O
,	O
95	O
.	O
1	O
%	O
single	O
copy	O
and	O
2	O
.	O
1	O
%	O
duplication	O
)	O
based	O
on	O
the	O
endopterygota_odb10	O
database	O
.	O

OpenChrom	B-BT
is	O
an	O
open	O
source	O
program	O
developed	O
to	O
view	O
and	O
analyse	O
chromatographic	O
and	O
other	O
data	O
.	O

Given	O
that	O
mesocosms	O
are	O
intrinsically	O
warmer	O
than	O
outside	O
,	O
present	O
‐	O
day	O
climates	O
matched	O
thermal	O
conditions	O
near	O
the	O
Metatron	O
(	O
meteorological	O
station	O
of	O
Saint	O
‐	O
Girons	O
Antichan	O
;	O
Bestion	O
,	O
Teyssier	O
,	O
et	O
al	O
.,	O
2015	O
).	O

The	O
cumulative	O
distributions	O
of	O
error	O
across	O
all	O
identified	O
IPA	O
sites	O
were	O
compared	O
between	O
InPACT	B-BT
and	O
IPAFinder	O
.	O

Notably	O
,	O
the	O
effectiveness	O
estimate	O
for	O
the	O
Sputnik	O
V	O
primary	O
scheme	O
increased	O
from	O
negative	O
values	O
within	O
less	O
than	O
3	O
months	O
from	O
the	O
second	O
dose	O
to	O
57	O
%	O
within	O
the	O
3	O
to	O
less	O
than	O
6	O
months	O
following	O
the	O
second	O
dose	O
,	O
particularly	O
during	O
the	O
Omicron	O
BA	O
.	O
1	O
/	O
BA	O
.	O
2	O
wave	O
.	O

•	O
Role	O
of	O
Travel	O
History	O
:	O
A	O
detailed	O
travel	O
history	O
is	O
pivotal	O
in	O
diagnosing	O
HLH	O
,	O
aiding	O
in	O
the	O
identification	O
of	O
potential	O
infectious	O
triggers	O
such	O
as	O
Dengue	O
fever	O
.	O

The	O
KVFinder	B-BT
-	O
web	O
portal	O
provides	O
an	O
easy	O
and	O
interactive	O
way	O
to	O
download	O
and	O
visualize	O
cavity	O
detection	O
results	O
.	O

By	O
contrast	O
,	O
ITHANET	B-BT
(	O
https	O
://	O
www	O
.	O
ithanet	B-BT
.	O
eu	O
/;	O
accessed	O
on	O
17	O
April	O
2024	O
)	O
is	O
a	O
web	O
portal	O
initially	O
conceived	O
specifically	O
for	O
hemoglobinopathies	O
,	O
which	O
,	O
as	O
of	O
this	O
writing	O
,	O
holds	O
in	O
its	O
databases	O
sequence	O
and	O
functional	O
annotation	O
for	O
3462	O
variants	O
in	O
538	O
genes	O
.	O

MINNO	B-BT
is	O
a	O
JavaScript	O
-	O
based	O
web	O
application	O
that	O
is	O
compatible	O
with	O
Google	O
Chrome	O
and	O
Mozilla	O
Firefox	O
browsers	O
.	O

The	O
bonding	O
of	O
cys188	O
and	O
cys207	O
in	O
the	O
malanin	O
B	O
chain	O
and	O
of	O
cys188	O
and	O
cys205	O
in	O
the	O
ricin	O
B	O
chain	O
were	O
analyzed	O
by	O
PyMOL	B-BT
2	O
.	O
3	O
(	O
Figure	O
7	O
).	O

Users	O
can	O
also	O
submit	O
a	O
gene	O
set	O
and	O
a	O
corresponding	O
abstract	O
to	O
rank	O
the	O
top	O
enriched	O
terms	O
from	O
Rummagene	B-BT
by	O
abstract	O
dissimilarity	O
.	O

We	O
used	O
jGoslin	B-BT
,	O
the	O
Java	O
implementation	O
of	O
Goslin	B-BT
,	O
11	O
which	O
parses	O
the	O
submitted	O
lipid	O
names	O
and	O
translates	O
them	O
into	O
a	O
normalized	O
hierarchical	O
representation	O
(	O
Table	O
S1	O
).	O

53	O
%	O
included	O
evidence	O
on	O
objective	O
heat	O
stress	O
,	O
19	O
%	O
subjective	O
heat	O
stress	O
,	O
and	O
58	O
%	O
adaptive	O
capacity	O
.	O

The	O
KVFinder	B-BT
-	I-BT
web	I-BT
service	O
is	O
publicly	O
available	O
at	O
https	O
://	O
kvfinder	B-BT
-	I-BT
web	I-BT
.	O
cnpem	O
.	O
br	O
,	O
which	O
is	O
free	O
and	O
open	O
to	O
all	O
users	O
without	O
login	O
requirement	O
.	O

SynDesign	B-BT
was	O
developed	O
using	O
Python	O
3	O
.	O
9	O
.	O
13	O
on	O
CodeIgniter	O
5	O
based	O
on	O
PHP	O
5	O
.	O
2	O
.	O
4	O
.	O

Based	O
on	O
the	O
ROC	O
curve	O
,	O
the	O
2	O
-	O
inputs	O
MI	O
-	O
CNN	O
with	O
the	O
LR	O
-	O
ROI	O
data	O
sets	O
also	O
showed	O
relatively	O
better	O
performance	O
than	O
the	O
1	O
-	O
input	O
CNN	O
(	O
left	O
-	O
or	O
right	O
-	O
lung	O
ROI	O
)	O
in	O
classifying	O
COVID	O
-	O
19	O
and	O
normal	O
CXRs	O
,	O
given	O
its	O
larger	O
AUC	O
value	O
(	O
mean	O
0	O
.	O
980	O
,	O
SD	O
0	O
.	O
005	O
),	O
as	O
shown	O
in	O
Figure	O
9	O
.	O

The	O
rNMPID	B-BT
database	O
provides	O
powerful	O
data	O
analysis	O
and	O
highly	O
customizable	O
visualization	O
.	O

Once	O
a	O
template	O
is	O
loaded	O
into	O
OntoloViz	B-BT
,	O
the	O
GUI	O
allows	O
for	O
customization	O
of	O
the	O
generated	O
sunburst	O
plots	O
.	O

In	O
terms	O
of	O
performance	O
comparison	O
,	O
both	O
deepDegron	O
and	O
DEGRONOPEDIA	B-BT
were	O
developed	O
for	O
predicting	O
N	O
-/	O
C	O
-	O
degrons	O
,	O
whereas	O
only	O
Degpred	O
supported	O
the	O
prediction	O
of	O
internal	O
degron	O
and	O
E3	O
-	O
degron	O
interactions	O
.	O

The	O
present	O
systematic	O
review	O
found	O
“	O
breakfast	O
skipper	O
”	O
as	O
the	O
most	O
commonly	O
investigated	O
pattern	O
of	O
unhealthy	O
diet	O
,	O
and	O
as	O
well	O
,	O
the	O
meta	O
-	O
analysis	O
part	O
reported	O
a	O
pooled	O
prevalence	O
of	O
28	O
%	O
for	O
unhealthy	O
diet	O
among	O
the	O
Iranian	O
students	O
.	O

In	O
this	O
work	O
,	O
we	O
introduce	O
scNovel	B-BT
,	O
a	O
powerful	O
deep	O
learning	O
-	O
based	O
neural	O
network	O
that	O
specifically	O
focuses	O
on	O
novel	O
rare	O
cell	O
discovery	O
.	O

The	O
input	O
and	O
output	O
data	O
are	O
provided	O
in	O
standardized	O
BED	O
and	O
narrowPeak	O
file	O
formats	O
,	O
which	O
makes	O
BaRDIC	B-BT
easy	O
to	O
use	O
and	O
simple	O
to	O
perform	O
downstream	O
analyses	O
on	O
its	O
results	O
.	O

We	O
integrated	O
the	O
TrIQ	O
algorithm	O
into	O
RmsiGUI	B-BT
and	O
provide	O
the	O
R	O
code	O
snippets	O
for	O
facilitating	O
its	O
adoption	O
into	O
other	O
programs	O
.	O

We	O
have	O
made	O
EmbedPVP	B-BT
freely	O
available	O
as	O
a	O
Python	O
package	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
bio	O
-	O
ontology	O
-	O
research	O
-	O
group	O
/	O
EmbedPVP	B-BT
.	O

SYBA	O
learns	O
synthetic	O
accessibility	O
via	O
Bayesian	O
optimization	O
,	O
while	O
RAScore	B-BT
,	O
GASA	O
,	O
and	O
DeepSA	O
employ	O
artificial	O
neural	O
networks	O
,	O
including	O
forward	O
neural	O
networks	O
,	O
graph	O
attention	O
neural	O
networks	O
,	O
and	O
fine	O
-	O
tuning	O
of	O
pretrained	O
language	O
models	O
,	O
respectively	O
.	O

In	O
this	O
updated	O
implementation	O
of	O
RCoV19	B-BT
,	O
we	O
have	O
made	O
significant	O
improvements	O
and	O
advancements	O
over	O
the	O
previous	O
version	O
.	O

We	O
describe	O
the	O
significant	O
developments	O
that	O
have	O
been	O
made	O
with	O
a	O
focus	O
on	O
how	O
we	O
are	O
positioning	O
MetaboLights	B-BT
(	O
3	O
,	O
4	O
)	O
to	O
address	O
its	O
increasing	O
use	O
and	O
importance	O
in	O
biosciences	O
.	O

The	O
Human	B-BT
Splicing	I-BT
Finder	I-BT
,	O
SpliceAI	O
,	O
and	O
varSEAK	O
database	O
were	O
used	O
to	O
predict	O
the	O
effect	O
of	O
mutations	O
on	O
splicing	O
function	O
.	O

When	O
calculating	O
the	O
2	O
-	O
digit	O
HLA	O
haplotype	O
data	O
,	O
due	O
to	O
the	O
limitation	O
of	O
not	O
being	O
able	O
to	O
calculate	O
>	O
5	O
,	O
000	O
haplotypes	O
using	O
PyPop	B-BT
,	O
A	O
*~	O
B	O
*,	O
A	O
*~	O
DRB1	O
*,	O
B	O
*~	O
DRB1	O
*	O
and	O
A	O
*~	O
B	O
*~	O
DRB1	O
*	O
haplotypes	O
were	O
calculated	O
using	O
GENE	O
[	O
RATE	O
]	O
alone	O
;	O
the	O
other	O
haplotypes	O
were	O
calculated	O
using	O
both	O
programs	O
.	O

Table	O
1Ten	O
cases	O
of	O
accidental	O
intra	O
-	O
arterial	O
administration	O
of	O
a	O
medicationCaseCannulation	O
siteAgePlace	O
of	O
occurrence	O
and	O
discoveryMedication	O
involvedClues	O
to	O
discoveryTime	O
from	O
cannulation	O
to	O
discoverySequelaePresumed	O
causes	O
and	O
backgrounds	O
of	O
misplacementPresumed	O
causes	O
and	O
backgrounds	O
of	O
administration1Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
3	O
monthsPICUMidazolam	O
,	O
morphine	O
,	O
5	O
%	O
glucosePulsatile	O
flashback	O
within	O
IV	O
tube7	O
h	O
50	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
US	O
-	O
guided	O
peripheral	O
venous	O
access	O
,	O
judgement	O
errorPoor	O
flashback	O
at	O
the	O
start	O
of	O
administration	O
,	O
non	O
-	O
bright	O
-	O
red	O
flash	O
of	O
blood	O
at	O
cannulation	O
,	O
use	O
of	O
infusion	O
pump2Subclavian	O
artery	O
(	O
left	O
)	O
27	O
daysNICUHeparin	O
,	O
5	O
%	O
glucose	O
,	O
normal	O
salineContrast	O
-	O
enhanced	O
CT26	O
days	O
,	O
2	O
h	O
22	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
PI	O
catheter	O
,	O
trisomy	O
18	O
,	O
VLBWMisdiagnosis	O
from	O
X	O
-	O
ray	O
(	O
diagnosed	O
as	O
PI	O
in	O
the	O
subclavian	O
vein	O
)	O
3Ulnar	O
artery	O
(	O
branch	O
)	O
(	O
left	O
)	O
4	O
years	O
5	O
monthsWard	O
,	O
ORFentanyl	O
,	O
rocuronium	O
,	O
phenylephrine	O
,	O
propofol	O
,	O
lidocaine	O
,	O
5	O
%	O
glucose	O
-	O
acetated	O
Ringer	O
'	O
sPulsatile	O
flashback	O
within	O
IV	O
tube	O
confirmed	O
by	O
BGA17	O
h	O
49	O
minNo	O
deficitNormal	O
vascular	O
anatomic	O
proximity	O
,	O
lack	O
of	O
anatomical	O
knowledgeConfirmation	O
of	O
free	O
IV	O
drip	O
at	O
the	O
start	O
of	O
administration	O
,	O
non	O
-	O
pulsatile	O
flashback	O
at	O
the	O
start	O
of	O
administration	O
,	O
no	O
resistance	O
to	O
drug	O
administration	O
in	O
the	O
use	O
of	O
infusion	O
pump4Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
2	O
yearsORFentanyl	O
,	O
remifentanil	O
,	O
propofol	O
,	O
rocuronium	O
,	O
atropine	O
sulfate	O
,	O
cefazolin	O
,	O
5	O
%	O
glucose	O
-	O
acetated	O
Ringer	O
’	O
sAbsence	O
of	O
free	O
IV	O
drip	O
confirmed	O
by	O
BGA2	O
h	O
23	O
mNo	O
deficitDifficult	O
IV	O
access	O
,	O
overconfidenceConfirmation	O
of	O
free	O
IV	O
drip	O
at	O
the	O
start	O
of	O
administration	O
,	O
non	O
-	O
pulsatile	O
flashback	O
at	O
start	O
of	O
administration	O
,	O
backflow	O
prevention	O
valve	O
on	O
IV	O
line5Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
8	O
years	O
3	O
monthsWardMaintenance	O
intravenous	O
fluidAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube53	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
US	O
-	O
guided	O
peripheral	O
venous	O
access	O
,	O
heparin	O
lock	O
immediately	O
after	O
cannulationConfirmation	O
of	O
free	O
IV	O
drip	O
before	O
drug	O
administration	O
IV	O
line	O
locked	O
with	O
heparin	O
before	O
administration6Dorsalis	O
pedis	O
artery	O
(	O
left	O
)	O
7	O
mWardVancomycin	O
,	O
maintenance	O
IV	O
solutionPulsatile	O
flashback	O
within	O
IV	O
tube60	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
normal	O
vascular	O
anatomical	O
proximity	O
,	O
overconfidence	O
,	O
premature	O
closureNon	O
-	O
pulsatile	O
flashback	O
at	O
the	O
start	O
of	O
administration	O
,	O
poor	O
flashback	O
at	O
the	O
start	O
of	O
administration7Radial	O
artery	O
(	O
right	O
)	O
5	O
years	O
7	O
monthsER	O
,	O
wardAmpicillin	O
,	O
5	O
%	O
glucose	O
-	O
acetated	O
Ringer	O
’	O
sPulsatile	O
flashback	O
within	O
IV	O
tube	O
,	O
skin	O
discoloration	O
around	O
cannulation	O
site16	O
h	O
23	O
minNo	O
deficitNormal	O
vascular	O
anatomic	O
proximity	O
,	O
lack	O
of	O
anatomical	O
knowledge	O
,	O
overconfidence	O
,	O
premature	O
closureRecognition	O
of	O
free	O
IV	O
drip	O
at	O
the	O
start	O
of	O
administration8Dorsalis	O
pedis	O
artery	O
(	O
right	O
)	O
3	O
monthsWard	O
,	O
ORMaintenance	O
intravenous	O
fluidAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube1	O
h	O
25	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
judgement	O
error	O
,	O
overconfidenceSmooth	O
injection	O
without	O
resistance	O
,	O
backflow	O
prevention	O
valve	O
on	O
IV	O
line9Dorsalis	O
pedis	O
artery	O
(	O
right	O
)	O
4	O
years	O
11	O
monthsWardGentamicin	O
,	O
maintenance	O
intravenous	O
fluid	O
,	O
normal	O
salineAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube1	O
day	O
,	O
14	O
h	O
15	O
minNo	O
deficitDifficult	O
IV	O
access	O
,	O
cannulation	O
in	O
a	O
dark	O
roomZebra	O
retreat	O
,	O
overconfidence	O
(	O
intra	O
-	O
arterial	O
cannulation	O
was	O
recognized	O
as	O
a	O
rare	O
event	O
)	O
10Anterior	O
tibial	O
artery	O
(	O
left	O
)	O
13	O
years	O
8	O
monthsPrevious	O
center	O
,	O
ERMidazolam	O
,	O
rocuronium	O
,	O
normal	O
salineAbsence	O
of	O
free	O
IV	O
drip	O
,	O
pulsatile	O
flashback	O
within	O
IV	O
tube4	O
h	O
22	O
minNo	O
deficitDifficult	O
IV	O
accessIV	O
line	O
established	O
in	O
previous	O
medical	O
center	O
,	O
lack	O
of	O
confirmation	O
,	O
failure	O
to	O
checkAbbreviations	O
:	O
OR	O
Operating	O
room	O
,	O
ER	O
Emergency	O
room	O
,	O
US	O
Ultrasound	O
,	O
PI	O
Peripherally	O
inserted	O
central	O
catheter	O
,	O
IV	O
Intravenous	O
flashback	O
,	O
regurgitant	O
blood	O
flow	O
from	O
cannula	O
,	O
BGA	O
Blood	O
gas	O
analysis	O

Critical	O
review	O
of	O
the	O
manuscript	O
for	O
important	O
intellectual	O
content	O
:	O
Kai	O
Yoshinaga	O
,	O
Artem	O
Tkachenko	O
,	O
Thomas	O
Murphy	O

Macromolecular	O
systems	O
and	O
CRISPR	O
-	O
Cas	O
systems	O
were	O
detected	O
using	O
MacSyFinder	B-BT
v2	O
.	O
1	O
.	O
3	O
with	O
TXSScan	O
v1	O
.	O
1	O
.	O
3	O
and	O
CasFinder	O
v3	O
.	O
1	O
.	O
0	O
models	O
[	O
44	O
–	O
46	O
].	O

For	O
comparison	O
,	O
the	O
new	O
datasets	O
for	O
the	O
26	O
urine	O
specimens	O
diluted	O
either	O
to	O
2	O
.	O
0	O
or	O
6	O
.	O
5	O
mM	O
creatinine	O
were	O
analyzed	O
with	O
both	O
CF4	O
and	O
with	O
MZmine	B-BT
.	O

Project	O
name	O
:	O
Torch	B-BT
-	I-BT
eCpGProject	I-BT
home	O
page	O
:	O
http	O
://	O
www	O
.	O
github	O
.	O
com	O
/	O
kordk	O
/	O
torch	B-BT
-	I-BT
ecpgOperating	I-BT
system	O
(	O
s	O
):	O
Platform	O
independentProgramming	O
language	O
:	O
Python	O
3	O
.	O
10	O
or	O
higherOther	O
requirements	O
:	O
click	O
~=	O
8	O
.	O
0	O
.	O
3	O
,	O
colorama	O
~=	O
0	O
.	O
4	O
.	O
4	O
,	O
matplotlib	O
~=	O
3	O
.	O
5	O
.	O
1	O
,	O
numpy	O
~=	O
1	O
.	O
24	O
.	O
1	O
,	O
pandas	O
~=	O
1	O
.	O
3	O
.	O
5	O
,	O
psutil	O
~=	O
5	O
.	O
9	O
.	O
4	O
,	O
requests	O
~	O
=	O
2	O
.	O
26	O
.	O
0	O
,	O
scipy	O
~=	O
1	O
.	O
10	O
.	O
0	O
,	O
setuptools	O
~=	O
63	O
.	O
3	O
.	O
0	O
,	O
torch	O
~=	O
1	O
.	O
13	O
.	O
1	O
+	O
cu116License	O
:	O
BSD	O
-	O
3	O
-	O
ClauseAny	O
restrictions	O
to	O
use	O
by	O
non	O
-	O
academics	O
:	O
license	O
needed	O
.	O

REAGENT	O
or	O
RESOURCESOURCEIDENTIFIERBiological	O
samplesPlasma	O
from	O
citrated	O
bloodHealthy	O
volunteersN	O
/	O
ASterile	O
acute	O
wound	O
fluidsProf	O
Artur	O
Schmidtchen	O
,	O
Lund	O
University	O
,	O
Sweden25	O
,	O
26	O
,	O
70N	O
/	O
AChemicals	O
,	O
peptides	O
,	O
and	O
recombinant	O
proteinsPseudomonas	O
aeruginosa	O
elastaseElastin	O
Products	O
Company	O
,	O
Inc	O
.	O
Cat	O
#	O
PE961Staphylococcus	O
aureus	O
V8Sigma	O
-	O
AldrichCat	O
#	O
P2922Human	O
neutrophil	O
elastaseSigma	O
-	O
AldrichCat	O
#	O
324681Human	O
neutrophil	O
cathepsin	O
GSigma	O
-	O
AldrichCat	O
#	O
219373NuPAGE	O
LDS	O
sample	O
buffer	O
(	O
4x	O
)	O
Invitrogen	O
™	O
Cat	O
#	O
NP0007Tris	O
-	O
Glycine	O
SDS	O
running	O
buffer	O
(	O
10x	O
)	O
Invitrogen	O
™	O
Cat	O
#	O
LC2675RapiGest	O
SFWatersCat	O
#	O
186001861Critical	O
commercial	O
assaysPierce	O
™	O
BCA	O
Protein	O
Assay	O
KitThermo	O
Scientific	O
™	O
Cat	O
#	O
23227Novex	O
™	O
Tris	O
-	O
Glycine	O
Mini	O
Protein	O
Gels	O
,	O
10	O
-	O
20	O
%	O
Invitrogen	O
™	O
Cat	O
#	O
XP10205BOXSilverQuest	O
™	O
Silver	O
Staining	O
KitInvitrogen	O
™	O
Cat	O
#	O
LC6070Deposited	O
dataMass	O
spectrometry	O
RAW	O
data	O
plasma	O
samplesThis	O
paperPRIDE	O
:	O
PXD037245Mass	O
spectrometry	O
RAW	O
data	O
wound	O
fluidsThis	O
paperPRIDE	O
:	O
PXD037047PEAKS	O
search	O
files	O
plasma	O
samplesThis	O
paperPRIDE	O
:	O
PXD037245PEAKS	O
search	O
files	O
wound	O
fluidsThis	O
paperPRIDE	O
:	O
PXD037047Mass	O
spectrometry	O
data	O
of	O
wound	O
dressing	O
extractsHartman	O
et	O
al	O
.	O
26PRIDE	O
:	O
PXD023244UniProtThe	O
UniProt	O
Consortium71https	O
://	O
www	O
.	O
uniprot	O
.	O
org	O
/	O
Software	O
and	O
algorithmsPEAKS	O
SoftwareBioinformatics	O
Solutions	O
Inc	O
.	O
https	O
://	O
www	O
.	O
bioinfor	O
.	O
com	O
/	O
peaks	O
-	O
software	O
/	O
Graphpad	O
PrismDotmaticshttps	O
://	O
www	O
.	O
graphpad	O
.	O
com	O
/	O
VennDisIgnatchenko	O
et	O
al	O
.	O
72http	O
://	O
kislingerlab	O
.	O
uhnres	O
.	O
utoronto	O
.	O
ca	O
/	O
projects	O
/	O
BoxPlotRSpitzer	O
et	O
al	O
.	O
73http	O
://	O
shiny	O
.	O
chemgrid	O
.	O
org	O
/	O
boxplotr	O
/	O
ImgflipImgflip	O
LLChttps	O
://	O
imgflip	O
.	O
com	O
/	O
chart	O
-	O
makerPeptigramManguy	O
et	O
al	O
.	O
74http	O
://	O
bioware	O
.	O
ucd	O
.	O
ie	O
/	O
peptigram	O
/	O
iceLogoColaert	O
et	O
al	O
.	O
27http	O
://	O
iomics	O
.	O
ugent	O
.	O
be	O
/	O
icelogoserver	O
/	O
CLIPPER	B-BT
2	I-BT
.	I-BT
0Kalogeropoulos	I-BT
et	O
al	O
.	O
75https	O
://	O
github	O
.	O
com	O
/	O
UadKLab	O
/	O
CLIPPER	O
-	O
2	O
.	O
0OtherMicrocon	O
-	O
30kDa	O
centrifugal	O
filtersMerckCat	O
#	O
MRCF0R030	O

Elderly	O
people	O
are	O
more	O
prone	O
to	O
suffer	O
from	O
musculoskeletal	O
disorders	O
of	O
the	O
foot	O
,	O
where	O
claw	O
toe	O
is	O
one	O
of	O
the	O
most	O
common	O
pathologies	O
.	O

The	O
results	O
provided	O
by	O
the	O
domain2GO	B-BT
schema	O
largely	O
support	O
the	O
same	O
conclusions	O
found	O
by	O
our	O
manual	O
curation	O
of	O
the	O
domain2Pfam	O
results	O
for	O
both	O
positive	O
and	O
negative	O
associations	O
,	O
highlighting	O
how	O
GO	O
annotation	O
provides	O
an	O
interpretability	O
that	O
appears	O
to	O
be	O
qualitatively	O
equivalent	O
to	O
human	O
curation	O
(	O
Figure	O
4C	O
;	O
Data	O
S2	O
,	O
sheet	O
“	O
domain2GOCount	B-BT
”;	O
see	O
also	O
Note	O
S6	O
for	O
additional	O
examples	O
).	O
29	O
Additionally	O
,	O
several	O
of	O
these	O
biological	O
roles	O
associated	O
with	O
prophage	O
density	O
are	O
performed	O
by	O
non	O
-	O
homologous	O
domains	O
.	O

Similarly	O
,	O
scPrisma	B-BT
,	O
a	O
spectral	O
template	O
-	O
matching	O
method	O
,	O
was	O
recently	O
proposed	O
for	O
the	O
inference	O
,	O
filtering	O
or	O
enhancement	O
of	O
underlying	O
signals	O
based	O
on	O
prior	O
knowledge	O
of	O
their	O
structure	O
(	O
such	O
as	O
the	O
cyclic	O
structure	O
of	O
the	O
cell	O
cycle	O
)	O
16	O
.	O

scAnnoX的	B-BT
.	O

Because	O
iPHoP	B-BT
outputs	O
multiple	O
predictions	O
,	O
both	O
the	O
highest	O
scoring	O
prediction	O
(“	O
iPHoP	B-BT
bp	O
”)	O
and	O
the	O
full	O
set	O
of	O
predictions	O
(“	O
iPHoP	B-BT
”)	O
were	O
reported	O
.	O

This	O
result	O
suggested	O
PHARE	B-BT
captured	O
aging	O
-	O
accelerated	O
features	O
,	O
which	O
can	O
help	O
assess	O
the	O
impact	O
of	O
treatment	O
.	O

(	O
B	O
)	O
Addressing	O
the	O
needs	O
of	O
3D	O
genomics	O
,	O
DataColor	B-BT
empowers	O
users	O
to	O
visualize	O
topological	O
domain	O
data	O
,	O
offering	O
compatibility	O
with	O
several	O
output	O
formats	O
,	O
including	O
jpg	O
,	O
png	O
,	O
pdf	O
,	O
and	O
svg	O
.	O

There	O
are	O
also	O
programs	O
written	O
in	O
Python	O
such	O
as	O
CarveMe	O
[	O
77	O
],	O
moped	O
[	O
79	O
],	O
Reconstructor	O
[	O
80	O
],	O
Bactabolize	O
[	O
81	O
]	O
and	O
AuCoMe	B-BT
[	O
82	O
]	O
that	O
provide	O
the	O
possibility	O
of	O
reconstructing	O
the	O
model	O
using	O
their	O
own	O
resources	O
.	O

PyCoMo	B-BT
could	O
detect	O
a	O
thermodynamically	O
infeasible	O
cycle	O
as	O
the	O
reason	O
,	O
allowing	O
D	O
.	O
vulgaris	O
to	O
take	O
up	O
H2	O
(	O
see	O
Supplementary	O
Material	O
,	O
Section	O
3	O
).	O

“	O
Module	O
1	O
–	O
Find	O
Drug	O
”	O
is	O
the	O
core	O
function	O
of	O
shinyDeepDR	B-BT
that	O
uses	O
DeepDR	O
to	O
predict	O
the	O
query	O
sample	O
’	O
s	O
response	O
to	O
265	O
anti	O
-	O
cancer	O
compounds	O
.	O

We	O
are	O
also	O
exploring	O
the	O
application	O
of	O
ProKinO	B-BT
for	O
machine	O
learning	O
-	O
based	O
knowledge	O
discovery	O
and	O
hypotheses	O
generation	O
.	O

PMAT	O
technology	O
exclusively	O
employs	O
the	O
SmD1	O
peptide	O
,	O
whereas	O
CIA	O
utilizes	O
a	O
full	O
Sm	O
protein	O
complex	O
,	O
consisting	O
of	O
the	O
D1	O
polypeptide	O
and	O
six	O
additional	O
peptides	O
[	O
18	O
].	O

Positional	O
annotation	O
of	O
N	O
‐	O
terminal	O
peptides	O
for	O
cleavage	O
sites	O
and	O
known	O
Merops	O
events	O
was	O
performed	O
using	O
Clipper	B-BT
2	I-BT
.	I-BT
0	I-BT
(	O
Kalogeropoulos	O
et	O
al	O
.,	O
2023	O
;	O
Rawlings	O
&	O
Bateman	O
,	O
2021	O
).	O

Complete	O
BUSCOs	O
(	O
C	O
):	O
95	O
.	O
4	O
%	O
[	O
Single	O
-	O
copy	O
:	O
92	O
.	O
7	O
%,	O
Duplicated	O
:	O
2	O
.	O
7	O
%]	O

(	O
A	O
)	O
the	O
microbial	O
genome	O
sequences	O
deposited	O
in	O
the	O
MarRef	B-BT
database	O
,	O
(	O
B	O
)	O
the	O
distribution	O
of	O
MarRef	B-BT
BGCs	O
according	O
to	O
their	O
products	O
.	O

Filtering	O
from	O
MarDB	B-BT
,	O
MarRef	O
,	O
and	O
OMD	O
databases	O
was	O
primarily	O
focused	O
on	O
isolation	O
location	O
.	O

Insider	O
activities	O
distributions	O
.	O

1MatchMiner	B-BT
overview	O
of	O
data	O
flow	O
and	O
modes	O
of	O
use	O
.	O
a	O
Data	O
inputs	O
from	O
patients	O
and	O
trials	O
are	O
utilized	O
by	O
the	O
MatchEngine	O
to	O
match	O
patients	O
to	O
trials	O
.	O

Accuracy	O
after	O
autoencoder	O
defense	O
,	O
where	O
(	O
a	O
)	O
represents	O
accuracy	O
rise	O
in	O
PGD	O
attack	O
(	O
b	O
)	O
represents	O
accuracy	O
rise	O
in	O
FGSM	O
attack	O
.	O

Five	O
bacterial	O
genomes	O
Agrococcus	O
pavilionensis	O
strain	O
RW1	O
,	O
Azotobacter	O
vinelandii	O
strain	O
DJ	O
,	O
Rhizobium	O
leguminosarum	O
,	O
and	O
two	O
genomes	O
of	O
Exiguobacterium	O
chiriqhucha	O
strain	O
RW2	O
and	O
strain	O
GIC31	O
were	O
compared	O
against	O
MerCat2	B-BT
,	O
kmc	O
,	O
and	O
Jellyfish	O
using	O
nucleotide	O
whole	O
-	O
genome	O
fasta	O
files	O
for	O
k	O
=	O
4	O
and	O
k	O
=	O
31	O
.	O

2021	O
),	O
and	O
MetaCerberus	B-BT
(	O
Figueroa	O
III	O
et	O
al	O
.	O

The	O
code	O
for	O
the	O
RIL	O
-	O
seq	O
analysis	O
is	O
available	O
online	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
maltesie	O
/	O
ChimericFragments	B-BT
and	O
in	O
this	O
study	O
we	O
used	O
a	O
preliminary	O
version	O
comparable	O
to	O
release	O
“	O
v0	O
.	O
1	O
.	O
0	O
[	O
10	O
.	O
5281	O
/	O
zenodo	O
.	O
7326918	O
]”	O
with	O
default	O
configuration	O
.	O

Bcftools	B-BT
did	O
not	O
detect	O
any	O
variants	O
at	O
allele	O
frequencies	O
<	O
∼	O
0	O
.	O
08	O
in	O
any	O
of	O
the	O
spiked	O
-	O
in	O
datasets	O
.	O

Admix	B-BT
-	I-BT
kit	I-BT
package	O
is	O
open	O
-	O
source	O
and	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
KangchengHou	O
/	O
admix	B-BT
-	I-BT
kit	I-BT
.	O

The	O
phageTB	B-BT
server	O
[	O
61	O
]	O
was	O
used	O
to	O
determine	O
the	O
interaction	O
of	O
the	O
phage	O
with	O
the	O
host	O
bacteria	O
.	O

Microtiter	O
(	O
96	O
-	O
well	O
)	O
plates	O
(	O
Corning	O
,	O
Corning	O
,	O
NY	O
)	O
were	O
coated	O
with	O
anti	O
-	O
ACE	O
mAbs	O
via	O
goat	O
anti	O
-	O
mouse	O
IgG	O
(	O
Invitrogen	O
,	O
Rockford	O
,	O
IL	O
or	O
IMTEK	O
,	O
Moscow	O
,	O
Russia	O
)	O
bridge	O
and	O
incubated	O
with	O
plasma	O
samples	O
diluted	O
10	O
times	O
.	O

A	O
Schematic	O
of	O
activity	O
-	O
based	O
screening	O
of	O
cysteine	O
reactive	O
compounds	O
;	O
cell	O
lysates	O
are	O
labeled	O
with	O
compound	O
or	O
DMSO	O
followed	O
by	O
chase	O
with	O
IAA	O
and	O
‘	O
click	O
’	O
conjugation	O
to	O
heavy	O
or	O
light	O
biotin	O
click	O
conjugation	O
to	O
our	O
isotopically	O
differentiated	O
heavy	O
and	O
light	O
biotin	O
-	O
azide	O
reagents	O
,	O
tryptic	O
digest	O
,	O
LC	O
-	O
MS	O
/	O
MS	O
acquisition	O
,	O
and	O
MSFragger	B-BT
analysis	O
.	O

On	O
the	O
other	O
hand	O
,	O
CancerLiver	B-BT
(	O
https	O
://	O
webs	O
.	O
iiitd	O
.	O
edu	O
.	O
in	O
/	O
raghava	O
/	O
cancerliver	B-BT
/)	O
is	O
more	O
focused	O
on	O
functional	O
enrichment	O
and	O
it	O
includes	O
GSEA	O
on	O
both	O
GO	O
and	O
KEGG	O
.	O

The	O
ProNet	B-BT
DB	I-BT
has	O
conducted	O
multi	O
-	O
scale	O
data	O
analyses	O
on	O
a	O
vast	O
array	O
of	O
entries	O
,	O
encompassing	O
326	O
,	O
175	O
proteins	O
across	O
16	O
different	O
model	O
organism	O
species	O
,	O
sorted	O
into	O
a	O
multitude	O
of	O
functional	O
categories	O
.	O

1A	O
),	O
using	O
an	O
MSFragger45	B-BT
,	O
46	O
command	O
line	O
pipeline	O
within	O
FragPipe	O
computational	O
platform	O
.	O

To	O
expand	O
its	O
capabilities	O
,	O
future	O
versions	O
will	O
incorporate	O
analysis	O
pipelines	O
for	O
other	O
single	O
-	O
cell	O
sequencing	O
methods	O
like	O
scATAC	O
-	O
seq	O
,	O
transforming	O
Shaoxia	B-BT
into	O
a	O
comprehensive	O
single	O
-	O
cell	O
omics	O
data	O
analysis	O
platform	O
.	O

In	O
our	O
experiment	O
,	O
we	O
employ	O
the	O
DisGeNET	B-BT
(	O
version	O
2023	O
),	O
which	O
comprises	O
1041	O
587	O
GDA	O
pairs	O
.	O

PySmooth	B-BT
detects	O
the	O
unique	O
number	O
of	O
chromosomes	O
and	O
runs	O
the	O
algorithm	O
separately	O
on	O
each	O
chromosome	O
.	O

Table	O
4	O
gives	O
an	O
overview	O
over	O
the	O
involved	O
databases	O
and	O
the	O
main	O
access	O
rules	O
of	O
the	O
different	O
requirement	O
clusters	O
;	O
detailed	O
listings	O
of	O
the	O
requirements	O
can	O
be	O
found	O
in	O
the	O
Additional	O
file	O
1	O
:	O
Tables	O
S1	O
–	O
S5	O
.	O
Table	O
4Databases	O
and	O
their	O
access	O
policies	O
considered	O
for	O
the	O
requirement	O
clusters	O
of	O
data	O
bridgesData	O
providersSummary	O
of	O
main	O
access	O
restrictions	O
and	O
policiesRequirement	O
cluster	O
:	O
Imaging	O
bridgeSee	O
:	O
Additional	O
file	O
1	O
:	O
Table	O
S1Mouse	O
tissue	O
imaging	O
data	O
(	O
Infrafrontier	O
),	O
Human	O
tumour	O
tissue	O
data	O
(	O
BBMRI	O
/	O
FIMM	O
),	O
MitoCheck	O
(	O
cell	O
-	O
based	O
RNAi	O
screens	O
),	O
WebMicroscope	O
(	O
mouse	O
and	O
human	O
image	O
data	O
sets	O
),	O
Ensembl	O
,	O
ArrayExpress	O
,	O
Phenotator	B-BT
,	O
MitoCheckRestricted	O
access	O
,	O
data	O
linking	O
only	O
possible	O
,	O
if	O
the	O
data	O
provider	O
gives	O
permission	O
based	O
on	O
the	O
availability	O
of	O
informed	O
consents	O
,	O
consent	O
form	O
which	O
permits	O
such	O
a	O
research	O
may	O
be	O
required	O
,	O
application	O
to	O
the	O
steering	O
committee	O
or	O
principal	O
investigator	O
,	O
Images	O
are	O
owned	O
by	O
image	O
generatorRequirement	O
cluster	O
:	O
Phenotypic	O
bridgeSee	O
:	O
Additional	O
file	O
1	O
:	O
Table	O
S2EuroPhenome	O
,	O
IMPC	O
,	O
Gene	O
Expression	O
Atlas	O
(	O
GXA	O
),	O
ArrayExpress	O
,	O
ChEMBL	O
,	O
Metabolights	O
,	O
Reactome	O
,	O
CERM	O
datasets	O
,	O
Biobank	O
/	O
BBMRI	O
(	O
University	O
of	O
Graz	O
,	O
Austria	O
)	O
Predominantly	O
open	O
access	O
,	O
open	O
restricted	O
for	O
private	O
data	O
(	O
pre	O
-	O
publication	O
/	O
unpublished	O
),	O
open	O
access	O
,	O
when	O
data	O
is	O
used	O
for	O
research	O
purposes	O
,	O
biobank	O
with	O
restricted	O
access	O
(	O
access	O
rules	O
include	O
project	O
application	O
and	O
approval	O
committee	O
)	O
Requirement	O
cluster	O
:	O
Personalised	O
Medicine	O
bridgeSee	O
:	O
Additional	O
file	O
1	O
:	O
Table	O
S3ICGC	O
(	O
International	O
Cancer	O
Genome	O
Consortium	O
),	O
TCGA	O
(	O
The	O
Cancer	O
Genome	O
Atlas	O
),	O
EGA	O
(	O
European	O
Genome	O
-	O
phenome	O
Archive	O
),	O
Cosmic	O
(	O
Catalogue	O
of	O
somatic	O
mutations	O
in	O
cancer	O
),	O
GEO	O
(	O
Gene	O
Expression	O
Omnibus	O
),	O
Array	O
-	O
Express	O
,	O
ChEMBL	O
,	O
Reactome	O
,	O
Ensembl	O
,	O
Drugbank	O
,	O
Pharmgkb	O
,	O
BioSD	O
,	O
Biobanks	O
(	O
BBMRI	O
),	O
EU	O
-	O
OPENSCREEN	O
,	O
ECRIN	O
(	O
CTIM	O
),	O
FIMM	O
Institute	O
for	O
Molecular	O
Medicine	O
Finland	O
(	O
EATRIS	O
)	O
Open	O
access	O
and	O
data	O
with	O
and	O
without	O
restricted	O
access	O
,	O
different	O
policies	O
apply	O
,	O
controlled	O
access	O
datasets	O
means	O
access	O
control	O
,	O
Data	O
Access	O
Compliance	O
Office	O
(	O
DACO	O
)	O
handles	O
requests	O
from	O
scientists	O
for	O
access	O
to	O
controlled	O
data	O
,	O
requirement	O
for	O
user	O
certification	O
via	O
Data	O
Access	O
Request	O
,	O
download	O
of	O
datasets	O
must	O
be	O
approved	O
by	O
the	O
specified	O
Data	O
Access	O
Committee	O
(	O
DAC	O
),	O
requires	O
users	O
to	O
sign	O
a	O
Data	O
Access	O
Agreement	O
(	O
DAA	O
),	O
which	O
details	O
the	O
terms	O
and	O
conditions	O
of	O
use	O
for	O
each	O
dataset	O
,	O
all	O
controlled	O
access	O
downloadable	O
datasets	O
are	O
encrypted	O
,	O
restricted	O
access	O
usually	O
for	O
pre	O
-	O
published	O
/	O
unpublished	O
dataRequirement	O
cluster	O
:	O
Structural	O
Data	O
bridgeSee	O
:	O
Additional	O
file	O
1	O
:	O
Table	O
S4UniProt	O
,	O
AmiGO	O
(	O
Gene	O
Ontology	O
database	O
),	O
EMDB	O
(	O
Electron	O
Microscopy	O
Data	O
Bank	O
),	O
IntAct	O
(	O
Molecular	O
Interaction	O
Database	O
),	O
GenBank	O
(	O
NCBI	O
),	O
ELIXIR	O
,	O
BMB	O
databaseAll	O
are	O
open	O
accessRequirement	O
cluster	O
:	O
Biosample	O
data	O
bridgeSee	O
:	O
Additional	O
file	O
1	O
:	O
Table	O
S5Mainly	O
restricted	O
access	O
.	O

OpenChrom	B-BT
was	O
used	O
to	O
produce	O
a	O
range	O
of	O
files	O
for	O
each	O
sample	O
which	O
were	O
saved	O
into	O
the	O
sample	O
folder	O
.	O

In	O
summary	O
,	O
Sven	O
Ivar	O
Seldinger	O
'	O
s	O
introduction	O
of	O
a	O
less	O
invasive	O
method	O
for	O
vascular	O
access	O
has	O
not	O
only	O
enhanced	O
the	O
capability	O
of	O
medical	O
practitioners	O
to	O
perform	O
a	O
wide	O
range	O
of	O
procedures	O
safely	O
but	O
has	O
also	O
greatly	O
reduced	O
patient	O
risk	O
and	O
discomfort	O
.	O

However	O
,	O
upon	O
solidification	O
of	O
the	O
Mars	O
’	O
s	O
magma	O
ocean	O
and	O
oxidation	O
of	O
Cr2	O
+	O
to	O
Cr3	O
+,	O
nearly	O
all	O
of	O
the	O
magma	O
ocean	O
’	O
s	O
Fe2O3	O
would	O
be	O
eliminated	O
(	O
10	O
),	O
resulting	O
in	O
a	O
highly	O
reduced	O
solidified	O
mantle	O
.	O

The	O
individuals	O
were	O
descendants	O
of	O
lizards	O
captured	O
in	O
the	O
Cevennes	O
,	O
France	O
,	O
in	O
2010	O
and	O
2013	O
,	O
maintained	O
in	O
the	O
Metatron	O
(	O
Ariège	O
,	O
France	O
)	O
for	O
several	O
experiments	O
(	O
Bestion	O
et	O
al	O
.,	O
2017	O
,	O
2019	O
;	O
Bestion	O
,	O
Teyssier	O
,	O
et	O
al	O
.,	O
2015	O
)	O
and	O
intermixed	O
regularly	O
before	O
the	O
present	O
experiment	O
to	O
prevent	O
high	O
levels	O
of	O
inbreeding	O
.	O

To	O
remove	O
water	O
molecules	O
in	O
PyMOL	B-BT
,	O
press	O
A	O
(	O
Action	O
)	O
next	O
to	O
the	O
structure	O
name	O
on	O
the	O
right	O
column	O
,	O
and	O
select	O
“	O
remove	O
waters	O
”.	O

Note	O
：	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Alumine	O
(	O
PRPCA	O
),	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
Cum	O
Zingibere	O
et	O
Alumine	O
(	O
PRPZA	O
),	O
and	O
Pinelliae	O
Rhizoma	O
Praeparatum	O
(	O
PRP	O
).	O

2scPrisma	B-BT
manipulates	O
the	O
cell	O
cycle	O
signal	O
in	O
HeLa	O
cells	O
.	O
a	O
,	O
PCA	O
representation	O
of	O
683	O
cells	O
in	O
the	O
unordered	O
and	O
ordered	O
raw	O
gene	O
expression	O
data	O
,	O
and	O
data	O
following	O
spectral	O
cyclic	O
enhancement	O
and	O
filtering	O
.	O

A	O
total	O
of	O
8697	O
and	O
94	O
Arabidopsis	O
LR	O
pairs	O
were	O
obtained	O
by	O
SWISSPROT	O
and	O
TrEMBL	O
annotation	O
in	O
ScTensor	B-BT
.	O

Lastly	O
,	O
we	O
should	O
like	O
to	O
acknowledge	O
and	O
highlight	O
the	O
contributions	O
of	O
Thomas	O
Lütteke	O
,	O
Martin	O
Frank	O
,	O
and	O
the	O
late	O
Willy	O
von	O
der	O
Lieth	O
,	O
pioneers	O
of	O
carbohydrate	O
structure	O
validation	O
,	O
whose	O
research	O
informed	O
some	O
of	O
the	O
methods	O
showcased	O
in	O
the	O
Privateer	B-BT
database	O
.	O

At	O
room	O
temperature	O
,	O
with	O
cat	O
-	O
E	O
as	O
the	O
catalyst	O
,	O
under	O
the	O
conditions	O
without	O
NBS	O
,	O
the	O
hydro	O
-	O
substituted	O
products	O
4q	O
,	O
4r	O
and	O
4s	O
were	O
obtained	O
in	O
excellent	O
stereoselectivities	O
from	O
substrates	O
3a	O
,	O
3o	O
and	O
3p	O
.	O

DAA	O
should	O
be	O
suspected	O
when	O
airway	O
symptoms	O
are	O
already	O
present	O
in	O
early	O
infancy	O
,	O
particularly	O
if	O
a	O
right	O
aortic	O
arch	O
is	O
noted	O
.	O

For	O
Windows	O
and	O
macOS	O
,	O
please	O
refer	O
to	O
the	O
official	O
website	O
of	O
Python	O
to	O
download	O
and	O
set	O
up	O
a	O
Python	O
environment	O
if	O
you	O
need	O
.#	O
install	O
from	O
PyPIpip	O
install	O
spaco	B-BT
-	O
release	O
#	O
or	O
install	O
from	O
latest	O
source	O
from	O
github	O
(	O
Recommended	O
)	O
pip	O
install	O
git	O
+	O
https	O
://	O
github	O
.	O
com	O
/	O
BrainStOrmics	O
/	O
Spaco	B-BT
.	O
git	O
.	O
Note	O
:	O
In	O
the	O
code	O
blocks	O
,	O
the	O
'#'	O
symbol	O
is	O
used	O
to	O
indicate	O
comments	O
,	O
which	O
are	O
not	O
executable	O
as	O
code	O
.	O
Note	O
:	O
When	O
you	O
install	O
this	O
package	O
,	O
all	O
required	O
dependencies	O
will	O
also	O
be	O
installed	O
automatically	O
by	O
'	O
pip	O
'.	O

In	O
experiments	O
,	O
PermuteDDS	B-BT
exhibits	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
performance	O
on	O
two	O
benchmark	O
data	O
sets	O
.	O

This	O
step	O
can	O
be	O
run	O
externally	O
to	O
scPipe	B-BT
and	O
the	O
resulting	O
BAM	O
file	O
can	O
be	O
re	O
-	O
entered	O
to	O
the	O
scPipe	B-BT
pipeline	O
if	O
samtools	O
is	O
not	O
installed	O
locally	O
.	O

Reprocessing	O
of	O
the	O
data	O
using	O
MZmine	B-BT
to	O
deconvolute	O
the	O
results	O
(	O
to	O
take	O
account	O
of	O
the	O
isotopic	O
contribution	O
,	O
for	O
example	O
)	O
and	O
obtain	O
a	O
matrix	O
in	O
which	O
one	O
line	O
corresponds	O
to	O
one	O
compound	O
.	O

As	O
for	O
the	O
partial	O
legislative	O
omission	O
,	O
it	O
must	O
be	O
constitutionally	O
regulated	O
so	O
that	O
the	O
Supreme	O
Constitutional	O
Court	O
does	O
not	O
exercise	O
constitutional	O
despotism	O
of	O
legislation	O
,	O
and	O
its	O
authority	O
is	O
limited	O
in	O
setting	O
standards	O
or	O
controls	O
that	O
are	O
overlooked	O
by	O
the	O
unconstitutional	O
legal	O
article	O
due	O
to	O
legislative	O
omission	O
,	O
in	O
cases	O
where	O
this	O
is	O
possible	O
.	O

Actions	O
such	O
as	O
rworkflows	B-BT
need	O
only	O
be	O
updated	O
on	O
the	O
centralised	O
Github	O
repository	O
(	O
see	O
Code	O
availability	O
section	O
),	O
which	O
then	O
propagates	O
to	O
all	O
users	O
who	O
call	O
the	O
rworkflows	B-BT
action	O
,	O
even	O
if	O
they	O
implemented	O
rworkflows	B-BT
in	O
their	O
package	O
prior	O
to	O
the	O
changes	O
.	O

The	O
code	O
for	O
the	O
evaluations	O
and	O
experiments	O
is	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
mourisl	O
/	O
centrifuger_evaluations	B-BT
[	O
57	O
].	O

The	O
Essex	O
Skipper	O
is	O
considered	O
at	O
low	O
risk	O
of	O
extinction	O
;	O
on	O
the	O
IUCN	O
Red	O
list	O
(	O
Europe	O
)	O
it	O
is	O
listed	O
as	O
being	O
of	O
Least	O
Concern	O
.	O

BUSCO	B-BT
results	O
for	O
assemblies	O
(	O
Table	O
1	O
)	O
show	O
a	O
comparable	O
degree	O
of	O
completeness	O
for	O
the	O
3	O
,	O
285	O
genes	O
in	O
the	O
BUSCO	B-BT
dipteran	O
benchmark	O
set	O
between	O
D	O
.	O

PCAO2	B-BT
development	O
process	O
.	O

2	O
.	O
7	O
)	O
pandas	O
commands	O
and	O
the	O
MatchMiner	B-BT
ingestion	O
date	O
to	O
consent	O
date	O
time	O
period	O
was	O
analyzed	O
for	O
MMC	O
and	O
non	O
-	O
MMC	O
using	O
a	O
two	O
-	O
tailed	O
Wilcoxon	O
rank	O
sum	O
test	O
with	O
R	O
gtsummary51	O
,	O
52	O
.	O

In	O
the	O
evaluation	O
,	O
we	O
refer	O
to	O
TACCO	B-BT
methods	O
to	O
simulate	O
spots	O
with	O
different	O
bead	O
sizes	O
using	O
scRNA	O
-	O
seq	O
data	O
and	O
use	O
L2	O
error	O
to	O
measure	O
differences	O
between	O
predicted	O
and	O
known	O
cell	O
composition	O
in	O
each	O
simulated	O
spot	O
.	O

TCMNPAS	B-BT
provides	O
two	O
methods	O
for	O
consolidating	O
highly	O
similar	O
core	O
formulas	O
:	O
“	O
Together	O
,”	O
which	O
merges	O
highly	O
similar	O
core	O
formulas	O
collectively	O
,	O
and	O
“	O
Step	O
,”	O
which	O
incrementally	O
merges	O
highly	O
similar	O
core	O
formulas	O
.	O

massPix	B-BT
supports	O
data	O
in	O
imzML	O
format	O
(	O
Race	O
et	O
al	O
.	O

ProNet	B-BT
DB	I-BT
’	O
s	O
analysis	O
of	O
the	O
protein	O
surface	O
fingerprint	O
,	O
particularly	O
within	O
the	O
Iface	O
region	O
,	O
reveals	O
the	O
nucleic	O
acid	O
-	O
binding	O
site	O
’	O
s	O
prominence	O
on	O
the	O
interacting	O
face	O
as	O
opposed	O
to	O
non	O
-	O
binding	O
areas	O
.	O

The	O
small	O
number	O
of	O
matches	O
all	O
along	O
its	O
sequence	O
can	O
make	O
it	O
very	O
hard	O
to	O
find	O
based	O
only	O
on	O
repetitiveness	O
,	O
but	O
the	O
presence	O
of	O
full	O
elements	O
in	O
the	O
Maylandia	O
zebra	O
genome	O
allowed	O
us	O
to	O
obtain	O
the	O
full	O
sequence	O
.	O

As	O
insider	O
researchers	O
,	O
we	O
have	O
a	O
duty	O
to	O
prioritize	O
research	O
questions	O
that	O
reflect	O
the	O
full	O
spectrum	O
of	O
lived	O
experiences	O
.	O

All	O
the	O
code	O
for	O
our	O
tests	O
is	O
available	O
in	O
the	O
public	O
repository	O
,	O
allowing	O
for	O
independent	O
verification	O
and	O
further	O
exploration	O
of	O
Zoish	B-BT
’	O
s	O
capabilities	O
.	O

Statistical	O
analysis	O
:	O
Manxue	O
Zhang	O
Obtained	O
funding	O
:	O
Jianqun	O
Fang	O
Administrative	O
,	O
technical	O
,	O
or	O
material	O
support	O
:	O
Manxue	O
Zhang	O
,	O
Chujun	O
Wu	O
,	O
Shaoxia	O
Wang	O
,	O
Yanrong	O
Wang	O
,	O
Jianqun	O
Fang	O
.	O

A	O
paclitaxel	O
-	O
coated	O
10	O
-	O
mm	O
balloon	O
(	O
InPact	O
)	O
was	O
expanded	O
across	O
the	O
stenosis	O
followed	O
by	O
post	O
dilation	O
with	O
a	O
12	O
-	O
mm	O
high	O
-	O
pressure	O
(	O
Vida	O
)	O
balloon	O
completely	O
resolving	O
the	O
occlusion	O
on	O
angiography	O
(	O
Figures	O
2A	O
and	O
2B	O
).	O

This	O
implies	O
that	O
the	O
observed	O
discrepancies	O
in	O
haplotype	O
frequencies	O
as	O
identified	O
by	O
PHARE	B-BT
and	O
the	O
frequency	O
of	O
NF54	O
in	O
the	O
original	O
sample	O
may	O
not	O
be	O
attributed	O
to	O
the	O
PHARE	B-BT
pipeline	O
.	O

According	O
to	O
the	O
data	O
gathered	O
the	O
bulk	O
of	O
replies	O
from	O
TASUED	O
,	O
NCS	O
,	O
PyCOM	B-BT
-	O
NG	O
,	O
and	O
APTECH	O
had	O
no	O
security	O
risk	O
throughout	O
the	O
SDLC	O
implementation	O
stage	O
,	O
but	O
the	O
majority	O
of	O
responses	O
from	O
other	O
companies	O
had	O
a	O
minimal	O
risk	O
.	O

In	O
the	O
benchmark	O
experiment	O
,	O
HapKled	O
achieved	O
the	O
best	O
results	O
in	O
both	O
presence	O
F1	O
and	O
GT	O
-	O
F1	O
in	O
the	O
overall	O
experiment	O
and	O
the	O
per	O
-	O
SV	O
type	O
experiments	O
.	O

The	O
precisions	O
(%)	O
of	O
DeepTMP	O
,	O
CDPred	B-BT
,	O
DeepHomo2	O
.	O
0	O
,	O
GLINTER	O
,	O
DeepHomo	O
,	O
and	O
DNCON2_Inter	O
are	O
based	O
on	O
the	O
test	O
set	O
of	O
52	O
transmembrane	O
protein	O
complexes	O
when	O
the	O
experimental	O
monomer	O
structures	O
(	O
predicted	O
monomer	O
structures	O
by	O
AlphaFold2	O
)	O
are	O
used	O
as	O
input	O
.	O

In	O
LipidSig	O
2	O
.	O
0	O
,	O
the	O
lipid	O
ID	O
annotation	O
process	O
has	O
been	O
significantly	O
refined	O
and	O
expanded	O
,	O
utilizing	O
data	O
curated	O
from	O
LIPID	O
MAPS	O
,	O
MetaNetX	O
(	O
18	O
),	O
and	O
SwissLipids	O
(	O
19	O
),	O
which	O
comprise	O
28	O
964	O
,	O
792	O
127	O
and	O
775	O
273	O
lipid	O
names	O
with	O
shorthand	O
notations	O
can	O
be	O
recognized	O
by	O
Goslin	B-BT
,	O
respectively	O
.	O

Another	O
key	O
development	O
in	O
TREE	B-BT
-	I-BT
QMC	I-BT
is	O
an	O
efficient	O
algorithm	O
for	O
constructing	O
the	O
quartet	O
graph	O
directly	O
from	O
k	O
gene	O
trees	O
,	O
each	O
on	O
n	O
species	O
.	O

Codon	O
optimization	O
for	O
the	O
vaccine	O
protein	O
was	O
performed	O
by	O
using	O
Jcat	B-BT
(	O
version	O
1	O
.	O
0	O
)	O
software	O
to	O
attain	O
the	O
elevated	O
expression	O
level	O
in	O
the	O
K12	O
E	O
.	O

Effect	O
of	O
inoculation	O
access	O
period	O
(	O
IAP	O
)	O
on	O
the	O
transmission	O
of	O
cowpea	O
mild	O
mottle	O
virus	O
by	O
Bemisia	O
tabaci	O
Middle	O
East	O
–	O
Asia	O
Minor	O
1	O
and	O
Bemisia	O
tabaci	O
Mediterranean	O
.	O

The	O
lower	O
boxplot	O
shows	O
the	O
functional	O
classification	O
of	O
reactions	O
grouped	O
into	O
pan	O
-	O
reactome	B-BT
categories	O
by	O
MetaCyc	O
pathways	O
ontology	O
(	O
d	O
).	O

The	O
peak	O
annotation	O
was	O
compared	O
by	O
calculating	O
the	O
fractions	O
of	O
false	O
positives	O
(	O
FP	O
),	O
false	O
negatives	O
(	O
FN	O
),	O
true	O
positives	O
(	O
TP	O
),	O
and	O
true	O
negatives	O
(	O
TN	O
)	O
of	O
all	O
observations	O
n	O
for	O
MZmine	B-BT
and	O
ATS	O
compared	O
to	O
the	O
manual	O
evaluation	O
in	O
TraceFinder	O
.	O

Fiji	O
also	O
has	O
a	O
sugar	O
-	O
sweetened	O
beverage	O
tax	O
;	O
however	O
,	O
previous	O
research	O
has	O
shown	O
that	O
this	O
tax	O
needs	O
to	O
be	O
higher	O
to	O
achieve	O
health	O
impacts	O
[	O
18	O
,	O
19	O
,	O
34	O
].	O

ASRS	O
SNPs	O
with	O
high	O
AStruct	B-BT
scores	O
demonstrated	O
an	O
enrichment	O
of	O
allele	O
-	O
specific	O
RBP	O
binding	O
sites	O
(	O
ASRBP	O
)	O
and	O
m6A	O
related	O
SNPs	O
(	O
m6Asnp	O
)	O
compared	O
to	O
SNPs	O
with	O
medium	O
or	O
low	O
scores	O
.	O

aureus	O
),	O
a	O
single	O
annotation	O
file	O
was	O
made	O
for	O
comparison	O
by	O
pooling	O
the	O
annotations	O
that	O
are	O
available	O
from	O
GenBank	O
with	O
the	O
annotations	O
provided	O
by	O
SubtiWiki	B-BT
,	O
EcoCyc	O
,	O
and	O
AureoWiki	O
,	O
respectively	O
,	O
in	O
order	O
to	O
encompass	O
as	O
many	O
known	O
annotations	O
as	O
possible	O
.	O

Since	O
sequences	O
shorter	O
than	O
50	O
aa	O
are	O
unsuitable	O
input	O
for	O
the	O
DEGRONOPEDIA	B-BT
,	O
we	O
excluded	O
them	O
from	O
our	O
FLG	O
mutant	O
variants	O
analysis	O
.	O

According	O
to	O
eTBLAST	B-BT
,	O
these	O
abstracts	O
have	O
a	O
similarity	O
score	O
of	O
.	O
998	O
.	O

Workflow	O
describing	O
the	O
main	O
steps	O
of	O
identifying	O
and	O
reassembling	O
additional	O
components	O
in	O
a	O
host	O
assembly	O
using	O
MarkerScan	B-BT
.	O

The	O
MoTrPAC	B-BT
RRBS	O
data	O
were	O
generated2	O
and	O
processed	O
using	O
the	O
pipeline	O
described	O
at	O
GitHub	O
:	O
https	O
://	O
github	O
.	O
com	O
/	O
MoTrPAC	B-BT
/	O
motrpacrrbs	B-BT
-	O
pipeline	O
.	O

We	O
compared	O
the	O
discriminative	O
ability	O
of	O
DeepSA	O
with	O
other	O
existing	O
models	O
for	O
evaluating	O
the	O
synthetic	O
accessibility	O
of	O
compounds	O
(	O
GASA	O
,	O
SYBA	O
,	O
RAscore	B-BT
,	O
SCScore	O
,	O
and	O
SAscore	O
).	O

oxysporum	O
Pangenome	O
Database	O
(	O
FoPGDB	B-BT
),	O
allowing	O
for	O
efficient	O
and	O
comprehensive	O
genomic	O
analysis	O
[	O
32	O
].	O

We	O
found	O
diverse	O
ontology	O
nomenclatures	O
,	O
including	O
Biological	O
,	O
Molecular	O
,	O
Cellular	O
,	O
KEGG	O
,	O
and	O
Reactome	B-BT
dimensions	O
,	O
among	O
others	O
,	O
and	O
thus	O
we	O
decided	O
to	O
use	O
the	O
Reactome	B-BT
analysis	O
for	O
consistency	O
with	O
our	O
previous	O
studies	O
[	O
39	O
,	O
40	O
].	O

Downregulated	O
plasma	O
miR	O
-	O
150	O
-	O
5p	O
served	O
as	O
a	O
diagnostic	O
biomarker	O
for	O
APE	O
and	O
predicted	O
the	O
predisposition	O
of	O
PAH	O
in	O
APE	O
patients	O
.	O

To	O
efficiently	O
extract	O
the	O
three	O
-	O
dimensional	O
information	O
of	O
the	O
pharynx	O
,	O
we	O
designed	O
a	O
multiple	O
instance	O
CNN	O
(	O
MI	B-BT
-	I-BT
CNN	I-BT
)	O
that	O
inputs	O
multiple	O
images	O
simultaneously	O
.	O

This	O
operative	O
technique	O
includes	O
the	O
well	O
-	O
known	O
Krakow	O
locking	O
stitch	O
in	O
addition	O
to	O
FiberTape	O
sutures	O
crisscrossing	O
in	O
a	O
suture	O
bridge	O
configuration	O
.	O

For	O
the	O
organization	O
,	O
storage	O
and	O
management	O
of	O
data	O
,	O
FoPGDB	B-BT
deployed	O
MySQL	O
(	O
https	O
://	O
www	O
.	O
mysql	O
.	O
com	O
).	O

CITEViz	B-BT
(	O
version	O
0	O
.	O
1	O
)	O
in	O
R	O
was	O
used	O
to	O
visualise	O
,	O
set	O
thresholds	O
,	O
and	O
gate	O
cells	O
from	O
the	O
original	O
multi	O
-	O
omics	O
dataset	O
based	O
on	O
ADT	O
information	O
.	O

Time	O
per	O
stitch	O
did	O
not	O
differ	O
between	O
nerve	O
transfers	O
(	O
5	O
.	O
4	O
±	O
1	O
.	O
6	O
min	O
)	O
or	O
TMR	O
(	O
5	O
.	O
1	O
±	O
0	O
.	O
5	O
min	O
),	O
but	O
with	O
neurotized	O
free	O
flaps	O
(	O
2	O
.	O
4	O
±	O
0	O
.	O
8	O
min	O
)	O
(	O
Fig	O
.	O

The	O
calculated	O
adsorption	O
energy	O
(−	O
45	O
.	O
98	O
kJ	O
mol	O
−	O
1	O
)	O
located	O
in	O
a	O
strong	O
physisorption	O
range	O
(	O
30	O
–	O
50	O
kJ	O
mol	O
−	O
1	O
),	O
32	O
which	O
supported	O
that	O
AdPS	O
/	O
TPMA	O
-	O
Me	O
with	O
polar	O
moieties	O
had	O
a	O
higher	O
affinity	O
for	O
CO2	O
.	O

During	O
quantitation	O
,	O
iMet	B-BT
-	I-BT
Q	I-BT
sequentially	O
detects	O
peaks	O
from	O
each	O
replicate	O
and	O
then	O
aligns	O
those	O
detected	O
peaks	O
across	O
replicates	O
/	O
samples	O
.	O

The	O
normalized	O
and	O
imputed	O
data	O
generated	O
by	O
FlexStat	B-BT
are	O
available	O
as	O
downloadable	O
files	O
for	O
downstream	O
analysis	O
.	O

This	O
graphical	O
plugin	O
operates	O
in	O
a	O
similar	O
way	O
to	O
KVFinder	B-BT
-	O
web	O
portal	O
,	O
the	O
characterizations	O
are	O
shown	O
in	O
lists	O
(	O
Supplementary	O
Figure	O
S1B	O
)	O
and	O
the	O
cavities	O
customized	O
by	O
their	O
properties	O
in	O
PyMOL	O
viewer	O
(	O
Supplementary	O
Figure	O
S1C	O
and	O
D	O
).	O

Collectively	O
,	O
these	O
results	O
show	O
the	O
advantages	O
of	O
performing	O
hybrid	O
-	O
DIA	O
rather	O
than	O
only	O
targeted	O
acquisition	O
methods	O
as	O
it	O
maximizes	O
the	O
information	O
retrieved	O
from	O
single	O
-	O
shot	O
phosphoproteomics	O
samples	O
.	O

The	O
input	O
is	O
a	O
compartmentalized	O
community	O
metabolic	O
model	O
in	O
SBML	O
format	O
,	O
such	O
as	O
generated	O
by	O
PyCoMo	B-BT
(	O
Predl	O
et	O
al	O
.	O

The	O
framework	O
,	O
core	O
system	O
and	O
programming	O
language	O
of	O
FOPGDB	B-BT
.	O

A	O
Amino	O
acid	O
sequence	O
alignment	O
of	O
equine	O
TK1	O
isoforms	O
with	O
human	O
TK1	O
using	O
the	O
Clustal	O
Omega	O
algorithm	O
(	O
https	O
://	O
www	O
.	O
ebi	O
.	O
ac	O
.	O
uk	O
/	O
Tools	O
/	O
msa	O
/	O
clustalo	O
/)	O
and	O
structural	O
alignment	O
using	O
ENDscript	B-BT
2	I-BT
.	I-BT
0	I-BT
software	O
(	O
http	O
://	O
endscript	O
.	O
ibcp	O
.	O
fr	O
/	O
ESPript	O
/	O
cgi	O
-	O
bin	O
/	O
ENDscript	O
.	O
cgi	O
)	O
with	O
the	O
human	O
TK1	O
structure	O
as	O
the	O
template	O
.	O

ABDpred	B-BT
server	O
is	O
also	O
capable	O
to	O
check	O
the	O
information	O
on	O
the	O
drugability	O
and	O
bioavailability	O
of	O
the	O
input	O
chemicals	O
.	O

PlantFUNCO	B-BT
is	O
available	O
at	O
https	O
://	O
rocesv	O
.	O
github	O
.	O
io	O
/	O
PlantFUNCO	B-BT
.	O

(	O
Step	O
3	O
)	O
Function	O
‘	O
Contextualize	O
with	O
Flux	O
Data	O
’:	O
Visualization	O
of	O
flux	O
ranges	O
of	O
potential	O
exchange	O
reactions	O
,	O
independent	O
of	O
the	O
community	O
composition	O
and	O
calculated	O
with	O
PyCoMo	B-BT
.	O

The	O
peptide	O
report	O
is	O
then	O
used	O
as	O
input	O
to	O
CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
,	O
without	O
a	O
need	O
for	O
the	O
protein	O
table	O
(	O
Supplemental	O
Fig	O
.	O

Here	O
,	O
we	O
describe	O
cytoviewer	B-BT
,	O
an	O
R	O
/	O
Bioconductor	O
package	O
for	O
interactive	O
visualization	O
and	O
exploration	O
of	O
multi	O
-	O
channel	O
images	O
and	O
segmentation	O
masks	O
.	O

Here	O
,	O
the	O
Privateer	B-BT
web	O
app	O
is	O
presented	O
,	O
which	O
is	O
always	O
up	O
to	O
date	O
and	O
available	O
to	O
be	O
used	O
online	O
(	O
https	O
://	O
privateer	B-BT
.	O
york	O
.	O
ac	O
.	O
uk	O
)	O
without	O
installation	O
.	O

The	O
single	O
-	O
cell	O
transcriptome	O
data	O
of	O
the	O
AtCASP	O
genes	O
in	O
Arabidopsis	O
roots	O
were	O
collected	O
from	O
the	O
PPRD	O
(	O
http	O
://	O
ipf	O
.	O
sustech	O
.	O
edu	O
.	O
cn	O
/	O
pub	O
/	O
plantrna	B-BT
/,	O
accessed	O
on	O
20	O
May	O
2024	O
).	O

Relative	O
abundance	O
(	O
a	O
)	O
and	O
biomass	O
(	O
b	O
)	O
of	O
the	O
seven	O
dominant	O
morphotypes	O
plus	O
other	O
cells	O
which	O
comprised	O
the	O
sHF	O
flow	O
-	O
sorted	O
from	O
samples	O
collected	O
in	O
the	O
South	O
Pacific	O
mesotrophic	O
(	O
SPacM	O
)	O
and	O
oligotrophic	O
(	O
SPacO	O
)	O
waters	O
.	O

We	O
first	O
outline	O
the	O
algorithms	O
behind	O
the	O
fastest	O
exact	O
global	O
aligners	O
:	O
dynamic	O
programming	O
(	O
DP	O
)-	O
based	O
band	O
-	O
doubling	O
(	O
used	O
by	O
Edlib	O
)	O
and	O
diagonal	O
transition	O
(	O
DT	O
)	O
(	O
used	O
by	O
BiWFA	B-BT
).	O

A	O
guide	O
sheath	O
(	O
UMIDAS	O
sheath	O
cannula	O
;	O
UMIDAS	O
Inc	O
.,	O
Kanagawa	O
,	O
Japan	O
)	O
was	O
inserted	O
into	O
the	O
stricture	O
and	O
a	O
biliary	O
metallic	O
stent	O
with	O
an	O
ultraslim	O
delivery	O
system	O
(	O
YABUSAME	O
Neo	O
;	O
KANEKA	O
Medics	O
,	O
Tokyo	O
,	O
Japan	O
)	O
was	O
successfully	O
passed	O
and	O
placed	O
through	O
the	O
guide	O
sheath	O
.	O

A	O
statistically	O
significant	O
enhancement	O
was	O
observed	O
for	O
spacers	O
composed	O
of	O
Palacos	O
R	O
+	O
G	O
(	O
group	O
C	O
:	O
149	O
.	O
4	O
mg	O
/	O
l	O
±	O
SD	O
15	O
and	O
group	O
D	O
:	O
226	O
.	O
1	O
mg	O
/	O
l	O
±	O
SD	O
13	O
.	O
7	O
;	O
p	O
<	O
0	O
.	O
001	O
,	O
respectively	O
),	O
but	O
no	O
effect	O
was	O
noticed	O
for	O
spacers	O
made	O
of	O
Copal	O
spacem	B-BT
(	O
group	O
A	O
:	O
28	O
.	O
9	O
mg	O
/	O
l	O
±	O
SD	O
3	O
.	O
2	O
and	O
group	O
B	O
:	O
26	O
.	O
1	O
mg	O
/	O
l	O
±	O
SD	O
1	O
.	O
1	O
;	O
p	O
=	O
1	O
.	O
0	O
,	O
respectively	O
)	O
or	O
Copal	O
G	O
+	O
V	O
(	O
group	O
E	O
:	O
200	O
.	O
2	O
mg	O
/	O
l	O
±	O
SD	O
24	O
.	O
4	O
and	O
group	O
F	O
:	O
203	O
.	O
3	O
mg	O
/	O
l	O
±	O
SD	O
18	O
.	O
7	O
;	O
p	O
=	O
1	O
.	O
0	O
,	O
respectively	O
).	O

We	O
also	O
designed	O
the	O
cell	O
-	O
calling	O
loss	O
to	O
allow	O
BIDCell	B-BT
to	O
capture	O
cell	O
-	O
type	O
specific	O
morphologies	O
.	O

A	O
recent	O
study	O
also	O
reported	O
the	O
significant	O
conversion	O
even	O
in	O
the	O
absence	O
of	O
a	O
PC	O
,	O
attributing	O
this	O
to	O
impurities	O
in	O
the	O
commercially	O
available	O
TPMA86	O
.	O

Higher	O
peaks	O
and	O
brighter	O
colours	O
(	O
e	O
.	O
g	O
.,	O
red	O
and	O
yellow	O
)	O
indicate	O
regions	O
of	O
greater	O
surface	O
roughness	O
and	O
more	O
pronounced	O
corrosion	O
damage	O
,	O
while	O
lower	O
peaks	O
and	O
cooler	O
colours	O
(	O
e	O
.	O
g	O
.,	O
purple	O
and	O
blue	O
)	O
suggest	O
smoother	O
surfaces	O
with	O
less	O
corrosion	O
.	O

cloudrnaSPAdes	B-BT
offers	O
an	O
effective	O
way	O
to	O
assemble	O
full	O
-	O
length	O
isoforms	O
from	O
cheap	O
and	O
accurate	O
read	O
cloud	O
data	O
.	O

The	O
three	O
-	O
dimensional	O
structure	O
of	O
malanin	O
was	O
created	O
by	O
Swiss	O
-	O
model	O
and	O
viewed	O
by	O
PyMOL	B-BT
2	O
.	O
3	O
(	O
Figure	O
3	O
).	O

Han	O
and	O
Molloy	O
(	O
2023	O
)	O
have	O
recently	O
developed	O
TREE	B-BT
-	I-BT
QMC	I-BT
,	O
which	O
is	O
based	O
on	O
wQMC	O
and	O
offers	O
a	O
fast	O
method	O
for	O
constructing	O
the	O
quartet	O
graph	O
directly	O
from	O
input	O
gene	O
trees	O
without	O
the	O
need	O
for	O
explicitly	O
computing	O
the	O
weighted	O
quartet	O
distributions	O
as	O
in	O
the	O
case	O
of	O
wQMC	O
and	O
wQFM	O
.	O

Multiple	O
datasets	O
,	O
including	O
Alphacoronavirus	O
,	O
Alphaherpesvirinae	O
,	O
and	O
Betacoronavirus	O
,	O
were	O
selected	O
to	O
evaluate	O
the	O
performance	O
and	O
robustness	O
of	O
Bd	B-BT
-	I-BT
RPC	I-BT
in	O
new	O
sample	O
placement	O
with	O
five	O
repetitions	O
.	O

Represents	O
the	O
three	O
-	O
dimensional	O
(	O
3D	O
)	O
structure	O
of	O
Saponarin	O
with	O
Cutibacterium	O
acnes	O
(	O
Propionibacterium	O
acnes	O
)	O
beta	O
-	O
keto	O
acyl	O
synthase	O
-	O
III	O
(	O
docked	O
using	O
patchdock	B-BT
and	O
analysed	O
using	O
pyMOL	O
method	O
)	O
↓	O
down	O
arrow	O
mark	O
represents	O
the	O
Histidine	O
(	O
His	O
)	O
amino	O
acid	O
at	O
position	O
257	O
and	O
↑	O
up	O
arrow	O
mark	O
represents	O
the	O
Asparagine	O
(	O
Asn	O
)	O
amino	O
acid	O
at	O
position	O
119	O
of	O
the	O
Cutibacterium	O
acnes	O
(	O
Propionibacterium	O
acnes	O
)	O
beta	O
-	O
keto	O
acyl	O
synthase	O
-	O
III	O
enzyme	O
interact	O
with	O
the	O
ligand	O
(	O
Saponarin	O
).	O

These	O
cross	O
-	O
sectional	O
studies	O
have	O
supported	O
a	O
relationship	O
between	O
centrality	O
of	O
the	O
bereavement	O
event	O
to	O
one	O
’	O
s	O
identity	O
and	O
life	O
story	O
and	O
the	O
presence	O
of	O
PGD	O
.	O

Furthermore	O
,	O
HTSlib	B-BT
has	O
demonstrated	O
the	O
best	O
performance	O
among	O
many	O
competitors	O
(	O
Bonfield	O
et	O
al	O
.	O

Using	O
RAMZIS	B-BT
,	O
each	O
sample	O
group	O
was	O
assessed	O
for	O
internal	O
consistency	O
and	O
put	O
into	O
pairwise	O
comparisons	O
:	O
the	O
control	O
was	O
compared	O
to	O
an	O
aggregate	O
of	O
the	O
CLA	O
,	O
MES	O
,	O
and	O
PRO	O
subtypes	O
as	O
well	O
as	O
to	O
each	O
subtype	O
on	O
its	O
own	O
;	O
the	O
subtypes	O
were	O
similarly	O
compared	O
against	O
each	O
other	O
.	O

Using	O
a	O
single	O
configuration	O
file	O
supports	O
automated	O
processing	O
of	O
several	O
files	O
in	O
parallel	O
,	O
while	O
allowing	O
users	O
to	O
adjust	O
RepairNatrix	B-BT
to	O
their	O
requirements	O
and	O
experimental	O
conditions	O
.	O

SyntenyViewer	B-BT
is	O
a	O
web	O
resource	O
to	O
perform	O
comparative	O
genomics	O
in	O
plants	O
;	O

According	O
to	O
the	O
Plant	O
Public	O
RNA	O
–	O
seq	O
Database	O
(	O
http	O
://	O
ipf	O
.	O
sustech	O
.	O
edu	O
.	O
cn	O
/	O
pub	O
/	O
plantrna	B-BT
/,	O
accessed	O
on	O
23	O
February	O
2024	O
),	O
LOC_Os05g40160	O
expression	O
was	O
significantly	O
up	O
–	O
regulated	O
under	O
Fe	O
–	O
deficient	O
conditions	O
(	O
Figure	O
4E	O
).	O

MHCpLogics	B-BT
can	O
deconvolute	O
immunopeptidomes	O
into	O
allotype	O
-	O
specific	O
ligandomes	O
by	O
macro	O
clustering	O
analysis	O
.	O

Panels	O
A	O
and	O
B	O
(	O
x100	O
objective	O
):	O
Plasma	O
cells	O
with	O
numerous	O
large	O
cytoplasmic	O
granules	O
and	O
a	O
few	O
Snapper	O
‐	O
Schneid	O
bodies	O
(	O
arrows	O
).	O

Shaoxia	O
Pu	O
,	O
Yanhua	O
Su	O
,	O
and	O
Anzhu	O
zhu	O
were	O
involved	O
in	O
revision	O
of	O
the	O
paper	O
for	O
intellectual	O
content	O
.	O

3Power	O
over	O
different	O
signal	O
strengths	O
of	O
gbdmr	B-BT
,	O
dmrff	O
,	O
and	O
EWAS	O
across	O
different	O
block	O
sizes	O

DEGRONOPEDIA	B-BT
indicated	O
the	O
previously	O
reported	O
processing	O
site	O
pointing	O
at	O
low	O
stability	O
of	O
both	O
SDE2	O
fragments	O
(	O
SDE2	O
-	O
UBL	O
and	O
SDE2	O
-	O
C	O
)	O
and	O
an	O
Arg	O
/	O
N	O
primary	O
degron	O
in	O
SDE2	O
-	O
C	O
(	O
Figure	O
5A	O
).	O

Thanks	O
to	O
a	O
light	O
rod	O
attached	O
to	O
the	O
back	O
of	O
the	O
skull	O
,	O
a	O
systematic	O
rotation	O
with	O
a	O
final	O
average	O
angle	O
of	O
nearly	O
17	O
degrees	O
is	O
revealed	O
,	O
always	O
in	O
the	O
direction	O
of	O
the	O
“	O
smoother	O
”	O
half	O
of	O
the	O
skull	O
.	O

CPPLS_MLP	B-BT
exhibits	O
excellent	O
accuracy	O
and	O
robustness	O
,	O
making	O
it	O
suitable	O
for	O
various	O
experimental	O
designs	O
,	O
single	O
-	O
cell	O
sequencing	O
presumably	O
derived	O
from	O
different	O
organs	O
and	O
cell	O
communication	O
of	O
ST	O
data	O
.	O

Built	O
on	O
an	O
R	O
Shiny	O
framework	O
integrated	O
with	O
Python	O
,	O
HTML	O
,	O
and	O
JavaScript	O
,	O
shinyDeepDR	B-BT
performs	O
deep	O
learning	O
computation	O
and	O
enables	O
interactive	O
exploration	O
of	O
prediction	O
results	O
.	O

Alternatively	O
the	O
vendors	O
commercial	O
software	O
VOCal	O
or	O
the	O
free	O
,	O
vendor	O
independent	O
software	O
OpenChrom	B-BT
(	O
version	O
1	O
.	O
5	O
)	O
can	O
be	O
used	O
to	O
read	O
and	O
visualize	O
GC	O
-	O
IMS	O
data	O
[	O
4	O
].	O

When	O
PyPop	B-BT
development	O
started	O
in	O
late	O
2001	O
Python	O
was	O
at	O
version	O
2	O
.	O

For	O
example	O
,	O
the	O
Hmrbase	B-BT
database	O
provides	O
a	O
comprehensive	O
resource	O
of	O
available	O
information	O
on	O
hormones	O
and	O
their	O
receptors	O
[	O
78	O
].	O

Addressing	O
these	O
challenges	O
,	O
I	O
have	O
developed	O
pyaging	B-BT
,	O
a	O
Python	O
-	O
based	O
package	O
that	O
acts	O
as	O
a	O
comprehensive	O
repository	O
for	O
various	O
biomarkers	O
of	O
aging	O
and	O
aging	O
clocks	O
.	O

The	O
reconstructed	O
draft	O
models	O
were	O
gapfilled	O
using	O
a	O
predicted	O
medium	O
,	O
and	O
their	O
quality	O
was	O
quantified	O
by	O
comparison	O
to	O
the	O
species	O
-	O
representative	O
reactome	B-BT
gold	O
standard	O
.	O

Commonly	O
used	O
tools	O
such	O
as	O
JCAT	B-BT
(	O
Grote	O
et	O
al	O
.	O

b	O
Distribution	O
of	O
run	O
time	O
for	O
QuickVariants	O
and	O
bcftools	B-BT
across	O
different	O
SAM	O
file	O
sizes	O
.	O

Table	O
1Characteristics	O
of	O
included	O
cancer	O
cases	O
across	O
different	O
treatment	O
phasesLung	O
cancerBreast	O
cancerColorectal	O
cancerEsophageal	O
cancerLiver	O
cancerGastric	O
cancerPhase	O
Ia	O
(	O
Surgical	O
-	O
related	O
treatment	O
),	O
N	O
*=	O
3738N	O
=	O
717N	O
=	O
824N	O
=	O
778N	O
=	O
376N	O
=	O
389N	O
=	O
654Region	O
,	O
N	O
(%)	O
North202	O
(	O
28	O
.	O
2	O
)	O
236	O
(	O
28	O
.	O
6	O
)	O
139	O
(	O
17	O
.	O
9	O
)	O
51	O
(	O
13	O
.	O
6	O
)	O
81	O
(	O
20	O
.	O
8	O
)	O
199	O
(	O
30	O
.	O
4	O
)	O
East182	O
(	O
25	O
.	O
4	O
)	O
193	O
(	O
23	O
.	O
4	O
)	O
213	O
(	O
27	O
.	O
4	O
)	O
140	O
(	O
37	O
.	O
2	O
)	O
92	O
(	O
23	O
.	O
7	O
)	O
148	O
(	O
22	O
.	O
6	O
)	O
Middle128	O
(	O
17	O
.	O
9	O
)	O
176	O
(	O
21	O
.	O
4	O
)	O
154	O
(	O
19	O
.	O
8	O
)	O
79	O
(	O
21	O
.	O
0	O
)	O
68	O
(	O
17	O
.	O
5	O
)	O
111	O
(	O
17	O
.	O
0	O
)	O
South88	O
(	O
12	O
.	O
3	O
)	O
80	O
(	O
9	O
.	O
7	O
)	O
91	O
(	O
11	O
.	O
7	O
)	O
35	O
(	O
9	O
.	O
3	O
)	O
64	O
(	O
16	O
.	O
5	O
)	O
67	O
(	O
10	O
.	O
2	O
)	O
West117	O
(	O
16	O
.	O
3	O
)	O
139	O
(	O
16	O
.	O
9	O
)	O
181	O
(	O
23	O
.	O
3	O
)	O
71	O
(	O
18	O
.	O
9	O
)	O
84	O
(	O
21	O
.	O
6	O
)	O
129	O
(	O
19	O
.	O
7	O
)	O
Hospital	O
type	O
,	O
N	O
(%)	O
General	O
hospital323	O
(	O
45	O
.	O
0	O
)	O
387	O
(	O
47	O
.	O
0	O
)	O
432	O
(	O
55	O
.	O
5	O
)	O
170	O
(	O
45	O
.	O
2	O
)	O
161	O
(	O
41	O
.	O
4	O
)	O
253	O
(	O
38	O
.	O
7	O
)	O
Specialized	O
hospital394	O
(	O
55	O
.	O
0	O
)	O
437	O
(	O
53	O
.	O
0	O
)	O
346	O
(	O
44	O
.	O
5	O
)	O
206	O
(	O
54	O
.	O
8	O
)	O
228	O
(	O
58	O
.	O
6	O
)	O
401	O
(	O
61	O
.	O
3	O
)	O
Age	O
at	O
diagnosis	O
Years	O
,	O
mean	O
(	O
SD	O
)	O
60	O
(	O
11	O
)	O
53	O
(	O
11	O
)	O
63	O
(	O
11	O
)	O
65	O
(	O
9	O
)	O
60	O
(	O
10	O
)	O
62	O
(	O
11	O
)	O
Gender	O
,	O
N	O
(%)	O
Male388	O
(	O
54	O
.	O
1	O
)	O
7	O
(	O
0	O
.	O
8	O
)	O
478	O
(	O
61	O
.	O
4	O
)	O
306	O
(	O
81	O
.	O
4	O
)	O
302	O
(	O
77	O
.	O
6	O
)	O
468	O
(	O
71	O
.	O
6	O
)	O
Female329	O
(	O
45	O
.	O
9	O
)	O
817	O
(	O
99	O
.	O
2	O
)	O
300	O
(	O
38	O
.	O
6	O
)	O
70	O
(	O
18	O
.	O
6	O
)	O
87	O
(	O
22	O
.	O
4	O
)	O
186	O
(	O
28	O
.	O
4	O
)	O
Clinical	O
stage	O
**,	O
N	O
(%)	O
I384	O
(	O
53	O
.	O
6	O
)	O
338	O
(	O
41	O
.	O
0	O
)	O
230	O
(	O
29	O
.	O
6	O
)	O
114	O
(	O
30	O
.	O
3	O
)	O
137	O
(	O
35	O
.	O
2	O
)	O
201	O
(	O
30	O
.	O
7	O
)	O
II151	O
(	O
21	O
.	O
1	O
)	O
281	O
(	O
34	O
.	O
1	O
)	O
210	O
(	O
27	O
.	O
0	O
)	O
114	O
(	O
30	O
.	O
3	O
)	O
111	O
(	O
28	O
.	O
5	O
)	O
159	O
(	O
24	O
.	O
3	O
)	O
III126	O
(	O
17	O
.	O
6	O
)	O
164	O
(	O
19	O
.	O
9	O
)	O
234	O
(	O
30	O
.	O
1	O
)	O
117	O
(	O
31	O
.	O
1	O
)	O
97	O
(	O
24	O
.	O
9	O
)	O
202	O
(	O
30	O
.	O
9	O
)	O
IV56	O
(	O
7	O
.	O
8	O
)	O
41	O
(	O
5	O
.	O
0	O
)	O
104	O
(	O
13	O
.	O
4	O
)	O
31	O
(	O
8	O
.	O
2	O
)	O
44	O
(	O
11	O
.	O
3	O
)	O
92	O
(	O
14	O
.	O
1	O
)	O
Phase	O
Ib	O
(	O
Non	O
-	O
surgical	O
treatment	O
),	O
N	O
=	O
5	O
,	O
940N	O
=	O
1	O
,	O
256N	O
=	O
1	O
,	O
282N	O
=	O
1	O
,	O
006N	O
=	O
719N	O
=	O
914N	O
=	O
763Region	O
,	O
N	O
(%)	O
North200	O
(	O
15	O
.	O
9	O
)	O
327	O
(	O
25	O
.	O
5	O
)	O
262	O
(	O
26	O
.	O
0	O
)	O
57	O
(	O
7	O
.	O
9	O
)	O
147	O
(	O
16	O
.	O
1	O
)	O
200	O
(	O
26	O
.	O
2	O
)	O
East307	O
(	O
24	O
.	O
4	O
)	O
224	O
(	O
17	O
.	O
5	O
)	O
194	O
(	O
19	O
.	O
3	O
)	O
251	O
(	O
34	O
.	O
9	O
)	O
221	O
(	O
24	O
.	O
2	O
)	O
213	O
(	O
27	O
.	O
9	O
)	O
Middle320	O
(	O
25	O
.	O
5	O
)	O
335	O
(	O
26	O
.	O
1	O
)	O
244	O
(	O
24	O
.	O
3	O
)	O
156	O
(	O
21	O
.	O
7	O
)	O
236	O
(	O
25	O
.	O
8	O
)	O
158	O
(	O
20	O
.	O
7	O
)	O
South126	O
(	O
10	O
.	O
0	O
)	O
191	O
(	O
14	O
.	O
9	O
)	O
141	O
(	O
14	O
.	O
0	O
)	O
91	O
(	O
12	O
.	O
7	O
)	O
158	O
(	O
17	O
.	O
3	O
)	O
79	O
(	O
10	O
.	O
4	O
)	O
West303	O
(	O
24	O
.	O
1	O
)	O
205	O
(	O
16	O
.	O
0	O
)	O
165	O
(	O
16	O
.	O
4	O
)	O
164	O
(	O
22	O
.	O
8	O
)	O
152	O
(	O
16	O
.	O
6	O
)	O
113	O
(	O
14	O
.	O
8	O
)	O
Hospital	O
type	O
,	O
N	O
(%)	O
General	O
hospital739	O
(	O
58	O
.	O
8	O
)	O
579	O
(	O
45	O
.	O
2	O
)	O
601	O
(	O
59	O
.	O
7	O
)	O
342	O
(	O
47	O
.	O
6	O
)	O
464	O
(	O
50	O
.	O
8	O
)	O
356	O
(	O
46	O
.	O
7	O
)	O
Specialized	O
hospital517	O
(	O
41	O
.	O
2	O
)	O
703	O
(	O
54	O
.	O
8	O
)	O
405	O
(	O
40	O
.	O
3	O
)	O
377	O
(	O
52	O
.	O
4	O
)	O
450	O
(	O
49	O
.	O
2	O
)	O
407	O
(	O
53	O
.	O
3	O
)	O
Age	O
at	O
diagnosis	O
Years	O
,	O
mean	O
(	O
SD	O
)	O
63	O
(	O
9	O
)	O
52	O
(	O
10	O
)	O
60	O
(	O
11	O
)	O
65	O
(	O
10	O
)	O
59	O
(	O
12	O
)	O
61	O
(	O
11	O
)	O
Gender	O
,	O
N	O
(%)	O
Male896	O
(	O
71	O
.	O
3	O
)	O
10	O
(	O
0	O
.	O
8	O
)	O
636	O
(	O
63	O
.	O
2	O
)	O
592	O
(	O
82	O
.	O
3	O
)	O
741	O
(	O
81	O
.	O
1	O
)	O
529	O
(	O
69	O
.	O
3	O
)	O
Female360	O
(	O
28	O
.	O
7	O
)	O
1	O
,	O
272	O
(	O
99	O
.	O
2	O
)	O
370	O
(	O
36	O
.	O
8	O
)	O
127	O
(	O
17	O
.	O
7	O
)	O
173	O
(	O
18	O
.	O
9	O
)	O
234	O
(	O
30	O
.	O
7	O
)	O
Clinical	O
stage	O
**,	O
N	O
(%)	O
I229	O
(	O
18	O
.	O
2	O
)	O
317	O
(	O
24	O
.	O
7	O
)	O
185	O
(	O
18	O
.	O
4	O
)	O
77	O
(	O
10	O
.	O
7	O
)	O
166	O
(	O
18	O
.	O
2	O
)	O
93	O
(	O
12	O
.	O
2	O
)	O
II205	O
(	O
16	O
.	O
3	O
)	O
429	O
(	O
33	O
.	O
5	O
)	O
271	O
(	O
26	O
.	O
9	O
)	O
178	O
(	O
24	O
.	O
8	O
)	O
228	O
(	O
24	O
.	O
9	O
)	O
194	O
(	O
25	O
.	O
4	O
)	O
III377	O
(	O
30	O
.	O
0	O
)	O
306	O
(	O
23	O
.	O
9	O
)	O
312	O
(	O
31	O
.	O
0	O
)	O
270	O
(	O
37	O
.	O
6	O
)	O
288	O
(	O
31	O
.	O
5	O
)	O
234	O
(	O
30	O
.	O
7	O
)	O
IV445	O
(	O
35	O
.	O
4	O
)	O
230	O
(	O
17	O
.	O
9	O
)	O
238	O
(	O
23	O
.	O
7	O
)	O
194	O
(	O
27	O
.	O
0	O
)	O
232	O
(	O
25	O
.	O
4	O
)	O
242	O
(	O
31	O
.	O
7	O
)	O
Phase	O
II	O
(	O
Follow	O
-	O
up	O
treatment	O
),	O
N	O
=	O
1	O
,	O
554N	O
=	O
283N	O
=	O
256N	O
=	O
262N	O
=	O
282N	O
=	O
201N	O
=	O
270Region	O
,	O
N	O
(%)	O
North26	O
(	O
9	O
.	O
2	O
)	O
43	O
(	O
16	O
.	O
8	O
)	O
12	O
(	O
4	O
.	O
6	O
)	O
15	O
(	O
5	O
.	O
3	O
)	O
6	O
(	O
3	O
.	O
0	O
)	O
32	O
(	O
11	O
.	O
9	O
)	O
East73	O
(	O
25	O
.	O
8	O
)	O
80	O
(	O
31	O
.	O
2	O
)	O
103	O
(	O
39	O
.	O
3	O
)	O
83	O
(	O
29	O
.	O
4	O
)	O
49	O
(	O
24	O
.	O
4	O
)	O
79	O
(	O
29	O
.	O
3	O
)	O
Middle67	O
(	O
23	O
.	O
7	O
)	O
37	O
(	O
14	O
.	O
5	O
)	O
69	O
(	O
26	O
.	O
3	O
)	O
49	O
(	O
17	O
.	O
4	O
)	O
30	O
(	O
14	O
.	O
9	O
)	O
32	O
(	O
11	O
.	O
9	O
)	O
South57	O
(	O
20	O
.	O
1	O
)	O
36	O
(	O
14	O
.	O
1	O
)	O
25	O
(	O
9	O
.	O
5	O
)	O
71	O
(	O
25	O
.	O
2	O
)	O
65	O
(	O
32	O
.	O
3	O
)	O
65	O
(	O
24	O
.	O
1	O
)	O
West60	O
(	O
21	O
.	O
2	O
)	O
60	O
(	O
23	O
.	O
4	O
)	O
53	O
(	O
20	O
.	O
2	O
)	O
64	O
(	O
22	O
.	O
7	O
)	O
51	O
(	O
25	O
.	O
4	O
)	O
62	O
(	O
23	O
.	O
0	O
)	O
Hospital	O
type	O
,	O
N	O
(%)	O
General	O
hospital124	O
(	O
43	O
.	O
8	O
)	O
109	O
(	O
42	O
.	O
6	O
)	O
159	O
(	O
60	O
.	O
7	O
)	O
124	O
(	O
44	O
.	O
0	O
)	O
56	O
(	O
27	O
.	O
9	O
)	O
107	O
(	O
39	O
.	O
6	O
)	O
Specialized	O
hospital159	O
(	O
56	O
.	O
2	O
)	O
147	O
(	O
57	O
.	O
4	O
)	O
103	O
(	O
39	O
.	O
3	O
)	O
158	O
(	O
56	O
.	O
0	O
)	O
145	O
(	O
72	O
.	O
1	O
)	O
163	O
(	O
60	O
.	O
4	O
)	O
Age	O
at	O
diagnosis	O
Years	O
,	O
mean	O
(	O
SD	O
)	O
61	O
(	O
11	O
)	O
53	O
(	O
11	O
)	O
62	O
(	O
11	O
)	O
64	O
(	O
9	O
)	O
60	O
(	O
12	O
)	O
61	O
(	O
11	O
)	O
Gender	O
,	O
N	O
(%)	O
Male173	O
(	O
61	O
.	O
1	O
)	O
3	O
(	O
1	O
.	O
2	O
)	O
161	O
(	O
61	O
.	O
5	O
)	O
233	O
(	O
82	O
.	O
6	O
)	O
169	O
(	O
84	O
.	O
1	O
)	O
173	O
(	O
64	O
.	O
1	O
)	O
Female110	O
(	O
38	O
.	O
9	O
)	O
253	O
(	O
98	O
.	O
8	O
)	O
101	O
(	O
38	O
.	O
5	O
)	O
49	O
(	O
17	O
.	O
4	O
)	O
32	O
(	O
15	O
.	O
9	O
)	O
97	O
(	O
35	O
.	O
9	O
)	O
Clinical	O
stage	O
**,	O
N	O
(%)	O
I100	O
(	O
35	O
.	O
3	O
)	O
67	O
(	O
26	O
.	O
2	O
)	O
52	O
(	O
19	O
.	O
8	O
)	O
66	O
(	O
23	O
.	O
4	O
)	O
62	O
(	O
30	O
.	O
8	O
)	O
65	O
(	O
24	O
.	O
1	O
)	O
II66	O
(	O
23	O
.	O
3	O
)	O
70	O
(	O
27	O
.	O
3	O
)	O
80	O
(	O
30	O
.	O
5	O
)	O
77	O
(	O
27	O
.	O
3	O
)	O
44	O
(	O
21	O
.	O
9	O
)	O
64	O
(	O
23	O
.	O
7	O
)	O
III62	O
(	O
21	O
.	O
9	O
)	O
55	O
(	O
21	O
.	O
5	O
)	O
96	O
(	O
36	O
.	O
6	O
)	O
81	O
(	O
28	O
.	O
7	O
)	O
55	O
(	O
27	O
.	O
4	O
)	O
63	O
(	O
23	O
.	O
3	O
)	O
IV55	O
(	O
19	O
.	O
4	O
)	O
64	O
(	O
25	O
.	O
0	O
)	O
34	O
(	O
13	O
.	O
0	O
)	O
58	O
(	O
20	O
.	O
6	O
)	O
40	O
(	O
19	O
.	O
9	O
)	O
78	O
(	O
28	O
.	O
9	O
)	O
Phase	O
III	O
(	O
Treatment	O
after	O
relapse	O
/	O
metastasis	O
),	O
N	O
=	O
2	O
,	O
513N	O
=	O
610N	O
=	O
446N	O
=	O
374N	O
=	O
329N	O
=	O
402N	O
=	O
352Region	O
,	O
N	O
(%)	O
North84	O
(	O
13	O
.	O
8	O
)	O
47	O
(	O
10	O
.	O
5	O
)	O
56	O
(	O
15	O
.	O
0	O
)	O
33	O
(	O
10	O
.	O
0	O
)	O
35	O
(	O
8	O
.	O
7	O
)	O
58	O
(	O
16	O
.	O
5	O
)	O
East148	O
(	O
24	O
.	O
3	O
)	O
111	O
(	O
24	O
.	O
9	O
)	O
102	O
(	O
27	O
.	O
3	O
)	O
78	O
(	O
23	O
.	O
7	O
)	O
102	O
(	O
25	O
.	O
4	O
)	O
129	O
(	O
36	O
.	O
6	O
)	O
Middle138	O
(	O
22	O
.	O
6	O
)	O
87	O
(	O
19	O
.	O
5	O
)	O
83	O
(	O
22	O
.	O
2	O
)	O
75	O
(	O
22	O
.	O
8	O
)	O
108	O
(	O
26	O
.	O
9	O
)	O
68	O
(	O
19	O
.	O
3	O
)	O
South67	O
(	O
11	O
.	O
0	O
)	O
103	O
(	O
23	O
.	O
1	O
)	O
53	O
(	O
14	O
.	O
2	O
)	O
54	O
(	O
16	O
.	O
4	O
)	O
72	O
(	O
17	O
.	O
9	O
)	O
49	O
(	O
13	O
.	O
9	O
)	O
West173	O
(	O
28	O
.	O
4	O
)	O
98	O
(	O
22	O
.	O
0	O
)	O
80	O
(	O
21	O
.	O
4	O
)	O
89	O
(	O
27	O
.	O
1	O
)	O
85	O
(	O
21	O
.	O
1	O
)	O
48	O
(	O
13	O
.	O
6	O
)	O
Hospital	O
type	O
,	O
N	O
(%)	O
General	O
hospital326	O
(	O
53	O
.	O
4	O
)	O
179	O
(	O
40	O
.	O
1	O
)	O
205	O
(	O
54	O
.	O
8	O
)	O
142	O
(	O
43	O
.	O
2	O
)	O
203	O
(	O
50	O
.	O
5	O
)	O
156	O
(	O
44	O
.	O
3	O
)	O
Specialized	O
hospital284	O
(	O
46	O
.	O
6	O
)	O
267	O
(	O
59	O
.	O
9	O
)	O
169	O
(	O
45	O
.	O
2	O
)	O
187	O
(	O
56	O
.	O
8	O
)	O
199	O
(	O
49	O
.	O
5	O
)	O
196	O
(	O
55	O
.	O
7	O
)	O
Age	O
at	O
diagnosis	O
Years	O
,	O
mean	O
(	O
SD	O
)	O
63	O
(	O
9	O
)	O
53	O
(	O
11	O
)	O
60	O
(	O
12	O
)	O
64	O
(	O
10	O
)	O
58	O
(	O
12	O
)	O
63	O
(	O
11	O
)	O
Gender	O
,	O
N	O
(%)	O
Male421	O
(	O
69	O
.	O
0	O
)	O
2	O
(	O
0	O
.	O
4	O
)	O
226	O
(	O
60	O
.	O
4	O
)	O
269	O
(	O
81	O
.	O
8	O
)	O
323	O
(	O
80	O
.	O
3	O
)	O
250	O
(	O
71	O
.	O
0	O
)	O
Female189	O
(	O
31	O
.	O
0	O
)	O
444	O
(	O
99	O
.	O
6	O
)	O
148	O
(	O
39	O
.	O
6	O
)	O
60	O
(	O
18	O
.	O
2	O
)	O
79	O
(	O
19	O
.	O
7	O
)	O
102	O
(	O
29	O
.	O
0	O
)	O
Clinical	O
stage	O
**,	O
N	O
(%)	O
I83	O
(	O
13	O
.	O
6	O
)	O
68	O
(	O
15	O
.	O
2	O
)	O
30	O
(	O
8	O
.	O
0	O
)	O
36	O
(	O
10	O
.	O
9	O
)	O
63	O
(	O
15	O
.	O
7	O
)	O
34	O
(	O
9	O
.	O
7	O
)	O
II62	O
(	O
10	O
.	O
2	O
)	O
98	O
(	O
22	O
.	O
0	O
)	O
53	O
(	O
14	O
.	O
2	O
)	O
54	O
(	O
16	O
.	O
4	O
)	O
66	O
(	O
16	O
.	O
4	O
)	O
51	O
(	O
14	O
.	O
5	O
)	O
III130	O
(	O
21	O
.	O
3	O
)	O
108	O
(	O
24	O
.	O
2	O
)	O
90	O
(	O
24	O
.	O
1	O
)	O
87	O
(	O
26	O
.	O
4	O
)	O
113	O
(	O
28	O
.	O
1	O
)	O
84	O
(	O
23	O
.	O
9	O
)	O
IV335	O
(	O
54	O
.	O
9	O
)	O
172	O
(	O
38	O
.	O
6	O
)	O
201	O
(	O
53	O
.	O
7	O
)	O
152	O
(	O
46	O
.	O
2	O
)	O
160	O
(	O
39	O
.	O
8	O
)	O
183	O
(	O
52	O
.	O
0	O
)	O
Note	O
*	O
N	O
stands	O
for	O
the	O
number	O
of	O
cases	O
counted	O
**	O
Clinical	O
stage	O
at	O
diagnosis	O

Here	O
,	O
we	O
employed	O
the	O
mentioned	O
technologies	O
to	O
create	O
scalepopgen	B-BT
,	O
an	O
easily	O
scalable	O
,	O
portable	O
,	O
and	O
reproducible	O
tool	O
that	O
implements	O
workflows	O
for	O
widely	O
used	O
population	O
genomics	O
analyses	O
on	O
genome	O
-	O
wide	O
biallelic	O
single	O
nucleotide	O
polymorphism	O
(	O
SNP	O
)	O
data	O
.	O

Complete	O
BUSCOs	O
(	O
C	O
):	O
95	O
.	O
1	O
%	O
[	O
Single	O
-	O
copy	O
:	O
92	O
.	O
5	O
%,	O
Duplicated	O
:	O
2	O
.	O
6	O
%]	O

Kmer	O
data	O
from	O
kmerDB	B-BT
can	O
find	O
applications	O
in	O
comparative	O
genomics	O
and	O
evolutionary	O
studies	O
[	O
42	O
],	O
[	O
50	O
],	O
aiding	O
sequence	O
specification	O
like	O
identifying	O
highly	O
-	O
specific	O
CRISPR	O
target	O
sites	O
[	O
60	O
].	O

For	O
the	O
variant	O
calling	O
,	O
SAMtools	B-BT
was	O
used	O
to	O
identify	O
the	O
SNPs	O
and	O
InDels	O
from	O
the	O
sorted	O
BAM	O
file	O
of	O
the	O
mapping	O
.	O

Specifically	O
,	O
for	O
type	O
N1	O
(	O
non	O
-	O
linear	O
signals	O
containing	O
complete	O
complex	O
-	O
valued	O
causality	O
),	O
CTE	O
achieves	O
slightly	O
higher	O
accuracy	O
than	O
the	O
sCTE	B-BT
and	O
18	O
.	O
7	O
–	O
85	O
.	O
9	O
%	O
higher	O
accuracy	O
than	O
the	O
three	O
real	O
-	O
valued	O
algorithms	O
.	O

We	O
compared	O
the	O
processing	O
times	O
of	O
QuickVariants	O
and	O
bcftools	B-BT
on	O
the	O
same	O
computer	O
offering	O
10	O
GB	O
RAM	O
,	O
15	O
threads	O
,	O
and	O
3	O
.	O
00	O
GHz	O
CPU	O
speed	O
.	O

In	O
this	O
manuscript	O
,	O
""""	O
KinCytE	B-BT
-	O
a	O
Kinase	O
to	O
Cytokine	O
Explorer	O
to	O
Identify	O
Molecular	O
Regulators	O
and	O
Potential	O
Therapeutic	O
""","	O
the	O
authors	O
present	O
a	O
web	O
resource	O
,	O
KinCytE	B-BT
,	O
that	O
lets	O
researchers	O
search	O
for	O
kinase	O
inhibitors	O
that	O
have	O
been	O
shown	O
to	O
affect	O
cytokine	O
and	O
chemokine	O
release	O
and	O
signaling	O
networks	O
.	O

However	O
,	O
data	O
from	O
other	O
multiplexed	O
imaging	O
technologies	O
including	O
t	O
-	O
CyCIF	O
[	O
6	O
],	O
CODEX	O
[	O
7	O
],	O
or	O
MIBI	O
[	O
8	O
],	O
which	O
produce	O
pixel	O
-	O
level	O
intensities	O
and	O
(	O
optionally	O
)	O
segmentation	O
masks	O
,	O
can	O
be	O
interactively	O
visualized	O
with	O
cytoviewer	B-BT
as	O
long	O
as	O
the	O
input	O
format	O
is	O
appropriate	O
.	O

We	O
thank	O
Chengdu	O
Genevector	O
Therapeutics	O
Inc	O
.	O

Also	O
,	O
CDBProm	B-BT
database	O
,	O
containing	O
the	O
predicted	O
promoter	O
sequences	O
obtained	O
from	O
this	O
study	O
is	O
freely	O
accessible	O
at	O
https	O
://	O
aw	O
.	O
iimas	O
.	O
unam	O
.	O
mx	O
/	O
cdbprom	B-BT
/.	O

In	O
addition	O
,	O
TrieDedup	B-BT
may	O
be	O
potentially	O
adapted	O
into	O
pRESTO	O
framework	O
.	O

The	O
main	O
database	O
source	O
for	O
our	O
genome	O
collection	O
was	O
the	O
Marine	O
Metagenomic	O
Portal	O
through	O
the	O
use	O
of	O
the	O
databases	O
MarRef	O
v4	O
.	O
0	O
(	O
N	O
=	O
943	O
,	O
available	O
at	O
https	O
://	O
mmp	O
.	O
sfb	O
.	O
uit	O
.	O
no	O
/	O
databases	O
/	O
marref	O
/),	O
MarDB	B-BT
v4	O
.	O
0	O
(	O
N	O
=	O
12	O
,	O
963	O
,	O
available	O
at	O
https	O
://	O
mmp	O
.	O
sfb	O
.	O
uit	O
.	O
no	O
/	O
databases	O
/	O
mardb	B-BT
/),	O
and	O
aquatic	O
representative	O
genomes	O
from	O
the	O
ProGenomes	O
database	O
v1	O
.	O
0	O
(	O
N	O
=	O
566	O
,	O
available	O
at	O
http	O
://	O
progenomes1	O
.	O
embl	O
.	O
de	O
/	O
data	O
/	O
habitats	O
/	O
aquatic	O
/	O
aquatic	O
.	O
repr	O
.	O
contigs	O
.	O
fasta	O
.	O
gz	O
).	O

With	O
the	O
designed	O
adaptive	O
NN	O
dynamic	O
surface	O
controller	O
,	O
the	O
system	O
output	O
effectively	O
tracks	O
the	O
reference	O
trajectory	O
,	O
and	O
the	O
tracking	O
error	O
can	O
converge	O
to	O
a	O
small	O
neighborhood	O
of	O
zero	O
.	O

In	O
the	O
Discussion	O
section	O
,	O
we	O
explain	O
the	O
possible	O
reasons	O
for	O
the	O
performance	O
disparity	O
between	O
gbdmr	B-BT
,	O
dmrff	O
,	O
and	O
other	O
DMR	O
detection	O
methods	O
under	O
different	O
correlations	O
of	O
adjacent	O
CpG	O
sites	O
.	O

As	O
can	O
be	O
seen	O
in	O
Figure	O
4	O
and	O
detailed	O
in	O
Supplementary	O
Table	O
S5	O
,	O
Enhancer	B-BT
-	I-BT
MDLF	I-BT
consistently	O
outperforms	O
Enhancer	O
-	O
IF	O
across	O
all	O
five	O
metrics	O
and	O
all	O
cell	O
lines	O
,	O
demonstrating	O
its	O
significant	O
superiority	O
.	O

b	O
Visualization	O
of	O
scDREAMER	B-BT
’	O
s	O
latent	O
space	O
embeddings	O
,	O
cells	O
are	O
colored	O
based	O
on	O
the	O
batch	O
information	O
.	O

Overall	O
,	O
the	O
vast	O
majority	O
of	O
the	O
FoldDesign	B-BT
scaffolds	O
possessed	O
stable	O
global	O
folds	O
,	O
outperforming	O
the	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
Rosetta	O
protocol	O
across	O
the	O
test	O
set	O
.	O

The	O
docking	O
analysis	O
,	O
3D	O
structure	O
of	O
CadA	O
protein	O
was	O
carried	O
out	O
by	O
PatchDock	B-BT
.	O

The	O
Supplementary	O
Material	O
includes	O
several	O
user	O
manuals	O
that	O
provide	O
more	O
results	O
of	O
this	O
application	O
example	O
and	O
in	O
-	O
depth	O
use	O
of	O
vizAPA	B-BT
.	O

RAMZIS	B-BT
and	O
GlycReSoft	O
may	O
be	O
freely	O
downloaded	O
at	O
https	O
://	O
www	O
.	O
bumc	O
.	O
bu	O
.	O
edu	O
/	O
msr	O
/	O
software	O
/.	O

Regarding	O
anti	O
-	O
SmD1	O
autoantibodies	O
,	O
PMAT	O
showed	O
a	O
clinical	O
sensitivity	O
of	O
10	O
.	O
9	O
%	O
(	O
95	O
%	O
CI	O
:	O
7	O
.	O
3	O
%–	O
16	O
.	O
1	O
%)	O
and	O
98	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
:	O
95	O
.	O
0	O
%–	O
99	O
.	O
8	O
%)	O
specificity	O
.	O

wget	O
https	O
://	O
github	O
.	O
com	O
/	O
inab	O
/	O
trimal	B-BT
/	O
archive	O
/	O
refs	O
/	O
tags	O
/	O
v1	O
.	O
4	O
.	O
1	O
.	O
tar	O
.	O
gzhttps	O
://	O
github	O
.	O
com	O
/	O
inab	O
/	O
trimal	B-BT
/	O
archive	O
/	O
refs	O
/	O
tags	O
/	O
v1	O
.	O
4	O
.	O
1	O
.	O
tar	O
.	O
gz	O

Reviewer	O
comment	O
#	O
1	O
:	O
On	O
its	O
official	O
webpage	O
,	O
a	O
few	O
tabs	O
on	O
the	O
wheatIS	B-BT
.	O
org	O
,	O
such	O
as	O
""""	O
submit	O
data	O
""""	O
and	O
""""	O
tools	O
""""	O
are	O
still	O
under	O
construction	O
and	O
not	O
available	O
for	O
use	O
.	O

The	O
protein	O
IDs	O
of	O
the	O
key	O
targets	O
were	O
obtained	O
from	O
the	O
utility	O
module	O
of	O
TCMNPAS	B-BT
and	O
converted	O
into	O
Protein	O
Data	O
Bank	O
(	O
PDB	O
)	O
IDs	O
(	O
every	O
molecular	O
model	O
in	O
the	O
PDB	O
has	O
a	O
unique	O
accession	O
or	O
identification	O
code	O
).	O

On	O
the	O
basis	O
of	O
these	O
results	O
,	O
an	O
updated	O
EOS	O
for	O
Fe	O
oxides	O
in	O
silicate	O
liquids	O
reveals	O
that	O
the	O
Fe2O3	O
generated	O
in	O
a	O
terrestrial	O
magma	O
ocean	O
with	O
mean	O
alloy	O
-	O
silicate	O
equilibration	O
pressures	O
of	O
28	O
to	O
53	O
GPa	O
could	O
feasibly	O
account	O
for	O
the	O
entire	O
BSE	O
redox	O
budget	O
and	O
would	O
produce	O
surface	O
conditions	O
ranging	O
from	O
IW	O
−	O
0	O
.	O
41	O
to	O
+	O
1	O
.	O
30	O
(	O
10	O
)	O
or	O
IW	O
+	O
0	O
.	O
68	O
to	O
+	O
1	O
.	O
98	O
(	O
15	O
),	O
which	O
would	O
foster	O
an	O
atmosphere	O
primarily	O
composed	O
of	O
CO	O
and	O
H2O	O
.	O

The	O
surface	O
morphology	O
was	O
evaluated	O
using	O
TEM	O
(	O
JEM	O
-	O
2100F	O
,	O
JEOL	O
Ltd	O
.,	O
Tokyo	O
,	O
Japan	O
).	O

For	O
Guatemala	O
,	O
xPONENT	O
output	O
files	O
were	O
uploaded	O
into	O
shinyMBA	B-BT
from	O
15	O
study	O
plates	O
.	O

Figure	O
2	O
—	O
figure	O
supplement	O
1	O
.	O
The	O
head	O
-	O
to	O
-	O
head	O
comparison	O
of	O
the	O
precisions	O
(%)	O
of	O
the	O
top	O
50	O
contacts	O
predicted	O
by	O
PLMGraph	O
-	O
Inter	O
and	O
other	O
methods	O
(	O
a	O
:	O
DRN	O
-	O
1D2D_Inter	O
;	O
b	O
:	O
DeepHomo	O
;	O
c	O
:	O
GLINTER	O
;	O
d	O
:	O
CDPred	B-BT
;	O
e	O
:	O
DeepHomo2	O
)	O
for	O
each	O
target	O
in	O
HomoPDB	O
and	O
HeteroPDB	O
using	O
experimental	O
structures	O
.	O

The	O
analyses	O
of	O
published	O
single	O
-	O
cell	O
RNA	O
sequencing	O
datasets	O
were	O
performed	O
using	O
the	O
Sperm	O
Maturation	O
Database	O
(	O
SperMD	B-BT
)	O
[	O
26	O
].	O

The	O
software	O
used	O
for	O
the	O
analysis	O
in	O
this	O
work	O
can	O
be	O
downloaded	O
from	O
https	O
://	O
github	O
.	O
com	O
/	O
LouisOb	O
/	O
VirusPredictor	B-BT
.	O

The	O
input	O
for	O
PyCoMo	B-BT
are	O
the	O
metabolic	O
models	O
of	O
the	O
community	O
members	O
,	O
in	O
any	O
of	O
the	O
file	O
formats	O
supported	O
by	O
COBRApy	O
(	O
SBML	O
,	O
MATLAB	O
,	O
JSON	O
,	O
and	O
YAML	O
).	O

Completed	O
Skipper	B-BT
run	O

The	O
widths	O
of	O
the	O
bars	O
indicate	O
the	O
relative	O
frequency	O
of	O
the	O
haplotype	O
written	O
on	O
the	O
bar	O
as	O
determined	O
by	O
the	O
PHARE	B-BT
pipeline	O
.	O

For	O
example	O
,	O
the	O
Byonic	O
searches	O
(	O
134	O
.	O
9	O
min	O
/	O
file	O
)	O
were	O
considerably	O
slower	O
than	O
the	O
MSFragger	B-BT
-	O
HLA	O
-	O
Glyco	O
searches	O
(	O
2	O
.	O
7	O
min	O
/	O
file	O
),	O
a	O
practical	O
limitation	O
we	O
mitigated	O
in	O
this	O
study	O
by	O
reducing	O
the	O
number	O
of	O
variable	O
modifications	O
and	O
by	O
adding	O
constraints	O
to	O
peptide	O
search	O
space	O
used	O
for	O
the	O
non	O
-	O
specific	O
search	O
strategy	O
.	O

We	O
developed	O
an	O
Embedding	O
-	O
based	O
Phenotype	O
Variant	O
Predictor	O
(	O
EmbedPVP	B-BT
),	O
a	O
computational	O
method	O
to	O
prioritize	O
variants	O
involved	O
in	O
genetic	O
diseases	O
by	O
combining	O
genomic	O
information	O
and	O
clinical	O
phenotypes	O
.	O

Serving	O
more	O
than	O
2	O
.	O
5	O
million	O
visitors	O
from	O
181	O
countries	O
/	O
regions	O
worldwide	O
,	O
with	O
total	O
downloads	O
of	O
over	O
10	O
billion	O
sequences	O
,	O
RCoV19	B-BT
played	O
an	O
important	O
role	O
in	O
the	O
study	O
of	O
SARS	O
-	O
CoV	O
-	O
2	O
.	O

Also	O
scTE	B-BT
and	O
SoloTE	O
tools	O
identified	O
distinct	O
cancer	O
cell	O
clusters	O
characterized	O
by	O
a	O
general	O
enrichment	O
of	O
LINE	O
and	O
LTR	O
subfamilies	O
(	O
Supplementary	O
Figure	O
S2D	O
-	O
F	O
).	O

In	O
particular	O
,	O
a	O
mutation	O
in	O
a	O
signal	O
peptide	O
,	O
p	O
.	O
Gln25Leu	O
,	O
did	O
not	O
influence	O
ACE	O
levels	O
,	O
similarly	O
to	O
the	O
non	O
-	O
frameshifting	O
insertion	O
,	O
p	O
.	O
L18_L19insPL	O
,	O
tested	O
earlier	O
[	O
2	O
],	O
which	O
is	O
not	O
associated	O
with	O
AD	O
risk	O
[	O
27	O
].	O

The	O
same	O
pattern	O
is	O
seen	O
for	O
the	O
three	O
peaks	O
:	O
aligning	O
with	O
MSIWarp	B-BT
visibly	O
tightens	O
the	O
peak	O
scatter	O
and	O
removes	O
the	O
systematic	O
shifts	O
related	O
to	O
spectrum	O
acquisition	O
time	O
.	O

Tensor	O
-	O
based	O
methods	O
,	O
such	O
as	O
Tensor	O
-	O
cell2cell	O
[	O
28	O
]	O
and	O
scTensor	B-BT
[	O
29	O
],	O
use	O
tensor	O
decomposition	O
-	O
based	O
methods	O
to	O
dissect	O
context	O
-	O
driven	O
LRIs	O
and	O
multi	O
-	O
to	O
-	O
multi	O
LRIs	O
.	O

The	O
identified	O
proteins	O
also	O
included	O
52	O
(	O
70	O
%)	O
of	O
the	O
79	O
proteins	O
previously	O
annotated	O
as	O
""""	O
sporulation	O
proteins	O
""""	O
in	O
the	O
SubtiWiki	B-BT
database	O
and	O
found	O
in	O
direct	O
protein	O
analysis	O
(	O
marked	O
in	O
yellow	O
in	O
the	O
Supplementary	O
Table	O
S4	O
).	O

Zoish	B-BT
workflow	O

Hence	O
,	O
we	O
analyzed	O
whether	O
KNeXT	B-BT
’	O
s	O
“–	O
unique	O
”	O
output	O
graphs	O
increase	O
modularity	O
using	O
two	O
different	O
community	O
detection	O
algorithms	O
.	O

In	O
snRNA	O
-	O
seq	O
,	O
IRescue	O
detected	O
more	O
LINE1	O
subfamilies	O
specific	O
to	O
neurons	O
against	O
glia	O
in	O
human	O
cells	O
,	O
compared	O
to	O
scTE	B-BT
and	O
SoloTE	O
,	O
and	O
identified	O
a	O
distinct	O
neurons	O
cluster	O
enriched	O
in	O
young	O
LINE1	O
expression	O
.	O

We	O
next	O
considered	O
that	O
when	O
isotopic	O
steady	O
state	O
for	O
a	O
given	O
fatty	O
acid	O
pool	O
has	O
been	O
reached	O
and	O
the	O
labelling	O
degree	O
of	O
lipogenic	O
acetyl	O
-	O
CoA	O
is	O
sufficient	O
(	O
distribution	O
of	O
labelled	O
isotopologues	O
does	O
not	O
overlap	O
with	O
M	O
+	O
0	O
),	O
13C	O
-	O
SpaceM	B-BT
data	O
could	O
be	O
used	O
to	O
determine	O
the	O
relative	O
uptake	O
of	O
different	O
fatty	O
acids	O
compared	O
with	O
their	O
de	O
novo	O
synthesis	O
at	O
a	O
single	O
-	O
cell	O
level	O
.	O

By	O
comparing	O
the	O
above	O
seven	O
studies	O
,	O
our	O
study	O
outperforms	O
the	O
research	O
[	O
29	O
,	O
33	O
,	O
35	O
,	O
37	O
,	O
40	O
,	O
46	O
,	O
53	O
]	O
in	O
terms	O
of	O
attack	O
performance	O
but	O
shows	O
vulnerability	O
to	O
FGSM	O
and	O
PGD	B-BT
attacks	O
with	O
a	O
high	O
accuracy	O
drop	O
.	O

The	O
MAR	O
databases	O
hosted	O
at	O
the	O
Center	O
for	O
Bioinformatics	O
(	O
SfB	O
),	O
The	O
Arctic	O
University	O
of	O
Norway	O
(	O
UiT	O
),	O
a	O
node	O
of	O
ELIXIR	O
Norway	O
,	O
contain	O
marine	O
microbial	O
genome	O
records	O
based	O
on	O
the	O
level	O
of	O
completeness	O
(	O
MarRef	O
v1	O
.	O
5	O
:	O
1270	O
manually	O
curated	O
records	O
and	O
MarDb	B-BT
v1	O
.	O
5	O
:	O
13237	O
incompletely	O
sequenced	O
marine	O
prokaryotic	O
genomes	O
records	O
including	O
metagenome	O
-	O
assembled	O
genomes	O
[	O
MAGs	O
]	O
and	O
single	O
amplified	O
genomes	O
[	O
SAGs	O
]).	O

By	O
learning	O
and	O
testing	O
the	O
m6A	O
datasets	O
identified	O
from	O
23	O
human	O
tissues	O
,	O
the	O
newly	O
integrated	O
framework	O
m6A	B-BT
-	I-BT
TCPred	I-BT
(	O
see	O
Fig	O
.	O

Until	O
now	O
,	O
ScTensor	B-BT
and	O
PlantPhoneDB	O
have	O
only	O
collected	O
or	O
curated	O
LR	O
pairs	O
for	O
Arabidopsis	O
,	O
and	O
LR	O
information	O
for	O
other	O
plant	O
species	O
has	O
been	O
retrieved	O
computationally	O
by	O
the	O
InParanoid	O
algorithm	O
in	O
PlantPhoneDB	O
.	O

Based	O
on	O
the	O
above	O
test	O
results	O
,	O
it	O
can	O
be	O
concluded	O
that	O
under	O
low	O
-	O
energy	O
impacts	O
,	O
the	O
toughness	O
due	O
to	O
the	O
addition	O
of	O
EMAA	O
stitching	O
can	O
absorb	O
part	O
of	O
the	O
impact	O
energy	O
,	O
so	O
that	O
the	O
damage	O
on	O
the	O
surface	O
of	O
the	O
specimen	O
is	O
less	O
serious	O
,	O
and	O
there	O
is	O
no	O
obvious	O
sign	O
of	O
damage	O
expansion	O
along	O
the	O
matrix	O
crack	O
.	O

A	O
novel	O
handheld	O
Electrical	O
Impedance	O
Myography	O
(	O
EIM	O
)	O
device	O
(	O
mScan	O
model	O
1301	O
,	O
Myolex	O
)	O
has	O
been	O
developed	O
to	O
assess	O
muscle	O
quality	O
by	O
calculating	O
tissue	O
impedance	O
.	O

Although	O
Sage	O
saves	O
approximately	O
five	O
times	O
more	O
memory	O
compared	O
to	O
MSFragger	B-BT
,	O
Dear	O
‐	O
PSM	O
still	O
consumes	O
6	O
–	O
25	O
times	O
less	O
memory	O
than	O
Sage	O
(	O
Figure	O
6B	O
).	O

SEPDB	B-BT
visualizes	O
public	O
epigenetic	O
data	O
on	O
secreted	O
proteins	O
using	O
the	O
embedded	O
WashU	O
Epigenome	O
Browser	O
,	O
which	O
allows	O
users	O
to	O
visualize	O
search	O
data	O
on	O
a	O
single	O
page	O
and	O
connect	O
genomic	O
coordinates	O
to	O
multi	O
-	O
resolution	O
3D	O
models	O
of	O
chromatin	O
.	O

Once	O
data	O
preprocessing	O
and	O
MS	O
1	O
annotation	O
using	O
MZmine	B-BT
was	O
done	O
,	O
the	O
molecular	O
network	O
was	O
generated	O
.	O

The	O
study	O
finds	O
that	O
older	O
adults	O
(≥	O
60	O
years	O
)	O
have	O
a	O
higher	O
odds	O
ratio	O
(	O
OR	O
)	O
for	O
T2DM	O
associated	O
with	O
VAI	O
and	O
LAP	O
compared	O
to	O
younger	O
individuals	O
(<	O
60	O
years	O
).	O

Theoretical	O
pI	O
was	O
10	O
.	O
07	O
based	O
on	O
Expasy	B-BT
analysis	O
,	O
total	O
number	O
of	O
negatively	O
charged	O
residues	O
(	O
Asp	O
,	O
Glu	O
)	O
was	O
21	O
,	O
and	O
total	O
number	O
of	O
positively	O
charged	O
residues	O
(	O
Arg	O
,	O
Lys	O
)	O
was	O
55	O
.	O

Response	O
:	O
We	O
appreciate	O
the	O
reviewer	O
’	O
s	O
insightful	O
feedback	O
regarding	O
the	O
KinCytE	B-BT
update	O
.	O

All	O
data	O
in	O
CovEpiAb	B-BT
are	O
available	O
at	O
https	O
://	O
pgx	O
.	O
zju	O
.	O
edu	O
.	O
cn	O
/	O
covepiab	B-BT
.	O

The	O
performance	O
advantage	O
of	O
RBProkCNN	B-BT
over	O
PreRBP	O
-	O
TL	O
was	O
observed	O
to	O
be	O
small	O
,	O
which	O
may	O
be	O
due	O
the	O
initial	O
large	O
language	O
generative	O
model	O
of	O
PreRBP	O
-	O
TL	O
where	O
the	O
test	O
data	O
set	O
of	O
RBProkCNN	B-BT
were	O
included	O
in	O
the	O
model	O
training	O
.	O

Furthermore	O
,	O
our	O
method	O
has	O
a	O
very	O
good	O
balance	O
between	O
batch	O
effect	O
correction	O
and	O
biological	O
variance	O
conservation	O
,	O
compared	O
to	O
Seurat	O
and	O
scDREAMER	B-BT
for	O
example	O
,	O
who	O
received	O
high	O
batch	O
effect	O
correction	O
scores	O
but	O
low	O
biological	O
variance	O
conservation	O
scores	O
(	O
Fig	O
.	O

This	O
cross	O
-	O
sectional	O
survey	O
was	O
part	O
of	O
a	O
broader	O
study	O
to	O
strengthen	O
food	O
policies	O
in	O
Fiji	O
[	O
21	O
].	O

In	O
blue	O
,	O
data	O
from	O
hybrid	B-BT
-	I-BT
DIA	I-BT
quantification	O
(	O
n	O
=	O
4	O
biological	O
replicates	O
);	O
and	O
in	O
pink	O
,	O
data	O
from	O
SureQuant	O
quantification	O
(	O
n	O
=	O
4	O
biological	O
replicates	O
).	O

There	O
has	O
been	O
a	O
recent	O
uptick	O
in	O
using	O
DL	O
techniques	O
to	O
assess	O
insider	O
threats	O
.	O

In	O
addition	O
,	O
tRNADB	O
-	O
CE	O
contains	O
1	O
,	O
352	O
tRNA	O
genes	O
derived	O
from	O
2	O
plant	O
species	O
,	O
while	O
PlantRNA	B-BT
database	O
contains	O
66	O
,	O
686	O
genes	O
derived	O
from	O
47	O
plant	O
species	O
.	O

The	O
FieldAnnotator	O
can	O
be	O
found	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
tschutli	O
/	O
Phenotator	O
-	O
Toolbox	O
or	O
at	O
the	O
Google	O
Play	O
Store	O
.	O

First	O
,	O
the	O
version	O
of	O
TREE	B-BT
-	I-BT
QMC	I-BT
presented	O
here	O
requires	O
binary	O
gene	O
trees	O
as	O
input	O
.	O

For	O
the	O
MZmine	B-BT
analysis	O
of	O
the	O
GC	O
dataset	O
,	O
two	O
sets	O
of	O
retention	O
times	O
were	O
used	O
,	O
(	O
i	O
)	O
a	O
list	O
with	O
retention	O
times	O
as	O
used	O
by	O
ATS	O
with	O
shifts	O
in	O
the	O
range	O
of	O
−	O
1	O
.	O
1	O
to	O
−	O
0	O
.	O
9	O
min	O
simulating	O
the	O
case	O
of	O
shifted	O
and	O
not	O
optimized	O
analysis	O
conditions	O
and	O
(	O
ii	O
)	O
the	O
same	O
list	O
of	O
analytes	O
but	O
with	O
exact	O
,	O
shift	O
-	O
corrected	O
retention	O
times	O
as	O
used	O
with	O
TF	O
.	O

Algorithm	O
1A	O
single	O
iteration	O
of	O
the	O
MaBoSS	B-BT
simulation	O
of	O
a	O
trajectory	O
,	O
given	O
the	O
state	O
S	O
and	O
time	O
t	O
.	O

For	O
a	O
specific	O
synteny	O
block	O
,	O
SyntenyViewer	B-BT
generates	O
an	O
image	O
to	O
show	O
the	O
homologous	O
gene	O
pairs	O
,	O
and	O
the	O
image	O
can	O
be	O
zoomed	O
in	O
or	O
out	O
for	O
different	O
views	O
(	O
Figure	O
2B	O
).	O

With	O
the	O
isotope	O
ratios	O
calculated	O
by	O
iMet	B-BT
-	I-BT
Q	I-BT
,	O
49	O
%	O
(	O
89	O
out	O
of	O
183	O
)	O
metabolite	O
candidates	O
were	O
filtered	O
out	O
.	O

Impact	O
of	O
the	O
machine	O
and	O
of	O
the	O
alignment	O
with	O
MSIWarp	B-BT
.	O

pyaging	B-BT
harmonizes	O
dozens	O
of	O
aging	O
clocks	O
,	O
covering	O
a	O
range	O
of	O
molecular	O
data	O
types	O
such	O
as	O
DNA	O
methylation	O
,	O
transcriptomics	O
,	O
histone	O
mark	O
ChIP	O
-	O
Seq	O
,	O
and	O
ATAC	O
-	O
Seq	O
.	O

The	O
passive	O
mast	O
cell	O
activation	O
test	O
(	O
pMAT	O
)	O
has	O
recently	O
emerged	O
as	O
a	O
potential	O
diagnostic	O
tool	O
.	O

To	O
do	O
this	O
in	O
PyMOL	B-BT
,	O
press	O
A	O
(	O
Action	O
)	O
next	O
to	O
the	O
structure	O
name	O
,	O
go	O
to	O
hydrogens	O
and	O
press	O
“	O
add	O
”.	O

The	O
in	O
vitro	O
whole	O
-	O
cell	O
uptake	O
showed	O
a	O
parallel	O
tendency	O
to	O
the	O
in	O
vivo	O
tumor	O
uptake	O
;	O
Cu2	O
+-	O
Tren	O
and	O
Cu2	O
+-	O
Dien	O
showed	O
higher	O
uptakes	O
than	O
Cu2	O
+-	O
TPMA	O
and	O
Cu2	O
+	O
ions	O
(	O
736	O
.	O
00	O
counts	O
±	O
156	O
.	O
03	O
for	O
Cu2	O
+-	O
Tren	O
,	O
530	O
.	O
60	O
counts	O
±	O
106	O
.	O
87	O
for	O
Cu2	O
+-	O
Dien	O
,	O
118	O
.	O
58	O
counts	O
±	O
59	O
.	O
33	O
for	O
Cu2	O
+-	O
TPMA	O
,	O
and	O
49	O
.	O
43	O
counts	O
±	O
34	O
.	O
33	O
for	O
Cu2	O
+	O
ions	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
accuracy	O
of	O
secondary	O
structure	O
prediction	O
may	O
have	O
a	O
direct	O
impact	O
on	O
the	O
performance	O
of	O
RNAthreader	B-BT
,	O
as	O
the	O
predicted	O
secondary	O
structure	O
is	O
an	O
essential	O
component	O
of	O
the	O
alignment	O
progress	O
.	O

Some	O
publications	O
cited	O
both	O
PyPop	B-BT
papers	O
.	O

As	O
MetaTiME	B-BT
MeCs	O
provides	O
a	O
highly	O
interpretable	O
basis	O
for	O
the	O
TME	O
in	O
single	O
cells	O
,	O
we	O
provided	O
a	O
toolkit	O
to	O
discover	O
MeC	O
signature	O
continuums	O
and	O
enriched	O
cell	O
states	O
in	O
scRNA	O
-	O
seq	O
TME	O
data	O
(	O
code	O
deposited	O
in	O
https	O
://	O
github	O
.	O
com	O
/	O
yi	O
-	O
zhang	O
/	O
MetaTiME	B-BT
).	O

Here	O
,	O
we	O
extend	O
EvoAug	O
’	O
s	O
functionality	O
to	O
TensorFlow	O
in	O
a	O
new	O
package	O
,	O
we	O
call	O
EvoAug	B-BT
-	I-BT
TF	I-BT
.	O

After	O
submission	O
,	O
DDK	B-BT
-	I-BT
Linker	I-BT
performed	O
the	O
linkage	O
analysis	O
to	O
discover	O
disease	O
-	O
associated	O
signals	O
(	O
307	O
candidate	O
disease	O
–	O
associated	O
genes	O
)	O
in	O
submitted	O
genes	O
.	O

The	O
eccDNA	O
identification	O
modules	O
incorporated	O
in	O
eccDNA	B-BT
-	I-BT
pipe	I-BT
include	O
AA	O
,	O
Circle	O
-	O
Map	O
and	O
CReSIL	O
,	O
which	O
are	O
by	O
far	O
the	O
best	O
algorithms	O
for	O
either	O
short	O
-	O
read	O
or	O
long	O
-	O
read	O
sequencing	O
eccDNA	O
analysis	O
.	O

In	O
rnaCrosslinkOO	B-BT
,	O
an	O
adjacency	O
matrix	O
is	O
created	O
for	O
all	O
chimeric	O
reads	O
based	O
on	O
the	O
nucleotide	O
difference	O
between	O
their	O
g	O
values	O
.	O

Peak	O
detection	O
is	O
achieved	O
in	O
OpenChrom	B-BT
following	O
the	O
steps	O
:(	O
i	O
)	O
right	O
-	O
click	O
on	O
the	O
chromatogram	O
,(	O
ii	O
)	O
hover	O
over	O
“	O
Peak	O
Detector	O
”	O
and	O
(	O
iii	O
)	O
select	O
“	O
AMDIS	O
(	O
extern	O
)”	O
from	O
the	O
menu	O
.	O

A	O
total	O
of	O
6205	O
CXR	O
images	O
(	O
including	O
3021	O
COVID	O
-	O
19	O
CXRs	O
and	O
3184	O
normal	O
CXRs	O
)	O
were	O
used	O
to	O
test	O
our	O
MI	O
-	O
CNN	O
models	O
.	O

carrolli	O
annotations	O
are	O
shorter	O
than	O
those	O
from	O
the	O
references	O
,	O
and	O
many	O
more	O
BUSCO	B-BT
dipteran	O
benchmark	O
genes	O
are	O
fragmented	O
in	O
the	O
D	O
.	O

As	O
far	O
as	O
auPRC	O
is	O
concerned	O
,	O
RBProkCNN	B-BT
achieved	O
better	O
accuracy	O
as	O
compared	O
to	O
the	O
PreRBP	O
-	O
TL	O
,	O
for	O
both	O
E	O
.	O
coli	O
and	O
Salmonella	O
(	O
Table	O
4	O
).	O

Text	O
and	O
interpretation	O
were	O
united	O
in	O
active	O
oral	O
performances	O
in	O
bardic	B-BT
chains	O
of	O
transmission	O
.	O

Secondary	O
structure	O
predictions	O
,	O
disorder	O
,	O
membrane	O
helix	O
and	O
profile	O
-	O
based	O
fold	O
recognition	O
of	O
viral	O
proteins	O
were	O
carried	O
out	O
using	O
the	O
PSIPRED	B-BT
Workbench	O
(	O
http	O
://	O
bioinf	O
.	O
cs	O
.	O
ucl	O
.	O
ac	O
.	O
uk	O
/	O
psipred	B-BT
/	O
(	O
accessed	O
on	O
9	O
March2024	O
)	O
[	O
21	O
].	O

GeNLP	B-BT
overview	O
.	O

Compare	O
by	O
visual	O
inspection	O
in	O
PyMOL	B-BT
software	O
.	O

83	O
.	O
1	O
%)	O
to	O
sCTE	B-BT
,	O
9	O
.	O
9	O
%	O
(	O
88	O
.	O
2	O
%	O
vs	O
.	O

All	O
attacks	O
are	O
executed	O
against	O
the	O
thermostat	O
FlexStat	O
BAC	O
-	O
131136CEW	O
(	O
BACnet	O
Application	O
-	O
Specific	O
Controller	O
).	O

Different	O
complementary	O
online	O
software	O
tools	O
were	O
employed	O
for	O
splicing	O
prediction	O
:	O
Human	B-BT
Splicing	I-BT
Finder	I-BT
(	O
HSF	O
)	O
Version	O
2	O
.	O
4	O
.	O
1	O
(	O
http	O
://	O
www	O
.	O
umd	O
.	O
be	O
/	O
HSF	O
/),	O
SpliceAI	O
(	O
https	O
://	O
spliceailookup	O
.	O
broadinstitute	O
.	O
org	O
/),	O
and	O
varSEAK	O
(	O
https	O
://	O
varseak	O
.	O
bio	O
/).	O

The	O
EE	O
of	O
the	O
ACE	O
-	O
I	O
-	O
ALG	O
-	O
CS	O
NPs	O
was	O
calculated	O
by	O
subtracting	O
the	O
amount	O
of	O
residual	O
peptide	O
in	O
the	O
supernatant	O
after	O
centrifugation	O
from	O
the	O
total	O
amount	O
of	O
peptide	O
initially	O
added	O
for	O
encapsulation	O
according	O
to	O
the	O
following	O
relation	O
:	O

Features	O
unique	O
to	O
IBDTransDB	B-BT
or	O
shared	O
with	O
other	O
tools	O

iPHoP	B-BT
differs	O
from	O
existing	O
HPTs	O
since	O
it	O
can	O
return	O
0	O
,	O
1	O
,	O
or	O
multiple	O
predicted	O
hosts	O
for	O
a	O
given	O
virus	O
.	O

The	O
porcelain	O
glazed	O
in	O
a	O
microwave	O
had	O
a	O
smoother	O
surface	O
than	O
porcelain	O
glazed	O
in	O
an	O
oven	O
.	O

In	O
addition	O
,	O
MHCpLogics	B-BT
allows	O
interrogation	O
of	O
peptide	O
sequence	O
sub	O
-	O
motifs	O
and	O
we	O
developed	O
a	O
new	O
approach	O
(	O
Calinski	O
–	O
Harabasz	O
strategy	O
)	O
to	O
optimize	O
the	O
number	O
of	O
clusters	O
in	O
the	O
immunopeptidome	O
data	O
.	O

The	O
DrugDomain	O
data	O
webpage	O
'	O
s	O
table	O
in	O
these	O
cases	O
includes	O
AF	O
accession	O
,	O
downloadable	O
PyMOL	B-BT
script	O
,	O
an	O
indication	O
that	O
this	O
interaction	O
between	O
molecule	O
and	O
protein	O
target	O
was	O
not	O
confirmed	O
experimentally	O
(	O
and	O
was	O
predicted	O
),	O
a	O
list	O
of	O
ECOD	O
domains	O
interacting	O
with	O
the	O
molecule	O
with	O
links	O
to	O
the	O
AF	O
‐	O
based	O
ECOD	O
database	O
and	O
names	O
of	O
corresponded	O
ECOD	O
X	O
‐	O
groups	O
.	O

For	O
data	O
visualization	O
,	O
heatmaps	O
were	O
generated	O
by	O
GraphPad	O
Prism	O
version	O
9	O
,	O
venn	O
diagrams	O
were	O
made	O
in	O
VennDis	O
,	O
72	O
boxplots	O
were	O
made	O
in	O
BoxPlotR	O
,	O
73	O
pie	O
charts	O
were	O
made	O
in	O
Imgflip	O
(	O
https	O
://	O
imgflip	O
.	O
com	O
/	O
chart	O
-	O
maker	O
),	O
while	O
peptide	O
profiles	O
and	O
peptide	O
alignment	O
maps	O
were	O
made	O
using	O
the	O
web	O
-	O
based	O
application	O
Peptigram	O
.	O
74	O
Finally	O
,	O
iceLogos	O
were	O
generated	O
using	O
the	O
iceLogo	O
server	O
,	O
27	O
using	O
the	O
cleavage	O
environment	O
of	O
the	O
detected	O
peptides	O
obtained	O
with	O
CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
.	O
75	O
For	O
this	O
purpose	O
,	O
the	O
Uniprot	O
database71	O
was	O
used	O
to	O
retrieve	O
the	O
full	O
protein	O
sequences	O
of	O
the	O
identified	O
peptides	O
.	O

In	O
addition	O
to	O
this	O
high	O
-	O
level	O
automation	O
of	O
analyses	O
,	O
PAPipe	B-BT
is	O
flexible	O
and	O
can	O
be	O
customized	O
by	O
users	O
.	O

WebMaBoSS	B-BT
can	O
also	O
perform	O
sensitivity	O
analyses	O
to	O
check	O
the	O
effect	O
of	O
a	O
knock	O
-	O
in	O
/	O
knock	O
-	O
out	O
of	O
each	O
node	O
on	O
the	O
network	O
.	O

Finally	O
,	O
the	O
WebMaBoss	B-BT
(	O
Noël	O
et	O
al	O
.)	O
web	O
interface	O
enables	O
easy	O
manipulation	O
of	O
Boolean	O
models	O
and	O
further	O
simulation	O
of	O
Boolean	O
networks	O
,	O
such	O
as	O
biological	O
networks	O
involved	O
in	O
gene	O
regulation	O
or	O
signaling	O
,	O
followed	O
by	O
online	O
visualization	O
and	O
analysis	O
.	O

Genotype	O
call	O
data	O
obtained	O
using	O
MCPtaggR	O
and	O
TASSEL	O
-	O
GBS	O
were	O
evaluated	O
based	O
on	O
the	O
estimated	O
dosage	O
generated	O
by	O
GBScleanR	B-BT
as	O
raw	O
genotype	O
data	O
containing	O
a	O
large	O
number	O
of	O
missing	O
values	O
and	O
erroneous	O
calls	O
,	O
including	O
heterozygote	O
undercallings	O
,	O
which	O
could	O
prevent	O
the	O
systematic	O
evaluation	O
of	O
software	O
performance	O
.	O

Another	O
important	O
aspect	O
of	O
scPipe	B-BT
is	O
the	O
ability	O
to	O
integrate	O
datasets	O
where	O
a	O
common	O
barcode	O
file	O
is	O
available	O
to	O
match	O
the	O
cells	O
between	O
SCE	O
objects	O
to	O
create	O
a	O
combined	O
SCE	O
object	O
,	O
as	O
occurs	O
for	O
example	O
in	O
10X	O
Genomics	O
multiome	O
experiments	O
.	O

(	O
B	O
)	O
NanoDeep	O
(	O
Ambrosetti	O
et	O
al	O
.,	O
2021	O
),	O
which	O
can	O
transform	O
the	O
organization	O
information	O
of	O
membrane	O
proteins	O
into	O
a	O
DNA	O
sequencing	O
readout	O
.	O

In	O
contrast	O
,	O
scTE	B-BT
employs	O
a	O
similar	O
strategy	O
but	O
rectifies	O
multi	O
-	O
mapping	O
errors	O
using	O
the	O
count	O
of	O
unique	O
-	O
mapping	O
reads	O
.	O

At	O
present	O
,	O
neither	O
GenBank	O
annotation	O
files	O
nor	O
species	O
-	O
specific	O
genome	O
browsers	O
,	O
such	O
as	O
the	O
BsubCyc	O
database	O
[	O
32	O
],	O
SubtiWiki	B-BT
[	O
33	O
],	O
AureoWiki	O
[	O
34	O
],	O
or	O
EcoCyc	O
[	O
35	O
],	O
are	O
updated	O
with	O
the	O
single	O
-	O
nucleotide	O
resolution	O
transcription	O
data	O
that	O
is	O
publicly	O
available	O
.	O

Step	O
1	O
:	O
kled	B-BT
collects	O
the	O
SV	O
signatures	O
for	O
different	O
types	O
of	O
SVs	O
,	O
along	O
with	O
the	O
read	O
depth	O
and	O
primary	O
alignment	O
information	O
.	O

We	O
have	O
integrated	O
cytoviewer	B-BT
into	O
our	O
widely	O
adopted	O
data	O
analysis	O
pipeline	O
for	O
multiplexed	O
imaging	O
data	O
[	O
10	O
]	O
(	O
https	O
://	O
bodenmillergroup	O
.	O
github	O
.	O
io	O
/	O
IMCDataAnalysis	O
/)	O
and	O
envision	O
that	O
the	O
package	O
will	O
meet	O
the	O
needs	O
of	O
the	O
fast	O
-	O
growing	O
community	O
of	O
highly	O
multiplexed	O
imaging	O
users	O
[	O
11	O
].	O

We	O
further	O
performed	O
PHARE	B-BT
on	O
another	O
bulk	O
RNA	O
-	O
seq	O
data	O
from	O
CAD	O
,	O
and	O
found	O
CAD	O
patients	O
also	O
had	O
higher	O
age	O
difference	O
than	O
HC	O
sample	O
(	O
Fig	O
.	O

Anti	O
-	O
ribosomal	O
-	O
P	O
autoantibodies	O
by	O
PMAT	O
were	O
also	O
included	O
.	O

The	O
authors	O
have	O
developed	O
an	O
in	O
-	O
silico	O
tool	O
,	O
named	O
PhageTB	B-BT
,	O
for	O
the	O
prediction	O
of	O
phage	O
-	O
bacteria	O
interactions	O
with	O
high	O
accuracy	O
.	O

Neutralization	O
titers	O
of	O
sera	O
from	O
Sputnik	O
V	O
vaccinees	O
42	O
and	O
180	O
dpv	O
against	O
SARS	O
-	O
CoV	O
-	O
2	O
variants	O
.	O

As	O
a	O
C	O
++	O
API	O
of	O
HTSlib	B-BT
,	O
vcfpp	O
inherits	O
all	O
functionalities	O
from	O
HTSlib	B-BT
and	O
is	O
implemented	O
in	O
a	O
single	O
header	O
file	O
that	O
can	O
be	O
easily	O
integrated	O
and	O
used	O
safely	O
.	O

In	O
contrast	O
,	O
we	O
design	O
a	O
special	O
MySQL	O
database	O
for	O
Shaoxia	B-BT
to	O
save	O
parameters	O
of	O
each	O
analysis	O
that	O
set	O
by	O
user	O
.	O

To	O
address	O
these	O
limitations	O
,	O
we	O
propose	O
the	O
creation	O
of	O
a	O
new	O
nanobody	O
database	O
—	O
Nanobody	O
Library	O
and	O
Archive	O
System	O
(	O
NanoLAS	B-BT
).	O

The	O
test	O
similarity	O
distribution	O
was	O
only	O
considered	O
to	O
reliably	O
emulate	O
the	O
comparison	O
if	O
the	O
original	O
data	O
comparison	O
,	O
or	O
the	O
Observed	O
Similarity	O
,	O
was	O
within	O
the	O
central	O
two	O
quartiles	O
of	O
the	O
test	O
distribution	O
as	O
a	O
percentile	O
or	O
within	O
two	O
standard	O
deviations	O
of	O
the	O
test	O
distribution	O
mean	O
;	O
if	O
it	O
fell	O
outside	O
this	O
region	O
,	O
then	O
RAMZIS	B-BT
was	O
not	O
considered	O
to	O
emulate	O
the	O
comparison	O
well	O
.	O

In	O
addition	O
to	O
the	O
effectiveness	O
of	O
modeling	O
high	O
-	O
order	O
intercellular	O
communications	O
,	O
the	O
main	O
differences	O
between	O
scHyper	O
and	O
tensor	O
-	O
cell2cell	O
and	O
scTensor	B-BT
may	O
include	O
the	O
following	O
.	O

A	O
dataset	O
of	O
cold	O
-	O
adapted	O
bacterial	O
genome	O
sequences	O
was	O
generated	O
based	O
on	O
the	O
five	O
databases	O
MarRef	B-BT
v	O
.	O
1	O
.	O
7	O
,	O
MarDB	B-BT
v	O
.	O
1	O
.	O
6	O
,	O
Ocean	O
Microbiomics	O
Database	O
(	O
OMD	O
)	O
v	O
.	O
1	O
.	O
1	O
,	O
BacDive	O
(	O
https	O
://	O
bacdive	O
.	O
dsmz	O
.	O
de	O
/	O
(	O
accessed	O
on	O
23	O
January	O
2023	O
)),	O
and	O
TEMPURA	O
(	O
http	O
://	O
togodb	O
.	O
org	O
/	O
db	O
/	O
tempura	O
(	O
accessed	O
on	O
4	O
April	O
2023	O
)).	O

To	O
address	O
this	O
gap	O
,	O
we	O
developed	O
sRNAfrag	B-BT
,	O
a	O
modular	O
and	O
interoperable	O
tool	O
designed	O
to	O
standardize	O
the	O
quantification	O
and	O
analysis	O
of	O
small	O
RNA	O
fragmentation	O
across	O
various	O
biotypes	O
.	O

Jimena	O
[	O
47	O
]	O
was	O
integrated	O
into	O
Cat	B-BT
-	I-BT
E	I-BT
,	O
facilitating	O
the	O
simulation	O
and	O
analysis	O
of	O
dynamic	O
gene	O
regulatory	O
networks	O
.	O

They	O
are	O
detected	O
using	O
tools	O
including	O
VirSorter	B-BT
(	O
categories	O
1	O
,	O
2	O
,	O
4	O
,	O
5	O
)	O
as	O
referenced	O
in	O
Rahlff	O
et	O
al	O
.	O
16	O
,	O
VirSorter2	B-BT
(--	O
min	O
-	O
score	O
0	O
.	O
9	O
),	O
VirFinder	O
(	O
with	O
a	O
score	O
of	O
≥	O
0	O
.	O
9	O
and	O
p	O
-	O
value	O
<	O
0	O
.	O
05	O
),	O
DeepVirFinder	O
(	O
with	O
a	O
score	O
of	O
≥	O
0	O
.	O
9	O
and	O
p	O
-	O
value	O
<	O
0	O
.	O
05	O
),	O
VIBRANT	O
,	O
geNomad	O
(	O
applying	O
the	O
--	O
conservative	O
flag	O
),	O
and	O
ViralVerify	O
(	O
classified	O
as	O
virus	O
).	O

Non	O
-	O
parametric	O
bootstrap	O
analysis	O
was	O
performed	O
on	O
the	O
TrimAl	B-BT
concatenation	O
matrix	O
,	O
using	O
RaxML	O
-	O
NG	O
(	O
v1	O
.	O
2	O
.	O
0	O
).	O

CF4	O
calculates	O
the	O
complete	O
ratio	O
between	O
the	O
sum	O
of	O
natural	O
abundance	O
isotopologues	O
and	O
the	O
sum	O
of	O
95	O
%	O
13C	O
isotopologues	O
,	O
in	O
contrast	O
to	O
considering	O
only	O
the	O
monoisotopic	O
peak	O
in	O
each	O
envelope	O
of	O
isotopologues	O
when	O
using	O
MZmine	B-BT
.	O

Provide	O
:/	O
home	O
/	O
user	O
/	O
skipper	B-BT
/	O
annotations	O
/	O
genome_ref	O

Because	O
NMF	O
is	O
performed	O
in	O
each	O
matricized	O
CCI	O
-	O
tensor	O
in	O
scTensor	B-BT
,	O
we	O
estimated	O
each	O
rank	O
of	O
NMF	O
based	O
on	O
the	O
residual	O
sum	O
of	O
squares	O
(	O
RSS	O
)	O
[	O
122	O
]	O
as8	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$\	O
begin	O
{	O
aligned	O
}	O
\	O
frac	O
{\	O
textrm	O
{	O
RSS	O
}	O
_	O
{\	O
textrm	O
{	O
max	O
}}	O
-	O
\	O
textrm	O
{	O
RSS	O
}	O
_	O
{	O
k	O
}}{\	O
textrm	O
{	O
RSS	O
}	O
_	O
{\	O
textrm	O
{	O
max	O
}}	O
-	O
\	O
textrm	O
{	O
RSS	O
}	O
_	O
{\	O
textrm	O
{	O
min	O
}}}	O
>	O
\	O
textrm	O
{	O
thr	O
}	O
_	O
{\	O
textrm	O
{	O
rank	O
}},	O
\	O
end	O
{	O
aligned	O
}$$\	O
end	O
{	O
document	O
}	O
RSSmax	O
-	O
RSSkRSSmax	O
-	O
RSSmin	O
>	O
thrrank	O
,	O
where	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$\	O
textrm	O
{	O
RSS	O
}	O
_	O
{\	O
textrm	O
{	O
max	O
}}$$\	O
end	O
{	O
document	O
}	O
RSSmax	O
is	O
the	O
RSS	O
by	O
full	O
rank	O
NMF	O
,	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$\	O
textrm	O
{	O
RSS	O
}	O
_	O
{\	O
textrm	O
{	O
min	O
}}$$\	O
end	O
{	O
document	O
}	O
RSSmin	O
is	O
the	O
RSS	O
by	O
rank	O
-	O
1	O
NMF	O
,	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$\	O
textrm	O
{	O
RSS	O
}	O
_	O
{\	O
textrm	O
{	O
k	O
}}$$\	O
end	O
{	O
document	O
}	O
RSSk	O
is	O
the	O
RSS	O
by	O
rank	O
-	O
k	O
NMF	O
,	O
and	O
\	O
documentclass	O
[	O
12pt	O
]{	O
minimal	O
}	O
\	O
usepackage	O
{	O
amsmath	O
}	O
\	O
usepackage	O
{	O
wasysym	O
}	O
\	O
usepackage	O
{	O
amsfonts	O
}	O
\	O
usepackage	O
{	O
amssymb	O
}	O
\	O
usepackage	O
{	O
amsbsy	O
}	O
\	O
usepackage	O
{	O
mathrsfs	O
}	O
\	O
usepackage	O
{	O
upgreek	O
}	O
\	O
setlength	O
{\	O
oddsidemargin	O
}{-	O
69pt	O
}	O
\	O
begin	O
{	O
document	O
}$$\	O
textrm	O
{	O
thr	O
}	O
_	O
{\	O
textrm	O
{	O
rank	O
}}$$\	O
end	O
{	O
document	O
}	O
thrrank	O
is	O
the	O
threshold	O
value	O
,	O
ranging	O
0	O
to	O
1	O
(	O
the	O
default	O
value	O
is	O
0	O
.	O
8	O
).	O

Another	O
benefit	O
is	O
that	O
it	O
does	O
not	O
need	O
a	O
large	O
number	O
of	O
repetitive	O
elements	O
to	O
identify	O
the	O
putative	O
sequences	O
,	O
relying	O
instead	O
on	O
the	O
presence	O
of	O
at	O
least	O
two	O
polymorphic	O
copies	O
in	O
the	O
pangenome	O
.	O

All	O
data	O
and	O
code	O
used	O
for	O
running	O
experiments	O
,	O
model	O
fitting	O
,	O
and	O
plotting	O
is	O
available	O
on	O
a	O
GitHub	O
repository	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
aoulas	O
/	O
scRANK	B-BT
/.	O

[	O
50	O
]	O
homogenously	O
deposited	O
porous	O
organic	O
polymer	O
containing	O
pyrimidine	O
atop	O
a	O
graphene	O
sheet	O
to	O
provide	O
composite	O
material	O
PyPOP	B-BT
@	O
G	O
(	O
Figure	O
4a	O
).	O

The	O
disease	O
-	O
gene	O
association	O
is	O
searched	O
in	O
the	O
DisGeNET	B-BT
database	O
v	O
7	O
.	O
0	O
for	O
gene	O
-	O
disease	O
associations	O
,	O
whereas	O
the	O
""""	O
N_PMIDs	O
(	O
citation	O
")"""	O
≥	O
3	O
were	O
considered	O
,	O
and	O
a	O
gene	O
-	O
disease	O
target	O
network	O
was	O
created	O
and	O
analyzed	O
using	O
CYTOSCAPE	O
version	O
3	O
.	O
10	O
.	O
0	O
.	O

This	O
presentation	O
will	O
shed	O
light	O
on	O
the	O
expansion	O
of	O
digital	O
technologies	O
and	O
health	O
data	O
in	O
health	O
policy	O
in	O
the	O
face	O
of	O
data	O
science	O
,	O
highlighting	O
the	O
need	O
to	O
delve	O
into	O
the	O
terminology	O
of	O
DiPH	O
,	O
understanding	O
its	O
boundaries	O
and	O
legal	O
differences	O
from	O
its	O
neighbors	O
(	O
not	O
twins	O
)	O
outside	O
health	O
policy	O
.	O

As	O
proof	O
of	O
concept	O
,	O
we	O
provide	O
three	O
examples	O
within	O
the	O
scifAI	B-BT
code	O
repository	O
on	O
how	O
to	O
analyze	O
IFC	O
datasets	O
from	O
Jurkat	O
cells	O
(	O
3	O
channels	O
per	O
image	O
)	O
24	O
,	O
white	O
blood	O
cells	O
(	O
12	O
channels	O
)	O
23	O
,	O
and	O
apoptotic	O
cells	O
(	O
2	O
channels	O
)	O
25	O
using	O
scifAI	B-BT
.	O

1	O
),	O
was	O
used	O
to	O
investigate	O
the	O
mechanism	O
underlying	O
the	O
hypothermic	O
effects	O
of	O
FQ	O
antimicrobials	O
during	O
fever	O
.	O

Our	O
study	O
found	O
that	O
AuraGain	O
and	O
Supreme	O
exhibited	O
superior	O
GT	O
insertion	O
performance	O
,	O
aligning	O
with	O
findings	O
reported	O
in	O
prior	O
research	O
.	O

Acquisition	O
,	O
analysis	O
,	O
or	O
interpretation	O
of	O
data	O
:	O
Ricardo	O
Noguera	O
Louzada	O
,	O
Dillan	O
Cunha	O
Amaral	O
,	O
Claudio	O
do	O
Carmo	O
Chaves	O
Filho	O
,	O
Daniel	O
Oliveira	O
Dantas	O
,	O
Francisco	O
Carlos	O
de	O
Castro	O
Neto	O
,	O
Milton	O
Ruiz	O
Alves	O

(	O
b	O
–	O
d	O
)	O
Illustration	O
of	O
envisioned	O
epitaxial	O
effects	O
on	O
the	O
self	O
-	O
assembly	O
of	O
PMAT	O
trimers	O
on	O
gold	O
surfaces	O
.	O

In	O
total	O
,	O
112	O
components	O
of	O
STF	O
were	O
obtained	O
from	O
the	O
TCMNPAS	B-BT
Database	O
.	O

TCMNPAS	B-BT
,	O
a	O
network	O
pharmacological	O
analysis	O
system	O
of	O
TCM	O
,	O
was	O
independently	O
developed	O
and	O
designed	O
by	O
Professor	O
Yang	O
Ming	O
in	O
Longhua	O
Hospital	O
,	O
Shanghai	O
University	O
of	O
Traditional	O
Chinese	O
Medicine	O
(	O
TCM	O
Network	O
Pharmacology	O
Analysis	O
System	O
v1	O
.	O
0	O
[	O
CP	O
/	O
CD	O
],	O
Copyright	O
Registration	O
No	O
.,	O
2019SR1127090	O
,	O
http	O
://	O
54	O
.	O
223	O
.	O
75	O
.	O
62	O
:	O
3838	O
/).	O

To	O
identify	O
a	O
trastuzumab	O
resistance	O
program	O
,	O
gene	O
sets	O
associated	O
with	O
clonal	O
expansion	O
versus	O
contraction	O
were	O
devised	O
using	O
GeneVector	O
on	O
pretreatment	O
expression	O
from	O
patients	O
who	O
received	O
either	O
TC	O
or	O
C	O
(	O
Supplementary	O
Methods	O
).	O

and	O
L	O
.	O
M	O
.)	O
chose	O
,	O
in	O
each	O
case	O
according	O
to	O
the	O
preoperative	O
characteristics	O
,	O
the	O
most	O
optimal	O
location	O
to	O
implant	O
the	O
claw	O
design	O
intraocular	O
lens	O
(	O
prepupillary	O
or	O
retropupillary	O
).	O

In	O
NanoLAS	B-BT
2	O
.	O
0	O
,	O
we	O
will	O
incorporate	O
additional	O
rigid	O
docking	O
programs	O
,	O
including	O
ZDOCK	O
[	O
32	O
],	O
GRAMM	O
-	O
X	O
[	O
33	O
],	O
pyDOCK	O
[	O
34	O
],	O
and	O
FTDock	O
[	O
35	O
].	O

Human	B-BT
Splicing	I-BT
Finder	I-BT
bioinformatics	O
software	O
packages	O

(	O
A	O
)	O
The	O
role	O
of	O
SpatialCells	B-BT
within	O
downstream	O
analyses	O
.	O

The	O
later	O
analysis	O
showed	O
that	O
NanoDeep	B-BT
recovered	O
the	O
species	O
composition	O
of	O
the	O
mock	O
sample	O
,	O
indicating	O
that	O
it	O
meets	O
the	O
requirement	O
for	O
adaptive	O
sampling	O
in	O
nanopore	O
platforms	O
.	O

The	O
HIResist	B-BT
database	O
contains	O
a	O
search	O
engine	O
to	O
retrieve	O
data	O
at	O
three	O
levels	O
using	O
auto	O
-	O
complete	O
fields	O
(	O
Fig	O
.	O

The	O
implementation	O
of	O
age	O
prediction	O
in	O
pyaging	B-BT
begins	O
with	O
preprocessing	O
the	O
data	O
matrix	O
.	O

To	O
facilitate	O
adaptive	O
controller	O
design	O
,	O
Eq	O
.	O

For	O
each	O
model	O
in	O
the	O
ensemble	O
,	O
enzyme	O
modules	O
were	O
constructed	O
for	O
each	O
reaction	O
using	O
a	O
nonlinear	O
parameter	O
fitting	O
package	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
opencobra	O
/	O
MASSef	B-BT
)	O
and	O
kinetic	O
data	O
extracted	O
from	O
the	O
literature	O
.	O

In	O
addition	O
,	O
we	O
show	O
how	O
using	O
scPrisma	B-BT
allows	O
us	O
to	O
better	O
distinguish	O
distinct	O
cellular	O
subtypes	O
of	O
SCN	O
neurons	O
following	O
temporal	O
filtering	O
,	O
and	O
uncover	O
signal	O
-	O
related	O
gene	O
regulatory	O
networks	O
and	O
cell	O
–	O
cell	O
interactions	O
following	O
enhancement	O
of	O
the	O
circadian	O
rhythm	O
signal	O
.	O

sRNAfrag	B-BT
’	O
s	O
ability	O
to	O
analyze	O
historical	O
data	O
offers	O
the	O
prospect	O
of	O
uncovering	O
evolutionary	O
patterns	O
,	O
such	O
as	O
the	O
conservation	O
of	O
the	O
5	O
’	O
miRNA	O
seed	O
sequence	O
across	O
different	O
miRNA	O
RNA	O
genes	O
.	O

For	O
subsequent	O
MScan	O
recordings	O
,	O
a	O
disposable	O
electrode	O
was	O
positioned	O
at	O
the	O
established	O
optimal	O
recording	O
site	O
.	O

PyChelator	B-BT
Colab	O
is	O
also	O
modified	O
to	O
use	O
the	O
built	O
-	O
in	O
Python	O
Decimal	O
module	O
,	O
introducing	O
user	O
-	O
defined	O
precision	O
in	O
the	O
calculations	O
,	O
which	O
are	O
otherwise	O
limited	O
by	O
double	O
precision	O
in	O
the	O
floating	O
-	O
point	O
arithmetic	O
of	O
Python	O
and	O
JavaScript	O
.	O

Phenotator	B-BT
has	O
a	O
feature	O
to	O
export	O
the	O
collected	O
EQ	O
annotations	O
as	O
an	O
OWL	O
file	O
containing	O
new	O
terms	O
that	O
are	O
logically	O
defined	O
according	O
to	O
the	O
SUBQ	O
pattern	O
,	O
10	O
which	O
can	O
be	O
expressed	O
in	O
Manchester	O
OWL	O
syntax	O
as	O
“(	O
has_part	O
some	O
(<	O
Quality	O
>	O
and	O
inheres_in	O
some	O
<	O
Entity	O
>))”.	O

We	O
applied	O
the	O
Horvath	O
[	O
15	O
],	O
Hannum	O
[	O
14	O
],	O
PhenoAge	O
[	O
16	O
],	O
and	O
cAge	O
[	O
28	O
]	O
epiclocks	O
to	O
the	O
methylation	O
data	O
in	O
the	O
main	O
dataset	O
by	O
using	O
the	O
methods	O
and	O
parameters	O
reported	O
by	O
the	O
authors	O
for	O
each	O
case	O
and	O
validated	O
using	O
the	O
implementations	O
in	O
the	O
pyaging	B-BT
Python	O
library	O
[	O
42	O
].	O

Hi	O
-	O
M	O
data	O
were	O
analyzed	O
using	O
pyHiM	B-BT
release	O
0	O
.	O
6	O
,	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
marcnol	O
/	O
pyHiM	B-BT
.	O

Consequently	O
,	O
the	O
running	O
time	O
needed	O
to	O
get	O
a	O
reasonable	O
prediction	O
is	O
actually	O
lower	O
for	O
LocoGSE	B-BT
than	O
GenomeScope	O
.	O

The	O
main	O
results	O
include	O
:	O
1	O
)	O
Human	O
position	O
-	O
defined	O
CGI	O
prediction	O
method	O
is	O
more	O
efficient	O
to	O
predict	O
position	O
-	O
defined	O
CGIs	O
with	O
multiple	O
consecutive	O
(	O
d	O
)	O
values	O
and	O
locate	O
more	O
potential	O
short	O
CGIs	O
than	O
previous	O
CGI	O
prediction	O
methods	O
;	O
2	O
)	O
Our	O
annotation	O
and	O
analysis	O
method	O
not	O
only	O
can	O
investigate	O
the	O
connections	O
between	O
position	O
-	O
defined	O
CGI	O
methylation	O
and	O
gene	O
expression	O
specificity	O
from	O
a	O
genome	O
-	O
wide	O
perspective	O
,	O
but	O
also	O
can	O
analyze	O
the	O
potential	O
association	O
of	O
position	O
-	O
defined	O
CGIs	O
with	O
gene	O
functions	O
;	O
(	O
3	O
)	O
PCGIMA	B-BT
provides	O
an	O
easy	O
-	O
to	O
-	O
use	O
analysis	O
and	O
visualization	O
platform	O
for	O
human	O
CGI	O
prediction	O
and	O
methylation	O
.	O

CDPred	B-BT
achieves	O
the	O
highest	O
contact	O
prediction	O
precision	O
across	O
the	O
board	O
among	O
all	O
the	O
methods	O
.	O

Here	O
we	O
report	O
antegrade	O
metallic	O
stenting	O
using	O
a	O
slim	O
cholangioscope	O
for	O
malignant	O
afferent	O
loop	O
obstruction	O
(	O
Video	O
1	O
).	O

From	O
the	O
outermost	O
:	O
Track1	O
:	O
Top	O
24	O
largest	O
scaffolds	O
of	O
the	O
red	O
snapper	O
genome	O
.	O

The	O
following	O
supporting	O
information	O
can	O
be	O
downloaded	O
at	O
:	O
https	O
://	O
www	O
.	O
mdpi	O
.	O
com	O
/	O
article	O
/	O
10	O
.	O
3390	O
/	O
v16101550	O
/	O
s1	O
,	O
Table	O
S1	O
:	O
Primers	O
used	O
in	O
this	O
study	O
;	O
Table	O
S2	O
:	O
References	O
genomes	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
RNA1	O
used	O
for	O
design	O
of	O
primer	O
;	O
Table	O
S3	O
:	O
References	O
genomes	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
RNA2	O
used	O
for	O
design	O
of	O
primer	O
;	O
Table	O
S4	O
:	O
References	O
genomes	O
of	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
)	O
used	O
for	O
design	O
of	O
primers	O
;	O
Table	O
S5	O
:	O
Summary	O
of	O
RNAseq	O
data	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
);	O
Table	O
S6	O
:	O
Summary	O
of	O
RNAseq	O
data	O
of	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
);	O
Table	O
S7	O
:	O
Primer	O
panel	O
for	O
tiled	O
amplicon	O
PCR	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
);	O
Table	O
S8	O
:	O
Primer	O
panel	O
for	O
tiled	O
amplicon	O
PCR	O
of	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
);	O
Table	O
S9	O
:	O
Summary	O
of	O
tiled	O
amplicon	O
PCR	O
data	O
for	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
);	O
Table	O
S10	O
:	O
Summary	O
of	O
tiled	O
amplicon	O
PCR	O
data	O
for	O
strawberry	O
vein	O
bending	O
virus	O
(	O
SVBV	O
).	O

As	O
an	O
open	O
-	O
source	O
tool	O
available	O
at	O
https	O
://	O
project123vcf	B-BT
.	O
sourceforge	O
.	O
io	O
,	O
it	O
is	O
accessible	O
to	O
the	O
global	O
scientific	O
and	O
clinical	O
community	O
,	O
paving	O
the	O
way	O
for	O
the	O
discovery	O
of	O
disease	O
-	O
causing	O
variants	O
and	O
facilitating	O
the	O
advancement	O
of	O
personalized	O
medicine	O
.	O

(	O
3	O
.)	O
Lack	O
of	O
Analytical	O
Tools	O
:	O
HAIviz	B-BT
currently	O
serves	O
as	O
a	O
visualisation	O
endpoint	O
,	O
devoid	O
of	O
any	O
analytical	O
tools	O
or	O
pipelines	O
.	O

Various	O
types	O
of	O
cytoplasmic	O
inclusions	O
have	O
been	O
documented	O
in	O
plasma	O
cell	O
neoplasms	O
,	O
including	O
Russell	O
bodies	O
,	O
crystals	O
,	O
and	O
Auer	O
rod	O
‐	O
like	O
inclusions	O
,	O
while	O
azurophilic	O
granules	O
and	O
Snapper	O
‐	O
Schneid	O
bodies	O
remain	O
uncommon	O
.	O

The	O
analysis	O
was	O
performed	O
using	O
our	O
pyHiM	B-BT
analysis	O
pipeline	O
(	O
https	O
://	O
pyhim	B-BT
.	O
readthedocs	O
.	O
io	O
/	O
en	O
/	O
latest	O
/).	O

Finally	O
,	O
we	O
confirm	O
new	O
PIFiA	B-BT
predictions	O
using	O
a	O
colocalization	O
assay	O
,	O
suggesting	O
previously	O
unappreciated	O
biological	O
roles	O
for	O
several	O
proteins	O
.	O

The	O
alignment	O
view	O
of	O
DiGAlign	B-BT
automatically	O
selects	O
the	O
position	O
and	O
orientation	O
of	O
sequences	O
to	O
clearly	O
visualize	O
complicated	O
alignments	O
,	O
including	O
circular	O
and	O
inverted	O
sequences	O
,	O
a	O
feature	O
that	O
is	O
not	O
commonly	O
available	O
in	O
other	O
tools	O
(	O
Table	O
1	O
).	O

Knud	O
will	O
delve	O
into	O
the	O
adaptation	O
of	O
co	O
-	O
creation	O
processes	O
within	O
the	O
Danish	O
context	O
.	O

3A	O
),	O
compared	O
with	O
the	O
time	O
per	O
stitch	O
for	O
the	O
first	O
three	O
cases	O
.	O

Costs	O
obtained	O
in	O
other	O
years	O
and	O
/	O
or	O
different	O
currencies	O
converted	O
to	O
Fijian	O
dollar	O
using	O
the	O
average	O
exchange	O
rate	O
in	O
that	O
year	O
[	O
21	O
],	O
adjusted	O
to	O
2020	O
prices	O
using	O
GDP	O
deflator	O
[	O
22	O
],	O
and	O
converted	O
back	O
to	O
US	O
$	O
using	O
2020	O
exchange	O
rates	O
.	O

This	O
drop	O
in	O
classification	O
accuracy	O
could	O
be	O
due	O
to	O
the	O
presence	O
of	O
marine	O
MAGs	O
,	O
SAGs	O
,	O
and	O
incomplete	O
genomes	O
in	O
the	O
MarDb	B-BT
database	O
[	O
14	O
],	O
which	O
is	O
a	O
component	O
of	O
MAR	O
database	O
.	O

The	O
Cytoscape	O
plugin	O
Reactome	B-BT
FIViz	O
classified	O
and	O
assembled	O
the	O
exported	O
gene	O
list	O
into	O
biological	O
pathways	O
.	O

The	O
primary	O
objective	O
of	O
the	O
study	O
is	O
to	O
evaluate	O
the	O
diagnostic	O
accuracy	O
of	O
pMAT	O
for	O
NMBAs	O
as	O
perioperative	O
allergens	O
.	O

While	O
bridging	O
the	O
gap	O
between	O
SHG	O
and	O
BF	O
modalities	O
through	O
CoMIRs	O
delivers	O
strongly	O
improved	O
cross	O
-	O
modality	O
retrieval	O
success	O
when	O
using	O
SIFT	O
or	O
SURF	O
,	O
the	O
I2I	O
approaches	O
are	O
less	O
advantageous	O
.	O

Custom	O
R	O
scripts	O
were	O
implemented	O
to	O
compile	O
modified_peptide_label_quant	O
.	O
tsv	O
(	O
quant	O
)	O
outputs	O
from	O
the	O
command	O
line	O
MSFragger	B-BT
pipeline	O
or	O
FragPipe	O
to	O
count	O
unique	O
quantified	O
cysteines	O
.	O

These	O
libraries	O
perform	O
file	O
access	O
in	O
a	O
single	O
-	O
threaded	O
manner	O
(	O
HTSLIB	B-BT
does	O
support	O
multi	O
-	O
threaded	O
decompression	O
,	O
but	O
not	O
file	O
reading	O
),	O
which	O
is	O
a	O
reasonable	O
design	O
choice	O
when	O
(	O
i	O
)	O
informatics	O
analysis	O
is	O
compute	O
bottlenecked	O
,	O
and	O
therefore	O
cannot	O
benefit	O
from	O
faster	O
data	O
access	O
;	O
or	O
(	O
ii	O
)	O
the	O
file	O
storage	O
and	O
transport	O
media	O
are	O
incapable	O
of	O
high	O
performance	O
,	O
e	O
.	O
g	O
.	O

Overall	O
,	O
76	O
isolates	O
(	O
72	O
%),	O
including	O
those	O
matched	O
with	O
MAGs	O
,	O
were	O
correctly	O
identified	O
at	O
the	O
species	O
level	O
;	O
i	O
.	O
e	O
.,	O
in	O
these	O
cases	O
,	O
MALDI	O
-	O
TOF	O
MS	O
identification	O
with	O
GPMsDB	B-BT
-	I-BT
tk	I-BT
gave	O
the	O
same	O
GTDB	O
taxonomy	O
string	O
down	O
to	O
the	O
species	O
level	O
with	O
those	O
of	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

For	O
example	O
,	O
RCoV19	B-BT
is	O
a	O
resource	O
for	O
the	O
2019	O
novel	O
coronavirus	O
[	O
18	O
],	O
which	O
provides	O
several	O
functional	O
modules	O
on	O
severe	O
acute	O
respiratory	O
syndrome	O
coronavirus	O
2	O
(	O
SARS	O
-	O
CoV	O
-	O
2	O
)	O
genome	O
sequences	O
,	O
genomic	O
mutations	O
,	O
variant	O
monitoring	O
,	O
early	O
-	O
warning	O
of	O
high	O
-	O
risk	O
variants	O
,	O
online	O
data	O
analysis	O
toolkits	O
,	O
and	O
related	O
literature	O
.	O

We	O
tested	O
the	O
ability	O
of	O
ChemoDOTS	B-BT
to	O
generate	O
these	O
compounds	O
.	O

(	O
b	O
)	O
Example	O
of	O
PyMOL	B-BT
script	O
result	O
—	O
structure	O
of	O
human	O
Proto	O
‐	O
oncogene	O
tyrosine	O
‐	O
protein	O
kinase	O
receptor	O
Ret	O
(	O
PDB	O
:	O
7DU9	O
)	O
in	O
complex	O
with	O
Pralsetinib	O
(	O
DB15822	O
).	O

PyChelator	B-BT
is	O
a	O
single	O
page	O
application	O
where	O
users	O
can	O
switch	O
constants	O
by	O
the	O
use	O
of	O
a	O
dropdown	O
menu	O
.	O

We	O
also	O
made	O
an	O
attempt	O
on	O
the	O
hydro	O
-	O
substituted	O
product	O
with	O
cat	O
-	O
E	O
as	O
the	O
catalyst	O
without	O
any	O
other	O
additives	O
,	O
but	O
the	O
reactivity	O
of	O
hydro	O
-	O
substituted	O
VQM	O
was	O
too	O
low	O
to	O
give	O
any	O
conversion	O
.	O

Note	O
that	O
Fiji	B-BT
needs	O
to	O
be	O
restarted	O
for	O
the	O
changes	O
to	O
take	O
effect	O
.	O

The	O
concordance	O
of	O
SNPs	O
called	O
by	O
GATK	O
and	O
BCFtools	B-BT
on	O
each	O
chromosome	O
.	O

We	O
then	O
asked	O
how	O
reliably	O
GEMLI	B-BT
identifies	O
categories	O
of	O
genes	O
displaying	O
gene	O
expression	O
memory	O
in	O
small	O
lineages	O
.	O

In	O
the	O
future	O
version	O
of	O
PySmooth	B-BT
,	O
an	O
automated	O
multi	O
-	O
core	O
processing	O
feature	O
will	O
be	O
incorporated	O
.	O

Therefore	O
,	O
we	O
primarily	O
focused	O
on	O
comparing	O
InPACT	B-BT
with	O
APAIQ	O
and	O
IPAFinder	O
by	O
evaluating	O
various	O
aspects	O
of	O
performance	O
.	O

Our	O
experiments	O
indicate	O
that	O
BiWFA	B-BT
starts	O
outperforming	O
the	O
original	O
WFA	O
when	O
aligning	O
sequences	O
longer	O
than	O
∼	O
30	O
Kbp	O
.	O

PyPOP	B-BT
has	O
an	O
intentional	O
affinity	O
for	O
CO2	O
due	O
to	O
its	O
rich	O
microporous	O
structure	O
(	O
Figure	O
4b	O
),	O
while	O
graphene	O
enhances	O
the	O
electrical	O
conductivity	O
of	O
the	O
composite	O
.	O

At	O
4	O
months	O
of	O
age	O
,	O
aortic	O
arch	O
repair	O
was	O
performed	O
,	O
including	O
removal	O
of	O
the	O
ductus	O
arteriosus	O
and	O
remnant	O
left	O
aortic	O
arch	O
to	O
release	O
the	O
vascular	O
ring	O
.	O

High	O
-	O
quality	O
truly	O
domain	O
-	O
centric	O
GO	O
annotations	O
that	O
were	O
supported	O
by	O
both	O
single	O
domain	O
UniProts	O
and	O
all	O
UniProts	O
(	O
including	O
multidomain	O
UniProts	O
)	O
were	O
downloaded	O
as	O
the	O
file	O
Domain2GO_supported_by_both	B-BT
.	O
txt	O
.	O

The	O
BAM	O
files	O
were	O
further	O
processed	O
to	O
demultiplex	O
based	O
on	O
spatial	O
barcodes	O
and	O
quantified	O
into	O
matrices	O
using	O
UMIs	O
and	O
aligned	O
gene	O
information	O
,	O
using	O
new	O
functions	O
introduced	O
in	O
scPipe	B-BT
.	O

Four	O
groups	O
of	O
countries	O
were	O
identified	O
based	O
on	O
data	O
accessible	O
on	O
the	O
ITHANET	B-BT
portal	O
[	O
9	O
].	O

Only	O
MetaTron	B-BT
allows	O
the	O
user	O
to	O
specify	O
a	O
DOI	O
and	O
annotate	O
the	O
related	O
abstract	O
extracted	O
from	O
Semantic	O
Scholar	O
or	O
OpenAIRE	O
.	O

Rectal	O
body	O
temperature	O
was	O
measured	O
again	O
18	O
h	O
after	O
administration	O
of	O
the	O
dried	O
yeast	O
solution	O
,	O
and	O
mice	O
with	O
a	O
fever	O
of	O
0	O
.	O
8	O
°	O
C	O
or	O
higher	O
compared	O
to	O
their	O
temperature	O
before	O
dried	O
yeast	O
solution	O
administration	O
were	O
considered	O
to	O
be	O
non	O
-	O
bacterial	O
fever	O
model	O
mice	O
.	O

reported	O
the	O
use	O
of	O
the	O
MatchMiner	B-BT
open	O
source	O
platform	O
to	O
computationally	O
match	O
genomically	O
profiled	O
cancer	O
patients	O
to	O
precision	O
medicine	O
clinical	O
trials	O
in	O
an	O
academic	O
large	O
-	O
volume	O
center	O
.	O

Project	O
home	O
page	O
:	O
https	O
://	O
github	O
.	O
com	O
/	O
lolrenceH	O
/	O
TrieDedup	B-BT
.	O

GenoMycAnalyzer	B-BT
includes	O
a	O
function	O
for	O
users	O
to	O
edit	O
the	O
knowledge	O
database	O
,	O
which	O
serves	O
as	O
a	O
valuable	O
bridge	O
until	O
regular	O
database	O
updates	O
occur	O
.	O

For	O
example	O
,	O
theoretical	O
calculations	O
(	O
12	O
)	O
predict	O
that	O
for	O
Earth	O
,	O
core	O
formation	O
in	O
a	O
magma	O
ocean	O
at	O
30	O
GPa	O
would	O
yield	O
a	O
mantle	O
in	O
which	O
4	O
to	O
7	O
%	O
of	O
the	O
iron	O
is	O
Fe2O3	O
,	O
whereas	O
extrapolation	O
of	O
existing	O
experimental	O
results	O
suggests	O
ratios	O
of	O
70	O
%	O
(	O
11	O
)	O
or	O
35	O
±	O
15	O
%	O
(	O
13	O
).	O

Future	O
research	O
could	O
examine	O
whether	O
therapy	O
targeting	O
event	O
centrality	O
is	O
particularly	O
beneficial	O
supporting	O
people	O
to	O
recover	O
from	O
PGD	O
.	O

A	O
final	O
roundtable	O
discussion	O
of	O
the	O
most	O
common	O
issues	O
and	O
bottlenecks	O
in	O
data	O
interpretation	O
was	O
held	O
,	O
with	O
the	O
overall	O
goal	O
of	O
encouraging	O
non	O
-	O
experts	O
in	O
bioinformatics	O
to	O
explore	O
user	O
-	O
friendly	O
resources	O
for	O
MS	O
data	O
analysis	O
,	O
at	O
Metabolomics	O
2023	O
,	O
the	O
workshop	O
‘	O
Data	O
Standardization	O
and	O
Reuse	O
through	O
Public	O
Repositories	O
’,	O
where	O
the	O
providers	O
of	O
the	O
major	O
public	O
metabolomics	O
repositories	O
(	O
Metabolomics	O
Workbench	O
,	O
MetaboBank	O
and	O
MetaboLights	B-BT
)	O
presented	O
the	O
current	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
guidelines	O
for	O
experimental	O
design	O
,	O
including	O
protocols	O
,	O
metadata	O
and	O
results	O
.	O

When	O
we	O
analysed	O
these	O
regions	O
in	O
the	O
STRIDE	B-BT
-	I-BT
DB	I-BT
,	O
within	O
50	O
-	O
kb	O
of	O
these	O
markers	O
,	O
there	O
were	O
GWAS	O
studies	O
which	O
were	O
associated	O
to	O
cholesterol	O
level	O
,	O
heart	O
rate	O
response	O
to	O
beta	O
blockers	O
and	O
asthma	O
-	O
related	O
disorders	O
found	O
,	O
which	O
also	O
coincides	O
with	O
the	O
symptoms	O
/	O
effects	O
of	O
Down	O
syndrome	O
(	O
Supplementary	O
Table	O
S1	O
)	O
(	O
21	O
–	O
24	O
),	O
thus	O
suggesting	O
that	O
these	O
variations	O
in	O
the	O
STRs	O
can	O
act	O
as	O
a	O
clinical	O
marker	O
in	O
screening	O
Down	O
syndrome	O
before	O
pregnancy	O
.	O

The	O
web	O
server	O
is	O
available	O
at	O
http	O
://	O
bioinf	O
.	O
cs	O
.	O
ucl	O
.	O
ac	O
.	O
uk	O
/	O
psipred	B-BT
/.	O

In	O
addition	O
,	O
RepairNatrix	B-BT
processes	O
Illumina	O
and	O
Oxford	O
Nanopore	O
data	O
.	O

Spread	O
ratio	O
and	O
diameter	O
of	O
the	O
biscuit	O
decreased	O
with	O
increasing	O
substitution	O
level	O
of	O
the	O
residue	O
.	O

Atrium	O
-	O
to	O
-	O
ventricle	O
and	O
ventricle	O
-	O
to	O
-	O
atrium	O
i2i	O
communication	O
success	O
rates	O
were	O
also	O
assessed	O
.	O

The	O
study	O
was	O
conducted	O
in	O
accordance	O
with	O
the	O
Declaration	O
of	O
Helsinki	O
and	O
approved	O
by	O
the	O
Institutional	O
Review	O
Board	O
of	O
the	O
University	O
of	O
New	O
South	O
Wales	O
,	O
May	O
2021	O
(	O
HC200469	O
)	O
and	O
the	O
Fiji	O
National	O
University	O
College	O
of	O
Human	O
Health	O
Research	O
Ethical	O
Committee	O
May	O
2021	O
(	O
CHHREC264	O
.	O
20	O
).	O

MaBoSS	B-BT
,	O
integrated	O
into	O
PhysiBoSS	O
2	O
.	O
0	O
,	O
can	O
perform	O
simulations	O
changing	O
the	O
proportion	O
of	O
activated	O
and	O
inhibited	O
status	O
of	O
a	O
given	O
node	O
.	O

Additionally	O
,	O
comprehensive	O
documentation	O
and	O
tutorials	O
are	O
available	O
at	O
https	O
://	O
molstar	B-BT
.	O
org	O
/	O
me	O
-	O
docs	O
/,	O
designed	O
to	O
help	O
users	O
maximize	O
their	O
experience	O
with	O
the	O
Mesoscale	O
Explorer	O
,	O
ensuring	O
a	O
smooth	O
and	O
enriching	O
journey	O
through	O
the	O
molecular	O
landscapes	O
that	O
underpin	O
life	O
itself	O
.	O

General	O
outlook	O
of	O
the	O
PERSEUS	B-BT
website	O
.	O

Lastly	O
,	O
trans	B-BT
-	I-BT
PCO	I-BT
tests	O
the	O
association	O
between	O
SNPs	O
and	O
gene	O
sets	O
by	O
using	O
PCO	O
.	O

Layout	O
overview	O
of	O
PIFiA	B-BT
results	O
page	O
.	O

a	O
The	O
top	O
L	O
precisions	O
of	O
DeepTMP	O
,	O
CDPred	B-BT
,	O
DeepHomo2	O
.	O
0	O
,	O
GLINTER	O
,	O
DeepHomo	O
,	O
and	O
DNCON2_Inter	O
in	O
different	O
ranges	O
of	O
contact	O
density	O
.	O

A	O
total	O
of	O
316	O
sequences	O
of	O
PSEN1	O
were	O
recovered	O
from	O
different	O
vertebrates	O
,	O
and	O
a	O
multiple	O
sequence	O
alignment	O
(	O
MSA	O
)	O
was	O
constructed	O
using	O
Jalview	B-BT
.	O

Table	O
1An	O
overview	O
of	O
benchmarked	O
variant	O
callersVariant	O
CallerUMI	O
AwarenessType	O
of	O
VariantInput	O
Files	O
bcftools	B-BT
NoSNP	O
+	O
IndelBAM	O
FreeBayes	O
NoSNP	O
+	O
IndelBAM	O
LoFreq	O
NoSNP	O
+	O
IndelBAM	O
Mutect2	O
NoSNP	O
+	O
IndelBAM	O
UMIErrorCorrect	O
YesSNPFASTQ	O
UMI	O
-	O
VarCal	O
YesSNP	O
+	O
indelBAM	O

We	O
compared	O
two	O
plant	O
single	O
copy	O
gene	O
sets	O
to	O
use	O
for	O
plant	O
genome	O
size	O
estimation	O
in	O
LocoGSE	B-BT
:	O
the	O
widely	O
used	O
BUSCO	O
Embryophyta	O
ancestral	O
proteins	O
(	O
Simão	O
et	O
al	O
.,	O
2015	O
;	O
Manni	O
et	O
al	O
.,	O
2021	O
)	O
(	O
https	O
://	O
busco	O
-	O
data	O
.	O
ezlab	O
.	O
org	O
/	O
v4	O
/	O
data	O
/	O
lineages	O
/	O
embryophyta_odb10	O
.	O
2019	O
-	O
11	O
-	O
20	O
.	O
tar	O
.	O
gz	O
),	O
and	O
the	O
OneKP	O
proteins	O
(	O
Leebens	O
-	O
Mack	O
et	O
al	O
.,	O
2019	O
).	O

a	O
Illustration	O
of	O
a	O
typical	O
pyHiM	B-BT
analysis	O
on	O
mouse	O
tissues	O
:	O
examples	O
of	O
raw	O
data	O
are	O
shown	O
in	O
the	O
top	O
row	O
and	O
the	O
most	O
relevant	O
pyHiM	B-BT
outputs	O
are	O
shown	O
in	O
the	O
bottom	O
row	O
.	O

Reaction	O
conditions	O
for	O
4q	O
–	O
4s	O
:	O
3	O
(	O
0	O
.	O
05	O
mmol	O
,	O
1	O
.	O
0	O
equiv	O
.),	O
cat	O
-	O
E	O
(	O
0	O
.	O
005	O
mmol	O
,	O
10	O
mol	O
%)	O
in	O
CHCl3	O
(	O
1	O
.	O
0	O
mL	O
)	O
at	O
rt	O
for	O
24	O
h	O
.	O

In	O
addition	O
,	O
LipidSig	O
2	O
.	O
0	O
analyzes	O
lipid	O
names	O
or	O
features	O
from	O
user	O
-	O
provided	O
lipidomics	O
data	O
using	O
Goslin	B-BT
,	O
which	O
assigns	O
corresponding	O
nomenclature	O
at	O
various	O
levels	O
,	O
including	O
species	O
(	O
only	O
total	O
carbon	O
and	O
double	O
bond	O
counts	O
),	O
molecular	O
species	O
(	O
with	O
individual	O
fatty	O
acid	O
chain	O
compositions	O
),	O
and	O
sn	O
-	O
position	O
(	O
detail	O
in	O
the	O
exact	O
positions	O
of	O
fatty	O
acids	O
on	O
the	O
backbone	O
).	O

There	O
are	O
several	O
tRNA	O
databases	O
such	O
as	O
tRNAdb	O
http	O
://	O
trna	O
.	O
bioinf	O
.	O
uni	O
-	O
leipzig	O
.	O
de	O
/	O
DataOutput	O
/	O
[	O
16	O
],	O
GtRNAdb	O
http	O
://	O
gtrnadb	O
.	O
ucsc	O
.	O
edu	O
/	O
[	O
17	O
],	O
tRNADB	O
-	O
CE	O
http	O
://	O
trna	O
.	O
ie	O
.	O
niigata	O
-	O
u	O
.	O
ac	O
.	O
jp	O
/	O
cgi	O
-	O
bin	O
/	O
trnadb	O
/	O
index	O
.	O
cgi	O
[	O
18	O
],	O
and	O
PlantRNA	B-BT
http	O
://	O
plantrna	B-BT
.	O
ibmp	O
.	O
cnrs	O
.	O
fr	O
/	O
[	O
19	O
].	O

acnes	O
beta	O
-	O
keto	O
acyl	O
synthase	O
-	O
III	O
enzymes	O
by	O
using	O
the	O
patchdock	B-BT
docking	O
method	O
.	O

Therefore	O
,	O
ordinary	O
individuals	O
do	O
not	O
have	O
the	O
power	O
or	O
right	O
to	O
file	O
a	O
direct	O
lawsuit	O
before	O
the	O
Federal	O
Supreme	O
Court	O
[	O
38	O
].	O

Thereafter	O
,	O
PASTEClassifier	B-BT
(	O
pseudo	O
agent	O
system	O
for	O
transposable	O
elements	O
classification	O
)	O
[	O
28	O
]	O
was	O
used	O
to	O
classify	O
transposable	O
elements	O
and	O
repetitive	O
sequences	O
to	O
generate	O
a	O
database	O
that	O
was	O
subsequently	O
combined	O
with	O
the	O
Repbase	O
database	O
[	O
29	O
]	O
to	O
create	O
the	O
final	O
repeat	O
sequence	O
database	O
utilized	O
here	O
.	O

Table	O
4Impact	O
of	O
complications	O
on	O
direct	O
medical	O
cots	O
across	O
different	O
cancer	O
typesLung	O
cancerBreast	O
cancerColorectal	O
cancerEsophageal	O
cancerLiver	O
cancerGastric	O
cancer	O
Complication	O
rate	O
192	O
/	O
2866	O
(	O
7	O
.	O
2	O
%)	O
121	O
/	O
2808	O
(	O
4	O
.	O
5	O
%)	O
227	O
/	O
2420	O
(	O
10	O
.	O
4	O
%)	O
243	O
/	O
1706	O
(	O
16	O
.	O
6	O
%)	O
192	O
/	O
1906	O
(	O
11	O
.	O
2	O
%)	O
189	O
/	O
2039	O
(	O
10	O
.	O
2	O
%)	O
CIC	O
(	O
Cost	O
increment	O
associated	O
with	O
complication	O
)	O
30	O
%	O
(	O
14	O
–	O
46	O
%)	O
22	O
%	O
(	O
3	O
–	O
41	O
%)	O
4	O
%	O
(-	O
11	O
–	O
19	O
%)	O
38	O
%	O
(	O
21	O
–	O
54	O
%)	O
8	O
%	O
(-	O
8	O
–	O
24	O
%)	O
2	O
%	O
(-	O
15	O
–	O
19	O
%)	O
Per	O
case	O
direct	O
medical	O
costs	O
Surgical	O
-	O
related	O
treatment11	O
,	O
911862211	O
,	O
35113	O
,	O
38610	O
,	O
42014	O
,	O
366Non	O
-	O
surgical	O
treatment907011	O
,	O
11810	O
,	O
28510	O
,	O
17193089690Follow	O
-	O
up	O
treatment472660578276417064875587Treatment	O
after	O
relapse	O
/	O
metastasis13	O
,	O
46116	O
,	O
45213	O
,	O
36811	O
,	O
97511	O
,	O
32810	O
,	O
382	O
PAF	O
%*	O
2	O
.	O
1	O
%	O
1	O
%	O
0	O
.	O
4	O
%	O
5	O
.	O
9	O
%	O
2	O
.	O
4	O
%	O
2	O
.	O
2	O
%	O
Cancer	O
-	O
related	O
direct	O
medical	O
costs	O
per	O
case	O
**	O
Surgical	O
-	O
related	O
treatment11	O
,	O
660853711	O
,	O
30412	O
,	O
59110	O
,	O
16914	O
,	O
050Non	O
-	O
surgical	O
treatment887911	O
,	O
00910	O
,	O
243956790849477Follow	O
-	O
up	O
treatment462659988242392263315464Treatment	O
after	O
relapse	O
/	O
metastasis13	O
,	O
17716	O
,	O
29113	O
,	O
31311	O
,	O
26411	O
,	O
05610	O
,	O
154Note	O
*	O
PAF	O
%,	O
Population	O
Attributable	O
Fraction	O
%,	O
calculated	O
by	O
:	O
complication	O
rate	O
*	O
CIC	O
/(	O
complication	O
rate	O
*	O
CIC	O
+	O
1	O
)**	O
Cancer	O
-	O
related	O
direct	O
medical	O
costs	O
per	O
case	O
=	O
Per	O
case	O
direct	O
medical	O
costs	O
*	O
PAF	O
%	O

From	O
these	O
multiple	O
alignments	O
,	O
HMM	O
profiles	O
were	O
generated	O
with	O
HMMER	O
(	O
v	O
.	O
3	O
.	O
3	O
.	O
2	O
,	O
using	O
hmmbuild	O
with	O
default	O
parameters	O
)	O
(	O
87	O
),	O
forming	O
the	O
basis	O
for	O
constructing	O
different	O
models	O
in	O
MacSyFinder	B-BT
.	O

The	O
reported	O
value	O
of	O
average	O
(	O
AVG	O
),	O
standard	O
deviation	O
(	O
STD	O
),	O
median	O
(	O
MED	O
),	O
and	O
5th	O
and	O
95th	O
percentiles	O
refer	O
to	O
the	O
time	O
spent	O
annotating	O
15	O
documents	O
50	O
timesMA	O
+	O
CL	O
+	O
REAVGSTD5thMED95thOnlineMetaTron638	B-BT
.	O
731	O
.	O
67636	O
.	O
97638	O
.	O
22642	O
.	O
49TeamTat842	O
.	O
930	O
.	O
76841	O
.	O
67843	O
.	O
03844	O
.	O
18LightTag661	O
.	O
131	O
.	O
23659	O
.	O
35660	O
.	O
85663	O
.	O
07OfflineMetaTron642	B-BT
.	O
391	O
.	O
30640	O
.	O
35642	O
.	O
28644	O
.	O
54INCEpTION704	O
.	O
852	O
.	O
14701	O
.	O
53705	O
.	O
12707	O
.	O
33The	O
boldface	O
values	O
represent	O
avg	O
and	O
median	O
results	O
of	O
the	O
tools	O
with	O
the	O
best	O
performances	O
,	O
i	O
.	O
e	O
.,	O
the	O
lowest	O
time	O
taken	O
to	O
annotate	O
15	O
documents	O
50	O
times	O

In	O
this	O
follow	O
-	O
up	O
study	O
,	O
to	O
compare	O
the	O
effect	O
of	O
the	O
three	O
populations	O
on	O
initial	O
infection	O
and	O
mycotoxin	O
production	O
on	O
different	O
hosts	O
,	O
we	O
dip	O
-	O
inoculated	O
spikes	O
of	O
the	O
moderately	O
resistant	O
wheat	O
cultivar	O
Alsen	O
and	O
the	O
susceptible	O
barley	O
cultivar	O
Voyager	O
using	O
five	O
strains	O
from	O
each	O
population	O
to	O
evaluate	O
disease	O
,	O
trichothecene	O
mycotoxin	O
accumulation	O
,	O
and	O
trichothecene	O
production	O
per	O
unit	O
of	O
fungal	O
biomass	O
.	O

10	O
employed	O
similar	O
criteria	O
in	O
their	O
studies	O
on	O
intrapartum	O
fever	O
associated	O
with	O
epidural	O
labor	O
analgesia	O
.	O

Sven	O
Ivar	O
Seldinger	O
'	O
s	O
innovative	O
technique	O
has	O
been	O
lauded	O
by	O
several	O
prominent	O
figures	O
in	O
the	O
field	O
.	O

Another	O
strategy	O
,	O
DDK	B-BT
-	I-BT
Linker	I-BT
[	O
25	O
]	O
may	O
also	O
enhance	O
personalized	O
medicine	O
by	O
analyzing	O
individual	O
genetic	O
and	O
proteomic	O
data	O
to	O
identify	O
specific	O
disease	O
signals	O
and	O
potential	O
drug	O
targets	O
.	O

GeneVector	B-BT
summarizes	O
co	O
-	O
expression	O
of	O
genes	O
as	O
mutual	O
information	O
between	O
the	O
probability	O
distribution	O
of	O
read	O
counts	O
across	O
cells	O
.	O

It	O
had	O
37	O
.	O
05	O
%	O
random	O
coils	O
,	O
2	O
.	O
64	O
%	O
β	O
-	O
strands	O
,	O
and	O
60	O
.	O
29	O
%	O
α	O
-	O
helices	O
predicted	O
by	O
the	O
PSIPRED	B-BT
server	O
.	O

Subsequently	O
,	O
PermuteDDS	B-BT
was	O
trained	O
using	O
these	O
resulting	O
noisy	O
cell	O
lines	O
.	O

Consistent	O
with	O
these	O
models	O
,	O
the	O
presence	O
of	O
PGD	O
is	O
associated	O
with	O
weaker	O
self	O
-	O
concept	O
clarity12	O
,	O
13	O
,	O
and	O
individuals	O
with	O
PGD	O
show	O
a	O
bias	O
to	O
recall	O
more	O
autobiographical	O
memories	O
linked	O
with	O
the	O
deceased14	O
.	O

The	O
resulting	O
protein	O
function	O
prediction	O
set	O
contains	O
5	O
,	O
046	O
,	O
060	O
GO	O
term	O
predictions	O
for	O
291	O
,	O
519	O
proteins	O
and	O
11	O
,	O
742	O
GO	O
terms	O
,	O
which	O
are	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
HUBioDataLab	O
/	O
Domain2GO	B-BT
.	O

Given	O
the	O
increasing	O
availability	O
of	O
epigenomics	O
and	O
functional	O
genomics	O
datasets	O
,	O
the	O
utility	O
of	O
PlantFUNCO	B-BT
will	O
continue	O
to	O
grow	O
and	O
serve	O
as	O
an	O
additional	O
resource	O
to	O
simplify	O
functional	O
conservation	O
annotations	O
for	O
a	O
more	O
diverse	O
set	O
of	O
species	O
such	O
as	O
Chlamydomonas	O
reinhardtii	O
,	O
Marchantia	O
polymorpha	O
,	O
and	O
Solanum	O
lycopersicum	O
.	O

Our	O
patient	O
,	O
a	O
26	O
-	O
year	O
-	O
old	O
woman	O
,	O
presented	O
with	O
fever	O
,	O
headache	O
,	O
rash	O
,	O
fleeting	O
arthralgia	O
,	O
nausea	O
,	O
diarrhoea	O
,	O
and	O
general	O
malaise	O
,	O
initially	O
presumed	O
as	O
sunburn	O
.	O

To	O
map	O
antiphage	O
defense	O
systems	O
in	O
cold	O
-	O
adapted	O
bacteria	O
,	O
we	O
generated	O
a	O
dataset	O
of	O
assembled	O
genomes	O
of	O
bacteria	O
that	O
were	O
considered	O
cold	O
-	O
adapted	O
either	O
based	O
on	O
isolation	O
location	O
(	O
MarRef	B-BT
,	O
MarDB	B-BT
,	O
and	O
OMD	O
databases	O
)	O
or	O
experimental	O
temperature	O
growth	O
data	O
(	O
BacDive	O
and	O
TEMPURA	O
databases	O
).	O

In	O
the	O
current	O
study	O
,	O
the	O
raw	O
data	O
for	O
metabolomics	O
can	O
be	O
obtained	O
in	O
Metabolights	O
,	O
with	O
the	O
ID	O
MTBLS10002	O
(	O
MetaboLights	B-BT
MTBLS	O
)	O
31	O
.	O

While	O
DeepVirFinder	O
,	O
VIBRANT	O
,	O
and	O
VirSorter	B-BT
were	O
each	O
found	O
once	O
in	O
these	O
high	O
-	O
accuracy	O
rulesets	O
,	O
they	O
were	O
not	O
found	O
in	O
combination	O
with	O
each	O
other	O
:	O
combining	O
tools	O
does	O
not	O
lead	O
to	O
optimal	O
performance	O
.	O

One	O
of	O
the	O
downsides	O
of	O
running	O
the	O
binary	O
is	O
that	O
as	O
a	O
user	O
it	O
can	O
be	O
difficult	O
or	O
even	O
impossible	O
to	O
harness	O
many	O
of	O
the	O
analytical	O
capabilities	O
of	O
Privateer	B-BT
.	O

Our	O
method	O
,	O
vector	B-BT
-	I-BT
clustering	I-BT
Multiple	I-BT
Sequence	I-BT
Alignment	I-BT
(	O
vcMSA	O
),	O
is	O
a	O
true	O
multiple	O
sequence	O
aligner	O
that	O
aligns	O
multiple	O
sequences	O
at	O
once	O
instead	O
of	O
progressively	O
integrating	O
pairwise	O
alignments	O
.	O

The	O
ProKinO	B-BT
ontology	O
consists	O
of	O
classes	O
,	O
sub	O
-	O
classes	O
,	O
class	O
types	O
,	O
relationships	O
,	O
relationship	O
types	O
,	O
and	O
constraints	O
of	O
protein	O
kinase	O
and	O
related	O
data	O
(	O
Fig	O
.	O

We	O
also	O
applied	O
these	O
six	O
computational	O
tools	O
(	O
VirSorter	B-BT
v1	O
.	O
0	O
.	O
3	O
(	O
categories	O
1	O
,	O
2	O
),	O
VirSorter2	B-BT
v2	O
.	O
2	O
.	O
3	O
(	O
score	O
≥	O
0	O
.	O
9	O
,	O
at	O
least	O
hits	O
to	O
one	O
viral	O
hallmark	O
gene	O
),	O
VirFinder	O
v1	O
.	O
1	O
(	O
score	O
≥	O
0	O
.	O
9	O
and	O
p	O
<	O
0	O
.	O
05	O
),	O
DeepVirFinder	O
v1	O
.	O
0	O
(	O
score	O
≥	O
0	O
.	O
9	O
and	O
p	O
<	O
0	O
.	O
05	O
),	O
VIBRANT	O
v1	O
.	O
2	O
.	O
15	O
(	O
score	O
of	O
medium	O
quality	O
or	O
higher	O
),	O
and	O
CheckV	O
v0	O
.	O
6	O
.	O
06	O
)	O
on	O
the	O
sequences	O
of	O
the	O
GPIC	O
(	O
a	O
gut	O
phage	O
isolate	O
collection	O
)	O
dataset	O
that	O
was	O
collected	O
by	O
Shen	O
et	O
al	O
.	O

Table	O
taken	O
from	O
the	O
Privateer	B-BT
database	O
report	O
for	O
3QVP	O
.	O

module	O
load	O
samtools	B-BT
/	O
1	O
.	O
16	O
.	O
1	O

An	O
open	O
source	O
implementation	O
of	O
the	O
cubeVB	B-BT
algorithm	O
is	O
available	O
from	O
https	O
://	O
github	O
.	O
com	O
/	O
rbouckaert	O
/	O
cubevb	B-BT
as	O
the	O
cubevb	B-BT
package	O
for	O
BEAST	O
2	O
.	O

The	O
MI	B-BT
-	I-BT
CNN	I-BT
architecture	O
consisted	O
of	O
a	O
CNN	O
-	O
based	O
encoder	O
that	O
generated	O
feature	O
maps	O
from	O
pharyngeal	O
images	O
,	O
and	O
a	O
multilayer	O
perceptron	O
classifier	O
that	O
pooled	O
features	O
and	O
output	O
a	O
hypertension	O
probability	O
score	O
.	O

Therefore	O
,	O
the	O
ACE	O
-	O
I	O
-	O
ALG	O
-	O
CS	O
NPs	O
prepared	O
via	O
ionic	O
gelation	O
and	O
polyelectrolyte	O
complexation	O
demonstrate	O
capability	O
as	O
successful	O
nanocarriers	O
for	O
improving	O
the	O
physicochemical	O
stability	O
,	O
bioavailability	O
,	O
and	O
in	O
vivo	O
efficacy	O
of	O
food	O
-	O
derived	O
peptides	O
,	O
facilitating	O
their	O
incorporation	O
as	O
therapeutic	O
ingredients	O
into	O
functional	O
food	O
formulations	O
.	O

Complete	O
documentation	O
available	O
at	O
https	O
://	O
c4tb	O
.	O
github	O
.	O
io	O
/	O
shinyExprPortal	B-BT
/	O
index	O
.	O
html	O
and	O
live	O
demonstration	O
available	O
at	O
https	O
://	O
c4tb	O
.	O
github	O
.	O
io	O
/	O
ramap_demo	O
/.	O

Using	O
ENDScript	B-BT
2	I-BT
.	I-BT
0	I-BT
(	O
Robert	O
and	O
Gouet	O
,	O
2014	O
),	O
residues	O
within	O
3	O
.	O
2	O
Å	O
and	O
3	O
.	O
2	O
-	O
5	O
Å	O
of	O
the	O
compound	O
were	O
evaluated	O
(	O
Figure	O
S5	O
).	O

Filtering	O
capabilities	O
offered	O
by	O
VCF	O
-	O
Miner	O
,	O
BrowseVCF	O
,	O
and	O
123VCF	B-BT
allow	O
the	O
use	O
of	O
custom	O
annotations	O
while	O
the	O
others	O
do	O
not	O

binotii	O
strain	O
Au	O
-	O
Mic3	O
(	O
B	O
)	O
were	O
visualized	O
with	O
a	O
genome	O
alignment	O
viewer	O
,	O
DiGAlign	B-BT
[	O
22	O
].	O

(%)	O
Constipation28	O
(	O
56	O
)	O
0Altered	O
liver	O
enzymes21	O
(	O
43	O
)	O
2	O
(	O
4	O
)	O
Renal	O
insufficiency13	O
(	O
27	O
)	O
1	O
(	O
2	O
)	O
Anaemia11	O
(	O
22	O
)	O
0Fatigue11	O
(	O
22	O
)	O
0Nausea	O
/	O
vomiting8	O
(	O
16	O
)	O
2	O
(	O
4	O
)	O
Leukopenia2	O
(	O
4	O
)	O
1	O
(	O
2	O
)	O
Thrombocytopenia2	O
(	O
4	O
)	O
0Table	O
5Renal	O
function	O
(	O
GFRa	O
,	O
MDRDb	O
formula	O
)	O
before	O
and	O
after	O
STZ	O
CTxStart	O
STZ	O
CTx	O
n	O
(%)	O
cStop	O
STZ	O
CTx	O
n	O
(%)	O
c6	O
months	O
after	O
the	O
end	O
of	O
STZ	O
CTx	O
n	O
(%)	O
d12	O
months	O
after	O
the	O
end	O
of	O
STZ	O
CTx	O
n	O
(%)	O
e	O
>	O
60	O
ml	O
/	O
min41	O
(	O
85	O
)	O
35	O
(	O
73	O
)	O
20	O
(	O
57	O
)	O
14	O
(	O
52	O
)	O
60	O
–	O
30	O
ml	O
/	O
min7	O
(	O
15	O
)	O
12	O
(	O
25	O
)	O
14	O
(	O
40	O
)	O
11	O
(	O
41	O
)	O
29	O
–	O
15	O
ml	O
/	O
min0	O
(	O
0	O
)	O
1	O
(	O
2	O
)	O
1	O
(	O
3	O
)	O
2	O
(	O
7	O
)<	O
15	O
ml	O
/	O
min0000aGFR	O
glomerular	O
filtration	O
rate	O
.	O
bMDRD	O
Modification	O
of	O
Diet	O
in	O
Renal	O
Disease	O
.	O
cGFR	O
available	O
in	O
48	O
patients	O
.	O
dGFR	O
available	O
in	O
35	O
patients	O
.	O
eGFR	O
available	O
in	O
27	O
patients	O
.	O

In	O
contrast	O
,	O
if	O
V	O
-	O
to	O
-	O
A	O
i2i	O
communication	O
fails	O
,	O
the	O
system	O
effectively	O
functions	O
in	O
VDD	O
mode	O
.	O

FRETpredict	B-BT
is	O
written	O
in	O
Python	O
and	O
is	O
available	O
as	O
a	O
Python	O
package	O
.	O

Remarkably	O
,	O
RNAthreader	B-BT
takes	O
less	O
than	O
two	O
hours	O
to	O
complete	O
alignments	O
with	O
∼	O
5000	O
RNAs	O
,	O
which	O
is	O
3	O
–	O
40	O
times	O
faster	O
than	O
other	O
methods	O
.	O

MDC	O
-	O
ANN	O
[	O
36	O
],	O
RT	B-BT
-	I-BT
transformer	I-BT
[	O
80	O
],	O
qGeoGNN	O
[	O
25	O
],	O
retention_time_GNN	O
[	O
37	O
],	O
1D	O
-	O
CNN	O
-	O
TL	O
[	O
42	O
],	O
MPNN	O
[	O
70	O
],	O
AWD	O
-	O
LSTM	O
-	O
TL	O
[	O
56	O
],	O
GNN	O
-	O
TL	O
-	O
HILIC	O
[	O
46	O
],	O
GNN	O
-	O
TL	O
-	O
RP	O
[	O
45	O
],	O
RGCN	O
[	O
44	O
],	O
DNNpwa	O
-	O
TL	O
[	O
35	O
],	O
Osipenko	O
[	O
81	O
],	O
Retip	O
[	O
73	O
],	O
Bouwmeeste	O
[	O
34	O
],	O
DLM	O
[	O
23	O
],	O
Hall	O
[	O
82	O
],	O
Wen	O
[	O
83	O
],	O
Wen	O
[	O
84	O
],	O
McEachran	O
[	O
85	O
],	O
Falchi	O
[	O
86	O
],	O
and	O
Amos	O
et	O
al	O
.	O

Voyager	O
,	O
susceptible	O
to	O
FHB	O
,	O
was	O
used	O
in	O
the	O
disease	O
assays	O
.	O

These	O
phytochemicals	O
have	O
been	O
well	O
established	O
as	O
chemotherapeutic	O
agents	O
with	O
multiple	O
tumour	O
-	O
inhibitory	O
mechanisms	O
under	O
drug	O
-	O
resistant	O
conditions	O
.	O

The	O
exclusion	O
of	O
indels	O
by	O
bcftools	B-BT
also	O
leads	O
to	O
an	O
underreporting	O
of	O
the	O
major	O
variant	O
,	O
which	O
in	O
turn	O
elevates	O
the	O
frequency	O
of	O
minor	O
variants	O
,	O
contributing	O
to	O
false	O
positives	O
in	O
point	O
mutation	O
identification	O
in	O
10	O
out	O
of	O
10	O
cases	O
we	O
examined	O
.	O

The	O
PIFiA	B-BT
computational	O
pipeline	O
offers	O
a	O
tool	O
for	O
predictions	O
of	O
protein	O
function	O
based	O
on	O
genome	O
-	O
scale	O
comparative	O
analysis	O
of	O
features	O
extracted	O
from	O
images	O
of	O
single	O
cells	O
endogenously	O
expressing	O
GFP	O
-	O
fusion	O
proteins	O
(	O
Razdaibiedina	O
et	O
al	O
.	O

Briefly	O
,	O
we	O
divided	O
the	O
sequencing	O
nanopore	O
array	O
(	O
512	O
nanopores	O
)	O
into	O
two	O
groups	O
with	O
the	O
same	O
number	O
of	O
channels	O
:	O
(	O
i	O
)	O
channels	O
1	O
–	O
255	O
will	O
be	O
subjected	O
to	O
adaptive	O
sampling	O
using	O
NanoDeep	B-BT
;	O
(	O
ii	O
)	O
channels	O
256	O
–	O
512	O
will	O
be	O
subjected	O
to	O
routine	O
nanopore	O
sequencing	O
pipeline	O
(	O
Figure	O
3A	O
).	O

As	O
expected	O
,	O
in	O
the	O
CTR	O
biscuits	O
,	O
the	O
concentration	O
of	O
reducing	O
sugars	O
quickly	O
increased	O
during	O
the	O
early	O
stages	O
of	O
duodenal	O
digestion	O
and	O
reached	O
a	O
plateau	O
after	O
1	O
h	O
,	O
showing	O
a	O
slightly	O
decreasing	O
trend	O
afterwards	O
.	O

The	O
only	O
two	O
times	O
the	O
images	O
are	O
displayed	O
to	O
the	O
users	O
are	O
in	O
Cellpose	O
for	O
the	O
determination	O
of	O
segmentation	O
parameters	O
,	O
and	O
in	O
Fiji	B-BT
for	O
verification	O
of	O
segmentation	O
.	O

Abbreviations	O
:	O
AZ	O
=	O
AstraZeneca	O
(	O
ChAdOx1	O
nCoV	O
-	O
19	O
),	O
PFZ	O
=	O
Pfizer	O
-	O
BioNTech	O
(	O
BNT162b2	O
),	O
SPh	O
=	O
Sinopharm	O
(	O
BBIBP	O
-	O
CorV	O
),	O
SPTV	O
=	O
Gamaleya	O
Sputnik	O
V	O
(	O
Gam	O
-	O
COVID	O
-	O
Vac	O
).	O

Summarize	O
success	O
rates	O
of	O
single	O
to	O
dual	O
chamber	O
leadless	O
pacemaker	O
upgrades	O
,	O
as	O
well	O
as	O
device	O
and	O
i2i	O
throughput	O
measurements	O
,	O
serious	O
adverse	O
device	O
effects	O
(	O
SADEs	O
)	O
and	O
mortality	O
in	O
this	O
cohort	O
.	O

Recently	O
,	O
kmerDB	B-BT
was	O
made	O
public	O
containing	O
5	O
,	O
186	O
,	O
757	O
nucleic	O
and	O
214	O
,	O
904	O
,	O
089	O
peptide	O
primes	O
isolated	O
from	O
the	O
examination	O
of	O
45	O
,	O
785	O
complete	O
organismal	O
genomes	O
and	O
22	O
,	O
386	O
reference	O
organismal	O
proteomes	O
[	O
171	O
].	O

In	O
order	O
to	O
overcome	O
these	O
limitations	O
,	O
we	O
developed	O
the	O
single	O
-	O
cell	O
imaging	O
flow	O
cytometry	O
AI	O
(	O
scifAI	B-BT
)	O
framework	O
for	O
the	O
unbiased	O
analysis	O
of	O
high	O
-	O
dimensional	O
high	O
-	O
throughput	O
IFC	O
data	O
.	O

Redundancies	O
found	O
in	O
identified	O
viral	O
contigs	O
from	O
VirFinder	O
and	O
VirSorter	B-BT
were	O
de	O
-	O
replicated	O
using	O
cd	O
-	O
hit	O
and	O
a	O
sequence	O
similarity	O
threshold	O
of	O
1	O
.	O
0	O
(	O
Fu	O
et	O
al	O
.,	O
2012	O
).	O

(	O
A	O
)	O
OntoloViz	B-BT
GUI	O
displaying	O
settings	O
for	O
generation	O
and	O
customization	O
of	O
phenotype	O
sunburst	O
plots	O
.	O

For	O
1	O
≤	O
d	O
≤	O
6	O
%,	O
exact	O
matches	O
have	O
less	O
overhead	O
than	O
inexact	O
matches	O
,	O
while	O
BiWFA	B-BT
is	O
fastest	O
for	O
d	O
≤	O
1	O
%.	O

Putative	O
nucleases	O
were	O
identified	O
by	O
searching	O
Subtiwiki	B-BT
functional	O
annotations	O
.	O

This	O
work	O
was	O
supported	O
by	O
the	O
Companhia	O
Energética	O
de	O
Minas	O
Gerais	O
(	O
Cemig	O
)	O
GT	O
/	O
ANEEL	O
R	O
&	O
D	O
GT	O
-	O
0604	O
.	O

We	O
train	O
the	O
machine	O
learning	O
methods	O
on	O
different	O
training	O
datasets	O
(	O
i	O
.	O
e	O
.,	O
Platinum	O
(	O
no	O
tyrosine	O
kinase	O
),	O
Platinum	O
,	O
and	O
MdrDB_Coreset	B-BT
(	O
single	O
substitution	O
))	O
and	O
report	O
the	O
test	O
performance	O
averaged	O
over	O
five	O
repetitions	O
for	O
each	O
method	O
on	O
the	O
TKI	O
dataset	O
in	O
Fig	O
.	O

MS	O
and	O
MS	O
/	O
MS	O
spectra	O
were	O
extracted	O
using	O
MZmine	B-BT
2	O
.	O
51	O
with	O
a	O
mass	O
detection	O
noise	O
level	O
set	O
to	O
1E3	O
and	O
1E0	O
,	O
respectively	O
.	O

To	O
make	O
this	O
simulation	O
process	O
more	O
accessible	O
,	O
we	O
have	O
implemented	O
these	O
functionalities	O
as	O
command	O
-	O
line	O
tools	O
within	O
admix	B-BT
-	I-BT
kit	I-BT
(	O
Supplementary	O
Fig	O
.	O

Finally	O
,	O
the	O
transmission	O
network	O
was	O
exported	O
into	O
a	O
DOT	O
-	O
formatted	O
directed	O
graph	O
using	O
R	O
(	O
71	O
)	O
and	O
interactively	O
explored	O
using	O
HAIviz	B-BT
v0	O
.	O
3	O
(	O
69	O
).	O

Greta	O
Bellinzona	O
(	O
Conceptualization	O
[	O
equal	O
],	O
Data	O
curation	O
[	O
lead	O
],	O
Formal	O
analysis	O
[	O
lead	O
],	O
Investigation	O
[	O
lead	O
],	O
Methodology	O
[	O
lead	O
],	O
Writing	O
—	O
original	O
draft	O
[	O
lead	O
]),	O
Davide	O
Sassera	O
(	O
Conceptualization	O
[	O
equal	O
],	O
Funding	O
acquisition	O
[	O
lead	O
],	O
Supervision	O
[	O
supporting	O
],	O
Writing	O
—	O
review	O
&	O
editing	O
[	O
supporting	O
]),	O
and	O
Alexandre	O
M	O
.	O
J	O
.	O
J	O
.	O

Illustrates	O
the	O
results	O
of	O
PatchDock	B-BT
analysis	O
conducted	O
to	O
examine	O
the	O
interaction	O
between	O
the	O
CadA	O
protein	O
and	O
various	O
heavy	O
metals	O
,	O
including	O
cadmium	O
,	O
cadmium	O
sulfate	O
,	O
arsenate	O
,	O
copper	O
,	O
chromium	O
,	O
cobalt	O
,	O
lead	O
,	O
nickel	O
,	O
silver	O
,	O
and	O
zinc	O
.	O

Bento	O
acknowledges	O
for	O
PhD	O
grant	O
10	O
.	O
54499	O
/	O
UI	O
/	O
BD	O
/	O
151008	O
/	O
2021	O
.	O

The	O
SVM	O
-	O
based	O
RNAPred	O
[	O
34	O
],	O
convolutional	O
neural	O
network	O
(	O
CNN	O
)-	O
based	O
DeepRBPPred	O
[	O
28	O
],	O
LGB	O
-	O
based	O
RBPLight	O
[	O
32	O
]	O
and	O
CNN	O
-	O
based	O
RBProkCNN	B-BT
[	O
33	O
]	O
are	O
RBPs	O
predictors	O
.	O

BIDCell	B-BT
is	O
a	O
DL	O
-	O
based	O
cell	O
segmentation	O
method	O
that	O
identifies	O
each	O
individual	O
cell	O
and	O
all	O
its	O
pixels	O
as	O
a	O
cohesive	O
mask	O
.	O

This	O
achievement	O
underscores	O
the	O
scalability	O
of	O
scNovel	B-BT
and	O
highlights	O
its	O
potential	O
for	O
deployment	O
in	O
large	O
-	O
scale	O
real	O
-	O
world	O
applications	O
.	O

eccDNA	B-BT
-	I-BT
pipe	I-BT
supports	O
data	O
from	O
various	O
sequencing	O
techniques	O
such	O
as	O
whole	O
-	O
genome	O
sequencing	O
(	O
WGS	O
),	O
circle	O
-	O
seq	O
,	O
and	O
circulome	O
-	O
seq	O
,	O
obtained	O
through	O
both	O
short	O
-	O
read	O
and	O
long	O
-	O
read	O
sequencing	O
.	O

This	O
is	O
a	O
significant	O
improvement	O
over	O
our	O
cutting	O
edge	O
PSIPRED	B-BT
method	O
,	O
which	O
achieves	O
a	O
Q3	O
accuracy	O
of	O
70	O
.	O
6	O
%	O
when	O
tested	O
on	O
single	O
sequences	O
without	O
any	O
provided	O
homology	O
information	O
.	O

A	O
total	O
of	O
six	O
putative	O
umbravirus	O
sequences	O
—	O
CMoV	O
,	O
CMoMV	O
,	O
wild	O
carrot	O
mottle	O
virus	O
(	O
WCMoV	O
),	O
parsley	O
mottle	O
virus	O
,	O
parsley	O
mottle	O
mimic	O
virus	O
,	O
and	O
tobacco	O
bushy	O
top	O
virus	O
(	O
TBTV	O
)	O
were	O
identified	O
by	O
RNAseq	O
analysis	O
,	O
however	O
parsley	O
mottle	O
virus	O
,	O
parsley	O
mottle	O
mimic	O
virus	O
,	O
and	O
TBTV	O
were	O
excluded	O
from	O
further	O
analysis	O
as	O
they	O
were	O
poorly	O
represented	O
in	O
the	O
overall	O
dataset	O
,	O
in	O
that	O
only	O
a	O
few	O
(	O
1	O
–	O
3	O
)	O
short	O
(<	O
700	O
nt	O
)	O
contigs	O
that	O
were	O
represented	O
by	O
<	O
1	O
%	O
of	O
the	O
total	O
virus	O
reads	O
for	O
the	O
sample	O
group	O
and	O
/	O
or	O
had	O
<	O
100x	O
genome	O
coverage	O
were	O
retrieved	O
for	O
each	O
of	O
these	O
viruses	O
(	O
Tables	O
2	O
,	O
3	O
).	O

We	O
first	O
started	O
modeling	O
the	O
signaling	O
pathways	O
of	O
a	O
single	O
cell	O
with	O
MaBoSS	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
sysbio	O
-	O
curie	O
/	O
MaBoSS	O
-	O
env	O
-	O
2	O
.	O
0	O
)	O
[	O
13	O
],	O
[	O
14	O
]	O
and	O
WebMaBoSS	B-BT
,	O
a	O
user	O
-	O
friendly	O
web	O
interface	O
(	O
https	O
://	O
github	O
.	O
com	O
/	O
sysbio	O
-	O
curie	O
/	O
WebMaBoSS	B-BT
)	O
[	O
35	O
].	O

7Hybrid	O
-	O
DIA	O
targeted	O
analysis	O
of	O
response	O
to	O
5	O
-	O
fluouracil	O
in	O
cell	O
culture	O
models	O
for	O
colorectal	O
cancer	O
.	O
a	O
Experimental	O
design	O
for	O
the	O
comparison	O
of	O
spheroids	O
against	O
monolayer	O
culture	O
of	O
HCT116	O
cancer	O
cells	O
treated	O
with	O
5	O
-	O
Fluorouracil	O
.	O

Using	O
the	O
phageTB	B-BT
tool	O
,	O
this	O
was	O
also	O
evident	O
as	O
there	O
was	O
no	O
interaction	O
of	O
the	O
phage	O
genome	O
analysis	O
with	O
the	O
host	O
K	O
.	O

The	O
firmware	O
version	O
of	O
the	O
FlexStat	O
controller	O
is	O
R2	O
.	O
1	O
.	O
0	O
.	O
18	O
.	O

Data	O
building	O
on	O
neck	O
pain	O
step	O
1	O
includes	O
results	O
from	O
our	O
lab	O
,	O
where	O
we	O
previously	O
found	O
a	O
longitudinal	O
relationship	O
between	O
long	O
SUMA	O
periods	O
and	O
neck	O
pain	O
[	O
33	O
,	O
70	O
].	O

Overall	O
,	O
PlantFUNCO	B-BT
aims	O
to	O
leverage	O
data	O
diversity	O
and	O
extrapolate	O
findings	O
from	O
different	O
models	O
to	O
determine	O
the	O
extent	O
of	O
molecular	O
conservation	O
,	O
thus	O
deepening	O
our	O
understanding	O
of	O
how	O
plants	O
epigenome	O
and	O
functional	O
noncoding	O
genome	O
have	O
fascinatingly	O
evolved	O
.	O

A	O
statistically	O
significant	O
enhancement	O
was	O
observed	O
for	O
spacers	O
composed	O
of	O
“	O
Palacos	O
R	O
+	O
G	O
”,	O
but	O
no	O
effect	O
was	O
noticed	O
for	O
spacers	O
made	O
of	O
“	O
Copal	O
spacem	B-BT
”	O
or	O
“	O
Copal	O
G	O
+	O
V	O
”.	O

HIResist	B-BT
is	O
freely	O
available	O
at	O
https	O
://	O
hiresist	B-BT
.	O
ahc	O
.	O
umn	O
.	O
edu	O
/	O

The	O
presence	O
of	O
EMAA	O
stitches	O
introduces	O
a	O
discernible	O
influence	O
that	O
interacts	O
with	O
both	O
the	O
fiber	O
bundles	O
and	O
the	O
matrix	O
.	O

Among	O
these	O
admissions	O
,	O
16	O
,	O
055	O
(	O
38	O
.	O
3	O
%)	O
had	O
composite	O
adverse	O
cardiovascular	O
outcomes	O
(	O
TACCO	O
)	O
during	O
hospitalization	O
.	O

A	O
finding	O
that	O
could	O
be	O
due	O
to	O
the	O
greater	O
surgical	O
manipulation	O
required	O
for	O
subluxated	O
IOL	O
replacement	O
,	O
which	O
leads	O
to	O
greater	O
inflammation	O
and	O
vitreomacular	O
traction	O
during	O
surgery	O
;	O
which	O
,	O
together	O
with	O
the	O
manipulation	O
of	O
the	O
iris	O
during	O
anchoring	O
of	O
the	O
claw	O
lens	O
,	O
favors	O
intraocular	O
inflammation	O
and	O
consequently	O
the	O
development	O
of	O
PME	O
.	O

The	O
difference	O
in	O
amino	O
acid	O
(	O
AA	O
)	O
residues	O
in	O
the	O
three	O
-	O
dimensional	O
structures	O
between	O
ricin	O
and	O
malanin	O
by	O
PyMOL	B-BT
2	O
.	O
3	O
.	O

Users	O
can	O
choose	O
between	O
processing	O
human	O
or	O
animal	O
experiment	O
data	O
with	O
calculations	O
on	O
specimen	O
or	O
single	O
-	O
structure	O
levelLoading	O
datatRigon	B-BT
can	O
also	O
be	O
used	O
to	O
load	O
other	O
data	O
(	O
e	O
.	O
g	O
.,	O
other	O
omics	O
datasets	O
)	O
or	O
already	O
processed	O
pathomics	O
filesStatisticsDescriptive	O
statisticsBased	O
on	O
a	O
provided	O
group	O
label	O
tRigon	B-BT
can	O
calculate	O
summary	O
statistics	O
(	O
e	O
.	O
g	O
.,	O
mean	O
,	O
median	O
,	O
standard	O
deviation	O
,	O
interquartile	O
range	O
)	O
for	O
each	O
chosen	O
featureStatistical	O
teststRigon	B-BT
supports	O
a	O
range	O
of	O
simple	O
non	O
-	O
parametric	O
statistical	O
tests	O
such	O
as	O
:(	O
1	O
)	O
pairwise	O
Wilcoxon	O
-	O
rank	O
tests	O
with	O
Bonferroni	O
correction	O
for	O
multiple	O
testing	O
(	O
2	O
)	O
Kruskal	O
–	O
Wallis	O
tests	O
(	O
3	O
)	O
differences	O
in	O
median	O
with	O
bootstrapped	O
confidence	O
intervals	O
for	O
each	O
desired	O
feature	O
and	O
provided	O
group	O
labelCorrelationSimple	O
and	O
multiple	O
correlations	O
based	O
on	O
the	O
Pearson	O
-	O
correlation	O
coefficient	O
can	O
be	O
calculated	O
and	O
visualized	O
as	O
a	O
scatter	O
plot	O
or	O
correlation	O
matrix	O
for	O
each	O
chosen	O
feature	O
.	O

•	O
Trans	B-BT
-	I-BT
PCO	I-BT
outperforms	O
existing	O
methods	O
by	O
finding	O
more	O
high	O
-	O
quality	O
trans	O
-	O
eQTLs	O
•	O
Trans	B-BT
-	I-BT
PCO	I-BT
offers	O
a	O
map	O
of	O
trans	O
regulation	O
of	O
gene	O
networks	O
and	O
biological	O
processes	O
•	O
Functional	O
annotation	O
of	O
gene	O
modules	O
helps	O
functional	O
interpretation	O
of	O
trans	O
signals	O
•	O
Trans	O
effects	O
via	O
regulatory	O
networks	O
and	O
pathways	O
reveal	O
the	O
mechanism	O
of	O
trait	O
loci	O

Seventy	O
-	O
eight	O
genomes	O
from	O
the	O
candidate	O
phyla	O
radiation	O
were	O
randomly	O
selected	O
as	O
whole	O
-	O
genome	O
nucleotide	O
fasta	O
where	O
compared	O
MerCat2	B-BT
,	O
kmc	O
,	O
and	O
Jellyfish	O
with	O
k	O
=	O
4	O
and	O
k	O
=	O
31	O
.	O

IthaPhen	O
and	O
all	O
associated	O
data	O
are	O
available	O
via	O
a	O
web	O
interface	O
at	O
https	O
://	O
ithanet	B-BT
.	O
eu	O
/	O
db	O
/	O
ithaphen	O
.	O

Here	O
,	O
we	O
address	O
this	O
problem	O
with	O
scRank	B-BT
,	O
which	O
employs	O
a	O
target	O
-	O
perturbed	O
gene	O
regulatory	O
network	O
to	O
rank	O
drug	O
-	O
responsive	O
cell	O
populations	O
via	O
in	O
silico	O
drug	O
perturbations	O
using	O
untreated	O
single	O
-	O
cell	O
transcriptomic	O
data	O
.	O

PHARE	B-BT
utilized	O
two	O
different	O
pipelines	O
for	O
scRNA	O
-	O
seq	O
and	O
bulk	O
RNA	O
-	O
seq	O
data	O
to	O
predict	O
physiological	O
age	O
from	O
new	O
datasets	O
(	O
Fig	O
.	O

The	O
integration	O
of	O
emerging	O
natural	O
language	O
processing	O
NLP	O
techniques	O
with	O
robust	O
classifiers	O
for	O
enhancing	O
the	O
detection	O
capabilities	O
for	O
addressing	O
insider	O
threats	O
.	O

As	O
shown	O
in	O
Table	O
3	O
,	O
GBScleanR	B-BT
completed	O
all	O
processes	O
of	O
genotype	O
estimation	O
faster	O
than	O
LB	O
-	O
Impute	O
and	O
magicImpute	O
for	O
the	O
simulation	O
data	O
sets	O
of	O
biparental	O
populations	O
,	O
including	O
homoP2_F2	O
and	O
hetP2_F1	O
.	O

Corresponding	O
author	O
:	O
Yu	O
-	O
Jie	O
Shu	O
,	O
MD	O
,	O
Doctor	O
,	O
Department	O
of	O
Gastroenterology	O
,	O
Yinzhou	O
District	O
Second	O
Hospital	O
,	O
No	O
.	O

We	O
wish	O
to	O
thank	O
Heliotext	O
for	O
maintaining	O
and	O
providing	O
the	O
text	O
similarity	O
software	O
,	O
Etblast	B-BT
.	O
org	O
,	O
for	O
this	O
work	O
and	O
as	O
a	O
free	O
service	O
provided	O
for	O
searching	O
against	O
Medline	O
/	O
Pubmed	O
.	O

The	O
GeNLP	B-BT
application	O
offers	O
two	O
primary	O
modes	O
of	O
operation	O
:	O
(	O
i	O
)	O
a	O
static	O
explanatory	O
mode	O
for	O
inspecting	O
the	O
gene	O
embedding	O
space	O
and	O
(	O
ii	O
)	O
a	O
custom	O
predictive	O
mode	O
for	O
querying	O
user	O
-	O
provided	O
data	O
(	O
Fig	O
.	O

CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
extracts	O
significant	O
terms	O
for	O
each	O
condition	O
,	O
and	O
exports	O
visualizations	O
optimized	O
for	O
clarity	O
and	O
robustness	O
.	O

In	O
addition	O
to	O
a	O
naming	O
convention	O
,	O
DandD	B-BT
also	O
creates	O
a	O
directory	O
structure	O
to	O
store	O
intermediate	O
sketches	O
and	O
databases	O
for	O
easy	O
reuse	O
and	O
access	O
.	O

shinyseg	B-BT
is	O
an	O
R	O
-	O
based	O
tool	O
built	O
with	O
Shiny	O
(	O
Chang	O
et	O
al	O
.	O

In	O
this	O
protocol	O
,	O
we	O
provide	O
step	O
-	O
by	O
-	O
step	O
demonstration	O
to	O
obtain	O
enhanced	O
cell	O
type	O
visualization	O
in	O
spatial	O
transcriptomic	O
data	O
,	O
using	O
the	O
Spaco	B-BT
(	O
version	O
0	O
.	O
2	O
.	O
0	O
)	O
package	O
with	O
Python	O
or	O
the	O
SpacoR	B-BT
(	O
version	O
0	O
.	O
1	O
)	O
package	O
with	O
R	O
.	O
Note	O
:	O
Although	O
we	O
limited	O
the	O
demonstration	O
to	O
spatial	O
transcriptomics	O
datasets	O
,	O
Spaco	B-BT
is	O
universally	O
applicable	O
for	O
categorical	O
data	O
visualization	O
across	O
research	O
fields	O
.	O

Additionally	O
,	O
this	O
page	O
features	O
a	O
module	O
that	O
enables	O
users	O
to	O
submit	O
their	O
own	O
gene	O
set	O
and	O
an	O
associated	O
abstract	O
to	O
receive	O
results	O
from	O
Rummagene	B-BT
of	O
ranked	O
highly	O
overlapping	O
gene	O
sets	O
with	O
low	O
abstract	O
similarity	O
.	O

Moreover	O
,	O
if	O
annotated	O
datasets	O
exist	O
,	O
scRANK	B-BT
supports	O
the	O
upload	O
of	O
meta	O
.	O
txt	O
files	O
containing	O
SEURAT	O
metadata	O
for	O
the	O
corresponding	O
dataset	O
.	O

We	O
developed	O
a	O
pipeline	O
(	O
Plant	B-BT
-	I-BT
LncPipe	I-BT
)	O
for	O
the	O
identification	O
and	O
characterization	O
of	O
plant	O
lncRNAs	O
by	O
implementing	O
key	O
steps	O
of	O
lncRNA	O
analysis	O
:	O
transcriptome	O
alignment	O
and	O
assembly	O
;	O
lncRNA	O
prediction	O
;	O
and	O
lncRNA	O
classification	O
and	O
origin	O
(	O
Fig	O
.	O

Similarly	O
,	O
we	O
include	O
executions	O
of	O
BiWFA	B-BT
limited	O
to	O
compute	O
the	O
alignment	O
score	O
as	O
‘	O
BiWFA	B-BT
.	O
score	O
’.	O

RNA	O
-	O
seq	O
data	O
processing	O
,	O
including	O
quality	O
control	O
,	O
read	O
trimming	O
,	O
alignment	O
,	O
and	O
expression	O
quantification	O
by	O
read	O
counting	O
,	O
was	O
carried	O
out	O
as	O
described	O
previously	O
47	O
,	O
using	O
our	O
standard	O
clinical	O
RNA	O
-	O
seq	O
pipeline	O
‘‘	O
CRISP	O
’’	O
(	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
mcieslik	O
-	O
mctp	O
/	O
bootstrap	O
-	O
rnascape	B-BT
).	O

In	O
contrast	O
to	O
AD	O
-	O
SAM	O
,	O
an	O
edge	O
-	O
on	O
conformation	O
of	O
the	O
initial	O
layer	O
is	O
only	O
possible	O
where	O
the	O
first	O
PMAT	O
layer	O
is	O
in	O
Z	O
-	O
conformation	O
.	O

Mix	O
by	O
pipetting	O
.	O
b	O
.	O
Incubate	O
the	O
eluted	O
DNA	O
in	O
the	O
on	O
-	O
deck	O
thermal	O
cycler	O
at	O
95	O
°	O
C	O
for	O
5	O
min	O
,	O
60	O
°	O
C	O
for	O
20	O
min	O
,	O
95	O
°	O
C	O
for	O
5	O
min	O
,	O
60	O
°	O
C	O
at	O
40	O
min	O
,	O
95	O
°	O
C	O
at	O
5	O
min	O
,	O
60	O
°	O
C	O
at	O
45	O
min	O
,	O
then	O
transfer	O
the	O
plate	O
to	O
20	O
°	O
C	O
–	O
25	O
°	O
C	O
on	O
deck	O
.	O
Table	O
1The	O
primary	O
metrics	O
used	O
for	O
assessing	O
the	O
quality	O
of	O
RRBS	O
libraries	O
by	O
the	O
MiSeq	O
systemFlagged	O
librariesPassed	O
QC	O
librariesRead	O
depth	O
<	O
25	O
%	O
of	O
the	O
median	O
sample	O
depthHigh	O
%	O
of	O
the	O
GC	O
content	O
in	O
trimmed	O
fastq	O
files20	O
%–	O
30	O
%	O
of	O
the	O
mean	O
per	O
-	O
base	O
GC	O
-	O
content	O
>	O
20	O
or	O
<	O
80	O
%%	O
bisulfite	O
conversion	O
efficiency	O
<	O
95	O
%>	O
95	O
%	O
Duplication	O
rate	O
based	O
on	O
UMI	O
>	O
20	O
%<	O
20	O
%%	O
reads	O
mapped	O
to	O
genome	O
<	O
50	O
%>	O
50	O
%%	O
OT	O
(	O
mapped	O
reads	O
aligned	O
to	O
the	O
original	O
top	O
stand	O
)<	O
30	O
%>	O
30	O
%%	O
OB	O
(	O
mapped	O
reads	O
aligned	O
to	O
the	O
original	O
bottom	O
stand	O
)>	O
70	O
%<	O
70	O
%%	O
CTOT	O
(	O
mapped	O
reads	O
aligned	O
to	O
the	O
complementary	O
to	O
original	O
top	O
strand	O
)>	O
10	O
%<	O
10	O
%%	O
CTOB	O
(	O
mapped	O
reads	O
aligned	O
to	O
the	O
complementary	O
to	O
original	O
bottom	O
strand	O
)>	O
10	O
%<	O
10	O
%	O
FastQC	O
plots	O
∗	O
ProblematicGoodFor	O
reference	O
,	O
see	O
the	O
MoTrPAC	B-BT
GET	O
QC	O
SOP	O
for	O
animal	O
studies	O
(	O
http	O
://	O
study	O
-	O
docs	O
.	O
motrpac	B-BT
-	O
data	O
.	O
org	O
/	O
Animal_GET_QC_SOP	O
.	O
pdf	O
).∗	O
FastQC	O
plots	O
comprise	O
‘	O
Per	O
base	O
sequence	O
quality	O
’	O
and	O
‘	O
Per	O
base	O
sequence	O
content	O
’,	O
which	O
plot	O
the	O
Q	O
-	O
score	O
of	O
the	O
raw	O
sequence	O
reads	O
for	O
each	O
cycle	O
and	O
the	O
proportion	O
of	O
each	O
base	O
at	O
each	O
cycle	O
,	O
respectively	O
.	O

2MetaTiME	B-BT
meta	O
-	O
components	O
are	O
biologically	O
interpretable	O
with	O
top	O
genes	O
.	O
a	O
Heatmap	O
of	O
top	O
ten	O
most	O
recurrent	O
clusters	O
of	O
MeCs	O
showing	O
normalized	O
gene	O
weights	O
.	O

To	O
improve	O
the	O
simulation	O
efficiency	O
,	O
FoldDesign	B-BT
introduces	O
10	O
auxiliary	O
movements	O
,	O
including	O
bond	O
length	O
and	O
angle	O
perturbations	O
,	O
segment	O
rotations	O
,	O
torsion	O
angle	O
substitutions	O
,	O
and	O
those	O
that	O
form	O
packing	O
interactions	O
between	O
specific	O
SS	O
elements	O
(	O
SI	O
Appendix	O
,	O
Text	O
S1	O
and	O
Fig	O
.	O

We	O
believe	O
that	O
PhageTB	B-BT
will	O
be	O
an	O
effective	O
method	O
for	O
prediction	O
of	O
phage	O
-	O
based	O
therapy	O
against	O
bacterial	O
infections	O
.	O

Several	O
databases	O
have	O
been	O
created	O
using	O
tRNAscan	O
,	O
including	O
GtRNAdb	O
[	O
21	O
],	O
tRNAdb	O
[	O
16	O
],	O
tRNADB	O
-	O
CE	O
[	O
18	O
],	O
and	O
PlantRNA	B-BT
[	O
19	O
].	O

Additionally	O
,	O
in	O
the	O
multi	O
-	O
label	O
prediction	O
of	O
DM3Loc	O
and	O
MRSLpred	B-BT
models	O
,	O
only	O
the	O
five	O
subcellular	O
locations	O
(	O
cytosol	O
,	O
exosome	O
,	O
nucleus	O
,	O
ribosome	O
,	O
and	O
membrane	O
)	O
overlap	O
with	O
the	O
predicted	O
locations	O
of	O
DRpred	O
,	O
whereas	O
in	O
the	O
multi	O
-	O
label	O
predictor	O
proposed	O
by	O
Wang	O
et	O
al	O
.,	O
the	O
overlapping	O
subcellular	O
locations	O
with	O
DRpred	O
are	O
cytosol	O
,	O
exosome	O
,	O
nucleus	O
,	O
ribosome	O
,	O
and	O
cytoplasm	O
.	O

PySmooth	B-BT
provides	O
additional	O
features	O
such	O
as	O
imputing	O
missing	O
data	O
,	O
better	O
user	O
-	O
friendly	O
usage	O
,	O
generates	O
summary	O
and	O
visualization	O
files	O
,	O
has	O
flexible	O
parameters	O
,	O
and	O
handles	O
more	O
genotype	O
codes	O
.	O

Structural	O
domains	O
functional	O
ontology	O
(	O
SDFO	O
)	O
that	O
mapped	O
information	O
from	O
a	O
theoretic	O
analysis	O
of	O
Domain2GO	B-BT
annotation	O
profiles	O
were	O
reported	O
from	O
the	O
file	O
SDFO	O
.	O
txt	O
.	O

Adjusted	O
odds	O
of	O
serum	O
Knext	O
-	O
4mo	O
<	O
4	O
mEq	O
/	O
l	O
were	O
greater	O
with	O
higher	O
serum	O
bicarbonate	O
levels	O
(	O
reflecting	O
reduced	O
protein	O
intake	O
),	O
higher	O
dialysis	O
dose	O
,	O
lower	O
serum	O
phosphorus	O
,	O
creatinine	O
,	O
albumin	O
,	O
and	O
urine	O
volume	O
levels	O
,	O
and	O
with	O
prescription	O
of	O
icodextrin	O
or	O
loop	O
diuretics	O
.	O

Next	O
,	O
we	O
analyzed	O
the	O
protective	O
efficacy	O
of	O
the	O
Sputnik	O
V	O
vaccine	O
on	O
K18	O
-	O
hACE2	O
-	O
transgenic	O
mice	O
against	O
different	O
SARS	O
-	O
CoV	O
-	O
2	O
variants	O
.	O

More	O
than	O
400	O
users	O
from	O
industry	O
and	O
academia	O
have	O
used	O
MolProphet	B-BT
in	O
their	O
work	O
.	O

For	O
example	O
,	O
[	O
29	O
]	O
modifies	O
cooltools	B-BT
to	O
extract	O
50	O
+	O
eigenvectors	O
,	O
which	O
are	O
then	O
used	O
to	O
find	O
multiple	O
classes	O
of	O
compartments	O
.	O

Consistently	O
,	O
in	O
the	O
case	O
of	O
a	O
human	O
skull	O
sinking	O
in	O
the	O
head	O
-	O
up	O
position	O
,	O
the	O
rotation	O
occurs	O
toward	O
its	O
smoother	O
part	O
,	O
i	O
.	O
e	O
.,	O
the	O
occipital	O
region	O
(	O
see	O
supplemental	O
material	O
in	O
ref	O
.	O

Next	O
,	O
their	O
UniProt	O
ID	O
and	O
human	O
gene	O
names	O
were	O
searched	O
in	O
the	O
UniProt	O
databases	O
,	O
and	O
their	O
disease	O
associations	O
were	O
found	O
in	O
the	O
DisGeNET	B-BT
database	O
v7	O
.	O
0	O
.	O

The	O
calculated	O
log	O
Po	O
/	O
w	O
values	O
for	O
Cu2	O
+-	O
Tren	O
,	O
Cu2	O
+-	O
Dien	O
,	O
and	O
Cu2	O
+-	O
TPMA	O
were	O
−	O
0	O
.	O
98	O
,	O
−	O
0	O
.	O
52	O
,	O
and	O
0	O
.	O
99	O
,	O
respectively	O
(	O
Table	O
1	O
).	O

Spectral	O
alignment	O
was	O
performed	O
using	O
the	O
MSIWarp	B-BT
algorithm	O
(	O
54	O
).	O

The	O
AlphaFold2	O
algorithm	O
(	O
UCSF	O
ChimeraX	O
version	O
1	O
.	O
70	O
)	O
and	O
the	O
PSIPRED	B-BT
tool	O
[	O
20	O
,	O
21	O
]	O
predicted	O
that	O
the	O
AGNLV	O
ORF3	O
protein	O
has	O
two	O
segments	O
:	O
a	O
disordered	O
region	O
from	O
amino	O
acids	O
1	O
to	O
57	O
,	O
and	O
a	O
region	O
of	O
alpha	O
helices	O
from	O
amino	O
acids	O
58	O
to	O
201	O
(	O
Figure	O
2A	O
,	O
C	O
and	O
File	O
S1	O
and	O
S2	O
).	O

1Implementation	O
of	O
CITEViz	B-BT
.	O

Typically	O
,	O
these	O
methodologies	O
involve	O
projecting	O
information	O
from	O
the	O
large	O
dataset	O
onto	O
small	O
datasets	O
containing	O
a	O
select	O
few	O
benchmark	O
chemicals	O
,	O
referred	O
to	O
as	O
''	O
anchor	O
compounds	O
''	O
[	O
23	O
],	O
or	O
employing	O
transfer	O
learning	O
techniques	O
on	O
smaller	O
datasets	O
[	O
35	O
–	O
37	O
,	O
44	O
,	O
70	O
].	O
Table	O
6Retention	O
time	O
prediction	O
models	O
established	O
in	O
the	O
last	O
5	O
years	O
(	O
2019	O
–	O
2023	O
)	O
NameMolecular	O
representationTrain	O
setTest	O
setModel	O
structureComparison	O
methodRefs	O
.	O
retention_time_GNNMolecular	O
graph	O
trained	O
by	O
GNNSMRT24	O
SD	O
including	O
PredRet	O
,	O
MoNA	O
,	O
and	O
in	O
-	O
house	O
datasetsGIN	O
+	O
Broyden	O
–	O
Fletcher	O
–	O
Goldfarb	O
–	O
Shanno	O
(	O
L	O
-	O
BFGS	O
)	O
optimizer	O
+	O
TLMDC	O
-	O
ANN	O
,	O
DNNpwa	O
-	O
TL	O
,	O
GNN	O
-	O
RT	O
-	O
TL	O
,	O
GCN	O
,	O
RGCN	O
,	O
and	O
1D	O
-	O
CNN	O
[	O
37	O
]	O
QGeoGNNMolecular	O
graph	O
integrating	O
descriptors	O
and	O
column	O
propertCMRT	O
(	O
25847	O
data	O
collected	O
from	O
644	O
reports	O
)	O
Train	O
set	O
split	O
(	O
5	O
%	O
validation	O
;	O
5	O
%	O
test	O
)	O
GeoGNN	O
+	O
quantile	O
loss	O
learningLGB	O
,	O
XGB	O
,	O
Artificial	O
neural	O
network	O
,	O
and	O
GNN	O
[	O
25	O
]	O
RT	B-BT
-	I-BT
transformerMolecular	I-BT
graph	O
with	O
34	O
features	O
per	O
node	O
and	O
5	O
features	O
per	O
bond	O
generated	O
by	O
RDKitSMRT41	O
PredRet	O
SDsGAT	O
+	O
1D	O
-	O
transformerGNN	O
-	O
RT	O
,	O
1D	O
-	O
CNN	O
;	O
Blender	O
,	O
CPORT	O
,	O
and	O
MPNN	O
[	O
80	O
]	O
Multi	O
-	O
data	O
combination	O
of	O
compounds	O
and	O
adaptive	O
neural	O
network	O
(	O
MDC	O
-	O
ANN	O
)(	O
1	O
)	O
Molecular	O
graph	O
with	O
25	O
features	O
(	O
referred	O
[	O
45	O
];	O
(	O
2	O
)	O
molecular	O
fingerprint	O
from	O
MACCS	O
calculated	O
by	O
RDKit	O
;	O
(	O
3	O
)	O
molecular	O
descriptors	O
from	O
SMILEs	O
calculated	O
by	O
Mordred	O
and	O
remain	O
1156	O
features	O
by	O
pre	O
-	O
processingSMRT	O
train	O
,	O
1511	O
in	O
-	O
house	O
standards	O
for	O
fine	O
-	O
tuning	O
;	O
14	O
small	O
datasets	O
and	O
807	O
in	O
-	O
house	O
standardsDNN	O
model	O
based	O
on	O
different	O
combinations	O
of	O
molecular	O
presentationsDNNpwa	O
-	O
TL	O
,	O
GNN	O
-	O
RT	O
-	O
TL	O
[	O
45	O
],	O
GCN	O
,	O
RGCN	O
,	O
1D	O
-	O
CNN	O
,	O
RF	O
,	O
GB	O
,	O
and	O
LASSO	O
and	O
XGBoost	O
,	O
MDC	O
-	O
CNN	O
[	O
36	O
]	O
Multi	O
-	O
target	O
QSRR	O
models	O
(	O
mt	O
-	O
QSRR	O
)	O
225	O
constitutional	O
,	O
topological	O
,	O
and	O
geometrical	O
descriptors	O
as	O
numerical	O
characteristics	O
molecular	O
descriptors	O
by	O
RDKitSeven	O
standards	O
at	O
five	O
different	O
pH	O
conditions	O
(	O
2	O
.	O
7	O
,	O
3	O
.	O
5	O
,	O
5	O
.	O
0	O
,	O
6	O
.	O
5	O
,	O
and	O
8	O
.	O
0	O
)	O
Train	O
set	O
splitRF	O
–[	O
87	O
]	O
CMM	O
-	O
RT5666	O
MD	O
and	O
2214	O
fingerprints	O
(	O
MACCS166	O
)	O
generated	O
by	O
alvaDesc	O
softwareSMRTPredRet	O
(	O
FEM_long	O
,	O
FEM_obitrap_plasma	O
,	O
LIFE_old	O
,	O
RIKEN	O
)	O
DNNSVM	O
,	O
XGB	O
,	O
LGB	O
,	O
CatBoost	O
,	O
and	O
a	O
blending	O
approach	O
[	O
47	O
]	O
Message	O
-	O
passing	O
neural	O
networks	O
(	O
MPNN	O
)	O
Molecular	O
graph	O
with	O
5	O
features	O
per	O
node	O
and	O
2	O
features	O
per	O
bondSMRTPredRet	O
(	O
FEM_long	O
,	O
LIFE_new	O
,	O
LIFE_old	O
,	O
Eawag_XBridgeC18	O
)	O
and	O
RIKEN	O
Retip	O
SDMPNN1D	O
-	O
CNN	O
and	O
GNN	O
[	O
45	O
][	O
70	O
]	O
1D	O
-	O
CNN	O
;	O
1D	O
-	O
CNN	O
-	O
TL	O
(	O
1	O
)	O
Topological	O
,	O
constitutional	O
,	O
and	O
electronic	O
molecular	O
descriptors	O
test	O
separated	O
and	O
combined	O
(	O
243	O
in	O
total	O
)	O
by	O
RCDK	O
(	O
2	O
)	O
ECFP	O
/	O
PCP	O
fingerprints	O
by	O
RCDK	O
;	O
(	O
2	O
)	O
SMILES	O
to	O
one	O
-	O
hot	O
matriceSMRT	O
(	O
for	O
1D	O
-	O
CNN	O
training	O
)	O
5	O
SD	O
(	O
RIKEN_Retip	O
,	O
MassBank1	O
,	O
MetaboBASE	O
,	O
LIFE_old	O
,	O
LIFE_new	O
)	O
for	O
TL	O
(	O
10	O
validation	O
)	O
1D	O
CNN	O
+	O
TLDLM	O
[	O
23	O
]	O
XGB	O
[	O
81	O
],	O
and	O
GNN	O
[	O
45	O
][	O
42	O
]	O
70	O
–	O
92	O
MDs	O
by	O
RDKit26	O
–	O
350	O
STDsSMRTBRidgeR	O
,	O
XGBR	O
and	O
SVR	O
–[	O
88	O
]	O
MultiConditionRT153	O
MDs78	O
STDs151	O
(	O
internal	O
)	O
&	O
324	O
[	O
91	O
]	O
RF	O
–[	O
89	O
]	O
HighResNPS4	O
MDs	O
+	O
one	O
-	O
hot	O
encoding707	O
STDs	O
train	O
,	O
190	O
STDs	O
optimization	O
,	O
191	O
STDs	O
validation193	O
STDsMLP	O
–[	O
90	O
]	O
GNN	O
-	O
RT	O
-	O
TLMolecular	O
Graph	O
generate	O
from	O
InChI	O
by	O
RDKit	O
,	O
and	O
extract	O
subgraph	O
by	O
GNNSMRT	O
(	O
for	O
GNN	O
training	O
)	O
11	O
SDs	O
from	O
MoNA	O
and	O
PredRet	O
(	O
TL	O
)	O
GNNs	O
+	O
TLMultichannel	O
-	O
CNN	O
(	O
MC	O
-	O
CNN	O
),	O
single	O
channel	O
-	O
CNN	O
(	O
SC	O
-	O
CNN	O
),	O
BRR	O
[	O
34	O
],	O
RFs	O
[	O
34	O
],	O
DLM	O
[	O
23	O
][	O
45	O
]	O
GNN	O
-	O
TLMolecular	O
graph	O
with	O
16	O
features	O
per	O
node	O
and	O
4	O
features	O
per	O
bondIn	O
silico	O
HILIC	O
RT	O
dataset	O
with	O
about	O
306	O
K	O
molecules	O
(	O
for	O
GNNs	O
training	O
)	O
880	O
compounds	O
(	O
Fiehn	O
HILIC	O
)	O
for	O
TLGNNs	O
+	O
TLRetip	O
(	O
XGB	O
,	O
BRNN	O
,	O
RF	O
,	O
LGB	O
,	O
Keras	O
DNN	O
)[	O
46	O
]	O
RGCN	O
,	O
GCNMolecular	O
graph	O
with	O
20features	O
per	O
node	O
and	O
5	O
features	O
per	O
bond	O
for	O
RGCN	O
;	O
20	O
features	O
per	O
node	O
for	O
GCN	O
generated	O
by	O
RDKitSMRT	O
train	O
,	O
validation	O
,	O
and	O
test	O
splits	O
follow	O
[	O
45	O
];	O
RIKEN	O
and	O
Fiehn	O
HILIC	O
follow	O
[	O
73	O
]	O
External	O
test	O
set	O
in	O
[	O
73	O
];	O
Train	O
set	O
splitGCN	O
and	O
RGCNMLP	O
with	O
ECFP	O
,	O
and	O
RF	O
,	O
SVM	O
,	O
GB	O
,	O
AB	O
with	O
descriptors	O
,	O
GNN	O
-	O
RT	O
,	O
and	O
Keras	O
[	O
44	O
]	O
DNNpwa	O
-	O
TL1470	O
MDs	O
calculated	O
by	O
MordredSMRT	O
pre	O
-	O
training	O
by	O
AE	O
-	O
wmi17	O
SDs	O
for	O
TL	O
(	O
1055	O
TL	O
+	O
133	O
test	O
)	O
DNNs	O
+	O
TLCALLC	O
,	O
PredRet	O
,	O
RF	O
,	O
GB	O
,	O
LASSO	O
,	O
DNN	O
,	O
and	O
GNN	O
-	O
RT	O
[	O
45	O
][	O
35	O
]	O
mixed	O
-	O
mode	O
-	O
MPNNSMILES398	O
STDsTrain	O
set	O
split	O
(	O
20	O
%)	O
MPNN	O
(	O
from	O
DeepChem	O
library	O
[	O
68	O
])	O
Linear	O
regression	O
;	O
RF	O
[	O
43	O
]	O
4	O
non	O
-	O
canonical	O
+	O
1	O
canonical	O
SMILESChEMBL	O
1	O
million	O
molecules	O
(	O
pre	O
-	O
training	O
)	O
4	O
SDs	O
(	O
Eawag_XBridgeC18	O
,	O
Beck	O
,	O
Stravs	O
,	O
and	O
FEM_long	O
)	O
for	O
TLFastAI	O
AWD	O
-	O
LSTM	O
/	O
TransformerXL	O
+	O
TL	O
(	O
median	O
fine	O
-	O
tuning	O
on	O
SMRT	O
,	O
second	O
fine	O
-	O
tuning	O
on	O
SDs	O
than	O
regression	O
fine	O
-	O
tuning	O
generates	O
RT	O
)	O
AB	O
,	O
BRR	O
,	O
RF	O
,	O
SVR	O
,	O
and	O
GB	O
[	O
56	O
]	O
Retip286	O
MDs981	O
(	O
HILIC	O
,	O
Fiehn	O
,	O
MoNA	O
)	O
&	O
852	O
(	O
RP	O
-	O
LC	O
,	O
PlaSMA	O
)	O
STDs143	O
metabolites	O
(	O
human	O
blood	O
plasma	O
MS	O
/	O
MS	O
data	O
)	O
as	O
external	O
setXGB	O
,	O
BRNN	O
,	O
RF	O
,	O
LGB	O
,	O
Keras	O
DNN	O
(	O
3	O
dense	O
layer	O
+	O
3	O
dropout	O
layer	O
)	O
XGB	O
,	O
BRNN	O
,	O
RF	O
,	O
LGB	O
,	O
Keras	O
DNN	O
(	O
3	O
dense	O
layer	O
+	O
3	O
dropout	O
layer	O
)[	O
73	O
]	O
DLM	O
;	O
SMRTECFP	O
fingerprint80	O
,	O
038	O
STDsPredRet	O
SDsKeras	O
deep	O
-	O
learning	O
regression	O
model	O
+	O
projection	O
by	O
robust	O
polynomial	O
regression	O
to	O
SDsRF	O
[	O
23	O
]	O
151	O
MDs6	O
,	O
759	O
STDs	O
from	O
36	O
public	O
small	O
datasetsTrain	O
set	O
splitBRidgeR	O
,	O
LASSO	O
,	O
DNNs	O
,	O
AB	O
,	O
GB	O
,	O
RF	O
,	O
and	O
SVRBRidgeR	O
,	O
LASSO	O
,	O
DNNs	O
,	O
AB	O
,	O
GB	O
,	O
RF	O
,	O
and	O
SVR	O
[	O
34	O
]	O
MDs	O
molecular	O
descriptors	O
,	O
SDs	O
small	O
datasets	O
,	O
STD	O
standard	O
chemical	O

The	O
incidence	O
of	O
PGD	O
at	O
30	O
days	O
was	O
3	O
.	O
7	O
%.	O

The	O
EQs	O
were	O
exported	O
from	O
Phenotator	B-BT
as	O
an	O
OWL	O
file	O
and	O
loaded	O
into	O
the	O
Protege	O
OWL	O
ontology	O
editor	O
.	O

R	O
’	O
s	O
formula	O
interface	O
for	O
linear	O
models	O
is	O
flexible	O
,	O
widely	O
used	O
,	O
and	O
well	O
documented	O
.	O
26	O
,	O
43	O
We	O
use	O
the	O
formula	O
interface	O
to	O
specify	O
the	O
models	O
,	O
making	O
it	O
easy	O
to	O
reproduce	O
an	O
analysis	O
performed	O
with	O
prolfqua	B-BT
in	O
other	O
statistical	O
programming	O
languages	O
.	O

REAGENT	O
or	O
RESOURCESOURCEIDENTIFIERAntibodiesRabbit	O
anti	O
-	O
SAM68Iijima	O
et	O
al	O
.	O
35N	O
/	O
ARabbit	O
anti	O
-	O
SLM2Iijima	O
et	O
al	O
.	O
35N	O
/	O
AGuinea	O
pig	O
polyclonal	O
anti	O
-	O
SLM2Iijima	O
et	O
al	O
.	O
35N	O
/	O
AMouse	O
anti	O
-	O
NeuNChemicon	O
#	O
MAB377Rat	O
anti	O
-	O
HA	O
monoclonal	O
clone	O
3F10Roche	O
#	O
11867431001Rabbit	O
anti	O
-	O
Ctip2	O
polyclonalNovus	O
Biological	O
#	O
NB100	O
-	O
2600Donkey	O
anti	O
-	O
guinea	O
pig	O
IgG	O
Cy5	O
-	O
conjugatedJackson	O
ImmunoResearch	O
#	O
706	O
-	O
175	O
-	O
148Donkey	O
anti	O
-	O
rabbit	O
IgG	O
Cy3	O
-	O
conjugatedJackson	O
ImmunoResearch	O
#	O
711	O
-	O
165	O
-	O
152Donkey	O
anti	O
-	O
guinea	O
pig	O
IgG	O
Cy3	O
-	O
conjugatedJackson	O
ImmunoResearch	O
#	O
706	O
-	O
165	O
-	O
148Donkey	O
anti	O
-	O
rabbit	O
IgG	O
Alexa	O
488	O
-	O
conjugatedThermo	O
Fisher	O
#	O
A	O
-	O
21206Chemicals	O
,	O
peptides	O
,	O
and	O
recombinant	O
proteinsanti	O
-	O
HA	O
magnetic	O
beads	O
clone	O
2	O
–	O
2	O
.	O
2	O
.	O
14Thermo	O
Fisher	O
/	O
Pierce	O
#	O
88836Complete	O
mini	O
Protease	O
Inhibitors	O
,	O
EDTA	O
-	O
freeRoche	O
#	O
04693159001RNAsinPromega	O
#	O
N2115CycloheximideSigma	O
#	O
C7698HeparinSigma	O
#	O
H3393IGEPAL	O
-	O
CA640	O
(	O
NP	O
-	O
40	O
)	O
Sigma	O
#	O
18896RNeasy	O
Micro	O
plus	O
kitQiagen	O
#	O
74034Dynabeads	O
™	O
Protein	O
AInvitrogen	O
#	O
10001DTURBO	O
™	O
DNase	O
(	O
2	O
U	O
/	O
ul	O
)	O
Invitrogen	O
#	O
AM2238Ambion	O
™	O
RNase	O
I	O
(	O
100	O
U	O
/	O
ul	O
)	O
Invitrogen	O
#	O
AM2295T4	O
PNK	O
(	O
10	O
U	O
/	O
ul	O
)	O
NEB	O
#	O
M0314LT4	O
RNA	O
Ligase	O
1	O
(	O
ssRNA	O
Ligase	O
),	O
High	O
ConcentrationNEB	O
#	O
M0437MProteinase	O
K	O
,	O
Molecular	O
Biology	O
Grade	O
(	O
0	O
.	O
8	O
U	O
/	O
ul	O
)	O
NEB	O
#	O
P8107SQ5	O
®	O
High	O
-	O
Fidelity	O
2X	O
Master	O
MixNEB	O
#	O
M0492SExoSAP	O
-	O
IT	O
™	O
Applied	O
Biosystems	O
#	O
78200	O
.	O
200	O
.	O
ULSuperScript	O
™	O
III	O
Reverse	O
TranscriptaseInvitrogen	O
#	O
18080093Dynabeads	O
™	O
MyOne	O
™	O
SilaneInvitrogen	O
#	O
37002DNuPAGE	O
™	O
Transfer	O
Buffer	O
(	O
20X	O
)	O
Invitrogen	O
#	O
NP0006NuPAGE	O
™	O
4	O
–	O
12	O
%,	O
Bis	O
-	O
Tris	O
,	O
1	O
.	O
5	O
mm	O
,	O
Mini	O
Protein	O
GelsInvitrogen	O
#	O
NP0335BOXNuPAGE	O
™	O
MOPS	O
SDS	O
Running	O
Buffer	O
(	O
20X	O
)	O
Invitrogen	O
#	O
NP0001Amersham	O
™	O
Protran	O
®	O
Western	O
blotting	O
membranes	O
,	O
nitrocelluloseSigma	O
#	O
GE10600002RNA	O
Clean	O
&	O
Concentrator	O
-	O
5Zymo	O
Research	O
#	O
R1015Acid	O
-	O
Phenol	O
:	O
Chloroform	O
,	O
pH	O
4	O
.	O
5Invitrogen	O
#	O
AM9720Phase	O
Lock	O
Gel	O
™	O
Heavy	O
tubes5	O
PRIME	O
#	O
2302830Urea	O
for	O
molecular	O
biologyAppliChem	O
#	O
A1049Prolong	O
Diamond	O
Antifade	O
MountantLife	O
Technologies	O
#	O
P36970Dako	O
Fluorescence	O
Mounting	O
mediumAgilent	O
#	O
S3023OCTTissue	O
-	O
TekCritical	O
commercial	O
assaysHiSeq	O
SBS	O
Kit	O
v4Illumina	O
#	O
FC	O
-	O
401	O
-	O
4003NGS	O
Fragment	O
Analysis	O
KitAdvanced	O
Analytica	O
#	O
DNF	O
-	O
473RNA	O
6000	O
Pico	O
ChipAgilent	O
#	O
5067	O
–	O
1513QuantiFluor	O
RNA	O
SystemPromega	O
#	O
E3310Deposited	O
dataRNA	O
-	O
seq	O
dataThis	O
paperGEO	O
:	O
GSE209870CLIP	O
-	O
seq	O
dataThis	O
paperGEO	O
:	O
GSE220062RNA	O
-	O
seq	O
data	O
Sam68KOWitte	O
et	O
al	O
.	O
66PRIDE	O
:	O
PRJEB27529RNA	O
-	O
seq	O
data	O
Slm2KOTraunmüller	O
et	O
al	O
.	O
37GEO	O
:	O
GSE79902Experimental	O
models	O
:	O
Organisms	O
/	O
strainsMouse	O
:	O
C57BL	O
/	O
6JJanvierN	O
/	O
AMouse	O
:	O
Grik4	O
-	O
creJackson	O
Laboratoriesstrain	O
#:	O
006	O
,	O
474Mouse	O
:	O
Camk2a	O
-	O
creJackson	O
Laboratoriesstrain	O
#:	O
005	O
,	O
359Mouse	O
:	O
Sst	O
-	O
IRES	O
-	O
CreJackson	O
Laboratoriesstrain	O
#:	O
013	O
,	O
044Mouse	O
:	O
Ai32	O
ROSA	O
-	O
stop	O
-	O
ChR2	O
/	O
H134RJackson	O
Laboratoriesstrain	O
#:	O
024	O
,	O
109Mouse	O
:	O
Slm2	O
/	O
KHDRBS3	O
floxTraunmüller	O
et	O
al	O
.	O
36N	O
/	O
AMouse	O
:	O
Ai9	O
ROSA	O
-	O
stop	O
-	O
tomatoJackson	O
Laboratoriesstrain	O
#:	O
007	O
,	O
909Mouse	O
:	O
RjOrl	O
:	O
SWISSJanvierN	O
/	O
AMouse	O
:	O
Rpl22	O
-	O
HAJackson	O
Laboratoriesstrain	O
#:	O
029	O
,	O
977OligonucletidesFor	O
oligonucleotides	O
,	O
see	O
Table	O
S3N	O
/	O
AN	O
/	O
ASoftware	O
and	O
algorithmsFijiTraunmüller	O
et	O
al	O
.	O
67RRID	O
:	O
SCR_002285FeatureCountsLiao	O
et	O
al	O
.	O
68RRID	O
:	O
SCR_012919CTKShah	O
et	O
al	O
.	O
42RRID	O
:	O
SCR_019034mCrossFeng	O
et	O
al	O
.	O
44N	O
/	O
AFastQC	O
0	O
.	O
11	O
.	O
8N	O
/	O
ARRID	O
:	O
SCR_014583Picard	O
v1	O
.	O
119N	O
/	O
ARRID	O
:	O
SCR_006525RSeQC	O
v2	O
.	O
3	O
.	O
9N	O
/	O
ARRID	O
:	O
SCR_005275SAMTOOLS	O
1	O
.	O
13Li	O
et	O
al	O
.	O
69RRID	O
:	O
SCR_002105STAR	O
2	O
.	O
7	O
.	O
9aDobin	O
et	O
al	O
.	O
70RRID	O
:	O
SCR_004463DESEQ2Love	O
et	O
al	O
.	O
71RRID	O
:	O
SCR_015687CLIPper	O
2	O
.	O
0	O
.	O
0Yeo	O
et	O
al	O
.	O
72https	O
://	O
github	O
.	O
com	O
/	O
YeoLab	O
/	O
clipperIDR	O
2	O
.	O
0	O
.	O
3Li	O
et	O
al	O
.	O
73RRID	O
:	O
SCR_017237Sashimi	O
.	O
pyZhang	O
et	O
al	O
.	O
74https	O
://	O
github	O
.	O
com	O
/	O
ygidtu	O
/	O
sashimi	O
.	O
pyDAVIDHuang	O
et	O
al	O
.	O
75RRID	O
:	O
SCR_001881SynGOKoopmans	O
et	O
al	O
.	O
45RRID	O
:	O
SCR_017330Ethovision10NoldusN	O
/	O
AStimfitGuzman	O
et	O
al	O
.	O
76RRID	O
:	O
SCR_016050pyABFN	O
/	O
Ahttp	O
://	O
swharden	O
.	O
com	O
/	O
pyabfImaris	O
7	O
.	O
0	O
.	O
0Bitplane	O
AGRRID	O
:	O
SCR_007370Cutadapt	O
3	O
.	O
4N	O
/	O
ARRID	O
:	O
SCR_011841UMI	O
-	O
tools	O
1	O
.	O
1	O
.	O
1Smith	O
et	O
al	O
.	O
77RRID	O
:	O
SCR_017048	O

The	O
localization	O
of	O
52	O
of	O
these	O
445	O
proteins	O
in	O
spores	O
is	O
listed	O
in	O
the	O
SubtiWiki	B-BT
database	O
(	O
Supplementary	O
Table	O
S5	O
).	O

Consequently	O
,	O
it	O
is	O
unknown	O
if	O
the	O
specimens	O
were	O
initially	O
smoother	O
or	O
rougher	O
and	O
whether	O
the	O
difference	O
shown	O
following	O
the	O
treatments	O
was	O
actually	O
brought	O
about	O
by	O
the	O
variations	O
in	O
traditional	O
oven	O
-	O
and	O
microwave	O
-	O
glazing	O
methods	O
.	O

There	O
is	O
currently	O
no	O
additional	O
information	O
available	O
on	O
the	O
alteration	O
in	O
activity	O
of	O
the	O
VL	O
muscle	O
and	O
its	O
connection	O
to	O
foot	O
abnormalities	O
,	O
indicating	O
a	O
need	O
for	O
further	O
research24	O
,	O
25	O
.	O

We	O
kept	O
viral	O
and	O
proviral	O
contigs	O
in	O
categories	O
1	O
–	O
3	O
from	O
VirSorter	B-BT
on	O
cyverse	O
which	O
corresponds	O
to	O
the	O
confidence	O
of	O
predicted	O
viruses	O
,	O
i	O
.	O
e	O
.,	O
(	O
1	O
)	O
“	O
most	O
confident	O
,”	O
(	O
2	O
)	O
“	O
likely	O
”	O
(	O
3	O
)	O
“	O
possible	O
”	O
(	O
Roux	O
et	O
al	O
.,	O
2015	O
).	O

Here	O
we	O
introduce	O
kmerDB	B-BT
,	O
a	O
novel	O
repository	O
that	O
contains	O
kmer	O
,	O
nullomer	O
,	O
nullpeptide	O
,	O
quasi	O
-	O
prime	O
,	O
and	O
prime	O
sequences	O
for	O
54	O
,	O
039	O
reference	O
genomes	O
and	O
21	O
,	O
865	O
reference	O
proteomes	O
.	O

The	O
limit	O
of	O
detection	O
(	O
LoD	O
)	O
of	O
RT	O
-	O
qPCR	O
for	O
assays	O
used	O
for	O
the	O
detection	O
of	O
strawberry	O
mottle	O
virus	O
(	O
SMoV	O
)	O
and	O
strawberry	O
vein	O
banding	O
virus	O
(	O
SVBV	O
)	O
was	O
calculated	O
using	O
synthetic	O
RNA	O
transcripts	O
.	O

Summary	O
of	O
matching	O
hits	O
for	O
the	O
T1RM	O
(	O
VC1769	O
-	O
68	O
-	O
65	O
)	O
model	O
,	O
detected	O
by	O
MacSyFinder	B-BT
v	O
.	O
2	O
.	O

We	O
combined	O
all	O
the	O
available	O
sequences	O
into	O
a	O
concatenation	O
matrix	O
with	O
22	O
species	O
and	O
80	O
loci	O
and	O
generated	O
3	O
different	O
datasets	O
:	O
(	O
1	O
)	O
a	O
concatenation	O
matrix	O
including	O
the	O
original	O
alignments	O
with	O
241	O
,	O
315	O
sites	O
;	O
(	O
2	O
)	O
a	O
concatenation	O
matrix	O
where	O
the	O
alignments	O
were	O
trimmed	O
prior	O
to	O
concatenation	O
using	O
a	O
heuristic	O
method	O
optimised	O
for	O
ML	O
phylogenetic	O
reconstruction	O
implemented	O
in	O
TrimAl	B-BT
(	O
92	O
.	O
44	O
%	O
sites	O
of	O
the	O
original	O
matrix	O
)	O
(	O
Capella	O
-	O
Gutiérrez	O
et	O
al	O
.	O

Drafting	O
of	O
the	O
manuscript	O
:	O
Ricardo	O
Noguera	O
Louzada	O
,	O
Dillan	O
Cunha	O
Amaral	O
,	O
Claudio	O
do	O
Carmo	O
Chaves	O
Filho	O
,	O
Daniel	O
Oliveira	O
Dantas	O
,	O
Francisco	O
Carlos	O
de	O
Castro	O
Neto	O
,	O
Milton	O
Ruiz	O
Alves	O

WebMaBoSS	B-BT
also	O
allows	O
the	O
simulation	O
of	O
more	O
complex	O
tasks	O
such	O
as	O
parameter	O
sensitivity	O
analyses	O
.	O

ElemeNT	B-BT
2023	I-BT
is	O
implemented	O
in	O
Perl	O
,	O
and	O
the	O
installation	O
package	O
of	O
the	O
command	O
line	O
version	O
is	O
available	O
for	O
download	O
in	O
GitHub	O
.	O

Although	O
born	O
from	O
the	O
need	O
to	O
optimize	O
serosurvey	O
QC	O
protocols	O
,	O
shinyMBA	B-BT
is	O
suitable	O
for	O
use	O
in	O
Luminex	O
MBA	O
research	O
and	O
laboratory	O
QC	O
applications	O
outside	O
of	O
this	O
scope	O
as	O
well	O
.	O

Is	O
such	O
semantic	O
mislabeling	O
really	O
on	O
par	O
with	O
the	O
substitution	O
of	O
tuna	O
for	O
escolar	O
,	O
or	O
the	O
substitution	O
of	O
snapper	O
for	O
tilapia	O
?	O

1Two	O
SwivelLock	O
(	O
Arthrex	O
,	O
Inc	O
)	O
suture	O
anchors	O
at	O
the	O
inferior	O
pole	O
of	O
the	O
patella	O
with	O
a	O
Krackow	O
stitch	O
brought	O
down	O
the	O
patella	O
in	O
a	O
locking	O
stitch	O
configuration	O
.	O
Fig	O
.	O

The	O
value	O
in	O
top	O
-	O
right	O
triangle	O
presents	O
the	O
number	O
of	O
common	O
ASRS	O
SNPs	O
;	O
the	O
value	O
in	O
bottom	O
-	O
left	O
triangle	O
presents	O
the	O
Pearson	O
correlation	O
coefficient	O
of	O
the	O
AStruct	B-BT
scores	O
.	O

ProKinO	B-BT
was	O
developed	O
following	O
FAIR	O
(	O
Findable	O
,	O
Accessible	O
,	O
Interoperable	O
,	O
and	O
Reusable	O
)	O
principles	O
(	O
Wilkinson	O
et	O
al	O
.,	O
2016	O
)	O
and	O
serves	O
as	O
an	O
integrated	O
knowledge	O
graph	O
for	O
relating	O
and	O
conceptualizing	O
diverse	O
forms	O
of	O
disparate	O
data	O
related	O
to	O
protein	O
kinase	O
sequence	O
,	O
structure	O
,	O
function	O
,	O
regulation	O
,	O
and	O
disease	O
(	O
cancer	O
).	O

Subsequently	O
,	O
PREDAC	B-BT
-	I-BT
CNN	I-BT
utilizes	O
the	O
CNN	O
model	O
to	O
assess	O
the	O
input	O
matrix	O
and	O
infer	O
the	O
antigenic	O
relationship	O
between	O
the	O
paired	O
strains	O
of	O
influenza	O
A	O
/	O
H3N2	O
or	O
A	O
/	O
H1N1	O
viruses	O
.	O

IDSL_MINT	B-BT
only	O
takes	O
MS	O
/	O
MS	O
spectra	O
accompanied	O
with	O
precursor	O
m	O
/	O
z	O
values	O
in	O
the	O
.	O
msp	O
text	O
format	O
.	O

The	O
expression	O
of	O
LOC_Os12g36890	O
was	O
significantly	O
down	O
–	O
regulated	O
after	O
2	O
days	O
of	O
the	O
Fe	O
toxicity	O
treatment	O
according	O
to	O
the	O
Plant	O
Public	O
RNA	O
–	O
Seq	O
Database	O
(	O
http	O
://	O
ipf	O
.	O
sustech	O
.	O
edu	O
.	O
cn	O
/	O
pub	O
/	O
plantrna	B-BT
/,	O
accessed	O
on	O
23	O
February	O
2024	O
)	O
(	O
Figure	O
5E	O
).	O

Nevertheless	O
,	O
some	O
of	O
the	O
comments	O
from	O
IFE	O
,	O
General	O
,	O
TASUED	O
,	O
SIDMACH	O
,	O
CCHUB	O
,	O
and	O
PyCOM	B-BT
-	O
NG	O
received	O
mixed	O
reviews	O
and	O
were	O
found	O
to	O
have	O
a	O
moderate	O
security	O
risk	O
,	O
while	O
General	O
and	O
PyCOM	B-BT
-	O
NG	O
respondents	O
were	O
found	O
to	O
have	O
a	O
high	O
-	O
security	O
risk	O
.	O

Further	O
research	O
is	O
required	O
to	O
investigate	O
the	O
association	O
between	O
VAT	O
and	O
muscle	O
health	O
and	O
to	O
validate	O
the	O
effectiveness	O
of	O
mScan	O
in	O
T1D	O
and	O
other	O
populations	O
.	O

In	O
conclusion	O
,	O
the	O
development	O
of	O
123VCF	B-BT
has	O
yielded	O
a	O
highly	O
efficient	O
VCF	O
file	O
filtering	O
tool	O
with	O
notable	O
advantages	O
over	O
existing	O
filtering	O
tools	O
.	O

Examples	O
are	O
eTBLAST	B-BT
(	O
http	O
://	O
etest	O
.	O
vbi	O
.	O
vt	O
.	O
edu	O
/	O
etblast3	B-BT
)	O
and	O
turnitin	O
(	O
https	O
://	O
www	O
.	O
turnitin	O
.	O
com	O
/).	O

(	O
A	O
)	O
An	O
exophytic	O
enhanced	O
mass	O
was	O
detected	O
in	O
the	O
left	O
retromolar	O
trigon	O
in	O
MRI	O
T1	O
-	O
weighted	O
images	O
with	O
contrast	O
.	O

Our	O
Interrupting	O
Prolonged	O
sitting	O
with	O
ACTivity	O
(	O
InPACT	O
)	O
at	O
Home	O
program	O
,	O
for	O
example	O
,	O
confirmed	O
the	O
importance	O
of	O
parental	O
support	O
.	O

(	O
a	O
,	O
b	O
)	O
Log	O
–	O
log	O
plots	O
comparing	O
variants	O
of	O
our	O
heuristic	O
,	O
including	O
the	O
simplest	O
(	O
SH	O
)	O
and	O
most	O
accurate	O
(	O
GCSH	O
with	O
DT	O
),	O
to	O
Edlib	O
,	O
BiWFA	B-BT
,	O
and	O
other	O
algorithms	O
(	O
averaged	O
over	O
106	O
–	O
107	O
total	O
bp	O
,	O
seed	O
length	O
k	O
=	O
15	O
).	O

The	O
NanoLAS	B-BT
database	O
can	O
be	O
accessed	O
at	O
https	O
://	O
www	O
.	O
nanolas	B-BT
.	O
cloud	O
,	O
and	O
we	O
also	O
maintain	O
a	O
project	O
repository	O
on	O
GitHub	O
,	O
facilitating	O
developers	O
and	O
researchers	O
for	O
deep	O
participation	O
and	O
contribution	O
.	O

State	O
TP	O
is	O
transient	O
concerns	O
and	O
attitudes	O
about	O
the	O
time	O
horizon	O
(	O
past	O
,	O
present	O
,	O
or	O
future	O
)	O
in	O
a	O
given	O
scenario	O
(	O
Stolarski	O
,	O
Fieulaine	O
&	O
Zimbardo	O
,	O
2018	O
),	O
significantly	O
impacting	O
an	O
individual	O
’	O
s	O
behavior	O
in	O
the	O
present	O
(	O
Klapproth	O
,	O
2011	O
).	O

We	O
compared	O
two	O
common	O
nontargeted	O
MS2	O
acquisition	O
strategies	O
with	O
liquid	O
chromatography	O
high	O
-	O
resolution	O
mass	O
spectrometry	O
for	O
structural	O
annotation	O
accuracy	O
by	O
SIRIUS	B-BT
+	O
CSI	O
:	O
FingerID	O
and	O
MS2Tox	O
toxicity	O
prediction	O
of	O
191	O
reference	O
chemicals	O
spiked	O
to	O
LC	O
-	O
MS	O
water	O
,	O
groundwater	O
,	O
surface	O
water	O
,	O
and	O
wastewater	O
.	O

Furthermore	O
,	O
an	O
online	O
information	O
retrieval	O
system	O
was	O
designed	O
based	O
on	O
the	O
PCAO2	B-BT
.	O

The	O
additive	O
effect	O
of	O
GbyE	B-BT
exhibits	O
high	O
significance	O
on	O
certain	O
chromosomes	O
,	O
while	O
the	O
interactive	O
effect	O
detects	O
more	O
significant	O
sites	O
on	O
other	O
chromosomes	O
,	O
which	O
were	O
not	O
detected	O
in	O
the	O
first	O
two	O
parts	O
.	O

In	O
the	O
20	O
×	O
data	O
,	O
HapKled	O
maintained	O
the	O
best	O
presence	O
F1s	O
and	O
GT	O
-	O
F1s	O
(	O
presence	O
F1	O
:	O
93	O
.	O
3	O
%,	O
GT	O
-	O
F1	O
:	O
90	O
.	O
13	O
%	O
overall	O
;	O
presence	O
F1	O
:	O
94	O
.	O
62	O
%,	O
GT	O
-	O
F1	O
:	O
92	O
.	O
29	O
%	O
for	O
deletion	O
;	O
and	O
presence	O
F1	O
:	O
92	O
.	O
27	O
%,	O
GT	O
-	O
F1	O
:	O
88	O
.	O
45	O
%	O
for	O
insertion	O
),	O
with	O
0	O
.	O
13	O
–	O
5	O
.	O
69	O
%	O
leads	O
for	O
presence	O
F1	O
and	O
0	O
.	O
57	O
–	O
8	O
.	O
51	O
%	O
leads	O
for	O
GT	O
-	O
F1	O
,	O
compared	O
to	O
other	O
tools	O
(	O
Figure	O
3	O
;	O
Supplementary	O
Table	O
S2	O
).	O

Recently	O
,	O
the	O
Korean	O
Genome	O
and	O
Epidemiology	O
Study	O
showed	O
that	O
LAP	O
levels	O
had	O
a	O
J	O
-	O
shaped	O
association	O
with	O
all	O
-	O
cause	O
mortality	O
[	O
18	O
].	O

The	O
software	O
,	O
installation	O
instructions	O
,	O
and	O
a	O
tutorial	O
covering	O
simulation	O
and	O
inference	O
are	O
all	O
available	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
phyloacc	O
/	O
PhyloAcc	B-BT
-	I-BT
C	I-BT
.	O

Clicking	O
the	O
‘	O
Run	O
’	O
button	O
runs	O
the	O
RNAscape	B-BT
pipeline	O
on	O
the	O
uploaded	O
structure	O
file	O
or	O
provided	O
PDB	O
ID	O
(	O
biological	O
assembly	O
1	O
).	O

Second	O
,	O
DataColor	B-BT
currently	O
lacks	O
interactive	O
interfaces	O
,	O
which	O
is	O
an	O
area	O
that	O
we	O
plan	O
to	O
focus	O
on	O
in	O
future	O
versions	O
.	O

In	O
addition	O
to	O
running	O
tRigon	B-BT
locally	O
via	O
the	O
R	O
console	O
,	O
the	O
application	O
is	O
freely	O
available	O
online	O
in	O
the	O
ShinyApps	O
.	O
io	O
workspace	O
(	O
https	O
://	O
labooratory	O
.	O
shinyapps	O
.	O
io	O
/	O
tRigon	B-BT
),	O
albeit	O
the	O
memory	O
size	O
for	O
free	O
use	O
is	O
limited	O
to	O
1	O
GB	O
of	O
Random	O
-	O
Access	O
Memory	O
(	O
RAM	O
).	O

Amount	O
of	O
collagen	O
(	O
B	O
)	O
measured	O
with	O
Sirius	O
red	O
staining	O
and	O
(	O
C	O
)	O
quantified	O
with	O
collagen	O
proportionate	O
area	O
analysis	O
in	O
PCLS	O
after	O
5	O
μM	O
erlotinib	O
treatment	O
for	O
72	O
hours	O
.	O

The	O
development	O
of	O
the	O
Just	O
Culture	O
Assessment	O
Tool	O
(	O
JCAT	O
)	O
is	O
a	O
direct	O
response	O
to	O
the	O
practical	O
needs	O
of	O
the	O
organization	O
to	O
effectively	O
distinguish	O
between	O
overall	O
patient	O
safety	O
culture	O
,	O
and	O
a	O
just	O
culture	O
for	O
patient	O
safety	O
[	O
9	O
,	O
17	O
].	O

Taken	O
together	O
,	O
ElemeNT	B-BT
2023	I-BT
empowers	O
researchers	O
with	O
comprehensive	O
tools	O
for	O
meticulous	O
analysis	O
of	O
sequence	O
elements	O
and	O
gene	O
expression	O
strategies	O
.	O

Mean	O
i2i	O
throughput	O
for	O
communication	O
from	O
the	O
RV	O
to	O
RA	O
and	O
the	O
RA	O
to	O
RV	O
improved	O
from	O
pre	O
-	O
discharge	O
to	O
3	O
months	O
and	O
remained	O
stable	O
through	O
the	O
subsequent	O
9	O
months	O
(	O
Figure	O
2	O
).	O

Our	O
Plant	B-BT
-	I-BT
LncPipe	I-BT
comprises	O
three	O
main	O
modules	O
for	O
distinct	O
tasks	O
:	O
(	O
1	O
)	O
transcriptome	O
alignment	O
and	O
transcriptome	O
assembly	O
;	O
(	O
2	O
)	O
lncRNA	O
identification	O
;	O
and	O
(	O
3	O
)	O
lncRNA	O
origin	O
and	O
classification	O
.	O

In	O
-	O
depth	O
transcriptional	O
and	O
functional	O
genomic	O
studies	O
have	O
validated	O
the	O
functional	O
relevance	O
of	O
CEMIG	B-BT
-	O
identified	O
motifs	O
across	O
various	O
cell	O
types	O
.	O

[	O
30	O
]	O
was	O
used	O
to	O
determine	O
the	O
thickness	O
,	O
spread	O
ratio	O
and	O
diameter	O
of	O
biscuits	O
,	O
with	O
slight	O
modifications	O
.	O

(	O
2	O
)	O
In	O
terms	O
of	O
state	O
time	O
perspective	O
,	O
depressed	O
adolescents	O
showed	O
a	O
significantly	O
higher	O
number	O
of	O
squares	O
related	O
to	O
past	O
negative	O
,	O
present	O
negative	O
,	O
and	O
future	O
negative	O
in	O
their	O
nine	O
-	O
grid	O
sandplay	O
productions	O
compared	O
to	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O
Conversely	O
,	O
they	O
had	O
significantly	O
fewer	O
squares	O
associated	O
with	O
past	O
positive	O
,	O
present	O
positive	O
,	O
future	O
positive	O
than	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Alignment	O
of	O
the	O
spectra	O
was	O
performed	O
after	O
the	O
preprocessing	O
step	O
with	O
MSIWarp	B-BT
,	O
a	O
Python	O
package	O
provided	O
with	O
C	O
++	O
implementation	O
.	O

The	O
application	O
of	O
PM	B-BT
-	I-BT
CNN	I-BT
to	O
human	O
gut	O
and	O
oral	O
microbiome	O
datasets	O
demonstrates	O
its	O
superior	O
performance	O
in	O
multi	O
-	O
status	O
classification	O
compared	O
to	O
other	O
existing	O
ML	O
models	O
.	O

The	O
gene	O
model	O
was	O
summarized	O
using	O
gFACs	O
v1	O
.	O
1	O
.	O
2	O
and	O
the	O
gene	O
model	O
completeness	O
was	O
assessed	O
using	O
BUSCO	B-BT
v5	O
.	O
3	O
.	O
0	O
based	O
on	O
the	O
endopterygota_odb10	O
database14	O
,	O
34	O
.	O

packageVersion	O
"("""	O
SpacoR	B-BT
""")"	O

Association	O
(	O
adjusted	O
odds	O
ratio	O
and	O
95	O
%	O
confidence	O
interval	O
)	O
between	O
baseline	O
factors	O
and	O
serum	O
Knext	O
-	O
4mo	O
<	O
3	O
.	O
5	O
mEq	O
/	O
l	O

The	O
incidence	O
of	O
cardiovascular	O
hospitalization	O
was	O
statistically	O
increased	O
in	O
patients	O
with	O
higher	O
LAP	O
quartiles	O
(	O
1st	O
quartile	O
8	O
.	O
5	O
%,	O
2nd	O
quartile	O
12	O
.	O
5	O
%,	O
3rd	O
quartile	O
22	O
.	O
2	O
%,	O
4th	O
quartile	O
22	O
.	O
6	O
%;	O
p	O
-	O
value	O
for	O
LAP	O
quartile	O
=	O
0	O
.	O
002	O
),	O
as	O
shown	O
Figure	O
1	O
.	O

globosa	O
Lipase	O
-	O
1	O
using	O
the	O
patchdock	B-BT
method	O

MAG	O
is	O
also	O
available	O
in	O
US	O
DOE	O
Joint	O
Genome	O
Institute	O
’	O
s	O
Integrated	B-BT
Microbial	I-BT
Genomes	I-BT
(	I-BT
IMG	I-BT
)	I-BT
system	O
under	O
the	O
taxon	O
ID	O
2886190707	O
.	O

As	O
expected	O
,	O
models	O
trained	O
with	O
EvoAug	B-BT
-	I-BT
TF	I-BT
augmentations	O
in	O
batch	O
mode	O
consistently	O
led	O
to	O
improved	O
performance	O
(	O
Fig	O
.	O

Different	O
from	O
the	O
DL	O
frameworks	O
of	O
the	O
other	O
models	O
,	O
NanoDeep	B-BT
includes	O
a	O
pretrained	O
model	O
to	O
classify	O
microbes	O
from	O
mammals	O
based	O
on	O
the	O
finding	O
that	O
the	O
signals	O
of	O
6	O
-	O
mers	O
in	O
bacterial	O
genomes	O
are	O
distinct	O
from	O
those	O
in	O
the	O
human	O
genome	O
[	O
20	O
].	O

In	O
addition	O
we	O
found	O
36	O
,	O
198	O
(	O
H1	O
)	O
and	O
47	O
,	O
651	O
(	O
HFFc6	O
)	O
high	O
frequency	O
bins	O
that	O
were	O
not	O
identified	O
by	O
cooltools	B-BT
.	O

We	O
consider	O
this	O
as	O
reasonable	O
costs	O
for	O
a	O
small	O
testbed	O
and	O
it	O
should	O
allow	O
other	O
research	O
groups	O
to	O
replicate	O
our	O
testbed	O
.	O
Table	O
3	O
.	O
BACnet	O
components	O
used	O
in	O
our	O
testbed	O
.	O
VendorProductBACnet	O
profileApproximate	O
costKMCBAC	O
-	O
5050Router	O
$	O
1	O
.	O
000	O
USDKMCFlexStat	O
BAC	O
-	O
131136CEWB	O
-	O
ASC	O
$	O
1	O
.	O
000	O
USDMBSBACeye	O
version	O
2	O
.	O
1	O
.	O
0	O
.	O
15B	O
-	O
OWS	O
$	O
500	O
USDJanitzaUMG	O
604	O
-	O
PROB	O
-	O
SA	O
$	O
1	O
.	O
000	O
USD	O

To	O
assign	O
short	O
non	O
-	O
coding	O
RNAs	O
to	O
tRNAs	O
,	O
alignment	O
files	O
for	O
18	O
–	O
36	O
nucleotide	O
small	O
RNAs	O
generated	O
by	O
tinyRNA	B-BT
(	O
above	O
)	O
were	O
converted	O
to	O
bed	O
files	O
using	O
bedtools	O
and	O
then	O
intersected	O
with	O
the	O
tRNA	O
coordinates	O
using	O
bedtools	O
intersect	O
.	O

Thus	O
,	O
the	O
Pfam	O
domain	O
search	O
algorithm	O
has	O
been	O
embedded	O
into	O
the	O
Hmrbase	B-BT
platform	O
.	O

In	O
contrast	O
,	O
the	O
IMP	O
is	O
primarily	O
mapped	O
to	O
the	O
gp120	O
outer	O
domain	O
and	O
contains	O
the	O
N332	O
supersite	O
,	O
which	O
is	O
conserved	O
in	O
73	O
%	O
of	O
~	O
30	O
,	O
000	O
cross	O
-	O
clade	O
Env	O
sequences	O
(	O
HIResist	B-BT
database	O
:	O
https	O
://	O
hiresist	B-BT
.	O
umn	O
.	O
edu	O
/;	O
reference	O
42	O
).	O

The	O
study	O
population	O
consisted	O
of	O
individuals	O
included	O
in	O
the	O
VOYAGER	O
(	O
Human	O

Implementing	O
RCTs	O
to	O
evaluate	O
the	O
effectiveness	O
of	O
targeted	O
interventions	O
aimed	O
at	O
reducing	O
VAI	O
and	O
LAP	O
levels	O
could	O
provide	O
robust	O
evidence	O
for	O
clinical	O
practice	O
.	O

An	O
important	O
feature	O
of	O
KGD	O
is	O
that	O
four	O
modules	O
recently	O
developed	O
by	O
our	O
groups	O
,	O
a	O
‘	O
GO	O
tool	O
’,	O
‘	O
Pathway	O
tool	O
’,	O
‘	O
SyntenyViewer	B-BT
’	O
and	O
‘	O
RNA	O
-	O
Seq	O
’,	O
have	O
been	O
implemented	O
to	O
extend	O
the	O
capabilities	O
of	O
the	O
database	O
.	O

(	O
1	O
)	O
BWA	O
v0	O
.	O
7	O
.	O
10	O
-	O
r789	O
:	O
aln	O
,	O
default	O
parameters	O
;	O
(	O
2	O
)	O
LACHESIS	O
:	O
CLUSTER_MIN_RE_SITES	O
=	O
547	O
;	O
CLUSTER_MAX_LINK_DENSITY	O
=	O
2	O
;	O
CLUSTER_NONINFORMATIVE_RATIO	O
=	O
2	O
;	O
ORDER_MIN_N_RES_IN_TRUN	O
=	O
1094	O
;	O
ORDER_MIN_N_RES_IN_SHREDS	O
=	O
1076	O
;	O
(	O
3	O
)	O
BUSCO	O
v3	O
.	O
0	O
:	O
--	O
evalue	O
1e	O
-	O
03	O
(	O
E	O
-	O
value	O
cutoff	O
for	O
BLAST	O
searches	O
),	O
-	O
sp	O
human	O
;	O
(	O
4	O
)	O
LTR_FINDER	O
:	O
default	O
parameters	O
;	O
(	O
5	O
)	O
RepeatScout	O
:	O
default	O
parameters	O
;	O
(	O
6	O
)	O
PASTEClassifier	B-BT
:	O
default	O
parameters	O
;	O
(	O
7	O
)	O
RepeatMasker	O
:	O
-	O
nolow	O
-	O
no_is	O
-	O
norna	O
-	O
engine	O
wublast	O
;	O
(	O
8	O
)	O
Genscan	O
:	O
default	O
parameters	O
;	O
(	O
9	O
)	O
Augustus	O
v2	O
.	O
4	O
:	O
default	O
parameters	O
;	O
(	O
10	O
)	O
GlimmerHMM	O
v3	O
.	O
0	O
.	O
4	O
:	O
default	O
parameters	O
;	O
(	O
11	O
)	O
GeneID	O
v1	O
.	O
4	O
:	O
default	O
parameters	O
;	O
(	O
12	O
)	O
SNAP	O
:	O
version	O
2006	O
-	O
07	O
-	O
28	O
,	O
default	O
parameters	O
;	O
(	O
13	O
)	O
GeMoMa	O
v1	O
.	O
3	O
.	O
1	O
:	O
default	O
parameters	O
;	O
(	O
14	O
)	O
Hisat	O
v2	O
.	O
0	O
.	O
4	O
:	O
--	O
max	O
-	O
intronlen	O
20000	O
,	O
--	O
min	O
-	O
intronlen	O
20	O
;	O
(	O
15	O
)	O
Stringtie	O
v1	O
.	O
2	O
.	O
3	O
:	O
default	O
parameters	O
;	O
(	O
16	O
)	O
TransDecoder	O
v2	O
.	O
0	O
:	O
default	O
parameters	O
;	O
(	O
17	O
)	O
GeneMark	O
-	O
ST	O
v5	O
.	O
1	O
:	O
default	O
parameters	O
;	O
(	O
18	O
)	O
PASA	O
v2	O
.	O
0	O
.	O
2	O
:	O
-	O
align_tools	O
gmap	O
,	O
-	O
maxIntronLen	O
20000	O
;	O
(	O
19	O
)	O
EVM	O
v1	O
.	O
1	O
.	O
1	O
:	O
default	O
parameters	O
;	O
(	O
20	O
)	O
BLAST	O
V2	O
.	O
2	O
.	O
31	O
:	O
-	O
evalue	O
1e	O
-	O
5	O
;	O
(	O
21	O
)	O
tRNAscan	O
-	O
SE	O
:	O
default	O
parameters	O
.	O

The	O
surface	O
morphology	O
is	O
significantly	O
smoother	O
with	O
minimal	O
corrosion	O
products	O
and	O
pitting	O
.	O

In	O
the	O
following	O
paragraphs	O
,	O
we	O
present	O
some	O
CytoPipeline	B-BT
visual	O
assessment	O
plots	O
,	O
according	O
to	O
6	O
different	O
use	O
cases	O
(	O
Table	O
1	O
).	O

Nonetheless	O
,	O
BaRDIC	B-BT
robustly	O
captures	O
background	O
features	O
of	O
both	O
OTA	O
and	O
ATA	O
data	O
to	O
detect	O
specific	O
RNA	O
–	O
DNA	O
interactions	O
.	O

This	O
outcome	O
underscored	O
the	O
effectiveness	O
of	O
PM	B-BT
-	I-BT
CNN	I-BT
in	O
harnessing	O
the	O
phylogenetic	O
relationships	O
among	O
microbes	O
for	O
classification	O
tasks	O
,	O
filling	O
the	O
gap	O
left	O
by	O
the	O
traditional	O
machine	O
learning	O
models	O
,	O
which	O
lacked	O
a	O
priori	O
knowledge	O
of	O
microbe	O
-	O
microbe	O
relations	O
.	O

The	O
open	O
-	O
source	O
program	O
RmsiGUI	B-BT
integrates	O
the	O
control	O
of	O
a	O
robotic	O
imaging	O
platform	O
and	O
the	O
compilation	O
of	O
imzML	O
[	O
83	O
].	O

To	O
assist	O
users	O
in	O
performing	O
their	O
novel	O
analysis	O
on	O
rNMP	O
samples	O
,	O
we	O
provided	O
the	O
free	O
download	O
of	O
collected	O
rNMP	O
sample	O
data	O
,	O
reference	O
genome	O
,	O
genome	O
annotations	O
,	O
and	O
formatted	O
data	O
showing	O
the	O
rNMP	O
-	O
embedment	O
characteristics	O
used	O
in	O
the	O
rNMPID	B-BT
database	O
.	O

The	O
development	O
of	O
scAnnoX	B-BT
has	O
enabled	O
effective	O
analyses	O
of	O
single	O
-	O
cell	O
RNA	O
sequencing	O
data	O
,	O
streamlining	O
the	O
processes	O
of	O
testing	O
,	O
evaluating	O
,	O
and	O
comparing	O
multiple	O
algorithms	O
,	O
thereby	O
equipping	O
researchers	O
with	O
the	O
tools	O
necessary	O
to	O
navigate	O
the	O
complexity	O
of	O
algorithm	O
selection	O
.	O

While	O
some	O
methods	O
tailor	O
complex	O
custom	O
probabilistic	O
models	O
to	O
the	O
specific	O
properties	O
of	O
scRNA	O
data	O
,	O
GeneVector	B-BT
instead	O
builds	O
upon	O
MI	O
,	O
a	O
simple	O
yet	O
powerful	O
tool	O
for	O
calculating	O
the	O
amount	O
of	O
information	O
shared	O
between	O
two	O
variables	O
.	O

Data	O
are	O
available	O
in	O
the	O
article	O
and	O
HIResist	B-BT
database	O
(	O
https	O
://	O
hiresist	B-BT
.	O
umn	O
.	O
edu	O
/).	O

Similarly	O
RNASeq	O
data	O
was	O
also	O
combined	O
and	O
mapped	O
to	O
the	O
genome	O
assembly	O
of	O
red	O
snapper	O
using	O
the	O
Hisat2	O
tool	O
to	O
generate	O
the	O
sam	O
file	O
and	O
subsequently	O
converted	O
to	O
and	O
sorted	O
to	O
bam	O
file	O
.	O

By	O
8	O
h	O
,	O
the	O
Tg	O
-	O
response	O
in	O
parental	O
cells	O
included	O
other	O
Reactome	B-BT
pathways	O
associated	O
with	O
normal	O
ER	O
function	O
including	O
Asparagine	O
N	O
-	O
linked	O
glycosylation	O
,	O
Cholesterol	O
biosynthesis	O
,	O
ER	O
to	O
Golgi	O
Anterograde	O
Transport	O
and	O
N	O
-	O
glycan	O
trimming	O
in	O
the	O
ER	O
and	O
Calnexin	O
/	O
calreticulin	O
cycle	O
,	O
a	O
glycoprotein	O
chaperone	O
pathway	O
in	O
the	O
ER40suggesting	O
the	O
ER	O
function	O
may	O
be	O
highly	O
compromised	O
by	O
8	O
h	O
.	O

(	O
A	O
,	O
C	O
)	O
Predictions	O
by	O
AlphaFold2	O
[	O
20	O
]	O
and	O
PSIPRED	B-BT
[	O
21	O
],	O
illustrate	O
the	O
ORF3	O
protein	O
structure	O
with	O
seven	O
alpha	O
helices	O
(	O
indicated	O
in	O
pink	O
).	O

Having	O
confirmed	O
the	O
proteasome	O
involvement	O
in	O
the	O
turnover	O
of	O
profilaggrin	O
,	O
we	O
next	O
set	O
out	O
to	O
determine	O
degron	O
components	O
in	O
the	O
protein	O
sequence	O
using	O
our	O
DEGRONOPEDIA	B-BT
web	O
server	O
,	O
which	O
enables	O
comprehensive	O
annotation	O
of	O
degron	O
motifs	O
and	O
potentially	O
related	O
PTMs	O
,	O
with	O
a	O
particular	O
focus	O
on	O
ubiquitination	O
and	O
phosphorylation	O
.	O

demonstrated	O
that	O
LAP	O
is	O
a	O
practical	O
index	O
for	O
identifying	O
individuals	O
at	O
risk	O
for	O
metabolic	O
syndrome	O
and	O
T2DM	O
,	O
independent	O
of	O
traditional	O
anthropometric	O
measures	O
like	O
BMI	O
[	O
25	O
].	O

By	O
observing	O
the	O
EWL	O
structure	O
,	O
extracting	O
EMAA	O
and	O
the	O
fiber	O
bundles	O
and	O
matrix	O
influenced	O
by	O
EMAA	O
(	O
stitch	O
-	O
influenced	O
area	O
),	O
a	O
local	O
mesoscopic	O
RVE	O
model	O
was	O
constructed	O
,	O
as	O
shown	O
in	O
Figure	O
4a	O
,	O
where	O
the	O
fibers	O
in	O
the	O
X	O
and	O
Y	O
directions	O
represent	O
the	O
warp	O
and	O
weft	O
fibers	O
,	O
respectively	O
.	O

(	O
b	O
)	O
N2	O
−	O
sorption	O
isotherms	O
for	O
the	O
PyPOP	B-BT
,	O
graphene	O
,	O
and	O
PyPOP	B-BT
@	O
G	O
[	O
50	O
].	O

RAMZIS	B-BT
uses	O
a	O
few	O
key	O
metrics	O
to	O
evaluate	O
the	O
dataset	O
.	O

The	O
report	O
was	O
saved	O
in	O
the	O
file	O
with	O
prefix	O
“	O
Report_	O
”	O
in	O
text	O
format	O
(	O
with	O
extension	O
“*.	O
txt	O
”);	O
the	O
report	O
is	O
obtained	O
following	O
the	O
steps	O
,(	O
i	O
)	O
right	O
-	O
click	O
on	O
the	O
chromatogram	O
,(	O
ii	O
)	O
select	O
“	O
Chromatogram	O
Reports	O
”,(	O
iii	O
)	O
select	O
“	O
OpenChrom	B-BT
Report	O
(*.	O
txt	O
)”,(	O
iv	O
)	O
save	O
the	O
report	O
by	O
following	O
the	O
same	O
process	O
as	O
in	O
item	O
5	O
,	O
and	O
by	O
replacing	O
prefix	O
“	O
Peaks_	O
”	O
with	O
“	O
Report_	O
”.	O

IBDTransDB	B-BT
also	O
provides	O
three	O
modules	O
for	O
data	O
analyses	O
and	O
integration	O
.	O

To	O
solve	O
these	O
issues	O
,	O
PhysiBoSS	O
2	O
.	O
034	O
was	O
re	O
-	O
designed	O
and	O
re	O
-	O
implemented	O
from	O
scratch	O
as	O
an	O
add	O
-	O
on	O
interface	O
which	O
decouples	O
PhysiCell	O
and	O
MaBoSS	B-BT
minimising	O
dependencies	O
and	O
fixing	O
many	O
design	O
problems	O
of	O
version	O
1	O
.	O
0	O
(	O
Fig	O
.	O

pyKVFinder	B-BT
(	O
66	O
)	O
was	O
used	O
for	O
cavity	O
calculation	O
.	O

Our	O
data	O
suggest	O
that	O
enamel	O
in	O
the	O
trigon	O
basin	O
of	O
Cercocebus	O
atys	O
molars	O
gains	O
fracture	O
resistance	O
from	O
its	O
enamel	O
decussation	O
complexity	O
and	O
wear	O
resistance	O
from	O
its	O
nanomechanical	O
properties	O
.	O

We	O
provide	O
a	O
case	O
study	O
integrating	O
enzyme	O
modules	O
within	O
a	O
mass	O
action	O
model	O
of	O
glycolysis	O
as	O
a	O
Jupyter	O
notebook	O
workflow	O
implemented	O
in	O
Python	O
(	O
scripts	O
available	O
on	O
github	O
.	O
com	O
/	O
opencobra	O
/	O
massef	B-BT
).	O

Most	O
of	O
the	O
data	O
we	O
currently	O
have	O
access	O
to	O
pertain	O
to	O
inhibitory	O
drugs	O
,	O
guiding	O
the	O
development	O
and	O
testing	O
of	O
scRank	B-BT
predominantly	O
within	O
this	O
context	O
.	O

Unlike	O
current	O
alternatives	O
for	O
sharing	O
findings	O
,	O
such	O
as	O
static	O
documents	O
for	O
supplementary	O
materials	O
and	O
open	O
repositories	O
,	O
shinyExprPortal	B-BT
allows	O
researchers	O
to	O
comment	O
and	O
curate	O
their	O
findings	O
whilst	O
still	O
enabling	O
interested	O
readers	O
to	O
explore	O
alternatives	O
and	O
interact	O
with	O
the	O
results	O
.	O

To	O
address	O
these	O
issues	O
,	O
this	O
paper	O
introduces	O
shinyExprPortal	B-BT
,	O
an	O
R	O
package	O
that	O
enables	O
the	O
deployment	O
of	O
web	O
portals	O
for	O
molecular	O
expression	O
data	O
using	O
a	O
text	O
-	O
based	O
configuration	O
file	O
and	O
requiring	O
minimal	O
coding	O
.	O

We	O
hypothesized	O
that	O
mScan	O
could	O
identify	O
individuals	O
with	O
worse	O
strength	O
and	O
body	O
composition	O
outcomes	O
among	O
older	O
adults	O
with	O
and	O
without	O
T1D	O
.	O

Similarly	O
,	O
there	O
was	O
a	O
sharp	O
decline	O
in	O
the	O
effectiveness	O
of	O
2	O
×	O
Sputnik	O
V	O
/	O
1	O
×	O
Pfizer	O
regimen	O
,	O
measuring	O
−	O
19	O
.	O
0	O
%	O
(	O
95	O
%	O
CI	O
,	O
−	O
60	O
.	O
2	O
–	O
10	O
.	O
6	O
)	O
(	O
see	O
Fig	O
3E	O
and	O
Table	O
2	O
).	O

And	O
5	O
in	O
top	O
10	O
genes	O
have	O
verified	O
to	O
be	O
highly	O
related	O
to	O
LUAD	O
according	O
to	O
DisGeNET	B-BT

The	O
dataset	O
used	O
in	O
[	O
75	O
]	O
is	O
collected	O
using	O
25	O
Pycom	O
LoRa	O
transceivers	O
and	O
2	O
USRP	O
B210	O
SDRs	O
.	O

Specifications	O
tableSubject	O
area	O
:	O
Materials	O
ScienceMore	O
specific	O
subject	O
area	O
:	O
Alcogel	O
formationName	O
of	O
your	O
method	O
:	O
Validation	O
of	O
alcogel	O
formationName	O
and	O
reference	O
of	O
original	O
method	O
:	O
Bento	O
,	O
C	O
.	O
S	O
.	O
A	O
.,	O
Agostinho	O
,	O
B	O
.,	O
Teixeira	O
,	O
A	O
.,	O
Reis	O
,	O
M	O
.	O
S	O
.,	O
Sousa	O
,	O
H	O
.	O
C	O
.	O
D	O
.,	O
Braga	O
,	O
M	O
.	O
E	O
.	O
M	O
.,	O
2024	O
.	O

To	O
investigate	O
the	O
influence	O
of	O
pharyngeal	O
images	O
on	O
the	O
predictions	O
,	O
we	O
also	O
examined	O
the	O
performance	O
of	O
an	O
MI	B-BT
-	I-BT
CNN	I-BT
model	O
using	O
pharyngeal	O
image	O
only	O
and	O
a	O
logistic	O
regression	O
model	O
using	O
demographic	O
information	O
only	O
.	O

The	O
Essex	O
Skipper	O
(	O
Thymelicus	O
lineola	O
),	O
also	O
known	O
as	O
the	O
European	O
Skipper	O
,	O
is	O
a	O
widely	O
distributed	O
butterfly	O
found	O
from	O
northern	O
Finland	O
to	O
North	O
Africa	O
,	O
and	O
from	O
Central	O
Asia	O
to	O
Great	O
Britain	O
.	O

The	O
Station	O
d	O
'	O
Ecologie	O
Théorique	O
et	O
Expérimentale	O
has	O
a	O
national	O
agreement	O
for	O
use	O
of	O
animals	O
in	O
the	O
laboratory	O
(	O
number	O
B09583	O
),	O
and	O
our	O
experiments	O
are	O
made	O
in	O
accordance	O
with	O
French	O
ethics	O
regulations	O
(	O
Ethics	O
permits	O
number	O
APAFIS	O
#	O
15897	O
‐	O
2018070615164391	O
v3	O
for	O
toe	O
clipping	O
and	O
APAFIS	O
#	O
19523	O
‐	O
201902281559649	O
v3	O
for	O
other	O
experimental	O
procedures	O
,	O
including	O
the	O
maintenance	O
of	O
lizards	O
in	O
the	O
Metatron	O
).	O

Among	O
the	O
rPPG	O
models	O
,	O
representative	O
methods	O
that	O
are	O
used	O
as	O
baselines	O
include	O
“	O
PhysNet	O
”,	O
“	O
RhythmNet	O
”,	O
and	O
“	O
Deephys	B-BT
”;	O
each	O
has	O
a	O
unique	O
approach	O
[	O
4	O
,	O
5	O
,	O
6	O
].	O

We	O
present	O
a	O
phylogenetic	O
method	O
,	O
PhyloAcc	B-BT
-	I-BT
C	I-BT
,	O
that	O
associates	O
nucleotide	O
substitution	O
rates	O
with	O
changes	O
in	O
a	O
continuous	O
trait	O
of	O
interest	O
.	O

In	O
brief	O
,	O
the	O
‘	O
SyntenyViewer	B-BT
’	O
module	O
can	O
not	O
only	O
reveal	O
syntenic	O
blocks	O
between	O
any	O
two	O
genome	O
sequences	O
but	O
also	O
connect	O
homologous	O
gene	O
pairs	O
in	O
syntenic	O
blocks	O
.	O

This	O
procedure	O
helps	O
to	O
correct	O
the	O
claw	O
toe	O
deformity	O
.	O

To	O
avoid	O
large	O
RAM	O
consumption	O
,	O
we	O
implemented	O
the	O
greedy	O
algorithm	O
for	O
tab	O
-	O
separated	O
merging	O
and	O
incremental	O
PCA	O
plot	O
limiter	O
from	O
MerCat2	B-BT
(	O
Figueroa	O
III	O
et	O
al	O
.	O

According	O
to	O
several	O
studies	O
,	O
LAP	O
may	O
be	O
a	O
sign	O
of	O
NAFLD	O
,	O
heart	O
disease	O
,	O
type	O
2	O
diabetes	O
,	O
and	O
MetS	O
(	O
21	O
,	O
25	O
–	O
27	O
).	O

Jane	O
’	O
s	O
approach	O
performed	O
well	O
and	O
showed	O
consistent	O
improvement	O
over	O
eTBLAST	B-BT
[	O
12	O
].	O

We	O
also	O
did	O
not	O
use	O
daratumumab	O
during	O
maintenance	O
therapy	O
as	O
was	O
done	O
in	O
the	O
D	O
-	O
RVd	O
arms	O
in	O
the	O
GRIFFIN	O
and	O
PERSEUS	O
trials	O
and	O
instead	O
utilized	O
the	O
previously	O
described	O
risk	O
-	O
stratified	O
maintenance	O
approach	O
per	O
our	O
standard	O
institutional	O
practice	O
[	O
14	O
].	O

This	O
web	O
server	O
is	O
freely	O
available	O
at	O
https	O
://	O
stcoexpnet	B-BT
.	O
julius	O
-	O
kuehn	O
.	O
de	O
.	O

2013	O
)	O
to	O
extract	O
curated	O
gene	O
sets	O
,	O
Rummagene	B-BT
(	O
Clarke	O
et	O
al	O
.	O

Altogether	O
,	O
it	O
was	O
suggested	O
that	O
Bd	B-BT
-	I-BT
RPC	I-BT
maintained	O
the	O
robustness	O
in	O
the	O
section	O
‘	O
Make	O
Database	O
’.	O

Furthermore	O
,	O
Domain2GO	B-BT
‐	O
S	O
and	O
Domain2GO	B-BT
‐	O
E	O
outperformed	O
the	O
baseline	O
predictors	O
and	O
DomFun	O
when	O
predicting	O
MF	O
and	O
BP	O
terms	O
,	O
achieving	O
Fmax	O
scores	O
of	O
0	O
.	O
48	O
and	O
0	O
.	O
46	O
for	O
MFO	O
,	O
and	O
0	O
.	O
36	O
and	O
0	O
.	O
35	O
for	O
BPO	O
,	O
respectively	O
.	O

BacPP	O
,	O
and	O
our	O
CDBProm	B-BT
.	O

Within	O
the	O
same	O
type	O
of	O
CRISPR	O
-	O
Sirius	O
system	O
,	O
sgRNAs	O
C6_sg1	O
and	O
C6_sg2	O
individually	O
were	O
equally	O
efficient	O
.	O

This	O
is	O
a	O
correction	O
to	O
:	O
Dmitry	O
E	O
Mylarshchikov	O
,	O
Arina	O
I	O
Nikolskaya	O
,	O
Olesja	O
D	O
Bogomaz	O
,	O
Anastasia	O
A	O
Zharikova	O
,	O
Andrey	O
A	O
Mironov	O
,	O
BaRDIC	B-BT
:	O
robust	O
peak	O
calling	O
for	O
RNA	O
–	O
DNA	O
interaction	O
data	O
,	O
NAR	O
Genomics	O
and	O
Bioinformatics	O
,	O
Volume	O
6	O
,	O
Issue	O
2	O
,	O
June	O
2024	O
,	O
lqae054	O
,	O
https	O
://	O
doi	O
.	O
org	O
/	O
10	O
.	O
1093	O
/	O
nargab	O
/	O
lqae054	O

Supplemental	O
Figure	O
S1CLIPPER	B-BT
2	I-BT
.	I-BT
0	I-BT
flowchart	O
indicating	O
different	O
features	O
,	O
capabilities	O
and	O
results	O
generated	O
.	O

The	O
nodes	O
in	O
the	O
BoostDiff	B-BT
network	O
have	O
a	O
small	O
overlap	O
with	O
the	O
list	O
of	O
DEGs	O
(	O
Jaccard	O
similarity	O
=	O
0	O
.	O
008	O
).	O

The	O
software	O
has	O
also	O
been	O
invented	O
for	O
automated	O
lipid	O
imaging	O
detection	O
,	O
including	O
Alex	O
,	O
129	O
LipostarMSI	O
,	O
130	O
MassPix	B-BT
,	O
131	O
,	O
and	O
common	O
alkali	O
metal	O
adducts	O
,	O
matrix	O
adducts	O
,	O
and	O
isotopes	O
,	O
including	O
Mass2adduct	O
.	O
132	O
Common	O
annotation	O
platforms	O
,	O
including	O
pySM	O
(	O
METASPACE	O
),	O
have	O
also	O
been	O
developed	O
for	O
lipid	O
and	O
metabolite	O
annotation	O
with	O
high	O
mass	O
accuracy	O
data	O
.	O
25	O
However	O
,	O
this	O
method	O
relies	O
more	O
on	O
predicting	O
peaks	O
and	O
combining	O
the	O
MS	O
/	O
MS	O
dataset	O
.	O

Here	O
,	O
we	O
systematically	O
benchmarked	O
10	O
end	O
-	O
to	O
-	O
end	O
preprocessing	O
workflows	O
,	O
including	O
scPipe	B-BT
,	O
zUMIs	O
,	O
kallisto	O
bustools	O
,	O
dropSeqPipe	O
[	O
36	O
],	O
Cell	O
Ranger	O
,	O
Optimus	O
,	O
salmon	O
alevin	O
,	O
alevin	O
-	O
fry	O
,	O
celseq2	O
[	O
35	O
]	O
and	O
scruff	O
[	O
37	O
].	O

Comparison	O
of	O
multi	O
-	O
label	O
prediction	O
performance	O
with	O
DM3Loc	O
,	O
MRSLpred	B-BT
,	O
and	O
Clarion	O
predictors	O
at	O
five	O
subcellular	O
localizations	O
on	O
the	O
independent	O
test	O
set	O
(	O
membrane	O
,	O
cytosol	O
,	O
exosome	O
,	O
nucleus	O
,	O
ribosome	O
).	O

The	O
MI	B-BT
-	I-BT
CNN	I-BT
inputs	O
images	O
taken	O
from	O
multiple	O
directions	O
and	O
locations	O
in	O
the	O
throat	O
into	O
a	O
CNN	O
-	O
based	O
feature	O
extractor	O
(	O
encoder	O
)	O
to	O
obtain	O
image	O
-	O
level	O
features	O
.	O

VCFtools	O
and	O
BCFtools	O
do	O
not	O
offer	O
distinct	O
benchmarking	O
capabilities	O
,	O
however	O
,	O
they	O
can	O
be	O
used	O
to	O
put	O
together	O
benchmarking	O
results	O
based	O
on	O
their	O
comparisons	O
.	O
Table	O
1Summary	O
of	O
VCF	O
file	O
handling	O
tools	O
and	O
their	O
capabilitiesComparisonGUIFilteringBenchmarkingVisualizationMetadataVCFtools	O
××	O
BCFtools	O
××	O
BrowseVCF	O
××	O
VCF	O
-	O
miner	O
××	O
VIVA	O
×××	O
123VCF	B-BT
××	O
VCF	O
observer	O
××××××	O
Features	O
present	O
in	O
various	O
tools	O
for	O
handling	O
VCF	O
files	O
are	O
marked	O
with	O
a	O
cross	O
.	O

The	O
ExPASy	B-BT
ProtParam	O
tool	O
predicted	O
218	O
,	O
25	O
.	O
40237	O
,	O
7	O
.	O
63	O
,	O
and	O
−	O
0	O
.	O
388	O
number	O
of	O
amino	O
acids	O
,	O
molecular	O
weight	O
,	O
theoretical	O
pI	O
,	O
and	O
GRAVY	O
,	O
respectively	O
,	O
for	O
glutathione	O
transferase	O
,	O
while	O
for	O
Cathepsin	O
L1	O
,	O
the	O
number	O
of	O
amino	O
acids	O
,	O
molecular	O
weight	O
,	O
theoretical	O
pI	O
,	O
and	O
GRAVY	O
of	O
326	O
,	O
36	O
.	O
89645	O
,	O
6	O
.	O
71	O
,	O
and	O
−	O
0	O
.	O
503	O
were	O
calculated	O
,	O
respectively	O
.	O

With	O
its	O
ultra	O
-	O
fast	O
algorithm	O
,	O
TrieDedup	B-BT
may	O
also	O
potentially	O
be	O
applied	O
to	O
barcode	O
or	O
UMI	O
assignment	O
when	O
considering	O
reads	O
with	O
a	O
few	O
low	O
-	O
quality	O
bases	O
in	O
the	O
UMIs	O
.	O

MarkerScan	B-BT
relies	O
on	O
the	O
presence	O
of	O
diagnostic	O
SSUs	O
in	O
the	O
assembled	O
sequence	O
set	O
.	O

First	O
,	O
the	O
GenoMycAnalyzer	B-BT
includes	O
a	O
molecular	O
typing	O
function	O
,	O
and	O
large	O
-	O
scale	O
validation	O
confirmed	O
accurate	O
lineage	O
and	O
spoligotype	O
predictions	O
.	O

Trained	O
separately	O
on	O
four	O
datasets	O
with	O
different	O
proportions	O
of	O
JCAT	B-BT
-	O
optimized	O
sequences	O
,	O
CodonBERT	O
consistently	O
achieved	O
accuracies	O
with	O
a	O
median	O
of	O
100	O
%	O
(	O
Supplementary	O
Fig	O
.	O

Concept	O
and	O
design	O
:	O
Ricardo	O
Noguera	O
Louzada	O
,	O
Dillan	O
Cunha	O
Amaral	O
,	O
Claudio	O
do	O
Carmo	O
Chaves	O
Filho	O
,	O
Daniel	O
Oliveira	O
Dantas	O
,	O
Francisco	O
Carlos	O
de	O
Castro	O
Neto	O
,	O
Milton	O
Ruiz	O
Alves	O

Although	O
there	O
are	O
some	O
outliers	O
with	O
a	O
high	O
reconstruction	O
error	O
,	O
SHAPRs	B-BT
was	O
generally	O
able	O
to	O
retrieve	O
real	O
-	O
world	O
3D	O
information	O
and	O
outperformed	O
naïve	O
3D	O
shape	O
fitting	O
models	O
on	O
both	O
datasets	O
.	O

If	O
there	O
is	O
a	O
demand	O
from	O
the	O
community	O
,	O
we	O
will	O
update	O
the	O
quickBAM	O
multiple	O
pileup	O
engine	O
to	O
behave	O
exactly	O
as	O
HTSLIB	B-BT
in	O
high	O
coverage	O
regions	O
.	O

Most	O
of	O
the	O
information	O
about	O
these	O
bioactive	O
peptides	O
is	O
available	O
in	O
various	O
databases	O
such	O
as	O
TumorHoPe	O
[	O
75	O
],	O
Biopep	O
-	O
UWM	O
,	O
StraPep	O
,	O
FeptideDB	O
,	O
ACEpepDB	O
,	O
BioPD	O
,	O
APD	O
,	O
BACTIBASE	O
[	O
76	O
],	O
CAMP	O
,	O
PenBase	O
[	O
77	O
],	O
RAPD	O
[	O
78	O
],	O
Hmrbase	B-BT
[	O
79	O
],	O
PhytAMP	O
[	O
80	O
],	O
PeptideDB	O
,	O
ACEpepDB	O
[	O
81	O
],	O
Amper	O
[	O
82	O
],	O
and	O
BAGEL3	O
[	O
83	O
].	O

subtilis	O
secretome	O
as	O
annotated	O
in	O
the	O
Subtiwiki	B-BT
knowledgebase	O
(	O
Supplementary	O
Fig	O
.	O

While	O
the	O
three	O
types	O
of	O
AdPS	O
/	O
TPMA	O
-	O
Me	O
with	O
different	O
network	O
topologies	O
(	O
dia	O
-,	O
lon	O
-,	O
and	O
sod	O
-	O
topologies	O
)	O
were	O
composed	O
of	O
the	O
same	O
components	O
,	O
they	O
exhibited	O
significantly	O
different	O
gas	O
adsorption	O
properties	O
depending	O
on	O
their	O
network	O
topologies	O
.	O

In	O
the	O
new	O
version	O
,	O
the	O
SARS	O
-	O
CoV	O
-	O
2	O
genome	O
data	O
curation	O
model	O
has	O
been	O
significantly	O
enhanced	O
with	O
an	O
automated	O
integration	O
pipeline	O
and	O
optimized	O
curation	O
rules	O
(	O
Figure	O
2	O
),	O
ensuring	O
efficient	O
daily	O
updates	O
in	O
RCoV19	B-BT
.	O

The	O
article	O
“	O
Concurrent	O
management	O
of	O
multiple	O
sclerosis	O
and	O
natalizumab	O
‑	O
induced	O
hepatitis	O
with	O
ofatumumab	O
:	O
a	O
case	O
report	O
”,	O
written	O
by	O
Shalom	O
Haggiag	O
,	O
Valerio	O
Giannelli	O
,	O
Luca	O
Prosperini	O
,	O
Alessandro	O
Cruciani	O
,	O
Andrea	O
Baiocchini	O
,	O
Serena	O
Ruggieri	O
,	O
Adriano	O
Pellicelli	O
,	O
Claudio	O
Gasperini	O
and	O
Carla	O
Tortorella	O
,	O
was	O
originally	O
published	O
electronically	O
on	O
the	O
publisher	O
’	O
s	O
internet	O
portal	O
on	O
11	O
July	O
2024	O
without	O
open	O
access	O
.	O

In	O
addition	O
to	O
generating	O
count	O
matrices	O
with	O
an	O
equivalent	O
number	O
of	O
reads	O
across	O
platforms	O
,	O
we	O
also	O
processed	O
reads	O
from	O
each	O
platform	O
in	O
specific	O
proportions	O
using	O
scPipe	B-BT
.	O

We	O
first	O
fit	O
the	O
in	O
vitro	O
data	O
alone	O
using	O
MASSef	B-BT
and	O
found	O
that	O
the	O
model	O
was	O
able	O
to	O
perfectly	O
capture	O
the	O
data	O
(	O
Fig	O
.	O

To	O
illustrate	O
its	O
practical	O
application	O
,	O
we	O
apply	O
DeePhys	B-BT
to	O
human	O
induced	O
pluripotent	O
stem	O
cell	O
–	O
derived	O
dopaminergic	O
neurons	O
obtained	O
from	O
both	O
patients	O
and	O
healthy	O
individuals	O
and	O
showcase	O
how	O
DeePhys	B-BT
enables	O
phenotypic	O
screenings	O
.	O

Alternatively	O
,	O
one	O
could	O
remove	O
the	O
“	O
chr	O
”	O
prefix	O
from	O
BAM	O
files	O
prior	O
to	O
running	O
‘	O
01	O
-	O
filter_bam	O
.	O
sh	O
’	O
using	O
the	O
‘	O
samtools	B-BT
reheader	O
’	O
command	O
.	O

Furthermore	O
,	O
BayesKAT	B-BT
implements	O
a	O
scalable	O
computational	O
strategy	O
to	O
boost	O
its	O
applicability	O
,	O
especially	O
for	O
high	O
-	O
dimensional	O
cases	O
where	O
other	O
methods	O
become	O
less	O
effective	O
.	O

The	O
data	O
were	O
stored	O
in	O
five	O
collections	O
or	O
tables	O
under	O
STRIDE	B-BT
-	I-BT
DB	I-BT
database	O
(	O
Figure	O
2	O
).	O

While	O
SIRIUS	B-BT
correctly	O
assigned	O
the	O
chemical	O
formula	O
C15H24O2	O
,	O
the	O
cosine	O
similarity	O
between	O
SIRIUS	B-BT
predicted	O
fingerprint	O
and	O
correct	O
structure	O
fingerprint	O
was	O
only	O
0	O
.	O
33	O
,	O
indicating	O
that	O
MS2	O
data	O
were	O
insufficient	O
for	O
correct	O
fingerprint	O
prediction	O
.	O

Notably	O
,	O
it	O
utilizes	O
the	O
PDBe	O
-	O
molstar	B-BT
library	O
[	O
https	O
://	O
github	O
.	O
com	O
/	O
molstar	B-BT
/	O
pdbe	O
-	O
molstar	B-BT
]	O
for	O
structure	O
visualization	O
,	O
including	O
features	O
such	O
as	O
pockets	O
and	O
interfaces	O
.	O

However	O
,	O
some	O
of	O
the	O
examinations	O
of	O
the	O
answers	O
from	O
PyCOM	B-BT
-	O
NG	O
,	O
SIDMACH	O
,	O
and	O
General	O
revealed	O
a	O
considerable	O
security	O
concern	O
.	O

As	O
shown	O
in	O
Figure	O
1	O
,	O
the	O
full	O
-	O
length	O
coding	O
sequence	O
(	O
CDS	O
)	O
of	O
TaPsb28	O
was	O
retrieved	O
from	O
WheatIS	B-BT
.	O

Those	O
studies	O
mainly	O
explored	O
individuals	O
’	O
attitudes	O
and	O
perceptions	O
of	O
the	O
past	O
,	O
present	O
,	O
and	O
future	O
in	O
different	O
mental	O
states	O
,	O
which	O
fall	O
under	O
the	O
research	O
category	O
of	O
state	O
TP	O
(	O
Stolarski	O
,	O
Fieulaine	O
&	O
Zimbardo	O
,	O
2018	O
).	O

MDP	O
(	O
MetaboLights	B-BT
Data	O
Provider	O
)	O
is	O
a	O
Galaxy	O
Project	O
tool	O
wrapper	O
on	O
MetaboLights	B-BT
Labs	O
to	O
use	O
MetaboLights	B-BT
LC	O
–	O
MS	O
files	O
in	O
workflows	O
.	O

Also	O
support	O
physical	O
location	O
based	O
inferenceDifferential	O
CombinationiTALK	O
[	O
51	O
]	O
Human2648	O
LRs	O
for	O
humanCircle	O
plotNAScores	O
are	O
calculated	O
by	O
differentially	O
expressed	O
LRsPyMINEr	O
[	O
52	O
]	O
Human52	O
,	O
612	O
LRs	O
for	O
humanCircle	O
plotPathway	O
enrichmentEnriched	O
interactions	O
are	O
calculated	O
by	O
a	O
Gaussian	O
null	O
distribution	O
between	O
cell	O
clustersTensor	O
basedScTensor	B-BT
[	O
46	O
]	O
Arabidopsis	O
,	O
11	O
animals12	O
species	O
(	O
21	O
,	O
882	O
[	O
SWISSPROT	O
]/	O
472	O
[	O
TrEMBL	O
]	O
LRs	O
for	O
human	O
,	O
8697	O
/	O
94	O
LRs	O
for	O
Arabidopsis	O
)	O
NAPathway	O
/	O
GO	O
enrichmentTucker	O
decomposition	O
on	O
a	O
tensor	O
of	O
order	O
three	O
to	O
identify	O
key	O
LRs	O
in	O
certain	O
cell	O
typesCombinationLIANA	O
[	O
48	O
]	O
NANANANA7	O
methods	O
from	O
other	O
toolsPlantPhoneDB	O
[	O
42	O
]	O
Arabidopsis	O
,	O
rice	O
,	O
tomato	O
,	O
maize	O
,	O
poplar3514	O
,	O
3762	O
,	O
1751	O
,	O
2823	O
,	O
3110	O
LRs	O
for	O
Arabidopsis	O
,	O
rice	O
,	O
tomato	O
,	O
maize	O
,	O
poplarCircle	O
plot	O
,	O
heatmapNAProvide	O
four	O
scoring	O
approaches	O
to	O
calculate	O
interaction	O
scoresPhysical	O
Location	O
basedCell2Cell	O
[	O
66	O
]	O
Human2005	O
LRs	O
for	O
human	O
,	O
supporting	O
multi	O
-	O
subunit	O
complexesCircle	O
plotPathway	O
enrichmentInfer	O
communication	O
distance	O
using	O
Gaussian	O
mixture	O
modelGiotto	O
[	O
67	O
]	O
NANACircle	O
plot	O
,	O
Bubble	O
plot	O
,	O
heatmapNAST	O
data	O
was	O
used	O
to	O
filter	O
interactions	O
between	O
cellsstLearn	O
[	O
69	O
]	O
NANACircle	O
plot	O
,	O
heatmapGO	O
enrichmentSignificant	O
LR	O
pairs	O
were	O
determined	O
using	O
CellPhoneDB	O
based	O
on	O
normalized	O
gene	O
expression	O
across	O
spatial	O
locationSVCA	O
[	O
70	O
]	O
NANANANAModel	O
gene	O
expression	O
as	O
a	O
function	O
of	O
intrinsic	O
cell	O
state	O
effects	O
,	O
environmental	O
effects	O
and	O
cell	O
-	O
cell	O
interactionsMISTy	O
[	O
68	O
]	O
NANANANAInteractions	O
are	O
calculated	O
by	O
weighting	O
the	O
gene	O
expressions	O
of	O
local	O
cell	O
neighborhoodDeepLinc	O
[	O
71	O
]	O
NANANANAUse	O
a	O
variational	O
graph	O
autoencoder	O
with	O
an	O
adversarial	O
network	O
for	O
regularization	O
to	O
infer	O
cell	O
interactions	O

RNAscape	B-BT
output	O
preserves	O
the	O
L	O
-	O
shaped	O
topology	O
(	O
as	O
opposed	O
to	O
known	O
‘	O
clover	O
leaf	O
’	O
shaped	O
secondary	O
structure	O
(	O
26	O
)	O
visualizations	O
)	O
and	O
annotates	O
non	O
-	O
standard	O
bases	O
and	O
base	O
-	O
pairing	O
geometries	O
(	O
critical	O
in	O
many	O
RNA	O
interactions	O
(	O
27	O
)).	O

The	O
genetic	O
correlation	O
among	O
traits	O
in	O
multiple	O
environments	O
is	O
the	O
major	O
immanent	O
cause	O
of	O
GbyE	B-BT
.	O

AuraGain	O
,	O
similar	O
to	O
Supreme	O
,	O
features	O
an	O
anatomically	O
curved	O
airway	O
tube	O
and	O
an	O
integrated	O
large	O
-	O
diameter	O
GT	O
channel	O
.	O

The	O
Fiji	O
costing	O
study	O
estimated	O
the	O
costs	O
per	O
bed	O
day	O
for	O
the	O
two	O
hospitals	O
(	O
LTK	O
and	O
CWM	O
),	O
so	O
we	O
used	O
the	O
lower	O
of	O
the	O
values	O
to	O
obtain	O
conservative	O
estimates	O
.	O

D	O
Confusion	O
matrix	O
comparing	O
GeneVector	B-BT
classification	O
with	O
summarized	O
cell	O
types	O
.	O

Definition	O
of	O
abbreviations	O
:	O
ARDS	O
=	O
acute	O
respiratory	O
distress	O
syndrome	O
;	O
Δ	O
=	O
Changes	O
;	O
OI	O
=	O
Oxygenation	O
Index	O
;	O
PCaO2	O
=	O
carbon	O
dioxide	O
arterial	O
partial	O
pressure	O
;	O
Q	O
˙	O
s	O
/	O
Q	O
˙	O
t	O
=	O
fraction	O
of	O
pulmonary	O
shunt	O
to	O
cardiac	O
output	O
;	O
Crs	O
=	O
compliance	O
respiratory	O
system	O
.	O

We	O
identified	O
each	O
pair	O
as	O
a	O
(	O
n	O
)	O
initial	O
/	O
raw	O
Domain2GO	B-BT
mapping	O
.	O

Further	O
,	O
training	O
a	O
NanoDeep	B-BT
model	O
with	O
a	O
broader	O
range	O
of	O
species	O
may	O
help	O
improve	O
the	O
performance	O
of	O
adaptive	O
sampling	O
.	O

After	O
completing	O
these	O
two	O
steps	O
,	O
users	O
submit	O
the	O
job	O
to	O
the	O
KVFinder	B-BT
-	I-BT
web	I-BT
service	O
by	O
clicking	O
the	O
‘	O
Submit	O
the	O
job	O
’	O
button	O
.	O

BIDCell	B-BT
captures	O
cell	O
morphologies	O
with	O
better	O
correspondence	O
to	O
the	O
input	O
images	O
,	O
with	O
a	O
more	O
diverse	O
set	O
of	O
cell	O
shapes	O
that	O
include	O
elongated	O
types	O
.	O

Subsequently	O
,	O
the	O
SMILES	O
strings	O
of	O
the	O
active	O
ingredient	O
numbers	O
,	O
PDB	O
IDs	O
of	O
the	O
key	O
targets	O
,	O
and	O
3D	O
structure	O
in	O
PDB	O
format	O
obtained	O
from	O
2	O
.	O
1	O
were	O
inputted	O
to	O
the	O
molecular	O
docking	O
module	O
of	O
TCMNPAS	B-BT
.	O

Clinical	O
variables	O
such	O
as	O
N	O
stage	O
,	O
age	O
,	O
and	O
T	O
stage	O
were	O
identified	O
as	O
having	O
the	O
most	O
significant	O
impact	O
on	O
DM	O
prediction	O
in	O
the	O
DM	O
-	O
slim	O
cohort	O
(	O
Figure	O
3D	O
).	O

Yanhua	O
Song	O
,	O
Wei	O
Shu	O
,	O
Yi	O
Pei	O
,	O
Juan	O
Du	O
,	O
Guihui	O
Wu	O
and	O
Hua	O
Wang	O
contributed	O
equally	O
to	O
this	O
work	O
.	O

While	O
not	O
particularly	O
designed	O
to	O
call	O
low	O
frequency	O
calls	O
,	O
we	O
include	O
bcftools	B-BT
for	O
benchmarking	O
here	O
as	O
one	O
of	O
the	O
most	O
widely	O
used	O
variant	O
callers	O
[	O
35	O
].	O

To	O
address	O
these	O
challenges	O
in	O
the	O
transcriptome	O
analyses	O
,	O
we	O
propose	O
IBDTransDB	B-BT
(	O
https	O
://	O
abbviegrc	O
.	O
shinyapps	O
.	O
io	O
/	O
ibdtransdb	B-BT
/),	O
a	O
manually	O
curated	O
transcriptomic	O
database	O
for	O
IBD	O
.	O

For	O
such	O
genetic	O
studies	O
and	O
breeding	O
projects	O
using	O
wild	O
species	O
,	O
GBScleanR	B-BT
could	O
be	O
the	O
first	O
choice	O
as	O
a	O
fundamental	O
tool	O
for	O
genotype	O
identification	O
coupled	O
with	O
an	O
RRS	O
-	O
based	O
genotyping	O
system	O
.	O

Taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
the	O
Sputnik	O
V	O
vaccine	O
induces	O
antibodies	O
that	O
are	O
similarly	O
able	O
to	O
interact	O
with	O
S	O
and	O
neutralizing	O
SARS	O
-	O
CoV	O
-	O
2	O
variants	O
,	O
with	O
the	O
Omicron	O
VOC	O
being	O
the	O
most	O
resistant	O
to	O
antibody	O
immunity	O
,	O
as	O
previously	O
reported	O
[	O
15	O
,	O
26	O
].	O

Besides	O
our	O
publicly	O
available	O
KVFinder	B-BT
-	I-BT
web	I-BT
service	O
,	O
a	O
local	O
web	O
service	O
can	O
also	O
be	O
configured	O
on	O
third	O
-	O
party	O
platforms	O
,	O
such	O
as	O
institutional	O
servers	O
or	O
cloud	O
services	O
,	O
using	O
parKVFinder	O
as	O
a	O
service	O
(	O
SaaS	O
).	O

Most	O
of	O
the	O
tools	O
can	O
correctly	O
quantify	O
true	O
positives	O
at	O
low	O
false	O
positive	O
rates	O
,	O
however	O
,	O
Perseus	O
,	O
prolfqua	B-BT
,	O
and	O
LFQ	O
-	O
Analyst	O
were	O
the	O
tools	O
that	O
performed	O
better	O
among	O
the	O
benchmarked	O
packages	O
in	O
the	O
two	O
data	O
sets	O
.	O

Core	O
Tip	O
:	O
This	O
manuscript	O
is	O
to	O
correct	O
the	O
citations	O
of	O
images	O
in	O
Figures	O
1	O
and	O
5	O
in	O
“	O
Shu	O
YJ	O
,	O
Lao	O
B	O
,	O
Qiu	O
YY	O
.	O

Additionally	O
,	O
CD	O
and	O
IH	O
could	O
not	O
be	O
assessed	O
on	O
three	O
and	O
four	O
farms	O
,	O
respectively	O
,	O
due	O
to	O
heavy	O
soiling	O
of	O
the	O
claws	O
,	O
poor	O
lighting	O
conditions	O
in	O
the	O
parlour	O
,	O
or	O
the	O
positioning	O
of	O
the	O
animals	O
in	O
the	O
milking	O
parlour	O
.	O

Overview	O
of	O
the	O
DEGRONOPEDIA	B-BT
outputs	O
using	O
FBXL15	O
cullin	O
-	O
RING	O
substrate	O
receptor	O
.	O

[	O
9	O
],	O
our	O
analysis	O
included	O
animals	O
that	O
were	O
already	O
undergoing	O
treatment	O
for	O
claw	O
lesions	O
.	O

The	O
data	O
transfer	O
time	O
—	O
from	O
OncoPanel	O
sign	O
-	O
out	O
to	O
when	O
the	O
data	O
are	O
ingested	O
into	O
MatchMiner	B-BT
and	O
algorithmically	O
matched	O
—	O
is	O
1	O
-	O
2	O
days	O
.	O

We	O
again	O
used	O
the	O
domain2Pfam	O
and	O
domain2GO	B-BT
annotation	O
schemes	O
to	O
search	O
for	O
homologous	O
regions	O
and	O
biological	O
roles	O
associated	O
with	O
maximum	O
height	O
(	O
log10	O
transformed	O
values	O
used	O
as	O
QVALs	O
).	O

We	O
developed	O
an	O
R	O
package	O
called	O
vizAPA	B-BT
for	O
visualizing	O
APA	O
dynamics	O
from	O
bulk	O
and	O
single	O
-	O
cell	O
data	O
.	O

Hence	O
,	O
we	O
first	O
aim	O
to	O
verify	O
whether	O
RNAthreader	B-BT
'	O
s	O
performance	O
is	O
primarily	O
influenced	O
by	O
improved	O
secondary	O
structure	O
prediction	O
.	O

This	O
research	O
was	O
funded	O
by	O
CHU	O
Nîmes	O
,	O
grant	O
number	O
:	O
Thematique	O
Phare	O
1	O
.	O

Note	O
that	O
no	O
permission	O
check	O
is	O
performed	O
when	O
loading	O
a	O
MTPpilot	B-BT
website	O
via	O
a	O
bookmark	O
.	O

We	O
preprocessed	O
fastq	O
files	O
from	O
multiple	O
platforms	O
using	O
their	O
respective	O
preprocessing	O
pipeline	O
(	O
where	O
provided	O
)	O
and	O
updated	O
scPipe	B-BT
to	O
allow	O
sample	O
processing	O
with	O
unified	O
functions	O
for	O
data	O
from	O
different	O
sST	O
technologies	O
starting	O
from	O
fastq	O
files	O
.	O

Even	O
though	O
the	O
raw	O
genotype	O
calls	O
contained	O
largely	O
different	O
genotype	O
information	O
with	O
different	O
error	O
patterns	O
,	O
GBScleanR	B-BT
could	O
estimate	O
highly	O
similar	O
dosages	O
.	O

NTG	O
+	O
suma	O
P	O
=	O
<	O
0	O
.	O
0001	O
).	O

PatchDock	B-BT
values	O
of	O
other	O
heavy	O
metals	O
binding	O
with	O
CadA	O
are	O
shown	O
in	O
Figure	O
5	O
.	O

The	O
extracted	O
patterns	O
were	O
classified	O
as	O
“	O
breakfast	O
skipper	O
,”	O
“	O
dinner	O
skipper	O
,”	O
“	O
fast	O
food	O
,”	O
“	O
hydrogenated	O
oil	O
consumption	O
,”	O
“	O
lunch	O
skipper	O
,”	O
“	O
poor	O
nutrition	O
,”	O
“	O
salty	O
snacks	O
,”	O
“	O
sweetened	O
beverages	O
,”	O
and	O
“	O
sweats	O
.”	O
The	O
most	O
common	O
pattern	O
was	O
“	O
breakfast	O
skipper	O
”	O
as	O
there	O
were	O
five	O
studies	O
for	O
this	O
pattern	O
,	O
followed	O
by	O
“	O
sweetened	O
beverages	O
”	O
and	O
“	O
salty	O
snacks	O
”	O
with	O
four	O
studies	O
for	O
each	O
.	O

MetaCerberus	O
has	O
provided	O
a	O
solution	O
to	O
this	O
scaling	O
issue	O
using	O
RAY	O
and	O
items	O
needed	O
from	O
our	O
kmer	O
counter	O
MerCat2	B-BT
.	O

Microvirus	O
host	O
taxonomy	O
to	O
the	O
genus	O
rank	O
was	O
predicted	O
using	O
iPHoP	B-BT
[	O
50	O
].	O

glabra	O
(	O
Licorice	O
)	O
phyto	O
-	O
constituents	O
were	O
aimed	O
to	O
investigate	O
the	O
docking	O
analysis	O
of	O
human	O
superoxide	O
dismutase	O
(	O
hSOD	O
),	O
human	O
phosphodiesterase	O
-	O
9	O
(	O
hPDE	O
9	O
)	O
and	O
human	O
dipeptidyl	O
peptidase	O
-	O
4	O
(	O
hDPP	O
4	O
)	O
by	O
employing	O
PatchDock	B-BT
method	O
.	O

We	O
thank	O
the	O
Nîmes	O
University	O
hospital	O
for	O
its	O
structural	O
,	O
human	O
and	O
financial	O
support	O
through	O
the	O
award	O
obtained	O
by	O
our	O
team	O
during	O
the	O
internal	O
call	O
for	O
tenders	O
«	O
Thématiques	O
phares	O
».	O

Similar	O
results	O
were	O
predicted	O
by	O
Human	B-BT
Splicing	I-BT
Finder	I-BT
(	O
HSF	O
)	O
and	O
the	O
NetGene2	O
servers	O
.	O

Multivariate	O
logistic	O
regression	O
analysis	O
showed	O
that	O
the	O
premature	O
timing	O
of	O
analgesia	O
and	O
amniotic	O
fluid	O
contamination	O
were	O
independent	O
risk	O
factors	O
affecting	O
intrapartum	O
fever	O
in	O
parturients	O
(	O
Table	O
2	O
).	O

The	O
most	O
prominent	O
databases	O
in	O
the	O
latter	O
category	O
include	O
IMG	O
/	O
M	O
[	O
23	O
],	O
[	O
24	O
],	O
MGnify	O
[	O
25	O
],	O
SPIRE	O
[	O
26	O
],	O
and	O
MG	O
-	O
RAST	O
[	O
27	O
].	O
Table	O
1Databases	O
and	O
Repositories	O
.	O
Table	O
1Database	O
NameDescriptionData	O
TypesAccessibilityUser	O
SubmissionGenBankArchive	O
for	O
sequencing	O
dataGenomes	O
,	O
Metagenomes	O
,	O
Metatranscriptomes	O
,	O
AmpliconsPublicly	O
accessibleYesSequence	O
Read	O
Archive	O
(	O
SRA	O
)	O
Archive	O
for	O
sequencing	O
dataRaw	O
sequencing	O
dataPublicly	O
accessibleYesEuropean	O
Nucleotide	O
Archive	O
(	O
ENA	O
)	O
Archive	O
for	O
all	O
publicly	O
available	O
nucleotide	O
sequencesGenomes	O
,	O
Metagenomes	O
,	O
Metatranscriptomes	O
,	O
AmpliconsPublicly	O
accessibleYesDOE	O
Systems	O
Biology	O
Knowledgebase	O
(	O
KBase	O
)	O
A	O
platform	O
for	O
sharing	O
,	O
integrating	O
,	O
and	O
analyzing	O
microbial	O
,	O
plant	O
,	O
and	O
community	O
dataGenomes	O
,	O
Metagenomes	O
,	O
Metatranscriptomes	O
,	O
AmpliconsPublicly	O
accessibleYesGenomes	O
OnLine	O
Database	O
(	O
GOLD	O
)	O
Repository	O
for	O
genome	O
projects	O
and	O
metadata	O
(	O
ecosystems	O
)	O
EcosystemsPublicly	O
accessibleYesIntegrated	O
Microbial	O
Genomes	O
&	O
Microbiomes	O
(	O
IMG	O
/	O
M	O
)	O
Community	O
-	O
driven	O
repository	O
hosting	O
genomes	O
of	O
cultivated	O
and	O
uncultivated	O
microbial	O
taxa	O
,	O
metagenomes	O
,	O
metatranscriptomes	O
,	O
amplicons	O
,	O
plasmids	O
,	O
and	O
genome	O
fragmentsMetagenomes	O
,	O
Metatranscriptomes	O
,	O
Amplicons	O
,	O
GenomesPublicly	O
accessibleYesMGnifyArchive	O
for	O
exploration	O
,	O
and	O
analysis	O
,	O
of	O
microbiome	O
sequencing	O
datasetsMetagenomes	O
,	O
Metatranscriptomes	O
,	O
Amplicons	O
,	O
MAGsPublicly	O
accessibleYesMetagenome	O
RAST	O
(	O
MG	O
-	O
RAST	O
)	O
Microbiome	O
repository	O
with	O
a	O
unified	O
pipeline	O
for	O
automated	O
analysis	O
of	O
metagenomic	O
samplesMetagenomesRegistered	O
usersYesIntegrated	O
Microbial	O
Viral	O
Genomes	O
(	O
IMG	O
/	O
VR	O
)	O
Viral	O
genomes	O
and	O
metagenomesViral	O
Genomes	O
,	O
Viral	O
MetagenomesPublicly	O
accessibleYesNMPFamsDBNovel	O
protein	O
families	O
from	O
IMG	O
’	O
s	O
metagenomes	O
and	O
metatranscriptomesProtein	O
FamiliesPublicly	O
accessibleNoFESnov	O
catalogCatalog	O
reporting	O
functionally	O
unannotated	O
proteins	O
derived	O
from	O
MAGsProteinsPublicly	O
accessibleNoNIH	O
Human	O
Microbiome	O
ProjectMetagenomes	O
from	O
human	O
host	O
-	O
associated	O
systems	O
,	O
such	O
as	O
the	O
gut	O
microbiomeHuman	O
Microbiome	O
MetagenomesPublicly	O
accessibleNoTerrestrialMetagenomeDBAnnotation	O
of	O
metagenomes	O
obtained	O
from	O
soil	O
samplesSoil	O
MetagenomesPublicly	O
accessibleYesMarineMetagenomeDBAnnotation	O
of	O
metagenomes	O
obtained	O
from	O
marine	O
samplesMarine	O
MetagenomesPublicly	O
accessibleYesHumanMetagenomeDBAnnotation	O
of	O
metagenomes	O
obtained	O
from	O
human	O
microbiome	O
samplesHuman	O
Microbiome	O
MetagenomesPublicly	O
accessibleYesSPIRESearchable	O
resource	O
of	O
ecosystem	O
metadata	O
obtained	O
from	O
MAGsEcosystem	O
MetadataPublicly	O
accessibleNoMarine	B-BT
Metagenomics	I-BT
Portal	I-BT
(	O
MMP	O
)	O
Collection	O
of	O
databases	O
annotating	O
marine	O
-	O
oriented	O
metagenomic	O
datasetsMarine	O
MetagenomesPublicly	O
accessibleNoNational	O
Microbiome	O
Data	O
Collaborative	O
(	O
NMDC	O
)	O
A	O
platform	O
for	O
collaboration	O
and	O
data	O
sharing	O
among	O
researchers	O
studying	O
microbiomes	O
across	O
diverse	O
ecosystemsMicrobiome	O
DataPublicly	O
accessibleYes	O

In	O
this	O
issue	O
,	O
we	O
delve	O
into	O
early	O
childhood	O
education	O
in	O
Delaware	O
,	O
with	O
articles	O
curated	O
by	O
our	O
esteemed	O
guest	O
editors	O
Madeleine	O
Bayard	O
,	O
Senior	O
Vice	O
President	O
at	O
Rodel	O
,	O
and	O
Matt	O
Amis	O
,	O
Director	O
of	O
Communications	O
.	O

OralExplorer	B-BT
consists	O
of	O
5	O
main	O
analysis	O
modules	O
(	O
differential	O
gene	O
expression	O
analysis	O
,	O
immune	O
infiltration	O
analysis	O
,	O
correlation	O
analysis	O
,	O
pathway	O
enrichment	O
analysis	O
and	O
single	O
-	O
cell	O
analysis	O
),	O
with	O
multiple	O
visualization	O
options	O
.	O

It	O
is	O
available	O
for	O
everyone	O
at	O
https	O
://	O
www	O
.	O
molprophet	B-BT
.	O
com	O
/.	O

These	O
metrics	O
have	O
also	O
been	O
used	O
to	O
demonstrate	O
some	O
properties	O
of	O
the	O
domain2Pfam	O
and	O
domain2GO	B-BT
annotations	O
.	O

To	O
tackle	O
more	O
advanced	O
use	O
cases	O
,	O
such	O
as	O
defining	O
a	O
new	O
feature	O
or	O
applying	O
scifAI	B-BT
to	O
an	O
entirely	O
new	O
dataset	O
,	O
more	O
programming	O
experience	O
is	O
required	O
.	O

In	O
our	O
fourth	O
application	O
,	O
we	O
applied	O
VirusPredictor	B-BT
to	O
predict	O
the	O
viruses	O
(	O
mostly	O
phages	O
)	O
used	O
in	O
an	O
existing	O
study	O
(	O
Ren	O
et	O
al	O
.	O

The	O
social	O
sciences	O
use	O
the	O
term	O
‘	O
insider	O
’	O
(	O
vs	O
‘	O
outsider	O
’)	O
to	O
describe	O
when	O
the	O
researcher	O
belongs	O
to	O
the	O
group	O
they	O
are	O
studying	O
based	O
on	O
a	O
shared	O
ethnicity	O
,	O
sexual	O
identity	O
and	O
gender	O
.	O
2	O
,	O
6	O
,	O
23	O
–	O
25	O
It	O
can	O
also	O
be	O
used	O
to	O
describe	O
when	O
the	O
researcher	O
shares	O
with	O
study	O
participants	O
some	O
lived	O
experience	O
.	O
7	O
,	O
26	O
–	O
29	O
Insider	O
-	O
outsider	O
status	O
is	O
not	O
dichotomous	O
as	O
there	O
is	O
a	O
diversity	O
of	O
experiences	O
among	O
‘	O
insiders	O
’,	O
and	O
each	O
person	O
has	O
multiple	O
social	O
identities	O
;	O
insider	O
status	O
may	O
also	O
change	O
over	O
time	O
.	O
23	O
Research	O
by	O
a	O
‘	O
person	O
with	O
lived	O
experience	O
’	O
has	O
distinct	O
challenges	O
and	O
benefits	O
.	O

In	O
the	O
KRT8	O
-	O
low	O
group	O
,	O
a	O
significant	O
enrichment	O
was	O
highlighted	O
for	O
PMC8567138	O
-	O
Table	O
2	O
.	O
xlsx	O
-	O
Sheet1	O
-	O
IGFBP5	O
AND	O
IGFBP7	O
NOT	O
IGFBP3	O
NR4A2	O
(	O
Rummagene	B-BT
transcription	O
factors	O
)	O
1	O
.	O
08	O
×	O
10	O
−	O
8	O
,	O
KLF9	O
(	O
ARCHS4	O
TFs	O
Coexp	O
)	O
8	O
.	O
4	O
×	O
10	O
−	O
7	O
,	O
WT1	O
KO	O
MOUSE	O
GSE15325	O
CREEDSID	O
GENE	O
2156	O
UP	O
TF	O
(	O
Perturbations	O
followed	O
by	O
expression	O
)	O
7	O
.	O
1	O
×	O
10	O
−	O
5	O
.	O

Ultimately	O
,	O
CEMIG	B-BT
forecasts	O
motifs	O
and	O
their	O
respective	O
lengths	O
by	O
extending	O
paths	O
within	O
the	O
digraph	O
(	O
Figure	O
1D	O
).	O

RAMZIS	B-BT
is	O
ultimately	O
a	O
quality	O
assurance	O
tool	O
,	O
and	O
it	O
should	O
be	O
backed	O
up	O
by	O
other	O
statistical	O
tests	O
on	O
likely	O
candidates	O
with	O
more	O
targeted	O
data	O
;	O
it	O
is	O
a	O
guide	O
,	O
not	O
a	O
determinant	O
,	O
and	O
allows	O
users	O
to	O
answer	O
the	O
question	O
:	O
“	O
Am	O
I	O
able	O
to	O
ask	O
the	O
question	O
I	O
want	O
to	O
ask	O
?”	O
If	O
the	O
Internal	O
Similarity	O
distributions	O
are	O
sufficiently	O
well	O
defined	O
,	O
then	O
it	O
is	O
possible	O
for	O
the	O
user	O
to	O
ask	O
the	O
next	O
question	O
:	O
“	O
Are	O
these	O
glycosites	O
likely	O
to	O
be	O
differentiable	O
?”	O
And	O
while	O
it	O
does	O
enable	O
differentiating	O
glycosylation	O
patterns	O
at	O
a	O
glycosite	O
,	O
the	O
rankings	O
it	O
provides	O
are	O
meant	O
to	O
steer	O
the	O
user	O
toward	O
the	O
likely	O
answers	O
will	O
inform	O
further	O
experimental	O
investigations	O
to	O
help	O
answer	O
the	O
final	O
question	O
:	O
“	O
How	O
are	O
these	O
glycosites	O
different	O
?”	O

We	O
then	O
searched	O
for	O
their	O
UniProt	O
ID	O
and	O
human	O
gene	O
names	O
in	O
the	O
UniProt	O
databases	O
and	O
looked	O
for	O
their	O
disease	O
associations	O
in	O
the	O
DisGeNET	B-BT
database	O
v7	O
.	O
0	O
.	O

In	O
PAPipe	B-BT
,	O
the	O
Manhattan	O
plot	O
is	O
automatically	O
generated	O
for	O
every	O
single	O
population	O
against	O
all	O
other	O
populations	O
using	O
information	O
on	O
genomic	O
regions	O
that	O
are	O
significantly	O
differentiated	O
by	O
default	O
.	O

APE	O
patients	O
showed	O
a	O
higher	O
level	O
of	O
D	O
-	O
D	O
than	O
DVT	O
patients	O
(	O
P	O
<	O
0	O
.	O
0001	O
).	O

The	O
original	O
formula	O
evaluation	O
algorithm	O
in	O
MaBoSS	B-BT
used	O
a	O
recursive	O
traversal	O
of	O
the	O
expression	O
tree	O
,	O
which	O
(	O
apart	O
from	O
other	O
issues	O
)	O
causes	O
memory	O
usage	O
patterns	O
unsuitable	O
for	O
GPUs	O
:	O
the	O
memory	O
required	O
per	O
each	O
core	O
is	O
not	O
achievable	O
in	O
current	O
GPUs	O
,	O
and	O
there	O
are	O
typically	O
too	O
many	O
cache	O
misses	O
[	O
20	O
].	O

In	O
this	O
study	O
,	O
compared	O
with	O
DeepSA	O
,	O
GASA	O
and	O
RAscore	B-BT
are	O
binary	O
classification	O
models	O
with	O
an	O
output	O
probability	O
between	O
0	O
and	O
1	O
.	O

Python	O
3	O
unfortunately	O
introduced	O
breaking	O
changes	O
(	O
breaking	O
the	O
existing	O
PyPop	B-BT
code	O
).	O

That	O
said	O
,	O
if	O
users	O
wish	O
to	O
create	O
a	O
more	O
customised	O
workflow	O
that	O
diverges	O
from	O
the	O
rworkflows	B-BT
action	O
(	O
and	O
only	O
use	O
it	O
as	O
an	O
initial	O
basis	O
for	O
their	O
script	O
),	O
a	O
full	O
workflow	O
version	O
can	O
be	O
created	O
with	O
rworkflows	B-BT
::	O
use_workflow	O
(	O
name	O
=”	O
rworkflows_static	B-BT
”),	O
which	O
offers	O
functionality	O
analogous	O
to	O
that	O
of	O
biocthis	O
.	O

The	O
IDSL_MINT	B-BT
transformer	O
model	O
architecture	O
for	O
predicting	O
molecular	O
fingerprint	O
is	O
displayed	O
in	O
Figs	O
.	O

The	O
process	O
of	O
codon	O
optimization	O
was	O
carried	O
out	O
by	O
utilizing	O
the	O
Jcat	B-BT
(	O
version	O
1	O
.	O
0	O
)	O
software	O
,	O
resulting	O
in	O
the	O
acquisition	O
of	O
an	O
ideal	O
DNA	O
sequence	O
.	O

BUSCO	O
:	O
--	O
evalue	O
1e	O
-	O
03	O
,	O
-	O
sp	O
Arabidopsis	O
.	O
LACHESIS	O
:	O
CLUSTER_MIN_RE_SITES	O
=	O
30	O
;	O
CLUSTER_MAX_LINK_DENSITY	O
=	O
2	O
;	O
CLUSTER_NONINFORMATIVE_RATIO	O
=	O
2	O
;	O
ORDER_MIN_N_RES_IN_TRUN	O
=	O
49	O
;	O
ORDER_MIN_N_RES_IN_SHREDS	O
=	O
49	O
.	O
Software	O
parameters	O
of	O
repeat	O
annotation	O
:	O
default	O
parameters	O
for	O
LTR_FINDER	O
,	O
RepeatScout	O
,	O
and	O
PASTEClassifier	B-BT
.	O

Forty	O
-	O
eight	O
or	O
eighty	O
-	O
five	O
hours	O
after	O
cell	O
seeding	O
,	O
all	O
HUVECs	O
(	O
with	O
or	O
without	O
APE	O
)	O
showed	O
uniform	O
vinculin	O
expression	O
.	O

Shenk	O
et	O
al	O
.	O
3	O
conducted	O
a	O
study	O
within	O
the	O
Preclinical	O
Animal	O
Sites	O
Studies	O
of	O
the	O
Molecular	O
Transducers	O
of	O
Physical	O
Activity	O
Consortium	O
(	O
MoTrPAC	B-BT
)	O
to	O
delineate	O
the	O
molecular	O
bases	O
of	O
adaptation	O
to	O
exercise	O
training	O
.	O
4	O
The	O
main	O
goals	O
of	O
this	O
study	O
were	O
to	O
establish	O
a	O
standardized	O
aerobic	O
exercise	O
protocol	O
and	O
to	O
create	O
a	O
biospecimen	O
repository	O
to	O
study	O
temporal	O
changes	O
in	O
response	O
to	O
the	O
aerobic	O
training	O
protocol	O
.	O

The	O
COVEP	O
webserver	O
is	O
available	O
at	O
https	O
://	O
pgx	O
.	O
zju	O
.	O
edu	O
.	O
cn	O
/	O
covepiab	B-BT
/	O
tools	O
/	O
covep	O
.	O

Full	O
summary	O
statistics	O
for	O
VOYAGER	B-BT
GWAS	O
can	O
be	O
accessed	O
via	O
dbGaP	O
(	O
OncoArray	O
:	O
Oral	O
and	O
Pharynx	O
Cancer	O
;	O
study	O
accession	O
number	O
:	O
phs001202	O
.	O
v1	O
.	O
p1	O
),	O
and	O
published	O
data	O
from	O
this	O
study	O
can	O
be	O
accessed	O
at	O
Lesseur	O
,	O
C	O
.	O

Regarding	O
the	O
modified	O
workflow	O
of	O
TACCO	B-BT
,	O
we	O
modified	O
the	O
cost	O
matrix	O
for	O
optimal	O
transport	O
.	O

cooltools	B-BT
detects	O
insulating	O
boundaries	O
as	O
local	O
minima	O
of	O
the	O
insulation	O
profile	O
and	O
quantifies	O
their	O
strength	O
as	O
their	O
topographic	O
prominence	O
.	O

We	O
describe	O
steps	O
for	O
cytoplasmic	O
extraction	O
,	O
protein	O
immunoprecipitation	O
,	O
sample	O
preparation	O
for	O
mass	O
spectrometry	O
,	O
and	O
data	O
analysis	O
with	O
Perseus	O
.	O

The	O
phylogenetic	O
tree	O
and	O
metadata	O
were	O
explored	O
and	O
visualized	O
using	O
HAIviz	B-BT
v0	O
.	O
3	O
(	O
69	O
)	O
and	O
ggtree	O
v2	O
.	O
4	O
.	O
1	O
(	O
70	O
,	O
71	O
).	O

Most	O
patients	O
received	O
antibiotics	O
(	O
67	O
.	O
8	O
%	O
with	O
antibiotics	O
vs	O
32	O
.	O
2	O
%	O
without	O
).	O
Table	O
1Comparison	O
of	O
clinico	O
-	O
biological	O
characteristics	O
of	O
antibiotic	O
and	O
non	O
-	O
antibiotic	O
groups	O
at	O
admission	O
.	O
Table	O
1TotalWithout	O
antibioticsWith	O
antibioticspN	O
(%)	O
14948	O
(	O
32	O
.	O
2	O
)	O
101	O
(	O
67	O
.	O
8	O
)	O
Age	O
(	O
years	O
),	O
median	O
[	O
IQR	O
]	O
85	O
.	O
50	O
[	O
82	O
.	O
00	O
,	O
89	O
.	O
00	O
]	O
86	O
.	O
00	O
[	O
83	O
.	O
00	O
,	O
90	O
.	O
00	O
]	O
85	O
.	O
00	O
[	O
82	O
.	O
00	O
,	O
88	O
.	O
00	O
]	O
0	O
.	O
560Sex	O
,	O
N	O
(%)	O
0	O
.	O
428	O
Male66	O
(	O
44	O
.	O
3	O
)	O
19	O
(	O
39	O
.	O
6	O
)	O
47	O
(	O
46	O
.	O
5	O
)	O
Female83	O
(	O
55	O
.	O
7	O
)	O
29	O
(	O
60	O
.	O
4	O
)	O
54	O
(	O
53	O
.	O
5	O
)	O
Living	O
place	O
,	O
N	O
(%)	O
0	O
.	O
619	O
Nursing	O
Home38	O
(	O
25	O
.	O
5	O
)	O
11	O
(	O
22	O
.	O
9	O
)	O
27	O
(	O
26	O
.	O
7	O
)	O
Home111	O
(	O
74	O
.	O
5	O
)	O
37	O
(	O
77	O
.	O
1	O
)	O
74	O
(	O
73	O
.	O
3	O
)	O
Number	O
of	O
Medications	O
before	O
hospitalization	O
,	O
mean	O
(	O
SD	O
)	O
7	O
.	O
38	O
(	O
3	O
.	O
33	O
)	O
6	O
.	O
73	O
(	O
2	O
.	O
83	O
)	O
7	O
.	O
69	O
(	O
3	O
.	O
51	O
)	O
0	O
.	O
074Charlson	O
Comorbidity	O
Index	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
6	O
.	O
00	O
[	O
5	O
.	O
00	O
,	O
7	O
.	O
00	O
]	O
6	O
.	O
00	O
[	O
5	O
.	O
00	O
,	O
7	O
.	O
00	O
]	O
6	O
.	O
00	O
[	O
5	O
.	O
00	O
,	O
7	O
.	O
00	O
]	O
0	O
.	O
306Infection	O
COVID	O
-	O
19	O
,	O
N	O
(%)	O
0	O
.	O
659	O
Nosocomiala25	O
(	O
16	O
.	O
8	O
)	O
9	O
(	O
18	O
.	O
8	O
)	O
16	O
(	O
15	O
.	O
8	O
)	O
Community124	O
(	O
83	O
.	O
2	O
)	O
39	O
(	O
81	O
.	O
2	O
)	O
85	O
(	O
84	O
.	O
2	O
)	O
MDRDb	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
62	O
.	O
00	O
[	O
42	O
.	O
25	O
,	O
94	O
.	O
00	O
]	O
73	O
.	O
00	O
[	O
53	O
.	O
00	O
,	O
96	O
.	O
00	O
]	O
57	O
.	O
00	O
[	O
40	O
.	O
00	O
,	O
91	O
.	O
25	O
]	O
0	O
.	O
057Corticoids	O
,	O
N	O
(%)	O
25	O
(	O
16	O
.	O
8	O
)	O
2	O
(	O
4	O
.	O
2	O
)	O
23	O
(	O
22	O
.	O
8	O
)	O
0	O
.	O
005Thromboprophylaxis	O
(%)	O
111	O
(	O
74	O
.	O
5	O
)	O
33	O
(	O
68	O
.	O
8	O
)	O
78	O
(	O
77	O
.	O
2	O
)	O
0	O
.	O
271CRPc	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
86	O
.	O
95	O
[	O
35	O
.	O
77	O
,	O
154	O
.	O
47	O
]	O
48	O
.	O
80	O
[	O
16	O
.	O
20	O
,	O
83	O
.	O
40	O
]	O
107	O
.	O
65	O
[	O
55	O
.	O
88	O
,	O
166	O
.	O
93	O
]<	O
0	O
.	O
001Haemoglobin	O
at	O
admission	O
,	O
mean	O
(	O
SD	O
)	O
12	O
.	O
42	O
(	O
1	O
.	O
85	O
)	O
11	O
.	O
99	O
(	O
2	O
.	O
02	O
)	O
12	O
.	O
62	O
(	O
1	O
.	O
74	O
)	O
0	O
.	O
062Leucocytes	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
6	O
.	O
92	O
[	O
5	O
.	O
10	O
,	O
10	O
.	O
00	O
]	O
6	O
.	O
10	O
[	O
4	O
.	O
90	O
,	O
8	O
.	O
50	O
]	O
7	O
.	O
15	O
[	O
5	O
.	O
30	O
,	O
10	O
.	O
38	O
]	O
0	O
.	O
169Saturation	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
95	O
.	O
00	O
[	O
93	O
.	O
00	O
,	O
97	O
.	O
00	O
]	O
95	O
.	O
00	O
[	O
94	O
.	O
00	O
,	O
97	O
.	O
00	O
]	O
95	O
.	O
00	O
[	O
92	O
.	O
25	O
,	O
97	O
.	O
00	O
]	O
0	O
.	O
342Oxygen	O
at	O
admission	O
,	O
median	O
[	O
Q1	O
,	O
Q3	O
]	O
2	O
.	O
00	O
[	O
0	O
.	O
00	O
,	O
4	O
.	O
00	O
]	O
0	O
.	O
00	O
[	O
0	O
.	O
00	O
,	O
3	O
.	O
00	O
]	O
3	O
.	O
00	O
[	O
1	O
.	O
00	O
,	O
4	O
.	O
00	O
]<	O
0	O
.	O
001Temperature	O
(°	O
C	O
),	O
mean	O
(	O
SD	O
)	O
37	O
.	O
03	O
(	O
0	O
.	O
88	O
)	O
36	O
.	O
97	O
(	O
0	O
.	O
73	O
)	O
37	O
.	O
06	O
(	O
0	O
.	O
95	O
)	O
0	O
.	O
557IQR	O
:	O
interquartile	O
range	O
,	O
SD	O
:	O
standard	O
deviation	O
.	O
The	O
NA	O
were	O
imputed	O
by	O
simple	O
imputation	O
to	O
not	O
exclude	O
patients	O
in	O
the	O
following	O
analysesMaximum	O
of	O
3	O
non	O
applicable	O
for	O
a	O
variable	O
.	O
Binary	O
variables	O
:	O
imputation	O
by	O
the	O
most	O
frequent	O
modality	O
.	O
Continuous	O
variables	O
:	O
imputation	O
by	O
the	O
median	O
.	O
anosocomial	O
infection	O
:	O
infection	O
occurring	O
in	O
a	O
patient	O
during	O
the	O
process	O
of	O
care	O
in	O
a	O
hospital	O
or	O
other	O
health	O
care	O
facility	O
,	O
which	O
was	O
not	O
present	O
or	O
incubating	O
at	O
the	O
time	O
of	O
admission	O
[	O
36	O
].	O
bMDRD	O
:	O
modification	O
of	O
diet	O
in	O
renal	O
disease	O
.	O
cCRP	O
:	O
C	O
-	O
reactive	O
protein	O
.	O

MSIWarp	B-BT
alignment	O
significantly	O
improved	O
the	O
performance	O
of	O
the	O
CNN	O
model	O
,	O
especially	O
for	O
the	O
two	O
machines	O
that	O
showed	O
lower	O
performances	O
without	O
alignment	O
.	O

The	O
development	O
of	O
the	O
JCAT	O
is	O
a	O
direct	O
response	O
to	O
the	O
measurement	O
and	O
interpretation	O
of	O
different	O
aspects	O
of	O
just	O
culture	O
.	O

PrOKiNO	B-BT
has	O
mapped	O
kinase	O
sequences	O
from	O
1321	O
species	O
to	O
families	O
from	O
KinBase	O
(	O
2012	O
).	O

Other	O
methods	O
either	O
failed	O
to	O
integrate	O
between	O
labs	O
or	O
batches	O
effectively	O
(	O
AutoClass	O
,	O
CLEAR	O
,	O
scANVI	O
,	O
scVI	O
,	O
and	O
Scanorama	O
)	O
or	O
,	O
in	O
doing	O
so	O
,	O
did	O
not	O
preserve	O
the	O
biological	O
information	O
by	O
mixing	O
cell	O
types	O
(	O
Harmony	O
and	O
Seurat	O
),	O
location	O
information	O
(	O
scGen	O
),	O
or	O
both	O
(	O
scDREAMER	B-BT
)	O
(	O
Fig	O
.	O

AagingBase	B-BT
serves	O
as	O
a	O
valuable	O
resource	O
for	O
researchers	O
,	O
scientists	O
and	O
clinicians	O
,	O
offering	O
several	O
key	O
functionalities	O
.	O

Since	O
the	O
chromosome	O
number	O
was	O
found	O
to	O
be	O
n	O
=	O
32	O
with	O
WZ	O
sex	O
chromosome	O
system	O
in	O
many	O
ghost	O
moth	O
species	O
,	O
we	O
consider	O
our	O
assembly	O
to	O
be	O
near	O
chromosome	O
level	O
but	O
expect	O
an	O
omission	O
of	O
W	O
chromosome	O
in	O
our	O
assembly	O
from	O
the	O
male	O
specimen48	O
.	O
Table	O
1Summary	O
statistics	O
and	O
key	O
characteristics	O
of	O
the	O
Druceiella	O
hillmani	O
genome	O
.	O
Assembly	O
statisticsGenome	O
size	O
(	O
bp	O
)	O
2	O
,	O
586	O
,	O
138	O
,	O
562Total	O
contigs	O
(	O
n	O
)	O
181N50	O
contig	O
length	O
(	O
bp	O
)	O
28	O
,	O
103	O
,	O
563L50	O
contigs	O
(	O
n	O
)	O
29GC	O
content	O
(%)	O
0	O
.	O
3003Average	O
sequence	O
read	O
coverage25xBUSCO	B-BT
scoresC	O
:	O
97	O
.	O
1	O
%[	O
S	O
:	O
96	O
.	O
1	O
%,	O
D	O
:	O
1	O
.	O
0	O
%],	O
F	O
:	O
0	O
.	O
8	O
%,	O
M	O
:	O
2	O
.	O
1	O
%,	O
n	O
:	O
2124Augustus	O
gene	O
prediction	O
models	O
and	O
functional	O
annotationTotal	O
predicted	O
genes61	O
,	O
160Complete	O
models59	O
,	O
371Monoexonic	O
genes13	O
,	O
595Multiexonic	O
genes47	O
,	O
527Functionally	O
annotated	O
genes	O
(	O
eggNOG	O
)	O
26	O
,	O
790Functionally	O
annotated	O
genes	O
(	O
blast	O
)	O
26	O
,	O
865BUSCO	B-BT
scoresC	O
:	O
89	O
.	O
4	O
%[	O
S	O
:	O
85	O
.	O
5	O
%,	O
D	O
:	O
3	O
.	O
9	O
%],	O
F	O
:	O
3	O
.	O
5	O
%,	O
M	O
:	O
7	O
.	O
1	O
%,	O
n	O
:	O
2124Repeat	O
and	O
transposable	O
elementsTotal	O
repeat	O
content	O
(%)	O
0	O
.	O
3759LINEs0	O
.	O
0457LTR	O
elements0	O
.	O
0178DNA	O
elements0	O
.	O
0538Unclassified	O
repeats0	O
.	O
1768non	O
-	O
coding	O
RNA	O
(	O
Infernal	O
)	O
0	O
.	O
0001helitron	O
-	O
related	O
sequences0	O
.	O
0088BioProject	O
AccessionPRJNA1047044BioSample	O
AccessionSAMN38512512SRA	O
AccessionSRR28055627Percentage	O
of	O
complete	O
BUSCOs	B-BT
is	O
given	O
based	O
on	O
BUSCO	B-BT
v5	O
.	O
3	O
.	O
0	O
using	O
the	O
endopterygota_odb10	O
dataset	O
.	O

Furthermore	O
,	O
an	O
increase	O
in	O
the	O
quantity	O
of	O
TPMA	O
leads	O
to	O
higher	O
polymerization	O
conversions	O
.	O

In	O
addition	O
,	O
according	O
to	O
the	O
Plant	O
Public	O
RNA	O
–	O
seq	O
Database	O
(	O
http	O
://	O
ipf	O
.	O
sustech	O
.	O
edu	O
.	O
cn	O
/	O
pub	O
/	O
plantrna	B-BT
/,	O
accessed	O
on	O
23	O
February	O
2024	O
),	O
LOC_Os01g40180	O
expression	O
was	O
significantly	O
down	O
–	O
regulated	O
in	O
response	O
to	O
a	O
2	O
-	O
day	O
Fe	O
toxicity	O
treatment	O
.	O

The	O
superiority	O
of	O
GBScleanR	B-BT
lies	O
in	O
the	O
IPO	O
in	O
which	O
allele	O
read	O
biases	O
and	O
mismapping	O
rates	O
of	O
markers	O
are	O
iteratively	O
estimated	O
.	O

The	O
short	O
story	O
tells	O
of	O
the	O
renowned	O
Italian	O
bandit	O
Ghino	O
di	O
Tacco	O
(	O
ca	O
.	O

The	O
aucome	B-BT
orthology	O
command	O
runs	O
the	O
orthology	O
propagation	O
step	O
,	O
which	O
complements	O
the	O
previous	O
GSMNs	O
with	O
GPR	O
associations	O
whose	O
genes	O
are	O
predicted	O
to	O
be	O
orthologs	O
to	O
genes	O
from	O
GPR	O
relations	O
of	O
other	O
GSMNs	O
of	O
the	O
data	O
set	O
(	O
Fig	O
.	O

SLiM	O
-	O
CRAB	O
-	O
positive	O
patients	O
presented	O
with	O
either	O
two	O
(	O
20	O
/	O
30	O
,	O
67	O
%),	O
three	O
(	O
7	O
/	O
30	O
,	O
23	O
%),	O
or	O
four	O
(	O
3	O
/	O
30	O
,	O
10	O
%)	O
features	O
.	O

BAT	O
,	O
basophil	O
activation	O
testing	O
;	O
NMBAs	O
,	O
neuromuscular	O
blocking	O
agents	O
;	O
pMAT	O
,	O
passive	O
mast	O
cell	O
activation	O
test	O
;	O
ST	O
,	O
skin	O
testing	O
.	O

All	O
genomes	O
from	O
MarRef	B-BT
and	O
MarDB	O
bacteria	O
classified	O
as	O
mesophilic	O
,	O
thermotolerant	O
,	O
and	O
thermophilic	O
were	O
excluded	O
,	O
as	O
well	O
as	O
those	O
bacteria	O
isolated	O
from	O
homoiotherms	O
and	O
hydrothermal	O
vents	O
.	O

The	O
results	O
reveal	O
that	O
the	O
two	O
volcanoes	O
have	O
distinct	O
magmatic	O
plumbing	O
systems	O
,	O
and	O
this	O
is	O
likely	O
the	O
reason	O
for	O
their	O
different	O
eruptive	O
styles	O
.	O

-	O
https	O
://	O
github	O
.	O
com	O
/	O
rbouckaert	O
/	O
cubevb	B-BT

The	O
objective	O
of	O
this	O
review	O
was	O
to	O
identify	O
the	O
technical	O
features	O
of	O
the	O
kinematic	O
evaluation	O
methods	O
used	O
in	O
patients	O
with	O
claw	O
toes	O
.	O

By	O
providing	O
these	O
analytical	O
tools	O
,	O
SpatialCells	B-BT
empowers	O
researchers	O
to	O
gain	O
deeper	O
insights	O
into	O
the	O
intricate	O
spatial	O
relationships	O
and	O
characteristics	O
of	O
cells	O
within	O
the	O
TME	O
.	O

For	O
instance	O
,	O
NanoDeep	B-BT
,	O
which	O
performed	O
best	O
except	O
ReadCurrent	O
,	O
had	O
a	O
10	O
%–	O
11	O
%	O
decrease	O
.	O

Database	O
URL	O
:	O
https	O
://	O
www	O
.	O
nanolas	B-BT
.	I-BT
cloud	O

Generally	O
,	O
Prokka	O
,	O
DRAM	O
,	O
and	O
MetaCerberus	B-BT
had	O
similar	O
pORF	O
calling	O
numbers	O
;	O
however	O
,	O
DRAM	O
did	O
call	O
more	O
pORF	O
from	O
eukaryotic	O
viruses	O
(	O
Supplementary	O
Fig	O
.	O

For	O
this	O
reason	O
,	O
the	O
concatenation	O
matrix	O
based	O
on	O
TrimAl	B-BT
alignments	O
was	O
used	O
for	O
all	O
subsequent	O
analyses	O
,	O
hereafter	O
referred	O
to	O
as	O
concatenation	O
matrix	O
.	O

KinCytE	B-BT
links	O
the	O
release	O
of	O
cytokines	O
and	O
chemokines	O
to	O
kinase	O
activity	O
and	O
recommends	O
drugs	O
that	O
target	O
specific	O
cytokine	O
sets	O
,	O
as	O
well	O
as	O
identifies	O
kinases	O
and	O
kinase	O
-	O
related	O
proteins	O
that	O
may	O
be	O
involved	O
.	O

To	O
benchmark	O
the	O
performance	O
of	O
EvoAug	B-BT
-	I-BT
TF	I-BT
,	O
we	O
utilized	O
the	O
data	O
and	O
deep	O
-	O
learning	O
model	O
from	O
the	O
DeepSTARR	O
study	O
(	O
de	O
Almeida	O
et	O
al	O
.	O

The	O
wheat	O
TaPsb28	O
gene	O
sequences	O
were	O
downloaded	O
from	O
the	O
WheatlS	O
database	O
(	O
https	O
://	O
urgi	O
.	O
versailles	O
.	O
inra	O
.	O
fr	O
/	O
wheatis	B-BT
,	O
accessed	O
on	O
10	O
October	O
2018	O
),	O
while	O
homologous	O
protein	O
sequences	O
were	O
retrieved	O
from	O
the	O
National	O
Center	O
for	O
Biotechnology	O
Information	O
(	O
NCBI	O
).	O

NTG	O
+	O
SUMA	O
,	O
P	O
<	O
0	O
.	O
0001	O
for	O
CGRP	O
;	O
P	O
<	O
0	O
.	O
0001	O
for	O
VIP	O
;	O
P	O
=	O
0	O
.	O
0005	O
for	O
PACAP	O
;	O
P	O
<	O
0	O
.	O
0001	O
for	O
IL	O
-	O
1beta	O
;	O
P	O
=	O
0	O
.	O
0323	O
for	O
IL	O
-	O
10	O
),	O
medulla	O
-	O
pons	O
(	O
NTG	O
vs	O
.	O

To	O
achieve	O
higher	O
accuracy	O
,	O
we	O
conducted	O
preliminary	O
experiments	O
for	O
hyperparameters	O
such	O
as	O
the	O
architecture	O
of	O
the	O
encoder	O
,	O
the	O
number	O
of	O
input	O
images	O
for	O
the	O
MI	B-BT
-	I-BT
CNN	I-BT
,	O
the	O
resolution	O
of	O
input	O
images	O
,	O
and	O
the	O
use	O
of	O
auxiliary	O
loss	O
functions	O
.	O

In	O
general	O
these	O
methods	O
are	O
characterised	O
by	O
a	O
“	O
repeat	O
first	O
”	O
approach	O
,	O
in	O
that	O
they	O
first	O
look	O
for	O
dispersed	O
repetitive	O
sequences	O
or	O
structural	O
motifs	O
and	O
then	O
try	O
to	O
cluster	O
them	O
and	O
extend	O
them	O
to	O
recreate	O
finally	O
the	O
complete	O
sequence	O
of	O
the	O
original	O
TE	O
.	O

4	O
).	O
Table	O
2Risk	O
factors	O
of	O
mortality	O
(	O
univariate	O
model	O
).	O
Table	O
2HR	O
brutIC95	O
%	O
pATBa1	O
.	O
98	O
[	O
0	O
.	O
926	O
;	O
4	O
.	O
23	O
]	O
0	O
.	O
08Age	O
(	O
years	O
)	O
1	O
.	O
009	O
[	O
0	O
.	O
954	O
;	O
1	O
.	O
067	O
]	O
0	O
.	O
7Sex0	O
.	O
5	O
Female	O
(	O
ref	O
)	O
1	O
Male1	O
.	O
205	O
[	O
0	O
.	O
690	O
;	O
2	O
.	O
104	O
]	O
Living	O
place0	O
.	O
2	O
Home	O
(	O
ref	O
)	O
1	O
Nursing	O
home1	O
.	O
549	O
[	O
0	O
.	O
838	O
;	O
2	O
.	O
862	O
]	O
Medications	O
before	O
hospitalization1	O
.	O
005	O
[	O
0	O
.	O
9209	O
;	O
1	O
.	O
096	O
]	O
0	O
.	O
9Charlson	O
Comorbidity	O
Index0	O
.	O
974	O
[	O
0	O
.	O
826	O
;	O
1	O
.	O
148	O
]	O
0	O
.	O
7Infection0	O
.	O
4	O
Community	O
(	O
ref	O
)	O
1	O
Nosocomial0	O
.	O
751	O
[	O
0	O
.	O
362	O
;	O
1	O
.	O
556	O
]	O
MDRDb	O
at	O
admission0	O
.	O
991	O
[	O
0	O
.	O
983	O
;	O
0	O
.	O
999	O
]	O
0	O
.	O
02Corticoids1	O
.	O
449	O
[	O
0	O
.	O
790	O
;	O
2	O
.	O
658	O
]	O
0	O
.	O
2Thromboprophylaxis0	O
.	O
605	O
[	O
0	O
.	O
330	O
;	O
1	O
.	O
111	O
]	O
0	O
.	O
1CRP	O
at	O
admission1	O
.	O
005	O
[	O
1	O
.	O
002	O
;	O
1	O
.	O
008	O
]<	O
0	O
.	O
001Haemoglobin	O
at	O
admission1	O
.	O
118	O
[	O
0	O
.	O
956	O
;	O
1	O
.	O
309	O
]	O
0	O
.	O
2Leucocytes	O
at	O
admission1	O
.	O
115	O
[	O
1	O
.	O
046	O
;	O
1	O
.	O
190	O
]<	O
0	O
.	O
001Saturation	O
at	O
admission0	O
.	O
9162	O
[	O
0	O
.	O
882	O
;	O
0	O
.	O
952	O
]<	O
0	O
.	O
001O2c	O
at	O
entrance1	O
.	O
153	O
[	O
1	O
.	O
094	O
;	O
1	O
.	O
216	O
]<	O
0	O
.	O
001Temperature	O
at	O
admission	O
(°	O
C	O
)	O
1	O
.	O
324	O
[	O
0	O
.	O
975	O
;	O
1	O
.	O
80	O
]	O
0	O
.	O
07p	O
:	O
Wald	O
testaATB	O
:	O
Antibiotics	O
.	O
bMDRD	O
:	O
modification	O
of	O
diet	O
in	O
renal	O
disease	O
.	O
cO2	O
:	O
Oxygen	O
.	O
Fig	O
.	O

massPix	B-BT
produces	O
single	O
ion	O
images	O
,	O
performs	O
multivariate	O
statistics	O
and	O
provides	O
putative	O
lipid	O
annotations	O
based	O
on	O
accurate	O
mass	O
matching	O
against	O
generated	O
lipid	O
libraries	O
.	O

To	O
reduce	O
the	O
ocean	O
-	O
scale	O
variance	O
,	O
we	O
selected	O
the	O
population	O
of	O
the	O
stHK	O
,	O
which	O
were	O
sampled	O
at	O
the	O
SPacO_3	O
station	O
(	O
Supplementary	O
Tables	O
1	O
and	O
6	O
)	O
to	O
make	O
comparisons	O
of	O
means	O
and	O
particularly	O
variances	O
with	O
the	O
clonal	O
isolates	O
of	O
P	O
.	O

The	O
source	O
code	O
of	O
eccDNA	B-BT
-	I-BT
pipe	I-BT
was	O
released	O
at	O
https	O
://	O
github	O
.	O
com	O
/	O
QuKunLab	O
/	O
ecc_pipe	O
.	O

In	O
addition	O
to	O
the	O
enrichment	O
of	O
COVID	O
-	O
19	O
-	O
related	O
genes	O
that	O
are	O
consistent	O
with	O
literature	O
,	O
BoostDiff	B-BT
also	O
identified	O
edges	O
between	O
TREX1	O
and	O
IFIT1	O
,	O
IFIT3	O
,	O
IFITM3	O
,	O
ISG15	O
,	O
and	O
OAS3	O
,	O
all	O
of	O
which	O
have	O
been	O
implicated	O
with	O
COVID	O
-	O
19	O
.	O

For	O
instance	O
,	O
averaged	O
on	O
the	O
73	O
samples	O
from	O
R1	O
,	O
TransMeta	O
correctly	O
reconstructed	O
∼	O
19	O
.	O
6	O
%	O
more	O
transcripts	O
than	O
PsiCLASS	B-BT
,	O
as	O
well	O
as	O
62	O
.	O
1	O
%	O
and	O
75	O
.	O
2	O
%	O
more	O
than	O
the	O
single	O
-	O
sample	O
assemblers	O
StringTie2	O
and	O
Scallop	O
,	O
respectively	O
.	O

As	O
shown	O
in	O
Figure	O
4	O
,	O
PhageTB	B-BT
outperform	O
previous	O
studies	O
at	O
each	O
taxonomic	O
level	O
,	O
with	O
an	O
accuracy	O
of	O
67	O
.	O
90	O
,	O
80	O
.	O
60	O
,	O
85	O
.	O
5	O
,	O
90	O
.	O
0	O
,	O
and	O
93	O
.	O
5	O
%	O
at	O
Genus	O
,	O
Family	O
,	O
Order	O
,	O
Class	O
,	O
and	O
Phylum	O
levels	O
.	O

Reference	O
literature	O
was	O
used	O
to	O
find	O
marker	O
genes	O
to	O
manually	O
annotate	O
different	O
cell	O
clusters	O
,	O
with	O
the	O
assistance	O
of	O
the	O
Python	O
package	O
MetaTime	B-BT
(	O
Supplementary	O
Figures	O
S1G	O
,	O
H	O
;	O
Supplementary	O
Table	O
S2	O
).	O

Before	O
trimming	O
,	O
we	O
perform	O
manual	O
inspection	O
for	O
sequence	O
alignment	O
using	O
Jalview	B-BT
and	O
exclude	O
one	O
sequence	O
(	O
in	O
red	O
rectangle	O
)	O
for	O
its	O
error	O
alignment	O
(	O
Figure	O
2	O
).	O

Several	O
parameters	O
can	O
be	O
set	O
during	O
GEMLI	B-BT
predictions	O
:	O
(	O
1	O
)	O
the	O
sampling	O
value	O
(	O
which	O
fraction	O
of	O
genes	O
is	O
selected	O
for	O
each	O
repetition	O
of	O
the	O
iterative	O
hierarchical	O
clustering	O
),	O
(	O
2	O
)	O
the	O
number	O
of	O
repetitions	O
of	O
the	O
iterative	O
clustering	O
(	O
based	O
on	O
which	O
the	O
confidence	O
level	O
is	O
calculated	O
),	O
(	O
3	O
)	O
the	O
number	O
of	O
clusters	O
in	O
which	O
clusters	O
are	O
split	O
during	O
each	O
iteration	O
(“	O
cluster	O
cut	O
”)	O
and	O
(	O
4	O
)	O
the	O
size	O
of	O
clusters	O
at	O
which	O
clustering	O
iterations	O
are	O
stopped	O
(“	O
lineage	O
size	O
parameter	O
”).	O

The	O
three	O
methods	O
have	O
distinct	O
manners	O
to	O
codify	O
the	O
input	O
information	O
to	O
submit	O
to	O
the	O
classifier	O
as	O
BacPP	O
employs	O
an	O
orthogonal	O
classification	O
and	O
CDBProm	B-BT
codifies	O
promoters	O
as	O
per	O
the	O
level	O
of	O
free	O
-	O
energy	O
in	O
-	O
between	O
dinucleotides	O
;	O
BDGP	O
method	O
of	O
coding	O
information	O
to	O
feed	O
their	O
Artificial	O
Neural	O
Network	O
was	O
not	O
informed	O
in	O
the	O
tool	O
'	O
s	O
documentation	O
.	O

The	O
Essex	O
Skipper	O
has	O
29	O
chromosomes	O
(	O
Federley	O
,	O
1938	O
;	O
Larsen	O
,	O
1975	O
).	O

Finally	O
,	O
the	O
Marine	B-BT
Metagenomics	I-BT
Portal	I-BT
(	O
MMP	O
)	O
[	O
43	O
]	O
is	O
a	O
collection	O
of	O
databases	O
annotating	O
marine	O
-	O
oriented	O
metagenomic	O
datasets	O
,	O
retrieved	O
from	O
MGnify	O
as	O
well	O
as	O
super	O
studies	O
conducted	O
by	O
large	O
microbiome	O
initiatives	O
,	O
such	O
as	O
AtlantECO	O
or	O
the	O
Tara	O
Oceans	O
expedition	O
[	O
44	O
].	O

Physical	O
and	O
chemical	O
parameters	O
of	O
amino	O
acid	O
sequences	O
related	O
to	O
RBD	O
were	O
predicted	O
using	O
ProtParam	O
ExPASy	B-BT
online	O
tool	O
.	O

Design	O
the	O
virtual	O
control	O
law	O
α1	O
,	O
parameter	O
adaptive	O
updating	O
control	O
laws	O
W	O
^	O
1	O
and	O
D	O
^	O
1	O
as	O
α1	O
=	O
1g1	O
(−	O
k1z1	O
−	O
W	O
^	O
1TS1	O
(	O
Z1	O
)−	O
D	O
^	O
1tanh	O
(	O
z1η1	O
)+	O
y	O
˙	O
d	O
−	O
c1λ1	O
)	O
(	O
20	O
)	O
W	O
^˙	O
1	O
=	O
a1z1S1	O
(	O
Z1	O
)−	O
σ1W	O
^	O
1	O
(	O
21	O
)	O
D	O
^˙	O
1	O
=	O
r1z1tanh	O
(	O
z1η1	O
)−	O
υ1D	O
^	O
1	O
(	O
22	O
)	O
where	O
k1	O
>	O
0	O
,	O
σ1	O
>	O
0	O
and	O
υ1	O
>	O
0	O
are	O
design	O
parameters	O
.	O

The	O
number	O
of	O
proteins	O
by	O
CATH	O
class	O
and	O
Enzyme	O
Commission	O
class	O
are	O
shown	O
in	O
(	O
b	O
)	O
and	O
(	O
c	O
)	O
panels	O
;	O
(	O
d	O
)	O
and	O
(	O
e	O
)	O
are	O
the	O
distributions	O
of	O
protein	O
sequence	O
length	O
and	O
the	O
effective	O
sequence	O
depth	O
(	O
Neff	O
)	O
of	O
all	O
the	O
alignments	O
in	O
PyCoMdb	B-BT
.	O

We	O
thank	O
the	O
youth	O
group	O
of	O
specialty	O
committee	O
of	O
network	O
pharmacology	O
of	O
World	O
Federation	O
of	O
Chinese	O
Medicine	O
Societies	O
(	O
WFCMS	O
)	O
for	O
their	O
helpful	O
comments	O
and	O
suggestions	O
,	O
which	O
substantially	O
improved	O
the	O
design	O
of	O
TCMNPAS	B-BT
.	O

High	O
-	O
coverage	O
domain	O
-	O
centric	O
GO	O
annotations	O
that	O
were	O
supported	O
only	O
by	O
all	O
UniProts	O
(	O
including	O
multidomain	O
UniProts	O
)	O
were	O
downloaded	O
as	O
the	O
file	O
Domain2GO_supported_only_by_all	B-BT
.	O
txt	O
.	O

•	O
Prokaryotic	O
RBPs	O
are	O
essential	O
for	O
post	O
-	O
transcriptional	O
regulation	O
,	O
mRNA	O
stability	O
,	O
and	O
adaptation	O
to	O
diverse	O
environmental	O
conditions	O
in	O
prokaryotes	O
.•	O
Existing	O
generic	O
computational	O
methods	O
are	O
less	O
accurate	O
for	O
predicting	O
prokaryotic	O
-	O
specific	O
RBPs	O
.•	O
A	O
novel	O
computational	O
model	O
,	O
RBProkCNN	B-BT
is	O
introduced	O
to	O
predict	O
prokaryotic	O
RBPs	O
with	O
higher	O
accuracy	O
.•	O
RBProkCNN	B-BT
achieved	O
higher	O
accuracy	O
than	O
several	O
existing	O
models	O
.•	O
The	O
developed	O
prediction	O
server	O
is	O
freely	O
accessible	O
at	O
https	O
://	O
iasri	O
-	O
sg	O
.	O
icar	O
.	O
gov	O
.	O
in	O
/	O
rbprokcnn	B-BT
/.	O

Source	O
codes	O
for	O
the	O
CPPLS_MLP	B-BT
R	O
,	O
python	O
packages	O
and	O
the	O
related	O
scripts	O
are	O
available	O
at	O
‘	O
CPPLS_MLP	B-BT
Github	O
[	O
https	O
://	O
github	O
.	O
com	O
/	O
wuzhenao	O
/	O
CPPLS	O
-	O
MLP	O
]’.	O

Cooltools	B-BT
implements	O
a	O
HiCCUPs	O
-	O
style	O
[	O
41	O
]	O
approach	O
for	O
peak	O
detection	O
(	O
Fig	O
6	O
):	O
briefly	O
,	O
(	O
i	O
)	O
maps	O
are	O
queried	O
with	O
a	O
dense	O
set	O
of	O
tiles	O
that	O
fit	O
easily	O
into	O
memory	O
,	O
(	O
ii	O
)	O
convolutional	O
kernels	O
are	O
swept	O
across	O
map	O
tiles	O
to	O
score	O
all	O
pixels	O
for	O
local	O
enrichment	O
(	O
iii	O
)	O
significant	O
pixels	O
are	O
determined	O
by	O
thresholding	O
relative	O
to	O
their	O
local	O
background	O
expected	O
values	O
,	O
using	O
a	O
modified	O
Benjamini	O
-	O
Hochberg	O
FDR	O
procedure	O
(	O
iv	O
)	O
adjacent	O
significant	O
pixels	O
are	O
optionally	O
clustered	O
and	O
further	O
filtered	O
by	O
enrichment	O
.	O

The	O
input	O
data	O
file	O
was	O
loaded	O
into	O
OntoloViz	B-BT
for	O
exploration	O
of	O
compounds	O
tested	O
for	O
COVID	O
-	O
19	O
in	O
clinical	O
trials	O
.	O

BCV	O
trends	O
were	O
similar	O
for	O
protein	O
coding	O
genes	O
and	O
lncRNAs	O
for	O
most	O
of	O
the	O
datasets	O
,	O
while	O
higher	O
variance	O
of	O
lowly	O
expressed	O
genes	O
were	O
observed	O
by	O
kallisto	O
bustools	O
,	O
alevin	O
-	O
fry	O
,	O
and	O
scPipe	B-BT
on	O
the	O
lung	O
tissue	O
data	O
;	O
zUMIs	O
on	O
cell	O
line	O
data	O
;	O
and	O
scPipe	B-BT
,	O
alevin	O
-	O
fry	O
,	O
and	O
zUMIs	O
on	O
the	O
PBMC	O
data	O
.	O

Annotation	O
files	O
from	O
the	O
ATLAS	O
(	O
3	O
)	O
and	O
MetaPathways	B-BT
(	O
18	O
,	O
19	O
)	O
pipelines	O
described	O
above	O
are	O
available	O
at	O
https	O
://	O
doi	O
.	O
org	O
/	O
10	O
.	O
6084	O
/	O
m9	O
.	O
figshare	O
.	O
21126166	O
.	O

Project	O
name	O
:	O
X	B-BT
-	I-BT
omics	I-BT
ACTION	I-BT
demonstrator	I-BT
multi	I-BT
-	I-BT
omics	I-BT
analysis	I-BT
workflow	I-BT

Further	O
,	O
while	O
researchers	O
with	O
only	O
3	O
–	O
5	O
-	O
kb	O
fragments	O
may	O
consider	O
using	O
more	O
tools	O
,	O
equally	O
accurate	O
predictions	O
can	O
still	O
be	O
achieved	O
from	O
the	O
VirSorter2	B-BT
and	O
tuning	O
removal	O
ruleset	O
.	O

PCa	O
-	O
related	O
lifestyles	O
were	O
collected	O
,	O
organized	O
and	O
classified	O
into	O
the	O
PCAO2	B-BT
based	O
on	O
systematic	O
evidence	O
-	O
based	O
analysis	O
.	O

This	O
matches	O
closely	O
with	O
what	O
MSFragger	B-BT
reported	O
,	O
showing	O
that	O
Dear	O
‐	O
PSM	O
'	O
s	O
findings	O
are	O
trustworthy	O
.	O

In	O
this	O
study	O
,	O
we	O
measured	O
smFRET	O
efficiency	O
to	O
monitor	O
the	O
conformations	O
of	O
ATL1cyto	O
and	O
its	O
pathogenic	O
mutations	O
in	O
the	O
absence	O
or	O
presence	O
of	O
different	O
nucleotides	O
,	O
despite	O
some	O
discrepancies	O
between	O
the	O
theoretical	O
dye	O
-	O
dye	O
distances	O
calculated	O
by	O
the	O
FRETpredict	B-BT
tool	O
(	O
Supplementary	O
table	O
2	O
)	O
52	O
,	O
53	O
and	O
the	O
experimental	O
dye	O
-	O
dye	O
distances	O
based	O
on	O
the	O
smFRET	O
efficiency	O
(	O
see	O
Methods	O
for	O
calculation	O
,	O
Supplementary	O
tables	O
1	O
,	O
3	O
,	O
4	O
,	O
and	O
6	O
),	O
which	O
could	O
be	O
attributed	O
to	O
uncertainties	O
in	O
the	O
Förster	O
radius	O
R0	O
and	O
limited	O
MD	O
sampling	O
.	O

The	O
outputs	O
include	O
both	O
per	O
-	O
cell	O
MetaTiME	B-BT
MeC	O
signature	O
scores	O
and	O
per	O
-	O
cluster	O
enriched	O
MeC	O
state	O
.	O

The	O
percentage	O
of	O
molecules	O
is	O
shown	O
that	O
fulfill	O
the	O
desired	O
criteria	O
:	O
(	O
i	O
)	O
valid	O
and	O
unique	O
molecules	O
,	O
(	O
ii	O
)	O
valid	O
,	O
unique	O
,	O
and	O
novel	O
molecules	O
,	O
(	O
iii	O
)	O
fraction	O
of	O
molecules	O
with	O
an	O
RAScore	O
of	O
≥	O
0	O
.	O
5	O
,	O
(	O
iv	O
)	O
average	O
Jaccard	O
distance	O
to	O
other	O
generated	O
molecules	O
from	O
the	O
same	O
run	O
(	O
indicating	O
diversity	O
),	O
and	O
(	O
v	O
)–(	O
viii	O
)	O
various	O
scaffold	O
metrics	O
,	O
including	O
unique	O
and	O
novel	O
carbon	O
and	O
atom	O
scaffolds	O
.	O

These	O
databases	O
are	O
ClinVar	O
,	O
Global	O
Variome	O
shared	O
LOVD	O
,	O
the	O
Globin	O
Gene	O
Server	O
/	O
HbVar	O
,	O
the	O
Malaysian	O
Node	O
of	O
the	O
Human	O
Variome	O
Project	O
Database	O
(	O
MyHVPDb	O
),	O
and	O
ITHANET	B-BT
.	O

BUSCO	B-BT
statistics	O
are	O
for	O
the	O
3	O
,	O
285	O
genes	O
in	O
the	O
diptera_odb10	O
benchmark	O
set	O
.	O

(	O
a	O
)	O
Result	O
of	O
the	O
prediction	O
in	O
varSEAK	O
online	O
consists	O
of	O
these	O
in	O
silico	O
assays	O
by	O
Human	B-BT
Splicing	I-BT
Finder	I-BT
(	O
HSF	O
).	O

S9	O
)	O
due	O
to	O
it	O
using	O
the	O
-	O
meta	O
option	O
in	O
Prodigal	O
;	O
whereas	O
,	O
MetaCerberus	B-BT
but	O
still	O
can	O
annotate	O
archaeal	O
viruses	O
and	O
phage	O
genomes	O
better	O
than	O
DRAM	O
-	O
v	O
on	O
a	O
much	O
smaller	O
database	O
(	O
Supplementary	O
Fig	O
.	O

In	O
brief	O
,	O
MetaPathways	B-BT
was	O
used	O
for	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
prediction	O
and	O
annotation	O
,	O
using	O
MetaCyc	O
(	O
2020	O
-	O
08	O
-	O
10	O
)	O
(	O
20	O
,	O
21	O
),	O
CAZy	O
(	O
2020	O
-	O
06	O
-	O
01	O
)	O
(	O
22	O
),	O
RefSeq	O
-	O
NR	O
(	O
2020	O
-	O
08	O
-	O
12	O
-	O
rel	O
-	O
201	O
)	O
(	O
23	O
),	O
and	O
UniProt	O
Sprout	O
(	O
2020	O
-	O
08	O
-	O
12	O
)	O
databases	O
(	O
24	O
).	O

rnaCrosslinkOO	B-BT
is	O
freely	O
available	O
to	O
noncommercial	O
users	O
and	O
implemented	O
in	O
R	O
,	O
with	O
the	O
source	O
code	O
and	O
documentation	O
accessible	O
at	O
https	O
://	O
CRAN	O
.	O
R	O
-	O
project	O
.	O
org	O
/	O
package	O
=	O
rnaCrosslinkOO	B-BT
.	O

A	O
total	O
of	O
753	O
sand	O
flies	O
were	O
collected	O
.	O

The	O
MSCAN	O
block	O
adopts	O
a	O
structure	O
similar	O
to	O
ViT	O
[	O
29	O
],	O
as	O
shown	O
in	O
Figure	O
4a	O
,	O
and	O
includes	O
two	O
residual	O
blocks	O
:	O
an	O
attention	O
mechanism	O
and	O
a	O
Feed	O
-	O
Forward	O
Network	O
(	O
FFN	O
).	O

In	O
this	O
study	O
,	O
patients	O
identified	O
by	O
MatchMiner	B-BT
consented	O
to	O
clinical	O
trials	O
55	O
days	O
earlier	O
than	O
those	O
included	O
through	O
traditional	O
methods	O
,	O
demonstrating	O
the	O
ability	O
of	O
these	O
tools	O
to	O
simplify	O
inclusion	O
workflows	O
.	O
16	O

SEPDB	B-BT
is	O
freely	O
available	O
online	O
at	O
https	O
://	O
sysomics	O
.	O
com	O
/	O
SEPDB	B-BT
/.	O

Cat	B-BT
-	I-BT
E	I-BT
allows	O
detailed	O
analysis	O
of	O
SNVs	O
,	O
which	O
are	O
significant	O
genetic	O
alterations	O
affecting	O
cellular	O
function	O
and	O
disease	O
progression	O
.	O

The	O
extracted	O
types	O
of	O
unhealthy	O
diet	O
in	O
the	O
present	O
systematic	O
review	O
were	O
“	O
breakfast	O
skipper	O
,”	O
“	O
fast	O
food	O
,”	O
“	O
hydrogenated	O
oils	O
consumption	O
,”	O
“	O
salty	O
snacks	O
,”	O
“	O
sweetened	O
beverages	O
,”	O
“	O
breakfast	O
skipper	O
,”	O
“	O
dinner	O
skipper	O
,”	O
“	O
launch	O
skipper	O
,”	O
and	O
“	O
sweets	O
.”	O
The	O
range	O
of	O
pooled	O
prevalence	O
for	O
different	O
types	O
was	O
0	O
.	O
06	O
–	O
0	O
.	O
75	O
.	O

Enhancer	B-BT
-	I-BT
MDLF	I-BT
undergoes	O
thorough	O
evaluation	O
across	O
multiple	O
dimensions	O
to	O
assess	O
its	O
performance	O
.	O

Lastly	O
,	O
several	O
nanobody	O
databases	O
,	O
such	O
as	O
INDI	O
[	O
41	O
]	O
and	O
NanoLAS	B-BT
[	O
42	O
],	O
have	O
been	O
created	O
to	O
store	O
all	O
the	O
information	O
related	O
to	O
this	O
specific	O
subclass	O
of	O
antibodies	O
.	O

For	O
the	O
OS	O
-	O
slim	O
cohort	O
,	O
which	O
included	O
3	O
,	O
605	O
patients	O
in	O
the	O
training	O
set	O
and	O
1	O
,	O
542	O
in	O
the	O
validation	O
set	O
with	O
14	O
clinical	O
variables	O
,	O
the	O
rfSRC_plus_stepCox	O
combination	O
displayed	O
the	O
highest	O
mean	O
C	O
-	O
index	O
(	O
Figure	O
4D	O
)	O
and	O
5	O
-	O
year	O
AUC	O
(	O
Figure	O
4E	O
)	O
values	O
of	O
0	O
.	O
742	O
and	O
0	O
.	O
782	O
,	O
respectively	O
.	O

While	O
multiple	O
packages	O
and	O
tools	O
are	O
available	O
for	O
statistical	O
analysis	O
of	O
these	O
data	O
,	O
we	O
selected	O
some	O
of	O
the	O
most	O
relevant	O
ones	O
and	O
novel	O
implementations	O
including	O
MSstats	O
,	O
20	O
Perseus	O
,	O
21	O
Proteus	O
,	O
22	O
prolfqua	B-BT
,	O
23	O
ProVision	O
,	O
24	O
LFQ	O
-	O
Analyst	O
,	O
25	O
Eatomics	O
,	O
26	O
ProStaR	O
,	O
27	O
and	O
msqrob2	O
.	O
28	O
−	O
30	O
Finally	O
,	O
we	O
used	O
three	O
different	O
data	O
sets	O
—	O
UPS	O
spiked	O
data	O
set	O
,	O
31	O
large	O
-	O
scale	O
mix	O
data	O
set32	O
and	O
toxicology	O
data	O
set33	O
—	O
to	O
evaluate	O
the	O
performance	O
of	O
each	O
tool	O
and	O
discuss	O
some	O
of	O
the	O
advantages	O
and	O
disadvantages	O
of	O
their	O
use	O
with	O
different	O
types	O
of	O
data	O
sets	O
.	O

Another	O
non	O
-	O
microscopy	O
-	O
based	O
method	O
is	O
called	O
NanoDeep	O
(	O
Figure	O
10B	O
).	O

Supplemental	O
material	O
,	O
sj	O
-	O
docx	O
-	O
1	O
-	O
qjp	O
-	O
10	O
.	O
1177_17470218231211549	O
for	O
The	O
irrepressible	O
influence	O
of	O
vocal	O
stereotypes	O
on	O
trust	O
by	O
Ilaria	O
Torre	O
,	O
Laurence	O
White	O
,	O
Jeremy	O
Goslin	O
and	O
Sarah	O
Knight	O
in	O
Quarterly	O
Journal	O
of	O
Experimental	O
Psychology	O

(	O
A	O
)	O
Chemical	O
structure	O
of	O
PMAT	O
and	O
the	O
respective	O
chain	O
lengths	O
for	O
2MAT	O
and	O
10MAT	O
.	O

Multivariate	O
regression	O
analysis	O
demonstrated	O
a	O
greater	O
total	O
femur	O
BMD	O
in	O
individuals	O
with	O
a	O
high	O
LAP	O
index	O
.	O

To	O
address	O
these	O
challenges	O
,	O
we	O
introduce	O
admix	B-BT
-	I-BT
kit	I-BT
,	O
an	O
integrated	O
and	O
flexible	O
python	O
toolkit	O
along	O
with	O
workflows	O
developed	O
using	O
Workflow	O
Development	O
Language	O
(	O
WDL	O
),	O
specifically	O
designed	O
for	O
the	O
simulation	O
and	O
analysis	O
of	O
genetic	O
data	O
from	O
admixed	O
populations	O
.	O

Structure	O
of	O
the	O
user	O
provided	O
json	O
file	O
that	O
describes	O
a	O
CytoPipeline	B-BT
object	O
.	O

We	O
present	O
the	O
rnaCrosslinkOO	B-BT
(	O
RNA	O
Crosslinking	O
Object	O
-	O
Oriented	O
)	O
R	O
package	O
,	O
a	O
novel	O
and	O
versatile	O
R	O
package	O
,	O
that	O
focusses	O
on	O
the	O
downstream	O
analysis	O
of	O
RNA	O
crosslinking	O
data	O
.	O

In	O
this	O
study	O
,	O
410	O
parturients	O
were	O
used	O
as	O
the	O
study	O
participants	O
to	O
analyze	O
the	O
influencing	O
factors	O
of	O
intrapartum	O
fever	O
in	O
parturients	O
who	O
received	O
epidural	O
labor	O
analgesia	O
.	O

f	O
Comparison	O
of	O
quantified	O
results	O
by	O
MATES	O
and	O
scTE	B-BT
to	O
the	O
simulated	O
ground	O
truth	O
for	O
the	O
Alu	O
repeat	O
simulated	O
data	O
.	O

Our	O
antibiotic	O
prediction	O
server	O
,	O
ABDpred	B-BT
,	O
used	O
a	O
soft	O
-	O
voting	O
technique	O
for	O
the	O
first	O
time	O
for	O
antibiotic	O
discovery	O
,	O
using	O
the	O
aggregation	O
of	O
top	O
four	O
classifiers	O
(	O
XGBoost	O
,	O
RF	O
,	O
GBC	O
and	O
DNN	O
).	O

The	O
detection	O
rates	O
of	O
VirSorter	B-BT
,	O
VirSorter2	B-BT
,	O
VirFinder	O
,	O
DeepVirFinder	O
,	O
and	O
VIBRANT	O
decreased	O
to	O
0	O
%,	O
66	O
%,	O
43	O
%,	O
20	O
%,	O
and	O
0	O
%,	O
respectively	O
(	O
Supplementary	O
Data	O
3	O
).	O

As	O
we	O
look	O
ahead	O
,	O
we	O
plan	O
to	O
continually	O
update	O
and	O
expand	O
FoPGDB	B-BT
to	O
enhance	O
its	O
utility	O
and	O
relevance	O
for	O
F	O
.	O

The	O
focus	O
was	O
on	O
comparing	O
the	O
TE	O
expression	O
levels	O
quantified	O
by	O
MATES	O
,	O
scTE	B-BT
,	O
and	O
SoloTE	O
from	O
the	O
short	O
-	O
read	O
data	O
against	O
the	O
long	O
-	O
read	O
data	O
,	O
considered	O
as	O
the	O
‘	O
ground	O
truth	O
’.	O

PASTEClassifier19	B-BT
was	O
used	O
to	O
categorize	O
different	O
types	O
of	O
repetitive	O
sequences	O
.	O

In	O
conclusion	O
,	O
LocoGSE	B-BT
is	O
the	O
only	O
software	O
that	O
can	O
be	O
used	O
at	O
any	O
sequencing	O
depth	O
,	O
and	O
although	O
the	O
running	O
time	O
is	O
higher	O
for	O
LocoGSE	B-BT
compared	O
to	O
k	O
-	O
mer	O
based	O
approaches	O
like	O
GenomeScope	O
for	O
a	O
given	O
readset	O
,	O
the	O
number	O
of	O
reads	O
required	O
is	O
much	O
lower	O
(	O
1X	O
vs	O
>	O
25X	O
).	O

The	O
validated	O
JCAT	O
developed	O
by	O
Petschonek	O
et	O
al	O
.	O

Immunolyser	O
;	O
https	O
://	O
immunolyser	O
.	O
erc	O
.	O
monash	O
.	O
edu	O
/,	O
&	O
MHCpLogics	B-BT
;	O
https	O
://	O
github	O
.	O
com	O
/	O
PurcellLab	O
/	O
MHCpLogics	B-BT
.	O

Taxonomic	O
and	O
sequence	O
data	O
from	O
version	O
1	O
.	O
6	O
of	O
the	O
MarRef	B-BT
database	O
(	O
24	O
,	O
25	O
)	O
was	O
used	O
both	O
to	O
simulate	O
metagenomic	O
reads	O
for	O
taxonomic	O
classification	O
and	O
as	O
a	O
source	O
of	O
artificial	O
marine	O
metagenomes	O
for	O
model	O
training	O
,	O
testing	O
,	O
and	O
validation	O
.	O

RAMZIS	B-BT
identified	O
an	O
outlier	O
sample	O
from	O
this	O
dataset	O
,	O
reducing	O
the	O
sample	O
size	O
to	O
three	O
separate	O
LC	O
runs	O
;	O
this	O
outlier	O
identification	O
and	O
removal	O
process	O
can	O
be	O
found	O
in	O
Supplementary	O
Fig	O
.	O

Compared	O
to	O
the	O
CTAB	O
,	O
the	O
complete	O
extraction	O
of	O
CTAB	O
templates	O
was	O
confirmed	O
by	O
FTIR	O
results	O
(	O
Figure	O
2A	O
),	O
showing	O
the	O
absence	O
of	O
characteristic	O
peaks	O
at	O
2916	O
,	O
2844	O
,	O
and	O
1470	O
cm	O
−	O
1	O
in	O
all	O
MSN	O
panels	O
.	O
62	O
The	O
FTIR	O
analysis	O
also	O
demonstrated	O
in	O
Figure	O
2A	O
that	O
the	O
inherent	O
silanol	O
peaks	O
at	O
964	O
cm	O
−	O
1	O
(	O
dashed	O
line	O
blue	O
arrow	O
)	O
were	O
markedly	O
diminished	O
after	O
amino	O
grafting	O
in	O
MSN	O
-	O
NH2	O
and	O
MSN	O
-	O
NH2	O
@	O
APE	O
.	O

(	O
A	O
)	O
Comparison	O
of	O
localization	O
classification	O
performance	O
of	O
DeepLoc	O
versus	O
PIFiA	B-BT
feature	O
profiles	O
coupled	O
with	O
a	O
logistic	O
regression	O
.	O

coli	O
(	O
strain	O
s_6558	O
),	O
Klebsiella	O
pneumoniae	O
(	O
strain	O
4300STDY7045912	O
),	O
and	O
Salmonella	O
enterica	O
(	O
strain	O
350627	O
)	O
were	O
compared	O
with	O
Jalview	B-BT
.	O

However	O
,	O
15	O
months	O
after	O
angioplasty	O
,	O
repeat	O
catheterization	O
revealed	O
a	O
9	O
-	O
mm	O
Hg	O
gradient	O
that	O
was	O
then	O
treated	O
with	O
a	O
12	O
-	O
mm	O
(	O
InPact	O
)	O
paclitaxel	O
-	O
coated	O
balloon	O
followed	O
by	O
a	O
high	O
-	O
pressure	O
14	O
-	O
mm	O
(	O
Vida	O
)	O
balloon	O
with	O
complete	O
resolution	O
of	O
the	O
stenosis	O
angiographically	O
(	O
Figures	O
3D	O
and	O
3E	O
).	O
Figure	O
3Angiogram	O
During	O
Catheterization	O
From	O
Case	O
2	O
:	O
Before	O
and	O
AfterYellow	O
arrows	O
showing	O
the	O
site	O
of	O
stenosis	O
before	O
and	O
after	O
DCB	O
angioplasty	O
in	O
A	O
,	O
D	O
,	O
B	O
,	O
and	O
E	O
,	O
respectively	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
obtained	O
GWAS	O
summary	O
statistics	O
across	O
a	O
range	O
of	O
traits	O
from	O
diverse	O
population	O
pairs	O
(	O
Table	O
1	O
,	O
material	O
and	O
methods	O
)	O
and	O
quantified	O
the	O
extent	O
to	O
which	O
shaPRS	B-BT
’	O
use	O
of	O
the	O
adjunct	O
data	O
improved	O
the	O
performance	O
of	O
two	O
PRS	O
methods	O
(	O
PRS	O
-	O
CS	O
and	O
LDpred2	O
)	O
that	O
only	O
make	O
use	O
of	O
GWAS	O
summary	O
statistics	O
from	O
the	O
proximal	O
ancestry	O
.	O

Currently	O
,	O
CITEViz	B-BT
accepts	O
Seurat	O
and	O
BioConductor	O
SingleCellExperiment	O
objects	O
.	O

The	O
dataset	O
is	O
provided	O
by	O
the	O
Carnegie	O
Mellon	O
University	O
Software	O
Engineering	O
Institute	O
as	O
the	O
Insider	B-BT
Threat	O
Test	O
Dataset54	O
.	O

Voyager	O
,	O
a	O
two	O
-	O
row	O
spring	O
barley	O
susceptible	O
to	O
FHB	O
.	O

For	O
the	O
10x	O
data	O
we	O
applied	O
dropSeqPipe	O
,	O
Cell	O
Ranger	O
,	O
Optimus	O
,	O
salmon	O
alevin	O
,	O
alevin	O
-	O
fry	O
,	O
scPipe	B-BT
,	O
zUMIs	O
and	O
kallisto	O
bustools	O
.	O

Since	O
the	O
dynamic	O
model	O
is	O
a	O
nonlinear	O
function	O
,	O
in	O
order	O
to	O
facilitate	O
the	O
use	O
of	O
adaptive	O
control	O
technology	O
,	O
the	O
parametric	O
linear	O
system	O
model	O
is	O
first	O
reconstructed	O
.	O

Finally	O
,	O
we	O
overlapped	O
the	O
5000	O
bp	O
square	O
bins	O
found	O
by	O
this	O
approach	O
with	O
the	O
high	O
frequency	O
bins	O
identified	O
by	O
cooltools	B-BT
and	O
reported	O
by	O
Oksuz	O
et	O
al	O
.	O

Renal	O
function	O
(	O
GFRa	O
,	O
MDRDb	O
formula	O
)	O
before	O
and	O
after	O
STZ	O
CTx	O

binotii	O
Au	O
-	O
Mic3	O
using	O
DiGAlign	B-BT
revealed	O
significant	O
differences	O
among	O
the	O
whole	O
genome	O
structures	O
and	O
sequences	O
even	O
though	O
the	O
16S	O
gene	O
is	O
100	O
%	O
identical	O
(	O
Figure	O
6	O
).	O

All	O
HLA	O
data	O
were	O
validated	O
before	O
statistical	O
analysis	O
and	O
analyzed	O
using	O
both	O
GENE	O
[	O
RATE	O
]	O
13	O
(	O
https	O
://	O
hla	O
-	O
net	O
.	O
eu	O
/	O
tools	O
/)	O
and	O
PyPop	B-BT
(	O
version	O
0	O
.	O
7	O
.	O
0	O
;).	O
14	O
Linkage	O
disequilibrium	O
(	O
LD	O
)	O
was	O
calculated	O
in	O
PyPop	B-BT
for	O
each	O
loci	O
pair	O
.	O

The	O
CRISPR	O
/	O
Cas	O
systems	O
were	O
detected	O
using	O
MacSyFinder	B-BT
.	O

This	O
is	O
a	O
correction	O
to	O
:	O
Ruiqing	O
Wang	O
,	O
Chao	O
Ren	O
,	O
Tian	O
Gao	O
,	O
Hao	O
Li	O
,	O
Xiaochen	O
Bo	O
,	O
Dahai	O
Zhu	O
,	O
Dan	O
Zhang	O
,	O
Hebing	O
Chen	O
,	O
Yong	O
Zhang	O
,	O
SEPDB	B-BT
:	O
a	O
database	O
of	O
secreted	O
proteins	O
,	O
Database	O
,	O
Volume	O
2024	O
,	O
2024	O
,	O
baae007	O
,	O
https	O
://	O
doi	O
.	O
org	O
/	O
10	O
.	O
1093	O
/	O
database	O
/	O
baae007	O

A	O
total	O
of	O
1	O
,	O
271	O
genomes	O
of	O
marine	O
prokaryotic	O
species	O
were	O
retrieved	O
from	O
MarRef	B-BT
to	O
develop	O
the	O
training	O
,	O
testing	O
,	O
and	O
validation	O
data	O
sets	O
.	O

Figure	O
2	O
—	O
figure	O
supplement	O
3	O
.	O
The	O
mean	O
precision	O
versus	O
contact	O
density	O
for	O
the	O
top	O
50	O
contacts	O
predicted	O
by	O
PLMGraph	O
-	O
Inter	O
,	O
GLINTER	O
,	O
DeepHomo	O
,	O
DeepHomo2	O
,	O
CDPred	B-BT
,	O
and	O
DRN	O
-	O
1D2D_Inter	O
on	O
the	O
HomoPDB	O
test	O
set	O
(	O
a	O
,	O
c	O
)	O
and	O
HeteroPDB	O
test	O
set	O
(	O
b	O
,	O
d	O
)	O
using	O
experimental	O
structures	O
(	O
first	O
row	O
)	O
and	O
AlphaFold2	O
predicted	O
structures	O
(	O
second	O
row	O
).	O

We	O
concluded	O
that	O
the	O
presence	O
of	O
these	O
impurities	O
would	O
not	O
significantly	O
affect	O
a	O
trend	O
in	O
the	O
reactivities	O
of	O
the	O
screened	O
PCs	O
;	O
therefore	O
,	O
we	O
did	O
not	O
proceed	O
with	O
any	O
additional	O
purification	O
processes	O
for	O
TPMA	O
.	O

However	O
,	O
we	O
hypothesized	O
that	O
the	O
underlying	O
decussated	O
enamel	O
of	O
its	O
trigon	O
basin	O
would	O
be	O
more	O
complex	O
than	O
it	O
is	O
in	O
the	O
other	O
taxa	O
.	O

After	O
CYP	O
induction	O
with	O
rifampicin	O
,	O
a	O
significant	O
change	O
of	O
AUC	O
ratios	O
was	O
observed	O
for	O
all	O
CYP	O
isoforms	O
except	O
for	O
CYP2C9	O
,	O
where	O
the	O
losartan	O
:	O
E3174	O
AUC	O
ratio	O
did	O
not	O
adequately	O
reflect	O
induced	O
CYP	O
activity	O
.	O
Table	O
1AUC	O
ratios	O
and	O
metabolic	O
ratios	O
after	O
administration	O
of	O
cocktail	O
probe	O
drugs	O
with	O
and	O
without	O
inhibitors	O
and	O
inducerCYPMetricTime	O
(	O
h	O
)	O
Cocktail	O
aloneCocktail	O
+	O
inhibitorsCocktail	O
+	O
inducer1A2AUC24par	O
/	O
AUC24caf0	O
.	O
63	O
(	O
0	O
.	O
58	O
–	O
0	O
.	O
71	O
)	O
0	O
.	O
38	O
(	O
0	O
.	O
35	O
–	O
0	O
.	O
45	O
)***	O
0	O
.	O
64	O
(	O
0	O
.	O
59	O
–	O
0	O
.	O
70	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
20	O
.	O
32	O
(	O
0	O
.	O
29	O
–	O
0	O
.	O
38	O
)	O
0	O
.	O
13	O
(	O
0	O
.	O
11	O
–	O
0	O
.	O
20	O
)***	O
b	O
0	O
.	O
38	O
(	O
0	O
.	O
35	O
–	O
0	O
.	O
44	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
40	O
.	O
46	O
(	O
0	O
.	O
41	O
–	O
0	O
.	O
55	O
)	O
0	O
.	O
21	O
(	O
0	O
.	O
18	O
–	O
0	O
.	O
27	O
)***	O
0	O
.	O
57	O
(	O
0	O
.	O
52	O
–	O
0	O
.	O
64	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
60	O
.	O
64	O
(	O
0	O
.	O
58	O
–	O
0	O
.	O
79	O
)	O
0	O
.	O
30	O
(	O
0	O
.	O
26	O
–	O
0	O
.	O
38	O
)***	O
a	O
0	O
.	O
78	O
(	O
0	O
.	O
72	O
–	O
0	O
.	O
89	O
)***	O
a	O
[	O
par	O
]/[	O
caf	O
]	O
80	O
.	O
80	O
(	O
0	O
.	O
71	O
–	O
0	O
.	O
97	O
)	O
0	O
.	O
39	O
(	O
0	O
.	O
35	O
–	O
0	O
.	O
49	O
)***	O
0	O
.	O
96	O
(	O
0	O
.	O
87	O
–	O
1	O
.	O
13	O
)***	O
a	O
2B6AUC24efa	O
/	O
AUC24OH	O
-	O
efa41	O
.	O
7	O
(	O
37	O
.	O
9	O
–	O
48	O
.	O
2	O
)	O
73	O
.	O
9	O
(	O
62	O
.	O
2	O
–	O
99	O
.	O
1	O
)***	O
21	O
.	O
1	O
(	O
19	O
.	O
7	O
–	O
23	O
.	O
2	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
223	O
.	O
7	O
(	O
21	O
.	O
1	O
–	O
29	O
.	O
0	O
)	O
51	O
.	O
2	O
(	O
43	O
.	O
3	O
–	O
70	O
.	O
0	O
)***	O
b	O
12	O
.	O
8	O
(	O
10	O
.	O
7	O
–	O
15	O
.	O
0	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
438	O
.	O
7	O
(	O
34	O
.	O
8	O
–	O
48	O
.	O
5	O
)	O
84	O
.	O
1	O
(	O
71	O
.	O
9	O
–	O
115	O
.	O
0	O
)***	O
19	O
.	O
3	O
(	O
17	O
.	O
9	O
–	O
21	O
.	O
3	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
643	O
.	O
7	O
(	O
39	O
.	O
5	O
–	O
51	O
.	O
3	O
)	O
77	O
.	O
6	O
(	O
69	O
.	O
3	O
–	O
94	O
.	O
2	O
)***	O
a	O
23	O
.	O
1	O
(	O
21	O
.	O
3	O
–	O
25	O
.	O
7	O
)***	O
a	O
[	O
efa	O
]/[	O
OH	O
-	O
efa	O
]	O
853	O
.	O
2	O
(	O
47	O
.	O
8	O
–	O
62	O
.	O
6	O
)	O
88	O
.	O
7	O
(	O
79	O
.	O
7	O
–	O
108	O
.	O
0	O
)***	O
27	O
.	O
7	O
(	O
26	O
.	O
0	O
–	O
30	O
.	O
8	O
)***	O
a	O
2C9AUClos	O
/	O
AUCE31740	O
.	O
09	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
15	O
)	O
0	O
.	O
24	O
(	O
0	O
.	O
19	O
–	O
0	O
.	O
41	O
)***	O
0	O
.	O
07	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
11	O
)	O
nsa	O
[	O
los	O
]/[	O
E3174	O
]	O
21	O
.	O
18	O
(	O
1	O
.	O
17	O
–	O
2	O
.	O
99	O
)	O
3	O
.	O
39	O
(	O
2	O
.	O
66	O
–	O
4	O
.	O
62	O
)	O
nsf	O
0	O
.	O
44	O
(	O
0	O
.	O
37	O
–	O
0	O
.	O
96	O
)**	O
b	O
[	O
los	O
]/[	O
E3174	O
]	O
40	O
.	O
17	O
(	O
0	O
.	O
14	O
–	O
0	O
.	O
37	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
03	O
–	O
2	O
.	O
09	O
)***	O
0	O
.	O
08	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
16	O
)**	O
a	O
[	O
los	O
]/[	O
E3174	O
]	O
60	O
.	O
10	O
(	O
0	O
.	O
08	O
–	O
0	O
.	O
19	O
)	O
0	O
.	O
55	O
(	O
0	O
.	O
47	O
–	O
1	O
.	O
01	O
)***	O
a	O
0	O
.	O
06	O
(	O
0	O
.	O
04	O
–	O
0	O
.	O
12	O
)***	O
c	O
[	O
los	O
]/[	O
E3174	O
]	O
80	O
.	O
05	O
(	O
0	O
.	O
04	O
–	O
0	O
.	O
08	O
)	O
0	O
.	O
24	O
(	O
0	O
.	O
20	O
–	O
0	O
.	O
42	O
)***	O
0	O
.	O
05	O
(	O
0	O
.	O
04	O
–	O
0	O
.	O
07	O
)	O
nsb	O
2C19AUCome	O
/	O
AUCOH	O
-	O
ome0	O
.	O
89	O
(	O
0	O
.	O
76	O
–	O
1	O
.	O
17	O
)	O
17	O
.	O
9	O
(	O
16	O
.	O
0	O
–	O
21	O
.	O
3	O
)***	O
0	O
.	O
22	O
(	O
0	O
.	O
19	O
–	O
0	O
.	O
30	O
)***	O
a	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
21	O
.	O
08	O
(	O
0	O
.	O
90	O
–	O
1	O
.	O
46	O
)	O
25	O
.	O
8	O
(	O
22	O
.	O
7	O
–	O
33	O
.	O
2	O
)***	O
0	O
.	O
25	O
(	O
0	O
.	O
22	O
–	O
0	O
.	O
35	O
)**	O
a	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
40	O
.	O
49	O
(	O
0	O
.	O
38	O
–	O
0	O
.	O
86	O
)	O
18	O
.	O
1	O
(	O
16	O
.	O
0	O
–	O
22	O
.	O
5	O
)***	O
0	O
.	O
18	O
(	O
0	O
.	O
15	O
–	O
0	O
.	O
24	O
)***	O
a	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
60	O
.	O
28	O
(	O
0	O
.	O
18	O
–	O
0	O
.	O
55	O
)	O
b	O
14	O
.	O
6	O
(	O
12	O
.	O
5	O
–	O
18	O
.	O
8	O
)	O
nta	O
na	O
[	O
ome	O
]/[	O
OH	O
-	O
ome	O
]	O
8nanana2D6AUC24met	O
/	O
AUC24OH	O
-	O
met1	O
.	O
69	O
(	O
1	O
.	O
54	O
–	O
1	O
.	O
93	O
)	O
7	O
.	O
57	O
(	O
5	O
.	O
48	O
–	O
10	O
.	O
89	O
)*	O
g	O
1	O
.	O
45	O
(	O
1	O
.	O
34	O
–	O
1	O
.	O
62	O
)***	O
b	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
21	O
.	O
93	O
(	O
1	O
.	O
56	O
–	O
2	O
.	O
47	O
)	O
e	O
na1	O
.	O
83	O
(	O
1	O
.	O
60	O
–	O
2	O
.	O
18	O
)	O
ntd	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
42	O
.	O
20	O
(	O
2	O
.	O
00	O
–	O
2	O
.	O
54	O
)	O
6	O
.	O
60	O
(	O
5	O
.	O
90	O
–	O
7	O
.	O
85	O
)***	O
2	O
.	O
02	O
(	O
1	O
.	O
84	O
–	O
2	O
.	O
31	O
)	O
nsa	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
62	O
.	O
36	O
(	O
2	O
.	O
16	O
–	O
2	O
.	O
69	O
)	O
a	O
8	O
.	O
99	O
(	O
8	O
.	O
33	O
–	O
10	O
.	O
01	O
)***	O
1	O
.	O
88	O
(	O
1	O
.	O
69	O
–	O
2	O
.	O
20	O
)*	O
a	O
[	O
met	O
]/[	O
OH	O
-	O
met	O
]	O
82	O
.	O
11	O
(	O
1	O
.	O
91	O
–	O
2	O
.	O
44	O
)	O
9	O
.	O
90	O
(	O
9	O
.	O
06	O
–	O
11	O
.	O
39	O
)***	O
1	O
.	O
67	O
(	O
1	O
.	O
51	O
–	O
1	O
.	O
93	O
)	O
nsb	O
3A4AUCmid	O
/	O
AUC1	O
-	O
OH	O
-	O
mid1	O
.	O
55	O
(	O
1	O
.	O
36	O
–	O
2	O
.	O
08	O
)	O
4	O
.	O
44	O
(	O
3	O
.	O
92	O
–	O
5	O
.	O
67	O
)***	O
3	O
.	O
89	O
(	O
3	O
.	O
30	O
–	O
7	O
.	O
87	O
)**	O
a	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
21	O
.	O
31	O
(	O
1	O
.	O
16	O
–	O
1	O
.	O
77	O
)	O
3	O
.	O
46	O
(	O
3	O
.	O
10	O
–	O
4	O
.	O
29	O
)***	O
1	O
.	O
73	O
(	O
1	O
.	O
54	O
–	O
2	O
.	O
11	O
)	O
nsa	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
41	O
.	O
51	O
(	O
1	O
.	O
33	O
–	O
1	O
.	O
97	O
)	O
3	O
.	O
81	O
(	O
3	O
.	O
43	O
–	O
4	O
.	O
58	O
)	O
ntna	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
61	O
.	O
64	O
(	O
1	O
.	O
35	O
–	O
2	O
.	O
31	O
)	O
c	O
4	O
.	O
50	O
(	O
3	O
.	O
94	O
–	O
5	O
.	O
60	O
)	O
nta	O
na	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
8nanana3A4	O
deglucAUCmid	O
/	O
AUCOH	O
-	O
mid	O
tot0	O
.	O
16	O
(	O
0	O
.	O
14	O
–	O
0	O
.	O
21	O
)	O
0	O
.	O
61	O
(	O
0	O
.	O
54	O
–	O
0	O
.	O
79	O
)***	O
0	O
.	O
04	O
(	O
0	O
.	O
03	O
–	O
0	O
.	O
05	O
)***	O
a	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot20	O
.	O
17	O
(	O
0	O
.	O
15	O
–	O
0	O
.	O
25	O
)	O
0	O
.	O
64	O
(	O
0	O
.	O
56	O
–	O
0	O
.	O
85	O
)***	O
0	O
.	O
06	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
08	O
)***	O
a	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot40	O
.	O
20	O
(	O
0	O
.	O
18	O
–	O
0	O
.	O
27	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
59	O
–	O
0	O
.	O
86	O
)***	O
0	O
.	O
14	O
(	O
0	O
.	O
06	O
–	O
0	O
.	O
23	O
)	O
nsh	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot60	O
.	O
18	O
(	O
0	O
.	O
15	O
–	O
0	O
.	O
26	O
)	O
0	O
.	O
65	O
(	O
0	O
.	O
59	O
–	O
0	O
.	O
78	O
)	O
nta	O
na	O
[	O
mid	O
]/[	O
OH	O
-	O
mid	O
]	O
tot8nananaData	O
are	O
presented	O
as	O
geometric	O
mean	O
ratios	O
with	O
90	O
%	O
confidence	O
intervals	O
AUC	O
area	O
under	O
plasma	O
concentration	O
-	O
time	O
curve	O
from	O
time	O
0	O
to	O
last	O
measurable	O
concentration	O
,	O
AUC	O
24	O
area	O
under	O
the	O
plasma	O
concentration	O
-	O
time	O
curve	O
from	O
time	O
0	O
to	O
24	O
h	O
,	O
caf	O
caffeine	O
,	O
E3174	O
losartan	O
carboxylic	O
acid	O
,	O
efa	O
efavirenz	O
,	O
los	O
losartan	O
,	O
met	O
metoprolol	O
,	O
mid	O
midazolam	O
,	O
na	O
not	O
available	O
,	O
ns	O
not	O
significant	O
,	O
nt	O
not	O
tested	O
,	O
OH	O
-	O
efa	O
8	O
-	O
hydroxyefavirenz	O
,	O
OH	O
-	O
mid	O
1	O
′-	O
hydroxymidazolam	O
,	O
OH	O
-	O
mid	O
tot	O
total	O
1	O
′-	O
hydroxymidazolam	O
concentration	O
after	O
deglucuronidation	O
,	O
OH	O
-	O
met	O
α	O
-	O
hydroxymetoprolol	O
,	O
OH	O
-	O
ome	O
5	O
-	O
hydroxyomeprazole	O
,	O
par	O
paraxanthine	O
*	O
p	O
<	O
0	O
.	O
025	O
;	O
**	O
p	O
<	O
0	O
.	O
01	O
;	O
***	O
p	O
<	O
0	O
.	O
001	O
(	O
Wilcoxon	O
signed	O
rank	O
test	O
)	O
N	O
=	O
16	O
unless	O
indicated	O
otherwise	O
:	O
a	O
n	O
=	O
15	O
;	O
b	O
n	O
=	O
14	O
;	O
c	O
n	O
=	O
13	O
;	O
d	O
n	O
=	O
10	O
;	O
e	O
n	O
=	O
8	O
;	O
f	O
n	O
=	O
7	O
;	O
g	O
n	O
=	O
6	O
;	O
h	O
n	O
=	O
3	O

The	O
remaining	O
60	O
%	O
was	O
used	O
to	O
optimize	O
SHAPRs	B-BT
model	O
weights	O
during	O
training	O
.	O

There	O
is	O
no	O
obvious	O
magma	O
chamber	O
in	O
the	O
shallow	O
crust	O
of	O
LGV	O
.	O

This	O
natural	O
‘	O
study	O
-	O
model	O
-	O
test	O
’	O
hierarchy	O
implies	O
a	O
universal	O
data	O
model	O
applicable	O
to	O
all	O
omic	O
analyses	O
and	O
it	O
is	O
therefore	O
employed	O
within	O
OmicNavigator	B-BT
(	O
Additional	O
file	O
2	O
:	O
Figs	O
.	O

While	O
MarRef	O
is	O
thoroughly	O
curated	O
,	O
MarDB	O
and	O
MarCat	B-BT
are	O
only	O
partly	O
curated	O
.	O

Text	O
similarity	O
(	O
eTBlast	B-BT
)	O
identifies	O
20	O
,	O
857	O
abstracts	O
similar	O
to	O
at	O
least	O
one	O
other	O
conference	O
or	O
published	O
abstract	O
.	O

This	O
is	O
similar	O
to	O
the	O
results	O
of	O
recent	O
MT	O
surveys	O
conducted	O
on	O
two	O
volcanoes	O
(	O
Kuju	O
volcanoes	O
,	O
and	O
Unzen	O
volcano	O
)	O
in	O
Japan	O
,	O
where	O
magma	O
can	O
migrate	O
along	O
structural	O
boundaries	O
within	O
a	O
relatively	O
high	O
permeability	O
zone24	O
,	O
31	O
.	O

